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ABSTRACT 
Twenty-nine heteroaromatic ligands, which are potentially capable of forming 
cyclometallated complexes, have been reacted with palladium and rhodium salts. In 
addition to a number of mono-cyclometallated complexes, two doubly cyclopalladated 
complexes have been prepared, as have a number of coordination complexes. 
Specifically, a number of phenoxy- and phenylthio-substituted pyridines and 
diazines, four of which could potentially be doubly cyclometallated, have been 
synthesised, and their coordination and cyclopalladation chemistry investigated. The 
previously reported reactions of 2~benzoylpyridine with rhodium trichloride trihydrate 
have been revisited, and are discussed in relation to the formation and characterisation 
of a novel cyclorhodated complex of the ligand. The syntheses-via homo-coupling 
· reactions of aryl halide precursors-and cyclopalladations of two structural analogues 
of 2,2':4',4":2",2"'-quaterpyridine are also described. 
All of the soluble complexes and ligands have been fully characterised by 1 H 
and Be NMR, using combinations of various one- and two-dimensional NMR 
techniques. The trends in the coordination induced shifts, observed for the NMR 
spectra of a series of cyclopalladated acetylacetonate complexes and the corresponding 
free ligands, are discussed, as are those for a related series of octahedral cyclorhodated 
complexes. Other methods, including IR spectroscopy, mass spectrometry and 
elemental analysis, have been used to characterise the prepared complexes. In addition, 
the characterisation of three cyclometallated complexes and four coordination 
complexes, by single crystal X ~ray structure determination, is described. 
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Introduction 
INTRODUCTION 
Cyclometallated complexes (also called organometallic intramolecular-
coordination complexes) are defined as those complexes in which a ligand has 
undergone "an intramolecular metallation with the formation of a chelate ring 
containing a metal-carbon cr bond" .1 Thus, cyclometallated complexes incorporate 
multidentate ligands in which one of the coordinating atoms is carbon, and may be 
conveniently represented by a general structure (figure 1).2 
Figure 1 
Such complexes were first described as "Metallorganische Innerkomplexe" by 
Bahr and Muller in 19553 and are characterised by the presence of a Y-M-C cyclic 
system in which Y represents a coordinating donor (Lewis base) that is directly 
connected by the ligand structure to the metallated carbon atom. Given that this cyclic 
system includes a donor-metal bond-characteristic of coordination complexes-and a 
carbon-metal bond-characteristic of organometallic complexes-cyclometallated 
complexes, the term introduced by Trofimenko in 1973,4 represent the interface 
between coordination and organometallic chemistry.5 Complexes of this type have 
been the subject of ongoing interest, both from theoretical and applied perspectives, 
many reviewsl,5-19 and a monograph20 having been published. 
For the general structure shown above (figure 1), an individual cyclometallated 
complex can be categorised according to: the type of carbon atom (aliphatic, aromatic 
etc.); the coordinating Lewis base, Y; the choice of metal, M; and the size of the chelate 
ring. Within this classification of cyclometallated complexes is the distinct category of 
orthometallated complexes, named as such because the metallation has occurred 
selectively at the ortho position of an aromatic system (scheme 1). The majority of 
reported cyclometallations are orthometallations,20 and it is such reactions, leading to 
3 
the activation of an aryl carbon-hydrogen bond, which are of prime interest within this 
thesis. 
6' 6' 
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Scheme 1* 
The first orthometallated complex, formed upon reaction of azobenzene and 
nickelocene, was reported in 1963 by Kleiman and Dubeck (scheme 2).21 The position 
of bonding between the phenyl ring and the nickel was reported, on the basis of steric 
considerations, to be ortho to the azo group.21 
r1 Yo 
N~ 
6 
M=PdorPt 
Scheme2 
Ni(cp)2 
L=CN, PPh3 
or i-BuNHz 
Two years later, Cope and Siekman reported that reaction of azobenzene with 
potassium tetrachloroplatinate or palladium dichloride gives chloro-bridged dimeric 
*Note that the numbering of the cyclometallated phenyl ring is the same in the complex as in the 
free ligand. Whilst this leads to non-standard numbering within the complex, this system is adopted 
throughout this thesis to permit easy comparison, when considering NMR spectra, between the spectra of 
equivalent positions in the complexes and the corresponding free ligands. 
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complexes (scheme 2).22 Upon treatment with cyanide, phosphines or amines, these 
compounds do not release the free ligand but give new mononuclear complexes, which 
are cleavage products of the chloro-bridged dimers (scheme 2).22 The authors 
determined the presence of a bond between the metal atom and the ortho carbon of the 
azobenzene ligand by decomposition of the chloro-bridged complexes with lithium 
aluminium deuteride. Hydrolysis of the reaction mixture with D20, followed by 
oxidation with air or mercuric oxide, gave azobenzene which was found to contain 4% 
do, 93% d1 and 3% ch species (scheme 2). Comparison of the lH NMR spectrum of the 
resultant d1-azobenzene with that of an authentic sample of the mono-ortho-deuterated 
compound showed that the two compounds were identical, thus establishing the 
position of metallation. 22 
The coordinating atom, Y, can be either a or rc bonded to the metal centre. In 
. a-coordinated complexes, which are the focus of this thesis, the donor atom represents 
nitrogen, phosphorus, arsenic and antimony in Group VA, oxygen and sulfur in Group 
VIA and chlorine, bromine and iodine in Group VII; however it is usually restricted to 
nitrogen, phosphorus, oxygen and sulfur.20 The cyclometallations described in this 
thesis are of ligands which incorporate a nitrogen-containing heterocycle (figure 2); 
thus the donor atom is limited to nitrogen. 
C£0 M 
Figure 2 
The first report of a cyclometallated complex incorporating a nitrogen-
containing heterocycle was some thirty years ago.23 Kasahara reacted sodium 
tetrachloropalladate with 2-phenylpyridine and with 2-phenylquinoline, and obtained 
the corresponding cyclopalladated chloro-bridged dimers. The position of the 
palladium-carbon bond was confirmed by deuteration experiments, analogous to those 
performed by Cope and Siekman (vide supra). 
Returning to the more general definition of cyclometallated complexes, 
represented by figure 1, two variables remain to be discussed: the nature of the metal, 
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M; and the size of the metallocycle. A variety of metals have been incorporated into 
metallocycles formed either by direct reaction of the ligand with a metal precursor or by 
transmetallation reactions. The majority of reported complexes, however, include the 
middle transition metals, particularly those in Group VIII. Much of the published 
research has been done with palladium and platinum, because of the relative ease with 
which cyclometallation occurs with these metals and the stability of the complexes so 
formed. The work herein described is restricted to complexes in which M = Pd24,25 
or Rh,26,27 that is cyclopalladated and cyclorhodated complexes. The first 
cyclorhodation was reported in 196928 followed, two years later, by the first 
cyclorhodation of a ligand which incorporates a nitrogen-containing heterocycle.29 
Whilst an exhaustive survey of all the other different metals that have been 
incorporated into such complexes is beyond the scope of this introduction, those of 
. particular note include: gold;30 iridium;31 manganese;32 mercury;33 and ruthenium.34 
The ring size of the metallocycle formed upon cyclometallation is dependent on 
the choice of metal and on the structure of the ligand. The formation of five-membered 
metallocycles is most often reported, paralleling the observation that, for coordination 
complexes, ligands which form five-membered chelate rings give the most stable 
products.20 Six-membered metallocycles are the most commonly observed of the other 
ring sizes, but reports of stmctures of this type remain comparatively rare.35 Despite 
this, the metallocyclic ring sizes reported range from three-membered to 
nine-membered.l4,20 
Cyclo- and ortho-metallation reactions result in the selective activation of a 
carbon-hydrogen bond. The complexes are generally produced by a reaction involving 
a two step mechanism (scheme 3).20 The initial step is coordination of the Y donor 
group or atom-for the work described herein this a nitrogen lone pair-and the second 
step is cyclisation via electrophilic attack on the proximately situated carbon atom, with 
concomitant loss of HX to give the coordinatively stable metallocyclic complex. This 
mechanism, initially proposed by Parsha1136 and discussed extensively by Ryabov in his 
review entitled, "Mechanisms of Intramolecular Activation of C-H Bonds in 
6 
Transition-Metal Complexes",9 has recently been supported by the isolation and 
characterisation of all intermediates in the cyclopalladation reaction of chiral 
phosphanes. 37 
N~ I HAJ 
MXm 
Scheme 3 
-HX 
An alternative oxidative addition mechanism, the "nucleophilic pathway", gives 
a product in which the hydrogen from the carbon-hydrogen bond remains coordinated 
to the metal centre, the oxidation number of which increases by two units (scheme 4).9 
This hydrido complex may be isolated, or reductive elimination of HX may ensue 
(scheme 4) to give a final product which is indistinguishable from the complex which 
. forms via the "electrophilic pathway" shown in scheme 3.9 
N~ I HAJ 
MXm 
N(A) 
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H 
Scheme 4 
Given that the product of the reaction is often the same, discriminating between 
the "oxidative addition/reductive elimination" and "electrophilic substitution" or a third 
multicentered pathway is rather complex.9 Given that this research focuses on the 
preparation and characterisation of cyclometallated complexes, further discussion of 
these mechanistic conundra, beyond the assumption that the reactions described herein 
occur via an electrophilic mechanism, falls outside of the scope of this introduction. 
The activation of a carbon-hydrogen bond, often in a site which is hindered to 
other reagents, has led to the widespread application of cyclopalladated complexes, in 
particular, as intermediates in organic synthesis. This topic has been the subject of two 
reviews,5,16 and the applications include: selective deuterations (of the type discussed 
above for structural elucidation); selective halogenation; carbon-carbon bond formation 
via alkene insertion into the palladium-carbon bond; and the preparation of heterocycles 
7 
via insertion of carbon monoxide into the palladium-carbon bond (or by cyclisation of 
the products of the above-mentioned alkene insertions). Examples of these reactions, 
starting from the cyclopalladated azobenzene chloro-bridged dimer, are illustrated in 
scheme 5.2 
rl1 Y'o 
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Scheme 5 
Related reactions, which have been the subject of much recent interest, are the 
insertion of alkynes into the carbon-palladium bond, together with investigation of the 
synthetic applications of the products of these reactions.38 Coordination of chiral 
phosphines to optically active cyclopalladated benzylamines has been used both for 
chiral resolution as well as for NMR-based enantiomeric excess determinations.39 
Cyclometallated complexes can also be used as starting materials for other 
cyclometallated complexes prepared via transmetallation reactions (vide infra). 
Cyclopalladation of 5-phenyl-1,4-benzodiazepin-2-one derivatives-for 
example, the tranquillisers Prazepam and Diazepam (Valium®)-has been used to 
selectively substitute the ortho position of the 5-phenyl group, such substitutions 
leading to improved activity of the drugs. 40 Cyclometallated complexes themselves 
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have been investigated for possible medicinal applications, particularly as potential 
chemotherapeutic anti-tumour agents. Recently, complexes of gold,41 as well as those 
of palladium and platinum,42 have been attracting the most attention. 
Cyclometallated compounds, especially cyclopalladated complexes, have also 
found application in the burgeoning field of materials science where they are of use as: 
building blocks in self-assembly processes;43 metalloreceptors;44 and liquid crystals.45 
In addition to the selective activation of a carbon-hydrogen bond, the effect that 
the formation of a metal-carbon bond has on the properties of the resultant complex, 
relative to complexes of N,N-bidentate analogues, has given rise to much interest in 
cyclometallated complexes. Investigations of cyclometallated complex photochemistry 
and luminescence have been used to probe their electronic properties and such studies 
of the complexes of iridium, osmium, palladium, platinum, rhodium and ruthenium 
have been reviewed.46 
The replacement, in a complex, of N,N-bidentate ligands with cyclometaUated 
analogues leads to higher energy ligand field (d-d) excited states. In addition, the 
strong a-donor properties of these ligands enhances the ease of oxidation at the metal 
centre, thus promoting low energy metal-to-ligand charge-transfer excited states. This 
combination of effects leads to cyclometallated complexes which, relative to their 
N-donor analogues, have light absorption properties and low energy excited states 
well-suited to participation in photo-redox chemistry. Cyclometallated complexes have, 
therefore, potential applications as photosensitisers, possibly in solar energy conversion 
schemes. 47-50 
There are many nitrogen heterocycles which are able to form complexes in 
which two or more metal centres are bridged by a single ligand. 51 Studies of such 
complexes, and their cyclometallated analogues (vide infra), show that interactions 
between the coordinated metals are mediated by the n:-system of the bridging ligand. 
These interactions, such as energy or electron transfer and magnetic coupling, may be 
influenced by altering the intermetal separation and the degree of conjugation between 
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the metal coordination sites within the ligand. Therefore, with the design of appropriate 
multiply cyclometallated ligands, there is the potential to 'tune' the magnitude of 
interaction between the metal centres. The resultant cyclometallated complexes, 
containing several metal atoms linked through a common bridging ligand, have 
potential applications in similar fields to their coordination complex analogues-the 
different electronic features of cyclometallated complexes offering the potential to 
prepare complexes with properties inaccessible through these coordination complexes. 
These applications include: multiple electron transfer catalysis; photosensitisation; and 
as components for molecular devices and low dimensional conducting polymers. 52 
This thesis, therefore, describes the synthesis and characterisation of a number 
of ligands, which are potentially capable of undergoing cyclometallation reactions, and 
their cyclo-rhodated and -palladated complexes, incorporating structural features 
. described above. The ligands included in this study all incorporate nitrogen-containing 
heterocycles as the donor moiety and a number are potentially capable of giving doubly 
cyclometallated products. 
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Chapter One 
Ligands Containing 
Five-membered Heterocycles 
and 
On Cyclometallation Site 
1.1 INTRODUCTION 
This chapter describes the reactions of ligands in which the donor group is a 
nitrogen atom within a five-membered heterocycle. The ligands discussed include 
those with two heteroatoms, their benzo-fused analogues and one with three 
heteroatoms. Whilst the cyclopalladation of a number of the ligands discussed in this 
chapter have been previously reported, the cyclorhodations herein described, and the 
subsequent ligand exchange reactions, all yield previously unknown complexes. The 
previously unexplored coordination chemistry and attempted cyclometallations of three 
phenyloxazoles are reported, as is the preparation of a complex in which the oxazole is 
mercurated. 
1.2 FIVE-MEMBERED HETEROCYCLES WITH TWO 
· HETEROATOMS 
101 
Initial investigation of the cyclometallation of the commercially available ligand 
2-phenylimidazoline (101) was concerned with its possible cyclorhodation. Reaction of 
this ligand with rhodium trichloride trihydrate in 2-methoxyethanol was unsuccessful, 
giving an insoluble black precipitate, so the reaction was repeated with ethanol as 
solvent. This gave a heterogeneous mixture of yellow, brown and black solids. 
Reaction of this product with sodium acetylacetonate gave an off-white solid, which 
was insoluble in common NMR solvents and remains uncharacterised. 
In 1996 a paper detailing the coordination chemistry of 101 with palladium(II) 
and platinum(II)-including its cyclo-palladation and -platination-was published.53 
The only mononuclear complex described was the coordination complex 102, whilst the 
cyclopalladated complexes described, the acetate-bridged complex 103 and the 
chloro-bridged complex 104, are dimeric. Both of these cyclopalladated complexes 
11 
were prepared by direct reaction of the ligand with the appropriate palladium(II) salt or 
by reaction of 102 with silver acetate to give 103 which was then converted to 104 by 
acetate-chloride metathesis (scheme 1.1). 
The reaction of palladium acetate and the ligand in acetic acid and subsequent 
conversion of the resultant acetate-bridged dimer, 103, to the corresponding 
chloro-bridged complex, was reported to give 104 in 24% yield (based on palladium). 53 
The reaction of palladium acetate and 101 was repeated in benzene as these conditions 
have been found, during the course of this work, to give cyclopalladated complexes of 
several ligands which could not be obtained by such reaction in acetic acid (vide infra). 
H 
I 
C~>-0 
101 
102 
Pd(OAc)2 
H 
104 I NaCI OR LiCI 
,H (:-9 
Pd 
/ ' 0 0 
-4: }-
o, /0 
Pd'-0--f~J 
H 
103 
Scheme 1.1 
,H 6' 5' 
c;:-P 
Pd 
/ " 0 0 
~ 
105 
This reaction, followed by acetate-chloride metathesis with lithium chloride, gave 104 
in comparable (28%) yield. The resonances in the lH NMR spectrum of 103--a sample 
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of which was isolated as an intermediate in this preparation-had chemical shifts in 
agreement with those reported. 53 The chloro-bridged dimer, 104, was not characterised 
but was subjected to ligand exchange with thallium acetylacetonate to give the desired, 
mononuclear complex, 105 (scheme 1.1) in 8% overall yield (based on palladium). 
The previously unreported acetylacetonate complex, 105, was completely 
characterised by microanalysis and 1 H and 13C NMR spectroscopy. The resonances for 
H-5' and H-6' overlap and their chemical shifts could not, therefore, be separated. The 
chemical shifts for C-5' (123.58 ppm) and C-6' (123.25 ppm) were assigned on the basis 
of the observation that, in the spectra of all the reported complexes of 101, the chemical 
shift for C-5' is always slightly upfield relative to that for C-6'.53 
The cyclopalladation-and subsequent conversion of the chloro-bridged dimer 
to the mononuclear acetylacetonate complex-of 2-phenylbenzoxazole has been 
previously reported. 54 This extended the work on the cyclopalladations of such ligands, 
the first such report-concerning the reactions of 2-p-tolylbenzoxazole and its 
6-methylated analogue (106) with palladium acetate-having been published in 1980.55 
Moreover, the synthesis and NMR structural analysis of several cyclopalladated 
complexes of 2-phenylbenzoxazole have recently been published, 56 demonstrating the 
continuing interest in the cyclopalladated complexes of such ligands. 
"0=~>-0-
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In addition to the published work on phenylbenzoxazoles discussed above, the 
cyclometa11ation chemistry of alkyl- and aryl-2-oxazolines has also been the subject of 
continuing attention in the literature. Reaction of 2-t-butyl-4,4-dimethyl-2-oxazoline 
with palladium acetate gives dimeric and trinuclear complexes in which the oxazoline 
nitrogen directs palladation of one of the methyl groups of the t-butyl substituent.57 
Similarly, 4,4-dimethyl-2-phenyloxazoline (107) and a number of its phenyl-substituted 
derivatives have been cyclopalladated by direct reaction with palladium acetate. 58 The 
acetate bridged dimers formed in these reactions have been reacted with carbon 
13 
monoxide to give diarylketones58 and with alkyl halides to give regioselectively 
ortho~alkylated derivatives. 59 
107 
Related 4,4-dimethyl~2-phenyloxazolines have also been ortho-lithiated-the 
lithiation being directed by the oxazoline heteroatoms-and these species 
transmetallated to give the ortho~cuprated complexes60 which, in turn, can be used to 
prepare the ortho-stannylated analogues.61 Such ortho-stannylated and 
ortho-mercurated derivatives can also be prepared by transmetallation of the 
ortho-lithiated species or, in the case of the latter, by direct reaction of the ligand with 
mercury(II) acetate. 62 Transmetallation of the ortho-mercurated 4,4-dimethyl-
. 2-phenyloxazolines so prepared, with tetramethylammonium tetrachloroaurate(III), has 
been shown to give cycloaurated analogues of the cyclopalladated complexes discussed 
above.30a 
Given the considerable interest in the cyclometallation chemistry of both 
phenylbenzoxazoles and phenyloxazolines, it is surprising that there are not more 
investigations of the coordination chemistry of phenyloxazoles reported in the literature. 
A literature search revealed that 2,5-diphenyloxazole (108) is the only ligand of this 
type for which there have been any such reports. In 1973, Cockburn et al. reported that 
the treatment of 108 with sodium tetrachloropalladate gives the mononuclear 
coordination complex, trans-Pd(108)2Cb.63 A subsequent account of the reactions of 
108 with palladium(II) and platinum(II) came to the conclusion that the ligand, 
"behaves generally as monodentate N-bonded with the exception of MLX2" and, 
furthermore, "In these MLX2 complexes the 2,5-diphenyloxazole acts as a bridging 
ligand". 64 The authors noted that this coordination behaviour is similar to that found 
for 3,5-diphenylisoxazole, the structural analogue of 108.65 The only reported 
cyclometallated complex containing an oxazole ring as the non-carbon donor is 
obtained upon the reaction of 108 with pentacarbonylmethylmanganese.66 
14 
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Consideration of phenyloxazoles, other than 108, which have the nitrogen donor 
atom in the necessary position to direct metallation of the phenyl ring gives 
2-phenyloxazole (109) and 4-phenyloxazole (110) as ligands which might be 
cyc1ometa11ated. The ligand 2,4-diphenyloxazole (111), would offer the opportunity to 
further investigate the subtleties of regioselection in the cyclometallation reaction. The 
two stereochemically and electronically inequivalent phenyl rings in this ligand are both 
suitably positioned for cyclometallation with respect to the nitrogen atom and the 
preferential cyclometallation of one of these would give useful information in this 
. respect. 
109 110 111 
A search of the literature showed that the three oxazoles above are well-known, 
with relatively straightforward preparations. The serendipitous preparation of 
2-(ortho-nitrophenyl)-oxazole, its hydrogenation and subsequent deamination-via the 
diazonium derivative-gave 109 in reasonable yield, this being the first reported 
synthesis of this oxazole.67 Seeking a more convenient synthesis led to a paper in 
which the preparation of 109 by the condensation of vinylene carbonate and benzamide 
is described.68 This reaction was repeated, the crude oxazole obtained from the 
reaction mixture being characterised by 1 H and 13C NMR spectroscopy69-72 and used 
without further purification. 
The isomeric phenyloxazole, 110, was prepared from 2-bromoacetophenone and 
ammonium formate according to the literature procedure. 73 The oxazole was purified 
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by distillation under reduced pressure and characterised by 1 H and 13C NMR 
spectroscopy. 69 '7 4 
The first reported synthesis of 111, from 2-bromoacetophenone and benzamide, 
was in 1884 and this remains the most convenient preparation of this compound.75 
Rather than distill the crude compound, as in the above mentioned report, it was found 
that purification was more conveniently achieved by recrystallisation from ethanol70 
and the resultant white crystalline solid was fully characterised. 
Investigation of the coordination chemistry of these three oxazoles began with 
their reactions with lithium tetrachloropalladate. For 109 and 110 the reactions gave the 
yellow coordination complexes, Pd(109)2Clz and Pd(110)2Cl2 (112 and 113, 
respectively) (scheme 1.2). These complexes are analogues of trans-Pd(108)2Cl2, 
which is the product of a similar reaction with the diphenyloxazole 108 (vide supra). 
The complexes are assigned the trans stereochemistry on the basis of the reported 
stereochemistry of this analogous complex and the observation that, in the 1 H and Be 
NMR spectra of each complex, the two ligands are equivalent. It is interesting to note 
that whilst 109 is quite soluble in chloroform, 110 is only sparingly soluble in this 
solvent but dissolves readily in DMSO. 
109 R2=Ph, R4=H 
110 R2=H, R4=Ph 
Scheme 1.2 
112 R2=Ph, R4=H 
113 R2=H, R4=Ph 
Reaction of 111 with lithium tetrachloropalladate gave a yellow solid which is 
sparingly soluble in chloroform. Examination of the FAB mass spectrum shows a peak 
corresponding to Pd(111)2Cl+, presumably formed via loss of a chloride ion from the 
coordination complex, Pd(111)2Clz. Acquisition of a lH NMR spectrum in CDCI3 
showed that the product appears to be a mixture of two complexes in an approximate 
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one:two ratio, the relative composition of which remains unchanged after several days 
in solution. The spectrum clearly shows two pairs of doublets* which can be assigned 
to the resonances due to the ortho protons, indicating that each of the ligands in the two 
complexes is unmetallated. The appearance of the spectrum changes very little with 
increasing temperature, suggesting that any dynamic process leading to interchange 
between the complexes is slow on the NMR time-scale, and that the temperature limit 
of the spectrometer is somewhat below the coalescence temperature. The two 
complexes are thought to be syn and anti rotamers which are in equilibrium, but 
interconvert relatively slowly, due to the steric interaction between ligands upon 
rotation about the palladium-nitrogen bond (scheme 1.3). This contrasts with the 
observed temperature dependence of the NMR spectra of related palladium coordination 
complexes for which the syn and anti rotamers interconvert more rapidly (vide infra). 
?2 ~ ,1 
06'\N Pd''-;j'''~'l 0 ""' .-::: 
;:--
~ /, 
SYN ANTI 
Scheme 1.3 
Having established that reaction with lithium tetrachloropalladate does not lead 
to cyclopalladation of the three phenyloxazoles, their reactions with palladium acetate 
were investigated. These reactions were performed in a variety of solvents, both at 
room temperature and under reflux, and were not successful. Similarly, reaction with 
rhodium trichloride failed to give cyclorhodated complexes. In the reactions of 110 and 
111, apparent reduction of the rhodium(III) to rhodium metal-indicated by the 
formation of a tenacious, silvery mirror on the inside of the reaction flask-was 
observed. 
* Throughout this thesis, resonances in 1 H NMR spectra are described according to their first 
order couplings only. The ID-TOCSY experiment, which pennits the isolation of individual spin 
systems within a given molecule has rendered the consideration of longer range couplings largely 
unnecessary. 
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In 1982, Wardell wrote; "Transfer of organic groups from mercury to other 
metals is a well established and indeed a classic synthetic route to organometallics."76 
This same route, namely the formation of organomercurials and their subsequent 
reaction (transmetallation) with labile transition metal compounds, has been used to 
prepare, for example: cyclo-aurated;30a,77,78 -palladated;79-81 -rhodated;82,83 and 
-ruthenated80 complexes, some of which are otherwise inaccessible. This method 
seemed to offer an attractive route to the preparation of cyclometallated phenyloxazoles, 
given that it had been established that such complexes could not be prepared directly. 
Attempted mercuration of 109 or 110 with mercuric acetate in refluxing 
ethanot84 was unsuccessful. Instead, apparent reduction of the mercury(II) to elemental 
mercury, with the formation of a small amount of motile, grey liquid phase, was 
observed-the small quantity of precipitate formed being insoluble in common NMR 
. solvents. 
N 
oHQ Hg(OAc)2 
111 
Scheme 1.4 
0 
N=( ryyo 
Hg 
I 
OAc 
114 
In contrast, reaction of 111 under the same conditions gave a pale yellow 
precipitate which is soluble in both chloroform and DMSO. The 1 H and 13c NMR 
spectra of this solid have resonances characteristic of the acetate ligand and its presence 
was confirmed with the recording of an IR spectrum. The NMR spectra, however, 
show signals which can be assigned to resonances from two inequivalent, 
monosubstituted phenyl rings and this clearly demonstrates that the complex was not 
cyclometallated. The 1 H NMR spectrum of the free ligand exhibits a singlet resonance 
assigned to the signal from the sole proton, attached to C-5, on the oxazole ring, whilst 
the spectrum of the complex has no such resonance. Microanalysis of the solid returned 
the stoichiometry Hg(111-H)(OAc), and the structure of this complex is, therefore, 
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assumed to be 114, which forms via an oxygen-directed mercuration of the oxazole ring 
at C-5 (scheme 1.4). 
The cyclopalladation of 2-phenylthiazole (115), the sulfur analogue of 109, with 
palladium acetate has previously been reported. 85 This paper also reported the 
conversion of the resultant acetate-bridged dimer into a number of mononuclear 
derivatives, including the palladium acetylacetonate complex which has subsequently 
been fully characterised by 1 H and 13C NMR. 54 
115 
Whilst there are no literature reports of 115 having been cyclorhodated, the 
thiazole ring has been used to provide the nitrogen donor atom in a number of 
analogous complexes in which an imine-as opposed to an arene --carbon-hydrogen 
bond has been activated. Reaction, in THF, of suitable rhodium(!) reagents with 
2-benzylideneaminothiazole and excess triphenylphosphine gives the cyclometallated 
rhodium(III) complex in which the imine C-H has undergone oxidative addition to the 
metal (scheme 1.5). 86 Repeating this reaction with a variety of phenyl-substituted 
analogues of this ligand gave a number of related cyclorhodated complexes. 
[RhCI(COD)]2 OR 
[RhCI(PPh3)s] 
Scheme 1.5 
Reaction of 115 with rhodium trichloride gave a chloro~bridged dimer, which 
was characterised by lH NMR spectroscopy and microanalysis, the latter because the 
· dimer was recrystallised prior to its use in ligand exchange reactions. Attempted ligand 
exchange reactions with sodium B-diketonates in methanol failed to give the desired 
mononuclear complexes in sufficient yield to permit their complete characterisation, the 
reaction with sodium benzoylacetonate not yielding any product at all. The ligand 
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exchange reactions were repeated using thallium acetylacetonate and thallium 
dibenzoylmethanate to give the desired mononuclear complexes, Rh(l15-H)2(acac) and 
Rh(l15-H)2(dbm) (1150\l(scheme 1.6), as crystalline solids in adequate yield. These 
complexes were fully characterised by 1 H and 13C NMR spectroscopy and 
microanalysis. 
115 
(i) RhCI3.SH20 
(ii) Tl(dbm) 
Scheme 1.6 
Whilst the 1 H NMR spectra of these two complexes are relatively 
straightforward, their assignment provides a typical illustration of the use of 
homonuclear irradiation (selective proton decoupling) experiments. For example, the 
lH NMR spectrum of 115q(figure l.la) has all the signals of interest within the range of 
chemical shifts; 6.2 < 8 < 8.0 ppm. In the assignment of this spectrum, the only 
difficulty is in the assignment of the resonances corresponding to the cyclometallated 
phenyl ring. Specifically, whilst on the basis of chemical shift the doublet at 6.41 ppm 
can be assigned as being from H-3' on this ring and the doublet at 7.52 ppm as being 
from H-6', assignment of the triplets at 6.85 ppm and 6.92 ppm-which correspond to 
H-4' and H-5'-is not possible from this spectrum alone. Figure l.lb shows the 
spectrum resulting from homonuclear decoupling of the doublet at 6.41 ppm (H-3'). 
The triplet at 6.85 ppm collapses to a doublet whilst the long range coupling is lost from 
the triplet at 6.92 ppm, thereby identifying these signals as being due to a proton ortho 
and nteta to that being irradiated; that is H-4' and H-5' respectively, and thus completing 
the assignment of the 1 H NMR spectrum. 
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1.3 BENZO-FUSED FIVE-MEMBERED HETEROCYCLES 
WITH TWO HETEROATOMS 
cN-o 
116 
The metallation chemistry of 1-phenylpyrazole (116) has been extensively 
investigated.4,36,54,66,85,87-99 The first account of the metallation of 116 was in 1958 
when the reaction of the ligand with n-butyllithium was reported.8 7 The 
cyclopalladation of 116 was cited as a private communication in 1970,36 the reactions 
with palladium(Il) being fully reported three years later.4 Ever since these first reports, 
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there has been on-going interest in the cyclometallated complexes of 116 and the ligand 
has-in addition to palladium54,88,89_been directed cyclometallated with: 
chromium;90 cobalt;90 iridium;91 manganese;66 mercury;85 platinum;88 rhodium;92-94 
and ruthenium.95 
Reaction of 116 with rhodium trichloride trihydrate gives a chloro-bridged, 
cyclorhodated dimer.91 This complex has been crystallographically characterised94 and 
converted into corresponding mononuclear rhodium B-diketonate complexes.96 In 
addition, the ortho-lithiated species has been used to prepare the bis-ligand, homoleptic 
cyclometallated complex with platinum.97,98 Also, analogous tris-ligand homoleptic 
complexes have been prepared from reaction of the corresponding Grignard reagent 
with cobalt, chromium, nickel, titanium or vanadium precursors.99 
In contrast to the many reports of the cyclometallation chemistry of 116, there is 
only one paper in the literature which reports the cyclometallation of its benzo-fused 
analogue, 2-phenylindazole (117), with palladium.89 Given the ease with which 116 is 
cyclorhodated, it was thought that the reaction of 117 with rhodium trichloride 
warranted investigation. 
CCN-o 
117 
Reaction of 117 with rhodium trichloride trihydrate gives a cyclorhodated, 
chloro-bridged dimer, [Rh(117-H)2Clh, in good yield. This pale yellow solid was 
characterised by lH NMR spectroscopy. The ligand exchange reactions of this complex 
with sodium B-diketonates were straightforward and gave the corresponding 
mononuclear rhodium B-diketonate complexes-Rh(117-H)2(acac) (118); 
Rh(117-H)2(dbm) (119); and Rh(117-H)2(bac) (120)-in good to excellent yields 
(scheme 1.7). All of these rhodium B-diketonate complexes were fully characterised by 
1 H and 13C NMR spectroscopy and, following recrystallisation, by microanalysis. 
22 
5 004 3 -o6' 5' {i) RhCI3.3H20 
N 4' N ~ b (ii) Na(B-diketonate) 
6 7 2' 3' 
117 
Scheme 1.7 
118 R=R'=CH3 
119 R=R'=C6Hs 
120 R=CH3, R'=C6Hs 
The assignment of the lH NMR spectrum of the acetylacetonate complex, 118, 
is complicated by the overlap of the resonances for H-6 and H-6' and those for H-4 and 
H-7. The signals in the corresponding 13C NMR spectrum, however, are well-separated 
and the acquisition of a heteronuclear multiple quantum coherence (HMQC) spectrum, 
combined with the use of selective proton decoupling experiments, enabled the full 
assignment of all signals in the NMR spectra. 
The resonances due to the cyclorhodated 2-phenylindazole ligands in the lH 
NMR spectrum of the corresponding dibenzoylmethanate complex, 119 (figure 1.2), 
have chemical shifts similar to those in the spectrum of 118. Assignment of these, 
however, is hampered by the positions of the resonances due to the aromatic protons of 
the dibenzoylmethanate ligand. All three of these resonances, together with seven of 
the nine due to the cyclorhodated 2-phenylindazole ligands, have chemical shifts within 
the range 6.6 < o < 7.8 ppm. Despite the proximity of the signals, a tentative 
assignment based on chemical shift and spin-spin coupling information is possible. The 
13C NMR spectrum of this complex has all twelve aromatic protonated carbons 
separated by at least 0.3 ppm, their chemical shifts within the range 112 < o < 136 ppm. 
Again, tentative assignment of many of these signals is possible, based on the 
information provided by their chemical shifts. The HMQC spectrum (figure 1.3) of the 
aromatic regions clearly shows all expected correlations and can be used to confirm 
unambiguously the tentative assignments of both the lH and 13C NMR spectra. 
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Figure 1.3 HMQC spectrum of 119 showing the twelve expected correlations. 
Reaction of 116 with rhodium trichloride trihydrate gives a chloro-bridged, 
cyclorhodated dimer, [Rh(116-H)2C1]2.92,94 Of the two likely isomers that might be 
formed in the reaction-the racemic diastereoisomer (Dz symmetry) or the meso 
diastereoisomer (Czh symmetry)-the structure of the complex was crystallographically 
determined to be the racem,ic isomer.94 The formation of this isomer was attributed to 
steric factors, as molecular models indicated that the meso diastereoisomer would have 
strong steric interactions between the protons on C-3 of the mirror related pyrazoles.94 
Attachment of a benzo moiety to the pyrazole rings of [Rh(116-H)2Cl]z to form the 
indazole rings of [Rh(117-H)2Cl]z would considerably increase the steric interactions 
between the mirror related N-donor rings, thereby further disfavouring formation of the 
meso diastereoisomer. Hence it is assumed that, in the case of 117 and, indeed, all other 
ligands in this work, steric reasons dictate that the chloro-bridged rhodium dimer 
obtained upon reaction with rhodium trichloride trihydrate has the structure of the 
racemic diastereoisomer. 
Preparation of 118 and 119, by ligand exchange from [Rh(117-H)2Cl]z with the 
symmetrical acetylacetonate or dibenzoylmethanate anions, gives mononuclear 
complexes with Cz symmetry. Both cyclorhodated ligands within such complexes are 
equivalent, and this is reflected in their NMR spectra. However, upon exchange with 
the unsymmetrical benzoylacetonate anion, the resultant mononuclear complex, 120, 
has a structure which has no symmetry elements. Therefore, the two cyclorhodated 
ligands within this complex are inequivalent, one being coordinated trans to the phenyl 
ring of the chelated benzoylacetonate ligand, the other trans to the methyl group. 
In principle, each of the atoms in analogous positions in the two different 
cyclorhodated ligands of 120, and, indeed, any such rhodium benzoylacetonate 
complex, should have different chemical shifts in the I H and 13C NMR spectra. In 
practice, however, the difference in the magnetic environments of such atoms may be 
relatively minor and their observed chemical shifts accidentally equivalent. Hence, not 
all signals in the lH and Be NMR spectra of 120 (figures 1.4 and 1.5 respectively) are 
resonances for individual atoms with different chemical shifts, 
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Figure 1.5 Partial 13C NMR spectrum of 120 
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some arise from the resonances of several atoms and individual chemical shifts cannot, 
therefore, be assigned. This often means that within such a complex, a given signal can 
only be assigned to a specific position in one or other of the two ligands but not to a 
specific ligand. When reporting the spectra of these complexes, for the purposes of 
distinguishing between the resonances arising from atoms in analogous positions in 
each of the two different cyclorhodated ligands, the assignments are arbitrarily assigned 
the subscripts "a" and "b". For example, H-3'a and H-3'b refer to protons in the same 
position-adjacent to the rhodium-carbon bonds-on each of the two cyclorhodated 
ligands. It is important to understand that these subscripts, being arbitrarily assigned, 
have no geometrical basis and are merely a convenient method for reporting the spectra, 
whilst indicating the presence of signals arising from analogous positions in two 
inequivalent cyclorhodated ligands within the same complex . 
Whilst the phenyloxazoles 109, 110 and 111 could not be cyclometallated, the 
cyclopalladation of the benzo-fused analogue, 2-phenylbenzoxazole (121), has been 
previously reported. 54,56 Reaction of this ligand with rhodium trichloride trihydrate in 
refluxing 2-methoxyethanol gives, in 72% yield, a chloro-bridged dimer, 
[Rh(121-H)2Cl]2 (122), as a light brown solid, which was characterised by lH NMR 
spectroscopy (scheme 1.8). 
~o,~ 
~N~ 
121 
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The 1 H NMR spectrum of 122 (figure 1.6) unequivocally confirms the 
cyclorhodated structure of the complex. The spectrum has all eight expected 
resonances-four each due to the cyclometallated phenyl ring and the benzoxazole 
moiety of the ligand-within the aromatic region. The doublets at 6.22 ppm and 8.24 
ppm are assigned to the signals due to H-3' and H-4 respectively, on the basis of 
chemical shift. H-3' has a coordination induced shift (CIS) of -1.33 ppm relative to the 
free ligand, due to the shielding ring current of the cyclometallated ring of the other 
ligand. H-4, however, has a CIS of 0.45 ppm as it lies above a chlorine atom and is 
consequently deshielded relative to its environment in the free ligand. Given this, 
assignment of the remaining resonances, using selective proton decoupling or 
2D-correlation spectroscopy (COSY) experiments, is straightforward. 
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Figure 1.6 1 H NMR spectrum of 122 
Ligand exchange reactions of this complex with the appropriate sodium 
B-diketonate gave the corresponding mononuclear complexes-Rh(121-H)2(acac) 
(123); Rh(121-H)2(dbm) (124); and Rh(121-H)2(bac) (125)-as yellow powders in 
excellent yield (scheme 1.8). The crude powders showed some contamination by the 
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chloro-bridged dimer, 122; however, after recrystallisation, these three rhodium 
B-diketonate complexes were fully characterised by microanalysis and 1 H and 13C 
NMR spectroscopy. 
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The cyclopalladation of 2-phenylbenzothiazole (126), the sulfur analogue of 
121, has previously been reported.54,56 The preparation of the mononuclear 
acetylacetonate complex, Pd(126-H)(acac), has also been reported together with the lH 
and 13C NMR spectra of the complex.54 In addition, the related ligand 
2-p-tolylbenzothiazole has also been cyclopalladated,55 as has 2-benzylbenzothiazole, 
the latter giving rise to complexes which incorporate a six-membered palladacycle.lOO 
126 
Upon reaction with rhodium trichloride trihydrate, 126 gives a chloro-bridged 
dimer, [Rh(l26-H)2Cl]2, as a brown powder in poor yield. All attempts to convert this 
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dimeric complex into mononuclear complexes by ligand exchange with B-diketonates 
gave solids which are insoluble in chloroform and, as such, were not characterised. 
1.4 FIVE-MEMBERED HETEROCYCLES WITH THREE 
HETEROATOMS 
The first reported cyclometallation of 2-phenyl-1 ,2,3-triazole (127) was in 1975 
when Allison et al. reported the reaction of this ligand-and several methyl- and 
phenyl-substituted derivatives-with lithium tetrachloropalladate.lOl The resultant 
chloro-bridged dimers were used to prepare selectively ortho-chlorinated derivatives of 
the 2-phenyl-1 ,2,3-triazoles .1 01 Subsequently the mononuclear palladium 
acety lace to nate complex of 127 was prepared from the corresponding chloro-bridged 
dimer and the complex characterised by lH and Be NMR.54 
Reaction of 12 7 with rhodium trichloride trihydrate in refluxing 
2-methoxyethanol gave a white powder, formulated as a chloro-bridged dimer, 
[Rh(l27-H)2Clh, in excellent yield. This complex was characterised by lH NMR 
spectroscopy, the resonance at 6.13 ppm, assigned to the signal due to H-3', being 
significantly broadened. Ligand exchange of this complex with sodium B-diketonates 
gave the corresponding mononuclear complexes-Rh(127 -Hh(acac) (128); 
Rh(127-Hh(dbm) (129); and Rh(127-H)2(bac) (130)-as white powders, in excellent 
yields (scheme 1.9). Diffusion of pentane vapour into chloroform solutions of the crude 
powders gave the complexes as analytically pure, pale yellow crystals. In addition to 
microanalysis, the complexes were fully characterised by 1 H and 13C NMR 
spectroscopy. 
Whilst assignment of the NMR spectra for all of the cyclorhodated complexes 
was straightforward, the chemical shifts of the protons on the triazole ring in each of the 
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complexes are noteworthy. Because of the symmetry of the 1,2,3-triazole ring, the 
signal due to both H-4 and H-5 appears at 7.82 ppm in the spectrum of the free ligand. 
(ii) Na(B-diketonate) 
127 
Scheme 1.9 
In the spectrum of the chloro-bridged dimer, [Rh(127-H)2Cl]2, H-4 resonates at 8.25 
ppm (CIS = 0.43 ppm) and H-5, which lies above a deshielding chlorine atom, at 8.53 
ppm (CIS 0.71 ppm). In addition, the signal for H-5 shows considerable broadening, 
whilst that for H-4 does not. The spectrum of the acetylacetonate complex, 128, also 
has two resonances corresponding to the signals for these protons, H-4 resonating at 
7.97 ppm (CIS= 0.15 ppm) and H-5 at 7.90 ppm (CIS= 0.08 ppm), neither of which is 
broadened. In the spectrum of 129, however, only one sharp peak, with a chemical shift 
of 7.92 ppm (CIS = 0.10 ppm) and an integral height corresponding to four protons, is 
seen, and this is assigned to the signal for both H-4 and H-5. The inequivalence of the 
two cyclorhodated ligands, a result of the coordination of the unsymmetrical 
benzoylacetonate anion, in the structure of 130 is reflected in the spectrum of the 
complex. Four signals-at 7.86 ppm; 7.94 ppm; and two at 7.95 ppm-are seen, and 
assigned to the signals due to the four protons in this complex, H-4a, H-4b, H-5a and 
H-Sb. 
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1.5 CONCLUSION 
In summary, this chapter has detailed the cyclorhodations of five ligands, all of 
which have previously been cyclometallated, and the conversion of the resultant chloro-
bridged dimers to, the corresponding mononuclear B-diketonate complexes. The 
preparation of three phenyloxazoles, according to literature methods, was also 
described, as were investigations of their complexation chemistry. This does not 
include any cyclometallations, however a metallation of the 5-position of the oxazole 
ring in 2,4-diphenyloxazole, by mercury(II), was described. 
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hapter wo 
Ligands Containing 
Sixmembered Heterocycles 
and 
One Cyclometallation Site 
2.1 INTRODUCTION 
This chapter describes the preparations and reactions of ligands in which the 
donor is a nitrogen atom within a six-membered heterocycle. The ligands discussed are 
grouped according to the size of the metallocycle which they could potentially form and 
include a series of six related oxygen- and sulfur-containing ligands. A novel, 
coordinatively unsaturated complex, the product of one of the cyclorhodations herein 
described, is reported. Three single crystal X-ray structure determinations (two partial, 
one complete) are described, including a cyclorhodated complex and two mononuclear 
palladium coordination complexes. In addition, a number of variable temperature lH 
NMR spectra are included and a possible explanation for the observed temperature 
dependences proposed. 
2.2 POTENTIAL FIVE-MEMBERED MET ALLOCYCLES 
In 1968 Kasahara reported that the reaction of 2-phenylpyridine (201) and 
sodium chloropalladate gave a pale yellow solid. This compound was assigned a 
chloro-bridged dimeric structure on the basis of IR spectroscopy and the products 
obtained upon lithium aluminium hydride and deuteride reductions (scheme 2.1).23 
201 
Scheme 2.1 
Since this first report 201 has been cyclometallated with several other metals 
including ruthenium, iridium and rhodium.20 The first reported preparation of the 
rhodium chloro-bridged dimer, [Rh(201-H)2Clh, was in 197129 and since then this 
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complex, and its derivatives, have been the subject of continuing interest. The 
cyclometallated 2011igand is an isoelectronic analogue of the well studied N,N-donor 
ligand bipy and several studies have been undertaken which compare the properties-
electrochemical; NMR; absorption and emission-of rhodium complexes in which bipy 
is replaced by cyclometallated 201Iigands.3la,49,50,83,102-l09 
Whilst several mononuclear derivatives have been prepared from 
[Rh(201-H)zClh, there have been no previous reports of any complex which has been 
prepared by ligand exchange of the chi oro-bridged dimer with B-diketonate anions. The 
corresponding cyclopalladated acetylacetonate complex, Pd(201-H)(acac) has 
previously been prepared by reaction of the chloro-bridged dimer with sodium 
acety lacetonate. 54 
The rhodium complex, [Rh(201-H)2Cl]2, was prepared by reacting rhodium 
trichloride with 201 in glycerol according to the literature procedure. 50 The 
mononuclear rhodium B-diketonate complexes-Rh(201-H)2(acac), Rh(201-H)2(dbm) 
and Rh(201-H)2(bac)-were prepared in good to excellent yields by ligand exchange of 
the chloro-bridged dimer with sodium B-diketonate anions. Allowing for the inclusion 
of solvent molecules these monomeric complexes all returned satisfactory 
microanalyses and were fully characterised by lH and 13C NMR spectroscopy. 
The commercially available ligand 4-phenylpyrimidine (202) (scheme 2.2) has 
previously been cyclometallated with lithium tetrachloropalladatellO and 
pentacarbonylmethylmanganese. 66 Reaction with rhodium trichloride in refluxing 
2-methoxyethanol gives, after two days, a yellow powder. The lH NMR spectrum of 
this product showed that it contained non-metallated ligands-identified by the familiar 
coupling pattern observed for phenyl rings-in the ratio two:one. This suggested the 
formation of a coordination complex, Rh(202)3Cl3 (scheme 2.2), with meridional 
stereochemistry-the alternative, facial stereochemistry, would have all ligands 
equivalent by NMR. Following recrystallisation from dichloromethane/ether this 
formulation was confitmed by microanalysis. 
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The reaction of 202 with rhodium trichloride in 2-methoxyethanol was repeated 
to establish whether the ligand could be cyclometallated under these conditions. After 
four days under reflux the suspension was filtered to give the same product, in slightly 
reduced yield, as that obtained above. Examination of the filtrate by 1 H NMR showed 
no evidence of cyclometallation. 
The difference in the mode of coordination observed for the reaction of 202 with 
rhodium(III) to that observed for the reaction with palladium(II) is worthy of further 
discussion. Given the ease with which the ligand is cyclopalladated in 96% yield under 
quite mild conditions-lithium tetrachloropalladate in methanol at room temperature-
it would be expected that the reaction to give the cyclorhodated analogue would readily 
occur. However all attempts to prepare this complex gave formation of the meridional 
coordination complex in which the ligand is coordinated in a monodentate fashion 
through N-1 as opposed to the N3,CZ'-bidentate coordination seen in the cyclopalladated 
complex. 
It is assumed that the difference in preferred pyrimidine donor atom results from 
the greater steric demands placed on the ligand by coordination to an octahedral 
rhodium(III) centre, relative to those by coordination to a square planar palladium(Il) 
centre. Coordination through N-3 places the metal centre in the correct orientation for 
the electrophilic attack on the phenyl ring leading to the formation of the favoured 
* The ligands are differentiated as cis and trans in order to facilitate unambiguous assignment of 
the NMR spectra, which are reported in the experimental section. 
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five-membered metallocycle. In the case of coordination to rhodium(III) the kinetic 
(steric) factors will greatly favour coordination through N-1, despite the relatively 
greater thermodynamic stability expected for the corresponding cyclometallated 
complex, [Rh(202)2Clh, within which the ligand must coordinate through the sterically 
less favourable N-3 atom (scheme 2.3). 
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Scheme 2.3 
The preparation of the first cyclopalladated complex of 2-phenylquinoline (203) 
was reported in the same paper as that which described the first cyclopalladation of 201 
(vide supra).23 Reaction of 203 with sodium tetrachloropalladate in alcohol gave a 
yellow solid which was assigned a chloro-bridged dimeric structure, [Pd(203-H)Cl]z, on 
the basis of its IR spectrum, microanalytical data and the products obtained upon 
reduction with lithium aluminium hydride and with lithium aluminium deuteride.23 
This known chloro-bridged dimer has subsequently been converted to the 
corresponding palladium acetylacetonate monomer which was then fully characterised, 
confirming the cyclopalladated nature of this complex.lll Another report of the 
metallation of 2-phenylquinoline describes the preparation of the mercurated complex, 
Hg(203-H)Cl, and its transmetallation with tellurium tetrabromide to give the 
ortho-tellurated analogue, Te(203-H)Br3, which was then reduced with sodium 
borohydride or hydrazine hydrate to give a variety of organic tellurides.112 
203 
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Given the relative ease with which 203 can be cyclopalladated and the absence 
of reports of its cyclorhodation the reaction of this ligand with rhodium trichloride was 
investigated. Reaction of a solution of rhodium trichloride trihydrate and 203 in 
2-methoxyethanol gave, after one day stirring at room temperature followed by one day 
heating under reflux, a yellow/green powder which is insoluble in CDCl3, but 
sufficiently soluble in CD3CN to allow the acquisition of a lH NMR spectrum. 
Examination of this spectrum, which exhibits some broadening at 23°C, showed the 
presence of two cyclometallated ligands-in an approximate one: two ratio-in different 
environments. Acquisition of a spectrum at 60°C showed that the observed broadening 
was due to a thermally-dependent process as this spectrum was significantly sharpened. 
Recrystallisation, by the vapour diffusion of ether into an acetonitrile solution of 
the powder, gives a mixture of two crystal forms-well-formed orange crystals and 
amorphous yellow blocks-and these were manually separated by microscopic 
inspection. 
The orange crystals were characterised by microanalysis, which returned the 
formulation [Rh(203-H)2Cl].l/4CH3CN, a stoichiometry which would be consistent 
with that of a chloro-bridged dimeric structure. Whilst this complex is insufficiently 
soluble in CD3CN to obtain 13c NMR data, the complex was able to be characterised 
by lH NMR spectroscopy. At 23°C the spectrum confirms that the broadening 
observed in the spectrum of the mixture is due to this complex, the signals for H-8 and 
H-7 being the most obviously affected. In addition, the spectrum shows that both of the 
ligands are in identical environments, therefore the other ligand observed as the minor 
component in the spectrum of the mixture must be due to another complex. At 60°C all 
signals are better resolved but that for H -8 still appears as a broad signal rather than, as 
would be expected, a doublet (figure 2.1). 
Given that the crystals of the complex appeared of suitable quality for single 
crystal X -ray structure analysis and that the broadening observed in the 1 H NMR 
spectrum could not easily be accounted for, the structure of this complex was 
determined. The solving and partial refinement of an X-ray data set revealed, however, 
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Variable temperature lH NMR spectra (CD3CN) of [Rh(203-H)2Cl] 
that the crystals were not of the expected chloro-bridged dimer, [Rh(203-H)2Cl]2, but of 
another complex, Rh(203-H)zCl (204) (figure 2.2). Unfortunately, the refinement of 
this structure, despite several recollections on different crystals, has not produced a 
result of publishable quality. It is assumed that the crystals are twinned, despite this not 
being apparent upon examination of them under the microscope. 
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Figure 2.2 Perspective view of 204 
Despite not being suitable for publication, the structure of 204 is noteworthy . 
. The molecule contains a coordinatively unsaturated rhodium(III) centre and two 
cyclometallated 203 ligands together with a single, non-bridging chlorine atom. It is 
interesting to contemplate the influence that the six-membered benzo-fused heterocycle 
has on complex formation given that, upon reaction with rhodium trichloride trihydrate 
under the same conditions, five-membered benzo-fused analogues give rise to 
chloro-bridged dimeric products (vide supra). The subtle alteration in the geometry of 
the coordination about the rhodium centre, upon expansion of the heterocycle, appears 
sufficient to render formation of the meso dimeric complex unfavourable, with respect 
to formation of the coordinatively unsaturated complex. Presumably, the proximity of 
the cyclometallated 203 ligands on adjacent ~hodium(III) centres in a dimeric structure 
would result in such a complex being considerably strained. 
The five-coordinate rhodium(III) centre in 204 is of particular interest, because a 
coordinatively unsaturated complex is required as an intermediate in catalytic cycles 
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involving rhodium. Isolable examples of this type of complex are rare, the first X-ray 
crystal structure having been reported in 1992.113 
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Having established the structure of the orange crystals, attention turned to 
determining the nature of the yellow complex obtained from the same recrystallisation. 
Microanalysis gave the formulation of this complex as [Rh(203-H)(CH3CN)Ch], which 
is consistent with several possible structures, two of which are considered more likely. 
The first is a chloro-bridged dimeric structure, [Rh(203-H)(CH3CN)Clzh-one of the 
many possible isomers of which is shown as 205 in scheme 2.4-in which the 
rhodium(III) centres are six-coordinate. The alternative structure, 
Rh(203-H)(CH3CN)Cl2, is monomeric and contains a coordinatively unsaturated 
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rhodium(III) centre. Given that, with only one ligand attached to each rhodium(III) 
centre, the steric interactions between the ligands on adjacent rhodium(III) atoms-and 
the assumed driving force to coordinative unsaturation-would be minimised, the 
chloro-bridged dimeric structure, 205, is considered the most probable structure of this 
complex. This is analogous to the structure, proposed by Nonoyama, for the complex 
that results upon dissolution in CD3CN of the adduct obtained when rhodium trichloride 
trihydrate is reacted with 8-methylquinoline (scheme 2.5).114 
Scheme2.5 
As with the orange crystals, the yellow complex is not sufficiently soluble in 
CD3CN to obtain 13C NMR data. The lH NMR spectrum shows no broadening, as 
expected, and the presence of a cyclometallated ligand. The spectrum of this complex 
is very different from that of 204 (figure 2.3) as there is only one ligand attached to each 
rhodium(III) centre and, therefore, a lack of through-space magnetic ring current effects 
between ligands. 
Ligand exchange, with sodium acetylacetonate, of the original mixture obtained 
from the reaction of 203 with rhodium trichloride trihydrate gave a yellow powder. 
This powder was separated by fractional crystallisation to give two complexes: 
Rh(203-H)2(acac) (206)-which was also independently prepared from separated 
204-and Rh(203-H)(acac)2 (207) (scheme 2.4). Both of these complexes are soluble 
in CDCl3 and were characterised by lH and 13C NMR spectroscopy and, in the case of 
206, by microanalysis. 
The 1 H NMR spectrum of 206 displays none of the broadening seen in the 
spectrum of the corresponding complex, 204, and all resonances are well-resolved. It is 
interesting to note that, whilst 204 adopts a coordinatively unsaturated structure, 
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Figure 2.3 lH NMR spectra (CD3CN) of: (a) the mixture from the reaction of 203 
with RhC1].3H20; (b) 204 (see figure 2.1 for assignments); and (c) 205 
the analogous acetylacetonate complex, 206, has a six-coordinate rhodium(III) centre. 
This is further evidence for the explanation given above, that the coordinatively 
unsaturated structure is formed because of the considerable steric strain-due to 
interactions between the cyclometallated ligands on the adjacent rhodium(III) centres-
that would be imposed on a chloro-bridged dimeric structure. The question that 
remains, however, is why the vacant coordination site is not occupied by an acetonitrile 
molecule, given the preference that rhodium(III) displays for six-coordination.114 
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The 13C NMR spectrum of 206 was easily assigned by means of an HMQC 
spectmm (figure 2.4) which enabled the correlations between the lH and 13C signals to 
be seen, including the signals for H -6 and H -7, despite the proximity of their resonances 
in the 1 H NMR spectrum. 
C-5 C-8 
C-7 C-4' C-6 C-3 
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Figure 2.4 Aromatic region of the HMQC spectmm of 206 
The two acac ligands in 207 are labelled acaea and acaCb in the experimental 
section for the purposes of differentiating the signals due to each but, due to the overlap 
of methyl signals from each of these ligands in the lH NMR spectrum, it is not possible 
to completely assign the spectrum to stereochemically unique atoms. By means of 
NOE experiments in which the CH signals are irradiated, the signals due to each of 
these ligands can be separated, but irradiation of H-8 and of H-3' gives enhancement at 
an overlapped resonance rather than at either of the two resolved methyl signals. 
The binuclear coordination chemistry of 4,6-bis(2'-pyridyl)pyrimidine (208)51 
and its doubly cyclometallated analogue, 4,6-diphenylpyrimidine (209)115 have been 
investigated. The literature on the coordination chemistry of the analogous ligand, 
4-phenyl-6-(2-pyridyl)pyrimidine (210) is confined to a report in which the preparation 
of the ligand and its tris-N,N-bidentate complex with iron(II) are described.l16 In 
principle, this ligand offers the possibility of preparing heteronuclear complexes with 
each of the metals in different coordination environments, one N,N-chelated and the 
other cyclometallated. 
208X=N 
209X=C 
210 
The ligand, 210, was prepared by the reaction of 1-phenyl-3-(2-pyridyl)-
1 ,3-propanedione (211) and formarnide as previously described (scheme 2.6).116 The 
required B-diketone precursor, 211, was prepared by the condensation of ethyl 
picolinate and acetophenone117 followed by an acetic acid work-up, in a modification 
of the procedure previously reported.118 
~OEt PhCOMe I"=: 
0 0 0 N'-..;:?N 
211 210 
Scheme 2.6 
Unreacted ligand is found to be the product when the black solid, obtained upon 
acetate-chloride exchange of the product from reaction of 210 with palladium acetate in 
refluxing acetic acid, is reacted with sodium acetylacetonate. This suggests that 
palladium acetate is not an effective metallating agent for this ligand, a conclusion that 
is supported by the observation that, regardless of whether the reaction is performed at 
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ambient or at higher temperatures, the reaction of 210 with one or two equivalents of 
palladium acetate in benzene gives the same product, namely the complex 
Pd(210)(0Ac)2 (212) (scheme 2.7). 
Pd(OAc)2 
210 212 
Scheme2.7 
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Analogues of 212, palladium coordination complexes containing monodentate 
acetate ligands, have been reported for the structurally related ligands: bipy (213); 
4,4'-dimethyl- 2, 2'- b i pyridine (214); 1,10-phenanthroline (215); 
2,9-dimethyl-1, 10-phenanthroline (216); 4, 7 -dimethyl-1,10-phenanthroline (217); 
3,4,7,8-tetramethyl-1, 10-phenanthroline (218) and 4,7-diphenyl-1, 10-phenanthroline 
(219) (figure 2.5).119-121 
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Figure 2.5 
215 R=R'=R"=H 
216 R=Me, R'=R"=H 
217 R=R'=H, R"=Me 
218 R=R'=R"=Me 
219 R=R'=H, R"=Ph 
The mode of acetate coordination in 212 was determined by correlating the 
carbon-oxygen stretching frequencies observed in theIR spectrum of the complex. For 
212 the absorption at 1609 cm-1 is assigned to the asymmetric carbon-oxygen stretching 
frequency (Vasym(C02)), the peak at 1632 cm-1 being assigned to a ligand-based 
absorption. The frequency observed for Vasym(COz) is an increase relative to that 
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observed for the parent compound, [Pd(0Ac)2]3 for which Vasym(COz)=l600 cm-1,119 
The frequency of the symmetric carbon-oxygen stretch, (Vsym(COz)), in the complex is 
observed to be 1319 cm-1, a decrease relative to that observed for the parent compound 
for which Vsym(C02)=1427 cm-1,119 The peak at 1364 cm-1 is again assigned to a 
ligand-based absorption. The separation between the carbon-oxygen stretching 
frequencies, LlV=Vasym(C02)-Vsym(C02), for the complex at 281 cm-1 is, therefore, 
considerably larger than that observed for the free anion in the parent compound 
(Av=173 cm-1). This observation is consistent with the assignment of the acetate 
coordination as being monodentate (end-on), which removes the equivalence of the two 
oxygen atoms, generating a pseudo-ester configuration.121-122 The characterisation of 
212 was completed with microanalysis and the assignment of its 1 H and 13C NMR 
spectra. 
Ligand exchange of 212 with lithium chloride gave the corresponding complex 
220 (scheme 2.7). This complex, which is insoluble in common NMR solvents, is 
assumed to have monodentate chloro ligands and was characterised by microanalysis 
and IR spectroscopy. Reaction of 210 with lithium tetrachloropalladate gave a yellow 
solid which is soluble in chloroform. Acquisition of 1 H and 13C NMR spectra in 
CDCl3 showed that this complex contains two inequivalent ligands, both of which are 
not cyclopalladated. Extensive investigation, with a variety of techniques, did not a1low 
characterisation of this complex and its exact formulation and structure remain 
unknown. Other attempts to cyclometallate 210 by reaction with mercuric acetate and 
with rhodium trichloride were unsuccessful. Thus, it appears that this ligand prefers to 
act simply as a N,N-bidentate ligand and does not readily undergo cyclometallation 
directed by the other nitrogen donor. 
2.3 POTENTIAL 6-MEMBERED METALLOCYCLES 
Complexes of 201 represent the classical example of a cyclometallated 
N-heterocyclic ligand with a five-membered metallocycle (figure 2.6A). The most 
obvious route to the preparation of analogous complexes with six-membered 
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metallocycles is through the insertion of a one atom spacer (denoted X) between the 
pyridine and phenyl rings (figure 2.6B). 
B 
Figure 2.6 
Perhaps the simplest such spacer is the methylene group, and insertion of this 
between the pyridine and phenyl rings gives the commercially available ligand 
2-benzylpyridine (221). 
221 
Reaction of 221 with palladium(II) chloride in ret1uxing methanol has been 
reported to give the coordination complex, Pd(221)2Cl2 (222), whilst reaction with 
palladium acetate in acetic acid-under reflux or at room temperature-gives the 
acetate-bridged dimer, [Pd(221-H)(OAc)h (223) (scheme 2.8).123,124 Subsequent 
acetate-chloride exchange gives the corresponding chloro-bridged dimer, 
[Pd(221-H)Clh (224).123 Ligand exchange reaction of 2-benzylpyridine with the 
cyclopalladated N,N-dimethylbenzylamine chloro-bridged dimer also gives this 
complex (scheme 2.8).125,126 Given the ease with which 224 can be prepared, it has 
been used as the starting material in several insertion38a, 127 and complexation 128 
reactions to investigate the properties of six-membered pa1ladacycles relative to those of 
their five-membered analogues. 
The coordination chemistry of the structural analogue of 221, 
2-(1-methylbenzyl)pyridine (225), has also been reported.129 This ligand gives a 
his-coordination complex (226) upon reaction with sodium tetrachloropalladate and a 
cyclopalladated acetate-bridged dimer upon reaction with palladium acetate (227), 
47 
which are analogues of the complexes obtained when 221 is reacted under similar 
conditions (scheme 2.8). 
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In addition to reactions with palladium(II), the reactions of 221, 225 and their 
analogue, 2-(1,1-dimethylbenzyl)pyridine (229), with gold(III) have been reported.30b 
Upon reaction with sodium tetrachloroaurate, 221 and 225 give the coordination 
complexes, AuLCI3, whilst 229 gives the salt, [LH]+[AuCl4]-. Warming these 
compounds in aqueous acetonitrile gives the mononuclear cycloaurated complexes, 
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Au(L-H)Cb, which can also be prepared directly by reaction of the ligands with gold 
trichloride dihydrate under reflux in water. 30b 
~ ~~ v 
229 
The reaction of 221 and rhodium trichloride trihydrate in 2-methoxyethanol has 
been reported to give the dimeric complex, [Rh(221-H)(221)Cl2h·H20, in which one of 
the ligands is cyclorhodated and the other coordinated solely through the pyridine 
nitrogen. Treatment of this complex with tertiary phosphines was reported to give 
mononuclear complexes, Rh(221-H)Cl2(PR3)2, which were characterised by 
microanalysis and IR and NMR spectroscopy, in contrast to the dimeric complex which 
was, due to low solubility, only characterised by microanalysis and IR spectroscopy)30 
OY1 
"NY 
Me 
230 
These mononuclear complexes are analogous to several reported complexes 
containing a single cyclorhodated ligand. Reaction of 8-methylquinoline (230) with 
rhodium trichloride trihydrate followed by treatment of the product with a variety of 
monodentate ligands (L) gives complexes formulated as Rh(230-H)X2L2 (X= Cl or 
Br).ll4 Of more significance to this discussion is the reaction of 2-anilinopyridine 
(231) (scheme 2.9) with rhodium trichloride trihydrate, as this ligand, like 221, would 
give a six-membered metallocycle upon cyclometallation. This reaction, followed by 
treatment with pyridine, gives Rh(231-H)Ch(py)2, which was characterised by a single 
crystal X-ray structure determination (scheme 2.9).131 Of particular note is the trans 
geometry of the chloride ligands-an observation supported by the presence of a single 
V(Rh-Cl) stretch in the IR spectrum-in contrast to the cis geometry ascribed to the 
chloride ligands in Rh(221-H)Cb(PR3h and Rh(230-H)X2L2 on the basis of IR 
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spectroscopy (two v(Rh-Cl) stretches observed) and the 1H_3lp and 13C_3lp couplings 
observed in the NMR spectra.ll4,130 
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In none of the reactions, with rhodium trichloride trihydrate, of 231, 229 and 
231, is the expected chloro-bridged dimer-as reported for 2-phenylpyridine (201),29 
benzo[h]quinoline,29 azobenzenes, 132 aromatic oximes133 and 1-phenylpyrazole (vide 
supra)9l_observed as the product. This has been attributed, in the case of 221 and 
231, to the fact that the ligands which give the chloro-bridged dimer consist of a 
conjugated system, whilst for these two ligands the moiety containing the metallated 
carbon atom is not conjugated with that containing theN-donor atom.l30 
As the initial step in an investigation of the formation of six-membered 
metallocycles, the reaction of 221 with rhodium trichloride trihydrate was carried out in 
2-methoxyethanol-according to the literature procedure 130-and in ethanol, as was the 
reaction with anhydrous rhodium trichloride in anhydrous ethanol. In all cases, 
however, the product obtained-regardless of reaction time-was not the cyclorhodated 
dimeric complex reported previously, but one ascribed a structure in which the ligands 
are monodentate, coordinated through the pyridyl nitrogen. This complex is isolated as 
an oil which gives an inconclusive FAB mass spectrum and is unable to be sufficiently 
purified to give satisfactory elemental analyses. The complex is soluble in chloroform 
and was characterised by lH and 13C NMR spectroscopy, which demonstrated that all 
ligands were in equivalent environments and clearly not metallated. The 
microanalytical results obtained suggest that the formulation of the complex is 
Rh(221)3Cb, with the equivalence of the ligands in the NMR spectra being consistent 
with facial stereochemistry (scheme 2.1 0). This is in contrast to the meridional 
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stereochemistry observed for the coordination complex formed when rhodium 
trichloride trihydrate is reacted with 202 (vide supra). 
221 
Scheme 2.10 
Given that there are still relatively few reports of complexes containing 
six-membered metallocycles in the literature, attention was focused on potential ligands 
with the necessary structural features which might lead to the formation of such 
complexes. Using the incorporation of an appropriate one atom spacer between the two 
aromatic rings in 201 as a starting point for ligand design, consideration was given to 
compounds, analogues of 221 and 230, whose coordination chemistry had not been 
investigated. 
A desirable structural feature for improving the relative reactivity of such a 
ligand would be the incorporation of a ortho-activating group as the spacer. It was felt 
that an electron-releasing Group VI atom would fulfil this criterion, giving an increase, 
relative to the analogues 201 and 221, in electron density on both the pyridyl nitrogen 
and the ortho carbons of the phenyl ring. This would increase the nucleophilicity of the 
former, whilst also making the latter more prone to electrophilic attack by the 
coordinated metal centre, thereby promoting both key steps of the postulated 
mechanism for cyclometallation (vide supra). The two compounds considered as 
potential ligands were, therefore, the ether, 2-phenoxypyridine (232), and the thioether, 
2-pheny lthiopyridine (233). 
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The first reported preparation of 232 was by Chichibabin in 1918, when the 
compound was obtained in poor yield upon the diazotisation of 2-aminopyridine in the 
presence of phenol.l34 The preparations of 232 reported subsequently-for 
investigations of its pharmaco1ogicaJ135 and herbicidaJ136 activity-have involved the 
reaction of 2-bromopyridine and phenol in the presence of anhydrous potassium 
carbonate. This reaction was repeated to give, in good yield, the desired ether as a 
white crystalline solid which was fully characterised, the Be NMR assignments being 
in agreement with those in the literature.l37, 138 
The preparation of the corresponding thioether, 23 3, is most easily 
accomplished by the nucleophilic substitution of 2-bromo-139 or 2-chloropyridine by 
thiophenolate anion in a reaction analogous to that used above to prepare 232. Thus, 
reaction of 2-chloropyridine with thiophenol in the presence of triethylamine according 
to the literature procedure gave, after distillation, 233 as an oil in good yield.140 Again 
this ligand was fully characterised, with the observed 1 H NMR shifts being similar to 
those previously reported.l41 
Having prepared and characterised the target ligands, 232 and 233, investigation 
of their coordination chemistry began with their reactions with lithium 
tetrachloropalladate in methanol. Reaction of both ligands under these conditions gave 
mononuclear coordination complexes, one of which was characterised by a single 
crystal X-ray structure determination (vide infra). 
Reaction of 232 with one equivalent of lithium tetrachloropalladate was 
expected to give the chloro-bridged dimer, [Pd(232-H)C1]2. Suspicions arose however, 
when the yellow product from the reaction in methanol-at room temperature or under 
reflux-was found to be quite soluble in chloroform, this being different to other known 
chloro-bridged cyclopalladated dimers, which are only sparingly soluble in this solvent. 
The 1 H NMR spectrum of the complex was recorded and the signals corresponding to 
the four protons on the pyridine ring displayed the expected coupling pattern. However, 
the signals for the protons on the other ring were significantly broadened at 23°C, 
fonning a single, relatively featureless resonance-such that the substitution of this ring 
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could not be ascertained-between 8 = 7.23-7.47 ppm. Acquisition of spectra at 
increasing temperatures saw this resonance take on the familiar appearance of a 
monosubstituted phenyl ring, confirming that cyclopalladation had not taken place 
(figure 2.7) 
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Figure 2. 7 Variable temperature 1 H NMR spectra of the product of the reaction of 
232 with lithium tetrachloropalladate 
Acquisition of 13C NMR spectra of the complex, both at 23°C and 53°C, 
showed that the carbon nuclei were also affected by the same process that led to 
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temperature-dependent broadening of the signals in the 1 H NMR spectrum. 
Information acquired from an HMQC experiment permitted the assignment of all 
resonances in the spectra. 
The formulation of the complex was established by microanalysis as being 
Pd(232)2Cl2 (234)-this stoichiometry confirming that the ligands were most likely 
monodentate. This formulation would also be consistent with a complex in which the 
ligands are N,O-bidentate (viz [Pd(232)2]Cl2); however this was not considered likely 
as this would require the formation of an unfavourable four-membered chelate ring. 
Having established that the ligands in the complex were not cyclopalladated, the nature 
of the temperature dependent process that was leading to the observed broadening of the 
spectra at room temperature seemed worthy of further investigation. Initially it was felt 
that this was due to an agostic interaction142 between the ortho protons and the 
palladium atom. This would lead to restricted rotation about the phenyl-oxygen bond, 
placing the ortho protons in different magnetic environments and accounting for the 
apparent inequivalence of their resonances at ambient temperature (figure 2.8). 
Figure 2.8 
In order to characterise the complex further, and to confirm the presence of the 
postulated agostic interaction, it was necessary to obtain crystals for a single crystal 
X -ray structure determination. Diffusion of petroleum ether vapour into a chloroform 
solution of the complex furnished suitable crystals as orange blocks. 
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Crystal Structure of 234 
The palladium complex, 234, crystallises in the monoclinic space group P21/c, 
the asymmetric unit of which contains half a molecule with the palladium atom sited on 
a centre of inversion. The two phenoxypyridine ligands are monodentate-through the 
pyridyl nitrogens-to the palladium atom, two chlorine atoms filling the other two 
coordination sites (figure 2.9). 
Figure 2.9 Perspective view and atom labelling of 234. Selected bond lengths (A) 
and angles (0 ): Pdl-Nl 2.029(5), Pdl-Cll 2.286(2), C2-0l 1.358(7), 01-Cl' 
1.410(7); Nl-Pdl-Cll 90.8(2), C6-Nl-C2 118.5(5), C2-01-Cl' 117.5(5). 
This type of complex forms the largest class of complexes obtained upon the 
reaction of monodentate N-donor ligands with the tetrachloropalladate anion or indeed, 
with palladium dichloride or bis(benzonitrile)palladium dichloride.l43 The trans 
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geometry of this complex is consistent with the observation that, in such preparations, 
"normally the trans isomer (or a mixture of isomers) is isolated."143 
The pyridine and phenyl rings are each essentially planar with the maximum 
displacement from a plane being 0.0 18(9) A for C6'. The meanplanes of the pyridine 
and phenyl rings are inclined to one another at 83.2° and are, therefore, almost 
orthogonal. 
By virtue of the centre of inversion, the coordination about the pa1ladium atom 
is crystallographically restricted to being planar and the mean plane of the pyridine ring 
is inclined at 100.7° to this coordination plane. The bond angles show that the 
coordination to the palladium is almost perfectly square planar with the Pd-N and Pd-Cl 
bonds-the lengths of which are within the expected rangel44_forming an angle of 
90.82(13)0 • 
It might be expected that this complex would show some interaction between 
the oxygen atom and the palladium centre; however, the distance between them, at 
2.999(7) A, precludes such an interaction. The structure has no unusually short 
intermolecular distances between non-hydrogen atoms with the shortest observed being 
> 3.4 A. The molecular packing is best described as involving the formation of 
channels of phenyl rings stacked along the b axis. 
The crystal structure analysis detailed above, suggests a possible explanation for 
the temperature dependent process affecting the NMR spectra. Rather than being due to 
an agostic interaction between the ortho protons and the palladium atom (figure 2.8), 
the observed broadening is thought to result from the interchange between syn and anti 
rotamers, as depicted in scheme 2.11. This is the same phenomenon that was observed 
for Pd(lll)zClz (vide supra). In the latter complex, the interchange between rotamers 
is observed to be slow on the NMR timescale, such that both rotamers are observed, 
whilst for 234 the interchange is obviously faster, as a time-averaged spectrum is 
observed. This is attributed to the energetic barrier between the two rotamers in 234 
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being somewhat less than in Pd(111)2Ch. The barrier is presumed due to the steric 
interactions that result during the 180° rotation, about the palladium-nitrogen bond, 
required to effect the interchange. Upon such a rotation in 234, only one phenoxy 
group must pass through the palladium coordination plane, and in the process a 
pyridine-oxygen bond eclipses a palladium-chlorine bond. In Pd(111)2Cb, the 
equivalent rotation requires two phenyl groups to pass through the plane and, 
consequently, two oxazole-phenyl bonds eclipse two palladium-chlorine bonds-the 
latter a much more energetically demanding process than the former. The formation of 
rotamers of this type, and the subsequent effects on the Be NMR spectra of the 
complexes, has been previously proposed for trans-dichloropalladium complexes of 
N-coordinated vitamin B6 compounds.145 It is perhaps surprising, given how readily 
such palladium coordination complexes are formed, that reports of this type of 
isomerism do not appear more frequently. 
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Reaction of the analogous thioether, 233, with lithium tetrachloropalladate gave 
a pale yellow solid which is sparingly soluble in chloroform. Acquisition of a 1 H NMR 
spectrum in CDCI3 (figure 2.10) showed that the product appears to be a mixture of two 
complexes in an approximate one:two ratio, the relative composition of which remains 
unchanged after several days in solution. In addition, the appearance of the spectrum 
does not change with increasing temperature. 
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Figure 2.10 1 H NMR spectrum of the product obtained upon reaction of 233 with 
lithium tetrachloropalladate 
The use of lD-TOCSY experiments enabled the isolation of the two different 
pyridyl spin systems, the signals assigned to H-3 in these systems-at o = 6.70 ppm 
(minor component) and 6.79 ppm (major component)-showing the greatest separation 
of the pairs of related signals, with resonances separated by 0.09 ppm. The two separate 
phenyl ring spin systems were unable to be distinguished due to the proximity of their 
resonances but the size of the integral of the peak assigned to the resonance due to the 
ortho protons confirmed the non-cyclometallated nature of the complexes. 
There are four possible non-cyclometallated coordination modes for this ligand: 
monodentate through the pyridyl nitrogen (A) or through the sulfur atom (B); 
mononuclear chelation through these two atoms (C); or a binuclear bidentate mode in 
which the ligand bridges two separate palladium centres (D) (figure 2.11). Given the 
similarity in chemical shifts for their equivalent positions, it is assumed that the ligands 
in the two complexes in the mixture adopt the same mode of coordination. 
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Figure 2.11 
Whilst a satisfactory microanalysis of the complex could not be obtained, even 
after repeated attempts at recrystallisation, those obtained are consistent with the 
formulation of the complex as being Pd(233)2Ch-a stoichiometry which discounts the 
bridging mode of coordination, D (figure 2.11). Unfortunately, these recrystallisations 
also failed to give crystals of a quality suitable for an X-ray crystal structure 
determination. 
It might be expected that palladium(II) as a 'soft' metal would preferentially 
coordinate to 233 through sulfur, rather than nitrogen. However, in complexes where 
the metal can bind to a harder or softer atom in a given ligand, it has been observed that 
"steric effects tend to determine the result." 144 Also, due to electronic factors, the 
sulfur atom in 233 is somewhat harder than usual whilst the nitrogen is concomitantly 
softer. The similarity in CIS values observed for this complex and those observed for 
the analogous, crystallographically characterised complex 234 (vide supra), suggests 
that the ligands in both complexes are coordinated in a monodentate fashion through the 
pyridyl nitrogen. 
Having established the mode of coordination and stoichiometry of the complex, 
one question remains unanswered: what are the structures of the two different 
complexes observed in the reaction between 233 and lithium tetrachloropalladate? 
Using the information discussed above, it is thought that the product is a mixture of syn-
and anti-Pd(233)2Cl2 rotamers, with the anti rotamer thought to be the lower energy 
conformation and, therefore, the major component. The observed difference in the 
temperature dependences of the 1 H NMR spectra of the product formed upon reaction 
of the analogous ligands 232 and 233 is attributed to the relative sizes of the atoms 
separating the pyridyl and phenyl rings. The relatively larger sulfur atom is thought to 
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lead to larger steric interactions upon a 180° rotation about the palladium-nitrogen 
bond. Alternatively, although not observed for the oxygen atoms in 234, interaction 
between the palladium and ligand sulfur atoms-given the donor preferences of 
palladium(II)-may account, either wholly or in conjunction with the respective size 
differences, for the observed temperature dependences. 
Having established that reaction of 232 or 233 with lithium tetrachloropalladate 
gives coordination complexes, their reactions with palladium acetate were investigated. 
Reaction of 232 with palladium acetate in acetic acid at room temperature-the same 
conditions used to cyclometallate 221124-gave, after stirring for one day, a pale yellow 
precipitate which shows appreciable solubility in chloroform. Using lD-TOCSY and 
HMQC experiments it was possible to unequivocally establish that this product is a 
cyclopalladated acetate-bridged dimer (235) (scheme 2.12). This was recrystallised by 
the diffusion of petroleum ether vapour into a chloroform solution to give the complex 
as analytically pure yellow blocks, the characterisation of which was completed with 
the recording of its IR spectrum. 
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Scheme 2.12 
Ligand metathesis of 235 with excess lithium chloride gave the chloro-bridged 
dimer, 236, as an analytically pure, pale yellow solid which is largely insoluble in 
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common NMR solvents. Additional characterisation of this complex was, therefore, 
restricted to IR spectroscopy. Reaction of 236 with sodium acetylacetonate gave 237, 
the desired mononuclear acetylacetonate complex, as an analytically pure white solid in 
moderate yield. The complex was completely characterised by means of IR and lH and 
13c NMR spectroscopy. 
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Figure 2.12 (a) Aromatic region of the lH NMR spectrum of 237 
(b) lD-TOCSY experiment irradiating H-6 
(c) lD-TOCSY experiment irradiating H-3' 
(d) lD-TOCSY experiment irradiating H-6' 
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Assignment of the lH NMR spectrum (figure 2.12a) was complicated by the 
overlap of the resonances for H-5, H-4' and H-5'. These signals could be separated 
however, by the use of lD-TOCSY experiments. Irradiation of the doublet at 8.81 ppm 
(assigned to H-6) provided the entry into the pyridyl ring spin system allowing the 
assignment of the triplet at 7.08 ppm as being the resonance due to H-5 (figure 2.12b). 
The doublets at 6.98 ppm (assigned to H-6') and at 7.62 ppm (assigned to H-3') offered 
two entries into the spin system of the cyclopalladated ring. Irradiation of the signal for 
H-3' at 7.62 ppm with a short mixing time (figure 2.12c), resulted in magnetisation 
transfer only to the adjacent proton, H-4', at 7.06 ppm .. Similarly, irradiation of the 
signal for H-6' at 6.98 ppm (figure 2.12d) allowed assignment of the adjacent proton 
H-5' at 7.12 ppm. 
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Figure 2.13 Aromatic region of the HMQC spectrum of 237 
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Having fully assigned all resonances in the 1 H NMR spectrum of 237, 
assignment of the 13C NMR spectrum of the complex was made straightforward by the 
use of an HMQC experiment which showed individual correlations between all of the 
resonances in the 13C NMR spectrum and the assigned resonances in the 1 H NMR 
spectrum (figure 2.13). 
Reaction of the corresponding thioether, 233, with palladium acetate in acetic 
acid at room temperature, or under reflux, failed to produce the desired acetate-bridged 
dimer. Having established that the reaction, under nitrogen, in benzene could be used to 
cyclopalladate ligands that failed to metallate with palladium acetate in acetic acid (vide 
infra), 233 was reacted under these conditions to give, following acetate-chloride 
exchange, a cyclopalladated chloro-bridged dimer, 238 (scheme 2.13), as an orange 
solid. This complex is insoluble in common NMR solvents and was, therefore, 
characterised only by IR spectroscopy. 
(XSX) 7'1 3 ~ ~ 
4 crsD 5' (i) Pd(OAc)2/C6H6 ld, I N I Cl, Cl 
5 ~ 2, o 4, (ii) LiCI Pd (J( ,~r s~ 6 3' 
Tl(acac) 
233 238 239 
Scheme 2.13 
Ligand exchange of 238 with thallium acetylacetonate gave the monomeric 
palladium acetylacetonate complex, 239, in relatively poor yield (scheme 2.13). 
Analytically pure, well-formed orange crystals were obtained following diffusion of 
pentane vapour into a chloroform solution of the complex. These crystals were 
completely characterised by means of IR and 1 H and 13C NMR spectroscopy. 
Having cyclopalladated both 232 and 233, their reactions with rhodium 
trichloride, in 2-methoxyethanol and in ethanol, were investigated. None of these 
reactions produced cyclorhodated complexes and, in the case of 2 3 2 in 
2-methoxyethanol, the apparent reduction of rhodium(III) to rhodium metal-indicated 
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by the formation of a solid silvery coating on the inside of the reaction vessel-was 
observed. Reactions with other metal ions, mercury(II) and platinum(II) for example, 
also did not yield cyclometallated complexes. 
The presence of a nitrogen-containing heterocycle offers the possibility, through 
a lithiation reaction, of selectively ortho activating an adjacent aromatic ring,l46-148 
The subsequent transmetallation of this lithiated ligand with a variety of metal ions can 
then be used to prepare a desired cyclometallated complex. This methodology has been 
used to prepare cyclometallated derivatives of a number of different heterocycles with 
different metal ions, for example: copper(I),60 mercury(II)61,62 and tin(IV)l49,150 with 
oxazolines; palladium(II)150 and platinum(II)97 with pyrazoles; palladium(II),97,151 
platinum(II)151,152 and tin(IV)149 with pyridines; and palladium(II) and platinum(II) 
with quinolines.l51 
Given the failure of direct reaction to produce cyclometallated complexes of 232 
with any metal other than palladium, it was thought that lithiation and transmetallation 
might offer the possibility to prepare such complexes. In addition, 232, was thought to 
be a good model compound for similar reactions of two diazine bis-ethers (vide infra). 
Rather than giving the desired lithiated compound, reaction of 232 with n-butyllithium 
in ether-in the presence or absence of TMEDA153_gave the hitherto unknown 
butylated compound, 6-butyl-2-phenoxypyridine (240) as a yellow oil which was 
characterised by mass spectrometry and lH and 13C NMR spectroscopy (scheme 2.14). 
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Scheme 2.14 
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2.4 POTENTIAL 7-MEMBERED METALLOCYCLES 
With the limited success of the strategy outlined above for the preparation of 
complexes containing a six-membered metallocycle, attention turned to the possibility 
of extending the application of this to the preparation of complexes with larger 
metallocycles. Just as 201-which forms five-membered metallocycles-was used as 
the prototype ligand for the insertion of a one-atom spacer (denoted X) to give 232 and 
233, these two ligands-which form six-membered metallocycles-could be used as 
prototypes for the insertion of an additional one-atom spacer (denoted Y) to give 
ligands which could, in theory, form complexes which incorporate a seven-membered 
metallocycle (figure 2.14). 
Reports of complexes which incorporate a seven-membered palladacycle are 
rare. Of those that have been reported, few have been prepared via direct 
cyclometallation reactions, the majority having been prepared via the insertion of 
various molecules into the palladium-carbon bond of cyclopalladated 
precursors. 38e, 154-158 
~X-Y0 ~N, A:J 
M 
A B 
Figure 2.14 
There are two positions into which a one-atom spacer might be inserted into the 
structures of 232 and 233-adjacent to the pyridine ring (figure 2.14A) or adjacent to 
the phenyl ring (figure 2.14B)-and, therefore, four possible ligands arise from the 
insertion of such a spacer. Considering perhaps the simplest such spacer, a methylene 
group, the four potential ligands are: 2-phenylmethoxypyridine (241); 
2-phenoxymethylpyridine (242); 2-[(phenylmethyl)thio]pyridine (243) and 
2-[(phenylthio )methyl]pyridine (244). 
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Whilst these four compounds have all been previously reported in the literature, 
a search revealed that the only previous report of the investigation of their coordination 
chemistry was a paper in which the products of reactions of 244 with potassium 
tetrachloroplatinate were described.l59 Reaction of these two compounds in water 
gives the insoluble salt, [Pt(244)2][PtC14], whilst the same reaction in DMF gives the 
soluble complex, cis-[Pt(244)Ch] and, in both complexes, the ligand adopts a bidentate 
mode of coordination with both the pyridyl nitrogen and the sulfur acting as donor 
atoms.l59 
Two reactions have previously led to the synthesis of 242, namely: (i) the 
reaction of phenol with 2-(chloromethyl)pyridine in the presence of sodium 
ethoxide; 160 and (ii) the reaction of 2-bromopyridine with sodium benzyloxide in 
benzyl alcoho1.161 The first of these reactions gives a product which is significantly 
contaminated by 2-ethoxymethylpyridine and, in the absence of a full procedure, or 
yields, for the latter, it was decided to investigate the preparation of this ligand by the 
reaction of 2-(chloromethyl)pyridine hydrochloride with phenol under phase transfer 
catalysed conditions. Thus, equimolar quantities of these two reagents were refluxed in 
benzene and aqueous sodium hydroxide with a catalytic amount of tetrabutylammonium 
hydroxide (TBAH) (scheme 2.15). This gave, after work-up and distillation, the desired 
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compound, 242, in good yield. The ligand was completely characterised by lH and 13C 
NMR spectroscopy and by mass spectrometry. 
Given the success of phase transfer catalysis in the preparation of 242, the 
synthesis of 241 under the same conditions was attempted. Therefore equimolar 
quantities of 2-hydroxypyridine (2(1H)-pyridone) and benzyl chloride were refluxed 
with a catalytic amount of TBAH in benzene and aqueous sodium hydroxide. lH NMR 
analysis of the crude solid from this reaction suggested that it was not the expected 
0-alkylated compound, 241-which is a liquid at room temperature-but was, instead, 
the N-alkylated product 1-benzyl-2(1H)-pyridone (245) (scheme 2.16).162,163 
Following recrystallisation of the crude solid from petroleum ether, this was confirmed 
by a melting point determination. In addition, 245 was also characterised by IR and 13C 
NMR spectroscopy and by mass spectrometry. Closer examination of the lH NMR of 
the crude solid showed that 241 was present. The ratio of N-alkylation: 0-alkylation 
was determined as 97:3, which differs from the 84:16 ratio previously reported for the 
reaction performed under similar conditions with tetrabutylammonium bromide as the 
catalyst.164 
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Previously, 241 has been prepared under phase transfer conditions by the 
reaction, in toluene, of 2-chloropyridine and benzyl alcohol in the presence of 
potassium hydroxide with 18-crown-6 as the catalyst.165 This reaction was repeated 
using TBAH in place of 18-crown-6 and the desired compound was isolated, after 
distillation, as an oil in good yield (scheme 2.17). The observed lH NMR and mass 
spectra of this ligand were in agreement with those previously reported and full 
characterisation was completed with the acquisition of a Be NMR spectrum. 
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There are several reports in the literature concerning the preparation of 243, the 
sulfur analogue of 241.166-169 The most convenient method for the preparation of this 
compound is the reaction of 2-mercaptopyridine with benzyl chloride either in 
acetone166 or under phase transfer conditions,167,168 the latter method giving lower 
published yields. 
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Given the ease with which the ether, 241, was prepared bythe phase transfer 
reaction of 2-chloropyridine and benzyl alcohol (vide supra), it was decided to 
investigate whether a similar reaction between 2-chloropyridine and benzyl mercaptan 
would give the analogous thioether, 243. Thus, reaction, in toluene, of 2-chloropyridine 
and benzyl mercaptan in the presence of potassium hydroxide with TBAH as the 
catalyst gave the desired compound in satisfactory yield (scheme 2.17). The compound 
was fully characterised by IR and 1 H and 13C NMR spectroscopy and by mass 
spectrometry. The chemical shifts observed in the 1H NMR spectrum and the 
fragmentation pattern observed in the mass spectrum are in close agreement with those 
previously reported.167,168 
The final compound in this series, 244, was synthesised according to a literature 
procedure.l59,l70 Thus, reaction of sodium thiophenoxide and 2-chloromethylpyridine 
hydrochloride gave the desired compound which was fully characterised by IR and 1 H 
and 13C NMR spectroscopy and by mass spectrometry. The alternative preparation-in 
a paper which investigates the compound's anti-inflammatory properties-involves the 
reaction of 2-(hydroxymethyl)pyridine and thiophenol in refluxing hydrobromic acid 
and this was not repeated as it gives lower reported yields.171 
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Having prepared and characterised the four target ligands, investigation of their 
coordination chemistry·· commenced with their reactions with lithium 
tetrachloropalladate in methanol at room temperature. Reaction of 241 with lithium 
tetrachloropalladate was carried out without stirring of the reaction mixture, in the hope 
that this might give the direct deposition of crystalline product. This was not the case 
and the reaction gave a yellow powder, which has limited solubility in chloroform. An 
IR spectrum of the solid was recorded and microanalysis gave the formulation 
Pd(241)2Ch (246), which suggested the formation of a coordination complex, assumed 
to have trans stereochemistry. 
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Figure 2.15 Variable temperature lH NMR spectra of 246 
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Acquisition, at ambient temperature, of I H NMR data for the complex gave a 
spectrum (figure 2.15) in which only two triplets were resolved, all other resonances 
displaying significant broadening. Acquisition of spectra at increasing temperatures 
saw all of the resonances sharpen and take on the familiar coupling pattern of the 
ligand, confirming that the ligand was not cyclometallated. Subsequent homonuclear 
decoupling experiments permitted the assignment of all signals in the spectrum and the 
two resonances which are not broadened at the lower temperature were assigned to H-3 
and H-4 of the pyridine ring. 
The 13C NMR spectrum was acquired only at ambient temperature because, 
given the low solubility of the complex, acquisition of a spectrum at higher temperature 
would necessitate a large number of transients with consequent risk of damage to the 
NMR probe. The 13C NMR spectrum so recorded enabled the assignment of all 
signals, with those for the ortho carbons and for C-6 being the most broadened. Hence, 
the complex was fully characterised, the NMR data supporting the formulation of the 
complex as 246. 
The nature of the temperature dependent process which leads to the broadening 
of the NMR spectra is assumed to be interconversion between syn and anti rotamers as 
has been observed for a number of related trans-dichloropalladium coordination 
complexes described above (scheme 2.18). 
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Reaction of 242 with lithium tetrachloropalladate was carried out without 
stirring of the reaction mixture, as in the reaction of 241. Again, no crystals were 
formed and the product was obtained as a yellow powder. Microanalysis, following 
recrystallisation by diffusion of petroleum ether into a chloroform solution of the 
product, gave the formulation Pd(242)2Cb (247), which again suggested the formation 
of a coordination complex, assumed to have trans stereochemistry. 
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Figure 2.16 Variable temperature lH NMR spectra of 247 
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As with the analogous complexes, 234 and 246, the 1 H NMR spectrum of the 
above complex displays an interesting temperature effect (figure 2.16). At ambient 
temperature there are only two well-resolved signals in the spectrum, and these are 
assigned to the resonances for H-3 and H-4 on the pyridine rings. ID-TOCSY 
experiments enabled the assignment of the resonances for H-5 and H-6 with these two 
signals appearing as a broad singlet and a broad doublet respectively. The resonances 
for the phenyl ring protons are all broad and overlap to such an extent that their 
assignment is not possible. Upon heating to 53°C all resonances sharpen appreciably 
and are able to be assigned with the ortho, meta and para protons appearing as the 
expected doublet, triplet and triplet respectively. The resonance for H-6 is not as 
well-resolved as might be expected at this temperature and it appears as a broad signal 
rather than a sharp doublet. 
The 13c NMR spectrum of 247 has only been acquired at ambient temperature 
because of low solubility. However, at this temperature the signals for C-6, ortho and 
methylene carbons are quite broad, the broadening of the latter of particular interest as 
this is not reflected in the NMR spectrum of the attached protons. 
The nature of the temperature dependent process which leads to the broadening 
of the NMR spectra of 247 is assumed to be the same as that observed for 246, namely 
interconversion of syn and anti rotamers which is relatively fast on the NMR timescale 
(scheme 2.19). It is noteworthy that in the variable temperature lH NMR spectra of 246 
and 247, the signal for the methylene protons is broadened in the spectrum of 246 but 
not in the spectrum of 247. A possible explanation is that, in 246, the methylene group 
is adjacent to the phenyl ring and, therefore, its magnetic environment is more 
influenced by the relative positions of the phenyl rings-that is, syn or anti -than is the 
environment of the corresponding methylene group in 247, which has an oxygen atom 
between it and the phenyl ring. 
72 
p 
do ,,,cp N-Pd'-' N I I.,.... ~ II 
0 
d 
ANTI 
247 
Scheme 2.19 
SYN 
Reaction of 243, the thioether analogue of 241, with lithium tetrachloropalladate 
gave the coordination complex, Pd(243)2Clz as a pale yellow powder in good yield. 
This complex is insoluble in common NMR solvents and was characterised, therefore, 
by IR spectroscopy and microanalysis. 
As discussed above, 244 is the only ligand in this series for which there is any 
literature report of complexation reactions, the ligand coordinating to platinum(II) in a 
bidentate fashion.159 Reaction of this ligand with lithium tetrachloropalladate gave the 
corresponding dichloropalladium(II) complex, Pd(244)Cb (248) as analytically pure, 
orange microcrystals which are insoluble in chloroform but display good solubility in 
DMSO. The complex was fully characterised by FAB mass spectrometry and by IR 
and 1 H and Be NMR spectroscopy. The appearance of the geminal methylene protons 
as an AB quartet in the 1 H NMR spectrum further confirms the formation of a chelate 
ring containing the methylene bridge. 
248 
It is interesting to contrast the product obtained upon reaction of 242 with 
lithium tetrachloropalladate to that obtained upon reaction of the analogous thioether, 
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244. As discussed above, reaction of the ether gives a his-ligand mononuclear 
dichloropalladium complex in which the ligands are coordinated solely through the 
pyridyl nitrogen. Reaction of the thioether, however, gives a mononuclear dichloro 
complex in which the ligand is coordinated in a bidentate fashion through the pyridyl 
nitrogen and the sulfur atom. This is consistent with the fact that palladium(II) is a 
'soft' metal that shows a preference for bis-monodentate N-coordination over 
N,O-bidentate coordination, and N,S-bidentate coordination over bis-monodentate 
N -coordination, upon reaction-under the same conditions-with these structurally 
related ligands. 
Having established that reaction with lithium tetrachloropalladate does not lead 
to cyclopalladation, with concomitant formation of a seven-membered palladacycle, the 
reactions of the four ligands with palladium acetate were investigated, as were the 
reactions with rhodium trichloride. Regardless of solvent or temperature, all attempts at 
direct cyclometallation of the ligands with these reagents were unsuccessful. 
Subsequent attempts at indirect cyclometallation via ortho-lithiated derivatives (vide 
supra) were also unsuccessful with unreacted ligand being recovered from the 
attempted lithiation reactions. 
An alternative approach to the indirect cyclometallation of N-donor ligands is 
via the his-ligand dichloro coordination complex. Abstraction of halogen atoms from 
these complexes creates coordinative unsaturation at the metal centre, increasing its 
electrophilicity and promoting subsequent attack on, and cleavage of, the 
ortho-carbon-hydrogen bond of the adjacent aryl ring)72, 173 Application of this 
method to primary benzylamines has facilitated the preparation of cyclo-palladated and 
-platinated complexes which are not accessible via direct cyclometallation 
reactions.l74,175 
Some preliminary investigations on this type of reaction had been performed on 
the N-coordinated 2-phenoxypyridine complex, 234, but subsequent direct 
cyclopalladation of this ligand removed the impetus from these studies. Given the 
availability of both 246 and 247, the seeming unreactivity of both ligands to direct 
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cyclometallation and the stated aim to prepare complexes with seven-membered 
metallocycles, their reactions with silver tetrafluoroborate were investigated. This 
silver salt was selected because tetrafluoroborate is a poorly coordinating anion and as 
such should, upon chloride abstraction from the complex, maximise the electrophilicity 
of the palladium centre. 
Reaction of 246 with silver tetrafluoroborate175 gave, upon filtration, a 
precipitate of silver chloride the weight of which corresponded to the removal of both 
chloro ligands from the palladium centre. Despite this initial success all subsequent 
attempts to isolate palladium complexes from the filtrate gave, at best, insoluble solids 
were could not be characterised. 
Similar reaction of 247 also gave a precipitate of silver chloride corresponding 
to the removal of both chloro ligands. Exhaustive attempts to isolate palladium 
complexes from the reaction mixture, after addition of sodium bromide, gave a small 
quantity of well-formed orange needles suitable for single crystal X-ray structure 
determination. 
The solving and refinement of a partial X-ray data set revealed that the crystals 
were not of the desired bromo-bridged cyclopalladated dimer, but of the coordination 
complex, trans-Pd(242)2Brz (249) (figure 2.17). Of particular interest in the structure 
of this complex is the fact that the phenyl rings lie approximately coplanar with the 
coordinated pyridine rings, in contrast to the orthogonal arrangement observed for 234 
(vide supra). Given that the relatively poor quality of the crystal used for the collection 
of this data set and that the complex was not cyclopalladated, further data were not 
collected and the structure was not further refined. 
The reaction of 242 with potassium tetrabromopalladate in methanol was carried 
out for the purposes of comparing the product with the mixture of complexes obtained 
above. The reaction mixture was left to stand overnight without stirring in order to 
allow direct formation of a crystalline product. The product was obtained as fine 
yellow needles, the melting point, IR and lH NMR spectra of which were identical to 
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Figure 2.17 Perspective view of 249 
that of the orange needles obtained upon reaction of 247 with silver tetrafluoroborate. 
Examination of the 1 H NMR spectrum of the dibromopalladium complex, 249, which is 
unchanged upon heating above ambient temperature, suggests that the complex forms 
as a mixture of syn and anti rotamers which are interconverting slowly, if at all, on the 
NMR timescale. This is in contrast to the dichloropalladium complex, 247, which does 
show interconversion at ambient temperature, the difference in observed temperature 
dependence presumably due to the increased rotational barrier upon replacement of the 
chlorine atoms with the significantly larger bromine atoms. 
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2.5 CONCLUSION 
In summary, the preparations of several noteworthy complexes have been 
described. Of particular note is the coordinatively unsaturated rhodium complex, 204. 
The preparation and characterisations of the cyclopalladated complexes, 237 and 239, 
both of which incorporate a six-membered metallocycle have also been described. A 
number of the complexes exhibit temperature-dependent NMR spectra and an 
explanation for the molecular processes leading to this observation, based on common 
and changing structural elements in the complexes, has been proposed. All attempts to 
prepare greater than five-membered rhodacycles were unsuccessful, as were attempts to 
prepare seven-membered palladacycles from a series of four pyridine-containing 
ligands. 
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Reactions of 
2-Benzoylpyridine 
with 
Rhodium Trichloride 
3.1 INTRODUCTION 
The coordination chemistry of 2-benzoylpyridine (301) has been regularly 
studied in the past. This versatile ligand has been reported to coordinate in a variety of 
modes. In coordination complexes it can act as a monodentate ligand, with coordination 
by either the nitrogen176-179 or oxygen atom;180 as a N,O-bidentate coordinated ligand 
with a five-membered chelate ring;176,181-185 or as a bridging N,O-coordinated ligand in 
binuclear complexes.177 
301 
The reactions of 301 with palladium chloride186 and palladium acetate54,186,187 
have been reported, the former giving rise to a coordination complex, Pd(301)2Ch and 
the latter to a cyclopalladated acetate-bridged dimer, [Pd(301-H)(0Ac)]2, in which 301 
acts as aN, C-coordinated ligand and forms a six-membered metallocycle. Ligand 
exchange of this acetate-bridged dimer with lithium chloride gives the chloro-bridged 
analogue, [Pd(301-H)Cl]2,54,186 which has also been indirectly prepared from the 
ligand via a transmetallation reaction.125 Reaction of the chloro-bridged dimer with 
thallium acetylacetonate186 or sodium acetylacetonate54 gives the corresponding 
mononuclear complex, Pd(301-H)(acac), which has been fully characterised by lH and 
13C NMR spectroscopy.54 
The reaction of 301 with rhodium(III) trichloride under mild conditions has been 
previously reported.l88,189 This reaction has been re-examined and attempts made to 
induce cyclometallation reactions under more vigorous reaction conditions. This chapter 
reports the results of these attempts, together with the single crystal X-ray crystal 
structures of three rhodium complexes of 2-benzoylpyridine, in two of which it acts as 
an N-0 chelating ligand and in the other as a cyclorhodated N, C-bidentate ligand. 
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3.2 REACTIONS OF 2-BENZOYLPYRIDINE WITH 
RHODIUM(III) TRICHLORIDE. 
Although some ligands readily undergo cyclorhodation with rhodium trichloride 
in refluxing ethanol, it has previously been reported that reaction of 301 under these 
conditions does not effect cyclometallation,l88 Osborne and McWhinnie described a 
series of octahedral rhodium(III) complexes of 301, to which they tentatively assigned 
structures on the basis of IR spectroscopic data.188 These reactions have been 
re-examined and lH and 13c NMR spectroscopy and single crystal X-ray diffraction 
studies used to assign the structures more definitively. 
Reaction of 301 with rhodium(III) trichloride trihydrate and sodium perchlorate 
in refluxing aqueous ethanol gives, as previously reported, a yellow salt that was 
assigned 188 the centrosymmetric structure 302. In accord with this proposed structure, 
the 1 H NMR spectrum (table 3.1, p.89) shows that the two coordinated ligands are 
symmetrically equivalent. However, four possible structures, 302-305 (figure 3.1), 
would fulfil this condition, and so it was necessary to obtain crystals of the complex for 
a single crystal X-ray structure determination. Recrystallisation from 
acetonitrile/methanol furnished suitable crystals as yellow blocks. 
302 303 
304 305 
Figure 3.1 
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Crystal Structure of Rh(30l)2Cb.Cl04 
The rhodium complex, Rh(301)2Clz.Cl04, crystallises in the monoclinic space 
group C2/c, the asymmetric unit of which comprises half a molecule of the octahedral 
cation, which lies on a crystallographic centre of inversion, and half a perchlorate anion, 
which lies on a two-fold rotation axis (figure 3.2). 
Figure 3.2 Perspective view and atom labelling of Rh(301)zClz.Cl04. Selected bond 
lengths (A) and angles (0 ): Rh-N1 2.019(2), Rh-01 2.009(2), Rh-Cl 2.3212(7); 
Nl-Rh-01 80.25(8), N1-Rh-Cl 88.17(7), Cl'-C1-C2 124.0(2). 
This single crystal X-ray analysis thus confirms the stmcture of the yellow 
complex as being the centrosymmetric isomer 302 previously proposed.188 The 
geometry about the rhodium atom is octahedral, in contrast to some of the six-coordinate 
copper complexes of 301, which contain relatively long copper-oxygen bonds)Sl-185 
The 2-benzoylpyridine ligand is coordinated in a N,O-bidentate mode and has similar 
bonding geometry to that previously reported for a number of copper complexes of 
301)81-185 The five-membered chelate ring deviates slightly from planarity 
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(Rhl-Nl-C2-Cl torsional angle= 10.9 °) and is inclined to the phenyl ring mean plane 
at an angle of 37.0 o. There are no unusually short intermolecular contacts. 
Upon warming in water, the yellow complex 302 has been reported to undergo 
rearrangement to an orange isomer, that was assigned structure 303 on the basis of 
infrared data.188 This reaction is found to be somewhat variable, in that it also produces 
a second product that is discussed below. The orange isomer is more conveniently 
prepared in quantitative yield (by lH NMR spectroscopy), from an acetonitrile solution 
of 302 left to stand at room temperature for 24 hours. The 1 H and Be NMR spectra of 
the orange isomer (tables 3.1 and 3.2, p.89 and 90) also show that the two coordinated 
ligands are in identical environments. However, this would be consistent with not only 
the C2v isomer 303, but also the two C2 isomers 304 and 305 and, therefore, further 
investigation of the structure of this complex was required. Diffusion of ether vapour 
into an acetonitrile solution of this orange complex produces very thin yellow plates, 
which were used for a single crystal X -ray crystal structure determination. 
Crystal Structure of rearranged Rh(301)2Ch.Cl04 
The rearranged rhodium complex, Rh(30l)2Cl2.Cl04, crystallises in the 
monoclinic space group C2/c, the asymmetric unit of which contains the octahedral 
cation, a disordered perchlorate anion and two molecules of acetonitrile (figure 3.3). 
This single crystal X-ray structure determination reveals that this isomer has, in 
fact, the c2 structure 304, with cis-chlorides and trans-nitrogens, rather than the 
previously proposed trans-dichloride structure 303. The potential C2 symmetry of the 
cation is destroyed in the solid state by torsion angle differences in the orientations of the 
phenyl rings. The bonding geometry about the rhodium atom and within the 
2-benzoylpyridine ligands is similar to that in the complex 302. Again, there are no 
unusually short non-bonded interactions. 
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N21~ 
013A , 
011 
012 
~N11 
Figure 3.3 Perspective view and atom labelling of rearranged Rh(30l)2Cl2.Cl04 . 
. Selected bond lengths (A) and angles (0 ): Rh-Nl 2.009(8), Rh-NlA 2.013(8), Rh-01 
2.051(8), Rh-OlA 2.051(8), Rh-Cll 2.290(4), Rh-Cl2 2.307(4); N1-Rh-N1A 
174.2(4), Nl-Rh-0 79.5(3), NlA-Rh-OlA 79.9(3), Cll-Rh-Cl2 91.7(1). 
As described above, 302 undergoes rearrangement to 304 on warming in water. 
This reaction also produces varying amounts of a red compound, the yield of which 
increases with time. Recrystallisation of this mixture from methanol/acetonitrile afforded 
a pure sample of this compound 306, as very fine needles, which were unsuitable for 
single crystal X -ray crystallographic structure determination. The 1 H NMR spectrum of 
these needles (table 3.1, p.89) is considerably more complex than that of 302 or 304 
and shows the presence of two 301 ligands in chemically different environments. 
Complete assignment of this spectrum was achieved by means of a series of one- and 
two-dimensional techniques. Specifically, the individual spin systems were located by 
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means of lD-TOCSY and COSY techniques and the two rings within each ligand were 
paired up by difference NOE spectroscopy on the basis of an NOE enhancement of the 
ortho protons of the phenyl ring on irradiation of the signal for the H-3 proton of the 
pyridine ring. 
Comparison of the chemical shifts of the two ligands in 306 with the spectra of 
302 and 304 (table 3.1) clearly shows that one of the ligands is coordinated in a 
N, 0-bidentate mode and the other in a monodentate mode. The 1 H NMR spectrum, IR 
spectra, microanalysis and the fact that this compound is a non-electrolyte, are in 
+he 
agreement witlJ.Astructure proposed by the previous workers188 who suggested that this 
compound, 306, is an octahedral rhodium complex containing two chloride ligands, one 
hydroxy ligand, and two 301 ligands one of which is N, 0-bidentate and the other 
0-monodentate. The exact stereochemistry of this compound remains unknown. 
In acetonitrile solution, this compound undergoes further rearrangement over a 
period of 6 days at room temperature to a new complex 307 which also has one 
N, 0-bidentate and one monodentate ligand. The 1 H and Be NMR spectra of 307 
(tables 3.1 and 3.2) were again fully assigned using techniques similar to those 
described above. Again, the exact structure of this compound remains unknown; it 
does, however, display an interesting exchange phenomenon. Although the two 
benzoylpyridine ligands were not observed to exchange on the NMR timescale, they 
were shown to undergo slow exchange by magnetisation transfer experiments. In 
particular, irradiation of the pyridine H-3 proton (at 7.08 ppm) of the monodentate 
ligand resulted in transfer of magnetisation to the signal (at 8.57 ppm) for H-3 of the 
bidentate ligand. This exchange process presumably occurs by dissociation of the 
bidentate ligand to a five-coordinate intermediate, followed by chelation of the ligand 
which had originally been monodentate: a degenerate exchange process. 
The original aim of the investigation of the reactions of rhodium(III) with 301 
was to effect cyclorhodation of the ligand. To this end the reaction with rhodium 
trichloride trihydrate under more vigorous reaction conditions was investigated. 
Reaction of rhodium trichloride trihydrate with two equivalents of 301 in refluxing 
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2-methoxyethanol gave a complex, formulated as Rh(301-H)(301)Ch (308), in high 
yield (Scheme 3.1); This complex is soluble in chloroform and was shown by NMR, 
IR spectroscopy and microanalysis to be a mononuclear rhodium complex containing 
two chloride ligands and two 301 ligands in different modes of coordination, one of 
which is cyclometallated. The existence of the cyclorhodated ligand in the complex was 
revealed in the lH NMR spectrum by the conversion of a five proton phenyl-ring spin 
system into a four proton system resonating between 7.4 and 8.0 ppm and located and 
assigned by a lD-TOCSY experiment. The full assignment of the 1H and l3c NMR 
spectra of 308 (tables 3.1 and 3.2) were made by methods similar to those described 
above. 
6' 0 3 
5
' 6(6~ 4 RhCia.3H20 I I 0 
4' ~ 2' N ~ 5 2-methoxyethanol 
3' 6 
301 308 
Scheme 3.1 
A mononuclear octahedral complex containing two identical monodentate ligands 
and two different chelating ligands can exist as six possible diastereoisomers. Of the six 
possible structures for the above compound the structure shown, 308, was deduced to 
be the most probable on the following basis: (i) a comparison of the NMR chemical 
shifts with those of other cyclorhodated compounds; 186,187 (ii) the fact that 
cyclorhodation of nitrogen containing ligands usually produces complexes with 
cis-chlorides;l86,187 (iii) a trans-dichloride isomer with a cyclometallated ligand would 
be highly sterically hindered; and (iv) most importantly, the observation of a significant 
NOB enhancement of the signal for H-3' (at 7.89 ppm) of the metallated benzene ring on 
irradiation of the pyridine H-6 proton (at 8.99 ppm) of the non-cyclometallated ligand, 
which requires these two rings to be mutually cis. 
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Osborne and McWhinnie reported that the red complex, 306, could be formed 
from the yellow complex, 302, or the orange complex, 304, by warming in water (vide 
supra). Refluxing this red complex in 75% aqueous ethanol gave a yellow product, 
soluble in chloroform, which they formulated as Rh(301)2C1],188 This complex 
contains two 301 ligands and it was reported that one is coordinated in a bidentate 
fashion through the nitrogen and oxygen atoms, whilst the other is monodentate 
N-coordinate.188 This reaction sequence was repeated and, indeed, found to give a 
yellow complex which was found to be soluble in chloroform. However, rather than 
having the structure described above, this complex was found by IR and 1 H NMR 
spectroscopy to be the yellow complex, 308, the second ligand being cyclorhodated 
rather than N-monodentate. Examination of the microanalysis data in the original 
reportl88_in which there is no chlorine analysis-suggests that the authors had, in fact, 
prepared Rh(301-H)(301)Ch.21f2H20, rather than Rh(301)2Cb. 
In order to confirm unambiguously the stereochemistry of 308, attempts were 
made to recrystallise a sample of the complex for a single crystal X-ray structure 
determination. A variety of solvents and solvent mixtures were used but these attempts 
gave, at best, fine yellow needles unsuitable for crystallography. However, an attempted 
recrystallisation by diffusion of pentane into a DMSO/chlorofmm solution of the complex 
produced yellow crystals suitable for X -ray analysis. The X -ray crystal structure and 
elemental analysis of these crystals showed that they were not of the original complex but 
of a solvolysis derivative. 
Crystal Structure of Rh(301-H)(DMS0)2Cl2 
The rhodium complex, Rh(301-H)(DMS0)2Ch (309), crystallises in the 
monoclinic space group P21/n, the asymmetric unit of which is comprised of a rhodium 
atom coordinated to a single cyclometallated ligand, two cis-chloride ligands and two 
DMSO ligands, one coordinated through sulfur and the second through oxygen, and a 
disordered solvate molecule (figure 3.4). This solvate molecule was initially thought to 
be a highly disordered chloroform molecule, but attempted refinement as such was 
unsuccessful. After many trial attempts at refinement it became apparent that the solvate 
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site was occupied by both a chloroform and a DMSO molecule, with equal (half) 
occupancies. This is the solvent combination from which the crystals had deposited. In 
support of this interpretation, elemental analysis of these crystals indicated the presence of 
half a molecule of DMSO as solvate, the chloroform having been lost on drying. 
03 
Cl4 
Figure 3.4 Perspective view and atom labelling of 309. Selected bond lengths (A) 
and angles (0 ): Rhl-C2' 2.005(5), Rhl-Nl 2.051(4), Rhl-01 2.234(3), Rh1-S2 
2.227(1), Rhl-Cll 2.355(1), Rhl-Cl2 2.346(1); N1-Rhl-C2' 89.6(2), Cll-Rh-Cl2 
92.11(5), S2-Rh1-01 90.5(1), C2-C7-Cl' 121.3(5). 
The crystal structure determination unambiguously demonstrates that the ligand 
has undergone cyclometallation. This results in a six-membered chelate ring which exists 
in a boat conformation. It is well known that cyclometal1ations which produce 
six-membered metallocycles are more difficult to induce than those that produce 
five-membered rings (vide supra). The presence of varying numbers of differently 
coordinated DMSO ligands in a single complex has been reported previously for crystal 
structures of ruthenium(II),l90-193 ruthenium(III),194 palladium(II),l95,196 
platinum(JI)l97 and rhodium(IJI)l98,199 complexes with monodentate ancillary ligands. 
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Structure 309 is the first single crystal X-ray structure to contain differently coordinated 
DMSO ligands together with a chelating ligand. 
When coordinated through sulfur, DMSO is a weak n-acceptor ligand and when 
coordinated through oxygen it is a strong cr-donor.193 This leads to a rationalisation for 
the formation of this novel complex 309 from 308 (scheme 3.2), and provides further 
support for the structure of 308. Given the strong trans-effect of the metallated carbon 
donor, it is likely that the rhodium-oxygen bond is the weakest bond to rhodium in the 
complex 308, and hence the most susceptible to substitution by DMSO. The metallated 
phenyl ring is a weak n-acceptor and a strong a-donor. The DMSO coordinating trans to 
this ring is, therefore, unlikely to coordinate through sulfur, as this would lead to 
competition for electron density in dn-donor orbitals on the Rh centre; 193 thus 
coordination through oxygen occurs for this DMSO molecule. Cleavage of the 
rhodium-oxygen bond in 308 converts the previously bidentate 2-benzoylpyridine ligand 
into a monodentate ligand coordinated through the pyridyl nitrogen. This results in a loss 
of stabilisation due to the chelate effect, which means that this ligand is prone to 
substitution by a second DMSO molecule. This DMSO ligand coordinates through sulfur 
due to the availability of electron density in dn-donor orbitals on the Rh atom which 
results from the pn-donor chloride ligand trans to it. 
0 
308 
DMSO 
0 
Scheme 3.2 
The final reaction in this series to be investigated was the reaction of 308 with 
. thallium acetylacetonate in dichloromethane. The reaction mixture was stirred for five 
days after which it was filtered and ether vapour diffused into the filtrate. This gave a 
small quantity of well-formed yellow crystals which were, unfortunately, not suitable for 
a single crystal X-ray structure determination. This complex is soluble in chloroform and 
acquisition of lH and l3C NMR spectra in CDCI3 (tables 3.1 and 3.2) revealed that, as 
expected, the cyclorhodated Rh(301-H) moiety had remained intact. The complex was 
also shown to contain, in addition to an acac ligand, another 2-benzoylpyridine ligand in 
which the phenyl ring, as before, was not metallated. Consideration of the chemical 
shifts of the observed resonances due to this ligand, suggests that this ligand is not 
coordinated in a N, 0-bidentate fashion, as in 308, but coordinated in a monodentate 
mode through the pyridyl nitrogen. An NOE difference experiment gave, upon 
irradiation of the signal due to H-3' on the cyclorhodated phenyl ring, enhancement of the 
signal due to the ortho protons of the free phenyl ring. The formulation of the complex, 
is therefore, most likely to be Rh(301-H)(301)Cl(acac) (310), with the structure of the 
complex as shown (scheme 3.3). 
Tl(acac) 
0 0 
308 310 
Scheme 3.3 
In summary, it has been shown that, in contrast to the reactions in refluxing 
ethanol, 2-benzoylpyridine can be made to undergo cyclorhodation under forcing 
conditions. The reaction product is not, however, the normal chloro-bridged dimer with 
two cyclometallated ligands on each rhodium, but a novel complex, 308, containing the 
ligand in two different bidentate modes of coordination (N, C and N, 0). Whilst crystals 
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of this complex suitable for single crystal X-ray structure determination could not be 
obtained, the preparation and structure determination of a solvolysis product has 
provided indirect support for the structure of the novel complex. 
Table 3.1 1 H NMR chemical shifts for 301 and its rhodium complexes 
Solvent Mode a H-3 H-4 H-5 H-6 ortho meta 
301 CD3CN 8.05 8.05 7.64 8. 74 8.06 7.57 7. 70 
302 CD3CN N,O 8.83 8.65 8.43 9.93 8.29 7.87 8.08 
304 CD3CN N,O 8.75 8.62 8.39 9.93 8.04 7.75 7.96 
306 CD3CN N,O 8.64 8.44 8.17 9.54 8.17 7.81 8.00 
N 6.99 7.95 7.67 9.52 7.84 7.43 7.43 
307 CD3CN N,O 8.57 8.44 8.22 9.83 8.00 7.75 7.94 
N 7.08 7.97 7.68 9.74 7.51 7.29 7.29 
301 CDCb 8.05 7.92 7.50 8.74 8.07 7.50 7.60 
308 CDCb N,O 8.19 8.08 7.73 8.99 8.09 7.69 7.82 
N,C 8.33 8.05 7.60 9.70 7.99b 7.30C 7.45C 
7.89d 
310 CDCb N 7.08 7.71 7.12 7.78 7.92 7.39 7.32 
N,C 8.14 7.94 7.43 9.22 7.93b 7.18C 7.14e 
6.92d 
301 DMSO 8.09 8.17 7.77 8.82 8.06 7.64 7.77 
308 DMSO N,O 8.53 8.46 8.16 8.88 8.26 7.88 8.03 
N,C 8.35 8.42 8.03 9.63 7.87b 7.40C 7.57e 
7.90d 
a Coordination models of the 2-benzoylpyridine ligands in each complex 
b H-6' c H-5' d H-3' e H-4' 
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Table 3.2 13c NMR chemical shifts for 301 and its rhodium complexes 
301 CD3CN 125.1 138.3 127.4 149.5 131.7 
304 CD3CN N,O 137.1 142.8 134.6 155.6 132.2 
307 CD3CN N,O 135.7 141.2 133.3 154.8 131.3 
N 125.2 140.4 125.7 151.2 127.4 
301 CDCI3 124.6 137.0 126.1 148.5 130.9 
310 CDCI3 N 123.7 138.2 123.1 148.2 127.2 
N,C 125.4 138.3 126.0 152.3 129.5b 
301 DMSO 124.3 137.8 126.9 148.7 130.7 
308 DMSO N,O 133.6 140.2 130.8 155.3 130.7 
N,C 125.9 140.2 127.5 153.7 128.ob 
a Coordination models of the 2-benzoylpyridine ligands in each complex 
b C-6' c C-5' d C-3' e C-4' 
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Chapter our 
Ligands Containing 
Two Cyclometallation Sites 
4.1 INTRODUCTION 
This chapter describes the preparations and reactions of a number of ligands 
which are potentially capable of giving doubly cyclometallated products. The ligands 
are divided into three groups based on structural similarity. Included is an investigation 
of the bromination of 2-phenylpyridine, carried out with a view to preparing precursors 
for two of the ligands herein described. Two of the ligands discussed have been 
previously cyclopalladated and the reactions of these with rhodium trichloride are 
described. The remaining ligands have all been reacted with lithium 
tetrachloropalladate and palladium acetate under a variety of conditions and the 
products characterised. One single crystal X-ray structure determination, which 
represents the first example of its kind, is also described. 
4.2 QUATERPYRIDINE ANALOGUES 
401 Y=N,Z=N 
402 Y=N, Z=CH 
403 Y =CH, Z=N 
The preparations of the bis-chelating ligand 2,2':4',4":2",2'"-quaterpyridine (401) 
and its binuclear complex with bis(bipy)ruthenium(II) have recently been reported.200 
The complex showed a metal-metal interaction, the weakness of which was attributed to 
free rotation about the 4'-4" bond which disrupts the overlap of the 1t systems of the two 
'bipy' subunits.200 Given that the anion of 2-phenylpyridine (20 1) is the 
cyclometallated isoelectronic analogue of the well-studied chelating ligand, bipy, the 
possibility of preparing bis-cyclometallated analogues of the binuclear complexes of 
401 with ligands that contained two symmetrically coupled 201 subunits, seemed 
worthy of investigation. The two ligands in question, 2,2'-diphenyl-4,4'-bipyridine 
(402) and 3,3'-di(2-pyridyl)biphenyl (403) have not previously been cyclometallated; 
indeed a search of Chemical Abstracts revealed that 402 has only been isolated as a 
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minor by-product in the preparation of 201, by the reaction of phenylmagnesium 
bromide with pyridine 1-oxide in anhydrous benzene201 and in the same reaction with 
THF as solvent,202 while the preparation of 403 has not previously been reported. 
A similar pair of ligands, binucleating analogues of 2,2':6',2"-terpyridine (terpy), 
have been prepared and their biruthenium(II) complexes studied. The 
biruthenium(II)(terpy) complex of the bis-chelating ligand 6' ,6"-di(2-pyridyl)-
2,2':4',4":2",2"'-quaterpyridine (404) shows no electronic interaction between the two 
ruthenium centres203 (with substitution of the ancillary terpy ligand in the 4' position 
having no effect on the lack of interaction204), whilst a biruthenium(II) complex of the 
bis-cyclometallated ligand 3,3',5,5'-tetra(2-pyridyl)biphenyl (405) shows strong 
electronic interaction between the two ruthenium centres.205,206 Initially this was 
thought to be due to the fact that the ruthenium centres in the latter complex are 
connected by a 4,4'-biphenyl dianion bridge, with a torsion angle, in the solid state, 
about the central C-C bond of the bridging ligand of 22.2(7)0 205, whilst in the former 
the two metal ions are connected through a 4,4'-bipyridine bridge with the two central 
rings of the bridging ligand assumed to be perpendicular to one another in solution, 
thereby relieving steric interaction but preventing conjugation and 1t system overlap 
between the two 'terpy' subunits.203 Given this information it was felt that the 
binuclear complexes of 402 and 403 could be expected to have different 
electrochemical properties, as in such complexes of 402 the two metal centres are 
connected by a 4,4'-bipyridine bridge, whilst in complexes of 403 the metal ions are 
connected by a 4,4'-biphenyl dianion bridge. 
404 Y=N 
405Y=CH 
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Subsequently, however, the biruthenium(II)( 6-phenyl-2,2' -bipyridine) complex 
of 404 was prepared and its metal-metal interaction measured. In this complex the two 
ruthenium centres are strongly coupled despite their being connected by a 
4,4'-bipyridine bridge and, as a result of this, the strong electronic coupling between the 
two ruthenium centres in this complex and the biruthenium(II) complex of 405 is now 
attributed to the presence of two NsC donor sets about the ruthenium centres.207 
Neither of the biruthenium(II) complexes of 404 have been characterised 
crystal1ographically and, therefore, the torsion angle between the two central rings of 
the bridging ligand for these two complexes, and the extent to which any differences in 
the electronic coupling between the metal centres could be accounted for by such 
differences and their effect on 1t system overlap between the two 'terpy' subunits, is not 
known. 
Despite the differences in metal-metal interactions between the biruthenium 
complexes of the bis-chelating ligand, 404, and the bis-cyclometallated ligand, 405, 
being accounted for by the nature of the coordination sphere about the ruthenium ions, a 
comparison of similar complexes of 402 and 403 would provide further evidence to 
clarify this issue. In such complexes the only variable would be the positions of the 
nitrogen and carbon donors, relative to the bridging subunit, in the donor set of the 
bis-cyclometallated ligand. In the previous studies the position of the carbon donor 
varies between the bridging bis-cyclometallated 405 ligand and the spectator 
6-phenyl-2,2'-bipyridine ligand for the analogous complex of 404. 
The synthesis of 402 has been investigated in earlier research with three 
approaches to the synthesis being employed with varying degrees of success (scheme 
4.1).208 Firstly the previously reported preparation of this compound202 was repeated 
to give a poor yield (<5% of the crude reaction product, as estimated by lH NMR) of 
402 which was not isolated. Secondly, phenylmagnesium bromide was reacted with 
4,4'-bipyridine-1,1'-dioxide. However, despite obviating the need for pyridine coupling 
in the reaction mechanism, this reaction gave none of the desired product. Reaction of 
4,4-bipyridine with phenyllithium, a reaction analogous to that used to prepare 201 
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(vide infra), gave a complex mixture of products which was subjected to radial 
chromatography to give both 2-phenyl-4,4'-bipyridine and 402 in low yield. 
0 N+ ~r I o· 
0 
-:?' 
N 
I " 
PhLi 4 
o· <5% 
I N+ Ph~ I " 4 
402 
Scheme 4.1 
Given the failure of these reactions to produce synthetically useful quantities of 
402, it was felt that the best approach to the synthesis of both 402 and 403 was by a 
fourth approach: the nickel(O)-catalysed coupling of appropriately halogenated 
2-phenylpyridine precursors. This strategy is analogous to that used in the preparation 
of 401200 and, indeed, many other polyazine,203,204,207 biheterocyclic,209-213 and 
biaryl compounds.210,211,214 
Utilisation of this procedure required the preparation of the halogenated 
precursors, namely 4-halo-2-phenylpyridine and 2-(3-halophenyl)pyridine. It has been 
shown that for nickel(O)-catalysed coupling reactions aryl bromides react faster and 
give higher yields of biaryls and bipyridines than do the corresponding aryl 
chlorides,211 therefore the initial synthetic targets were 4-bromo-2-phenylpyridine ( 406) 
and 2-(3-bromophenyl)pyridine (407). 
The bromopyridine 406 has previously been prepared by aromatisation of the 
dihydropyridine obtained from the reaction of 4-bromopyridine with phenylmagnesium 
chloride.215 The bromobenzene 407 has previously been prepared by the treatment of 
diazotised 3-bromoaniline with pyridine to give the three isomeric 
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(3-bromophenyl)pyridines, which were then separated.216,217 Given that none of the 
above methods gave either of the required compounds in greater than 50% yield, it was 
decided to investigate the possibility of preparing them by direct bromination of 201. 
An extensive literature search revealed that no attempts to directly brominate 201 have 
been reported. 
Br Br 
1':::: 
N ..& 
406 407 
Given that bromination is an electrophilic substitution reaction, it would be 
expected that such a reaction of 201 would lead to bromination of the phenyl ring, 
rather than the pyridine ring, as the electron-withdrawing inductive effect of the 
electronegative nitrogen atom leads to low reactivity of pyridine rings towards 
electrophilic attack.218 Hence a direct bromination of 201 is unlikely to yield any of the 
desired 4-brominated pyridine 406. Considering the influence of the pyridine ring on 
the position of attack of the bromine electrophile on the phenyl ring, it would be 
expected that substitution would occur in the meta-position as the electron-withdrawing 
pyridine substituent deactivates the phenyl ring to electrophilic substitution, the 
meta-positions being the least deactivated.219 The expected product of such a reaction 
would thus be the desired 3'-brominated compound, 407. Note also that protonation of 
the pyridine nitrogen, as would be expected if the reaction were carried out in acidic 
media, would lead to further deactivation of the system. 
Despite the absence of any reported attempts to brominate 201, a number of 
different procedures for the bromination of deactivated aromatic substrates have been 
described in the literature and several of these reactions were carried out. The reactions 
produced a variety of mono- and di-brominated compounds (scheme 4.1). For each 
reaction the product mixture was analysed by 1 H NMR spectroscopy in order to 
determine its composition. The product mixture for one of the reactions was 
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chromatographically separated to enable the complete characterisation of a 
di-brominated 2-phenylpyridine. 
Investigation of the bromination of 201 commenced with the reaction of this 
substrate with bromine and iron powder in glacial acetic acid so1ution.220 This reaction 
(table 4.1, A) gave a quantitative return of unreacted 201. 
Br Br 
Br Br 
+ + 
201 407 408 409 410 
Scheme4.2 
Table 4.1 Composition of the product mixture obtained upon attempted bromination of 
201 under a variety of reaction conditions 
RXN. CONDITIONS 201 407 408 409 410 
A Br2/Fe/CH3C02H 100 
B Br2/SbCls/ClC2H4Cl 89 trace 11 
c Br2/Ag2S04faq. H2S04 (16M) 12 16 36 26 10 
D KBr03/aq. H2S04 (6M) 100 
E KBr03/aq. H2S04 (9M) 39 18 24 <5 5 
F 100 
The bromination of deactivated aromatic compounds in 1 ,2-dichloroethane with 
the mixed halogen BrCl formed in situ by the interaction of antimony(V) chloride and 
bromine has been reported.221 Reaction of 201 under these conditions (table 4.1, B) 
gave, after work-up, an oil containing 89% unreacted starting material and only a trace 
of the desired product 407, with the remaining 11% being the para-brominated product, 
2-( 4-bromophenyl)pyridine ( 408). 
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Halogenations of aromatic compounds bearing an electron-withdrawing group 
have traditionally been carried out under severe conditions involving high temperatures 
and/or strong electrophilic catalysts with the silver(I) salt-catalysed bromination 
reaction in concentrated acid being an example. As part of the investigation 201 was 
treated with bromine in aqueous sulfuric acid in the presence of silver sulfate222 (table 
4.1, C) to give, after work-up, a small quantity of an oil containing four different 
brominated products, namely: 407 (16%); 408 (36%) and the two dibrominated 
compounds 2-(2,5-dibromophenyl)pyridine (4 0 9 ) (26%) and 
2-(3,4-dibromophenyl)pyridine (410) (10%), with the remaining 12% being unreacted 
201. 
Potassium bromate in sulfuric acid has been in use as a brominating agent since 
1875 and the reaction has been the subject of investigations to establish the identity of 
the attacking species which is believed to be hypobromous acid.223,224 Reaction of 201 
with potassium bromate in 65% sulfuric acid (table 4.1, E) gave, after work-up, an oil 
in good yield which contained the four brominated products previously observed in the 
following proportions: 407 (18%); 408 (24%); 409 (<5%) and 410 (5%) with 39% 
being unreacted 201. Separation of this mixture by radial chromatography afforded a 
pure sample of 410 which was fully characterised. 
The yield of meta-bromonitrobenzene when nitrobenzene is brominated using 
this procedure has been shown to be dependent upon the sulfuric acid concentration.224 
When the above reaction of 201 was repeated with sulfuric acid concentrations of 38% 
(table 4.1, D) and 85% (table 4.1, F) a quantitative return ofunreacted starting material 
was obtained. 
Having established that the direct bromination of 201 did not offer a convenient 
method for the preparation of 406 or 407, the preparation of the required halogenated 
precursors by other means was necessary. Whilst there is no straight-forward method 
for the synthesis of 4 0 6, the preparation of its chlorinated analogue, 
4-chloro-2-phenylpyridine (411), in good yield from 201 via the corresponding 1-oxide 
is well-known.225,226 
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Reaction of pyridine with phenyllithium gave 201227 in satisfactory yield, with 
the reaction giving a small amount of a by-product identified as 4,4'-bipyridine. 
Treatment of an acetic acid solution of 201 with hydrogen peroxide gave 
2-phenylpyridine 1-oxide (412)228 which was then treated with sulfuryl chloride to give 
411 contaminated by a small amount of 6-chloro-2-phenylpyridine (413) (scheme 
4.3).226 The required 411 was separated from the mixture by treatment with alcoholic 
picric acid followed by liberation of the free base with aqueous sodium hydroxide 
solution. 
0 N Phli 
201 412 
Cl t so,c1, 
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411 413 
Scheme 4.3 
The previously reported preparations of 407 involve the treatment of diazotised 
3-bromoaniline with pyridine and separation of the three resultant isomeric 
(3-bromophenyl)pyridines.216,217 Diazotisation of 3-bromoaniline with nitrous acid228 
followed by addition to pyridine gave, after work-up, a small quantity of the three 
(3-bromophenyl)pyridines contaminated by unreacted 3-bromoaniline and other 
3-bromosubstituted aromatic species. Separation of this oil by radial chromatography 
afforded a pure sample of 407, which was fully characterised. The reaction was 
repeated using isoamyl nitrite as the diazotising agent217 to give, after work-up and 
column chromatographic separation, 407 in satisfactory yield (scheme 4.4). 
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Scheme 4.4 
With the preparation of 411 and 407, the halogenated precursors of 402 and 403, 
accomplished, attention turned to the development of a coupling procedure that would 
give the two bis-cyclometallated ligands in satisfactory yield. 
In earlier research, the coupling of 411 to give 402 using zinc in the presence of 
triphenylphosphine to reduce NiCb(PPh3)2 to Ni0(PPh3)4 in DMF (the same procedure 
that was used to prepare 401) was attempted.208 This gave a poor yield of 402. This 
method was repeated, with an ammoniacal work-up204 replacing the cyanide 
demetallation of the earlier method, using 407 as the starting material to give a small 
quantity of 403. It was apparent that, whilst the nickel(O)-catalysed coupling strategy 
was giving the required products, the procedure required some modification to increase 
the yield of coupled product. 
"Nickel Complex Reducing Agents" have been known for some time and 
contain low oxidation state metal species.214 Recently these reagents have been used 
for the preparation of a wide variety of biheterocyclic compounds by the coupling of 
heterocyclic halides.210 The investigation of these as potential coupling reagents for 
the two aromatic halides seemed worthwhile. The coupling procedure using the reagent 
formed from tert-butanol, sodium hydride, triphenylphosphine and nickel acetate in 
DME210 was carried out using 2-chloropyridine as a model substrate. This reaction 
gave no bipy (the expected coupling product) and the reaction was repeated with nickel 
acetate that had been dried by heating under reduced pressure. This reaction also gave 
no bipy and the method was not pursued further. 
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A modified procedure for the coupling of aryl halides based on that used to 
prepare 401 has been published and this method appears to have several advantages as 
no additional triphenylphosphine is added during catalyst preparation, assisting in the 
separation of the products once the reaction is complete and THF is used as the solvent 
rather than the higher boiling solvent DMF.211 The method differs from that used to 
prepare 401 as NiBr2(PPh3)2, rather than NiCi2(PPh3)2, is used as the catalyst precursor 
and the reduction by zinc is carried out in the presence of tetraethylammonium iodide. 
When this method was trialled, again using 2-chloropyridine as the model substrate, a 
quantitative conversion to bipy was observed in the crude reaction product, and it 
seemed that a more satisfactory coupling procedure had been found. 
Similar reactions of 411 and of 407 proceeded smoothly to give 402 and 403, 
respectively, with the yield of both reactions being approximately 50%. Both of the 
ligands were fully characterised, but the observed melting point of 402, 112-113.5°C, 
differs quite markedly from those reported previously for this compound, viz 190°C201 
and 170-173°C. 202 Given the absence of additional supporting evidence for the 
formulation of the compound as 201 in these previous reports, doubts must remain as to 
which compound had actually been isolated. 
Reaction of 402 with one equivalent of lithium tetrachloropalladate in methanol 
at room temperature gave the monometallated chloro-bridged complex, [(402-
H)Pd(~-Cl)h in quantitative yield and this was converted to the monomeric 
acetylacetonate complex, (402-H)Pd(acac) (413), by ligand exchange with thallium 
acetylacetonate in chloroform (scheme 4.5). Microanalysis confirmed this formulation 
with the addition of one third of a chloroform molecule per molecule of complex. 
Reaction of 403 under similar conditions failed to give the analogous monometallated 
complex. 
In addition to microanalysis, the monocyclopalladated complex, 413, was fully 
characterised by FAB mass spectrometry, IR and lH and 13C NMR spectroscopy. 
When compared to the 1 H NMR spectrum of the free ligand, 402, (figure 4.la), the 
spectrum of 413 (figure 4.lb) clearly demonstrates that cyclopalladation has occurred. 
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The spectrum for 413 is more complex than that of 402, as single cyclopalladation of 
the ligand renders the two phenylpyridine subunits inequivalent. The spectrum of the 
complex was assigned using techniques described in previous chapters, extensive use 
being made of lD-TOCSY experiments to assign resonances to specific positions in the 
isolated spin systems. The NMR characterisation of 413 was completed with the 
acquisition of a 13C NMR spectrum and its assignment by way of an HMQC 
experiment. 
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Reaction of both ligands with palladium acetate in refluxing acetic acid, 
followed by acetate-chloride metathesis with lithium chloride, gave the expected 
bis-cyclometallated chloro-bridged complexes [(402-2H)(Pd(J..t-Cl)h]x and 
[(403-2H)(Pd(J..t-Cl))2]x. These complexes could also be prepared by reaction of the 
ligands with lithium tetrachloropalladate in refluxing methanol. Ligand exchange with 
sodium acetylacetonate afforded the bis-palladium(acac) complexes, 
(402-2H)(Pd(acac))2 (414) (scheme 4.5) and (403-2H)(Pd(acac))2 (415) (scheme 4.6). 
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Both 414 and 415 were fully characterised, although a 13C NMR spectrum was 
not acquired for the former complex due to its low solubility. The lH NMR spectrum 
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of 415 (figure 4.2b) shows that the equivalence of the two phenylpyridine subunits in 
the ligand (figure 4.2a) has been maintained. In addition, the resonances in the lH 
NMR spectrum of 415 exhibit the coupling pattern expected of an ortho-disubstituted 
phenyl ring, confirming that the ligand has been doubly cyclopalladated. 
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Exhaustive attempts to produce crystals of 414 and 415, suitable for single 
crystal X-ray structure determination, were unsuccessful and, therefore, the 
intermetallic distances and the torsional angles about the central inter-ring bonds in 
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these complexes are unknown. The electrochemistry of these complexes has not been 
examined, as the two electron palladium(II)-palladium(IV) couple is less amenable to 
such studies than the corresponding one electron mthenium(II)-mthenium(III) couple. 
Thus, electrochemical studies, and the determination of the magnitude of metal-metal 
communication in complexes of 402 and 403, await the preparation of doubly 
cyclomthenated complexes. 
4.3 POTENTIALLY BRIDGING ANALOGUES OF 
2~PHENOXYPYRIDINE AND 2-PHENYLTHIOPYRIDINE 
232 233 
Having successfully cyclopalladated both 2-phenoxypyridine (232) and 
2-phenylthiopyridine (233), the possibility of preparing potentially doubly metallated 
analogues of these ligands was considered. The most obvious synthetic route to such 
compounds is by the nucleophilic substitution of appropriate halogenated precursors 
with the phenoxide or thiophenoxide anions, the route that was used to prepare both 232 
and 233. To prepare quaterpyridine-type analogues in this manner would require the 
precursors 2,2'-dihalo-4,4'-bipyridine (416) and/or 3,3'-dihydroxybiphenyl (417) and its 
sulphur analogue ( 418), none of which are readily available. Hence attention turned to 
other structures that would permit the linking of two 232- or two 233-like subunits that 
would incorporate the essential feature of two N-donors with 2-phenoxy or 2-phenylthio 
substituents attached. 
X OH SH 
X HO HS 
416 417 418 
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The diazines-pyridazine; pyrimidine and pyrazine (figure 4.3)-offer the 
possibility of linking these subunits through a common central ring which includes both 
of theN-donor atoms. 
n 
N-N 
r=\ 
N N 
'L!! 
pyridazine pyrimidine pyrazine 
Figure 4.3 
Addition of the required substituents to the diazine ring gives the structures 
3,6-diphenoxypyridazine ( 419), 4,6-diphenoxypyrimidine ( 420), 2,3-diphenoxypyrazine 
(4 21) and 2,5-diphenoxypyrazine (4 2 2) and their analogues, 
3,6-bis(thiophenyl)pyridazine (4 2 3 ), 4,6-bis(thiophenyl)pyrimidine (424), 
2,3-bis(thiophenyl)pyrazine (425) and 2,5-bis(thiophenyl)pyrazine (426), where sulfur 
atoms replace the oxygen atoms in these compounds. 
x _;;==';;-x 
d N-N b~ -
419X=O 
423X=S 
420X=O 
424X=S 
421 X=O, R3=0Ph, R5=H 
425 X=S, R3=SPh, Rs=H 
422 X=O, R3=H, R5=0Ph 
426 X=S, R3=H, R5=SPh 
Such ligands would be cyclometallated analogues of the well-studied 
multidentate bridging ligands 3,6-bis(2-pyridyl)pyridazine (427), 4,6-bis(2-pyridyl)-
pyrimidine (208), 2,3-bis(2-pyridyl)pyrazine (428) and 3,5-bis(2-pyridyl)pyrazine 
(429).51 
~-/\ ~NT\'N-~1\'N_f 
427 
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~N 
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~N 
208 428 R3=2-py, R5=H 
429 R3=H, R5=2-py 
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Indeed, 4,6-diphenylpyrimidine (209),110 2,3-diphenylpyrazine (430)111 and 
2,5-diphenylpyrazine ( 431),229 which are also analogues of these bridging binuclear 
coordinating ligands, have been prepared and doubly cyclometallated. 
209 430 R3=Ph, Rs=H 
431 R3=H, R5=Ph 
A search of the literature revealed that both 3,6-diphenoxypyridazine 
(419)230,231 and 3,6-bis(phenylthio)pyridazine (423)232 are known compounds. 
Although there have been several phenoxypyrimidines reported in the literature, for 
example 2-phenoxypyrimidine (432),233,234 4-methyl-2-phenoxypyrimidine 
(433),233,234 4,6-dimethyl-2-phenoxypyrimidine (434)234 ,235 and the his-ether, 
2,4-diphenoxypyrimidine ( 435),236 the preparation of 420 has not previously been 
described. 
Q 
h ('IT ~ No NyN NyN NyN NyN 
C( 0 00 0 00 0 00 0 
432 433 434 435 
Similarly, although the synthesis of 4,6-bis(phenylthio)pyrimidine (424) has not 
previously been reported, the preparations of several other (phenylthio)pyrimidines, for 
example 2-(phenylthio )pyrimidine ( 436)237 and 4-phenyl-2-(phenylthio )pyrimidine 
(437),238 have been described. 
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436 437 
A search for phenoxy- and (phenylthio)pyrazines yielded preparations for 
phenoxypyrazine (438)239 and for 3-methyl-2-phenoxy- (439) and 3-methyl-2-
(phenylthio)pyrazine (440)240 whilst reports of diphenoxypyrazines are confined to a 
paper (no preparations given) which describes some properties of 
2,6-diphenoxypyrazine (441), an isomer which would be unable to doubly 
cyclometallate, in addition to a number of other phenoxy- and (phenylthio)pyrazines, all 
of which have other substituents on the pyrazine nucleus and some of which have 
substituents on the phenyl ring of the phenoxy and phenylthio substituents.241 
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The literature preparations for the known phenoxy- and (phenylthio)diazines 
mentioned above do involve the nucleophilic substitution of the appropriate 
chlorodiazine with phenoxide or thiophenoxide anions and, given the ready availability 
of both 3,6-dichloropyridazine (442) (scheme 4.7) and 4,6-dichloropyrimidine (443) 
(scheme 4.8) and the absence of a convenient preparation of either 2,3- or 
2,5-dihalopyrazine, attention was focused on the preparation of the pyridazine and 
pyrimidine ligands. 
In addition to providing a convenient route to potentially doubly 
cyclometallating ligands, the method of preparation of these ligands offered, through 
the preparation of unsymmetrical phenoxy(thiophenyl)diazines, the potential to further 
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investigate the regioselectivity of the cyclometallation reaction by establishing the 
relative ease of cyclometallation of a thiophenoxide system, with respect to a phenoxide 
system, when both are in a B-arrangement with similar nitrogen donor atoms in the 
same ligand. Such unsymmetrical ligands could be prepared by the reaction of the 
dichlorodiazine with one equivalent of phenoxide anion followed by isolation of the 
mono-ether and its subsequent reaction with thiophenoxide anion or vice versa. 
The first attempt to prepare 3,6-bis(thiophenyl)pyridazine (423) was by the 
reaction of 442 with thiophenol in the presence of triethylamine, in a reaction analogous 
to that used to prepare 233 from 2-chloropyridine.l40 Examination of the lH NMR 
spectrum of the product from this reaction revealed that the product was not that 
expected, the pattern of pyridazine proton signals showing an unsymmetrically 
substituted system and the presence of a broad singlet at 12.56 ppm suggested a signal 
due to an N-H moiety. Mass spectrometry and microanalysis confirmed the identity of 
this product as the hitherto unknown compound 6-phenylthiopyridazin-3(2H)one ( 444) 
(scheme 4.7). The melting point of the starting material employed in this reaction 
(126-136°C) indicated that the 442 (Iit.242 68-69°C) had hydrolysed during storage to 
3-chloropyridazin-6(1H)one (Iit.243 138-139°C). 
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The bis-thioether ( 423) was obtained by the reaction, in ethanol, of sodium 
thiophenoxide with fresh 442 according to the previously published procedure (scheme 
4.7).232 The compound was fully characterised using NMR and IR spectroscopy and 
mass spectrometry. 
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The corresponding bis-ether, 3,6-diphenoxypyridazine (419), was obtained by 
the reaction of 442 with sodium· phenoxide according to the literature. procedure 
(scheme 4.7).230 Again, this compound was fully characterised using the techniques 
described for the bis-thioether. Worthy of note is the fact that all signals in the lH 
NMR spectrum of the ligand in CDC!} are broadened, with the spectrum in d6-DMSO 
being broadened to an apparently lesser extent and the 13C NMR spectra in both 
solvents seemingly unaffected. Similar broadening has been observed in the lH NMR 
spectrum of 1,4-bis(3-pyridoxy)benzene, an isoelectronic analogue of 419.244 
Tamura and Jojima231 report that reaction of 442 with one equivalent of sodium 
phenoxide in refluxing benzene gives only the mono-ether, 3-chloro-
6-phenoxypyridazine ( 446), and that disubstituted 419 forms only when the reaction is 
carried out at higher temperature in refluxing toluene. In addition, the authors state that 
446 and 419 can be easily separated from one another by recrystallisation from ether or 
ethanol. However, when the reaction in benzene was carried out the product mixture 
was found to contain approximately 15% 419 and recrystallisation of this mixture failed 
to enrich the proportion of mono-ether. Unlike 419 (vide supra), the signals in the 
NMR spectra of 446 show no apparent broadening. 
c1-(}-o 
N-N b 
446 
In a reaction analogous to that used to prepare 232,135 phenol and 
4,6-dichloropyrimidine (443) were melted together in the presence of potassium 
carbonate to give, after work-up, the new bis-ether 4,6-diphenoxypyrimidine (420) in 
excellent yield (scheme 4.8). The compound was fully characterised by microanalysis, 
mass spectrometry and IR and NMR spectroscopy, the NMR spectra showing no 
apparent broadening. 
Using a procedure analogous to that which gave 423,232 the corresponding 
bis-thioether, 4,6-bis(phenylthio)pyrimidine (424), was prepared in satisfactory yield 
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from 443 and sodium thiophenoxide (scheme 4.8). This ligand was also fully 
characterised using the techniques described for the his-ether. 
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As with the pyridazine series, the preparation of the mono-ether, 
4-chloro-6-phenoxypyrimidine (447), from the dichlorodiazine, 443, was attempted. 
When 443 was melted together with excess phenol in the presence of one equivalent of 
potassium carbonate an equimolar mixture of 447 and 420 was obtained, as determined 
by 1 H NMR analysis of the crude product. Reaction in refluxing benzene with one 
equivalent of sodium as the base gave a greater proportion of 447 in the product 
mixture, the molar ratio 447:420 being approximately four:one. As with the analogous 
pyridazine ethers, repeated attempts to separate the two ethers by recrystallisation were 
unsuccessful. 
447 
The only report of mono-(phenoxy)ethers being prepared from 
dichloropyrimidines is that of 2-chloro-4-phenoxypyrimidine ( 448) and 2-chloro-
4-phenoxy-6-methylpyrimidine (449), from 2,4-dichloropyrimidine (450) and 
2,4-dichloro-6-methylpyrimidine (451) respectively (scheme 4.9). In these reactions the 
successful preparation of the mono-ether (and the small amount of his-ether observed in 
the crude product) can be attributed to the difference in susceptibility to nucleophilic 
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attack between the 2-chloro substituent and the more reactive 4-chloro substituent,236 
such a difference not existing between the two equivalent chlorine atoms in 443. 
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Investigation of the complexation chemistry of the bis-ether ligands 419 and 420 
and of the bis-thioether ligands 423 and 424 began with their reactions with lithium 
tetrachloropalladate in methanol. When reacted under these conditions all four ligands 
gave coordination complexes, with no cyclometallation observed. 
Reaction of the pyridazine bis-ether, 419, with lithium tetrachloropalladate gave 
Pd( 419)2Cl2 in excellent yield. The complex was recrystallised from nitromethane and 
is insoluble in CDCI3 but is soluble in d6-DMSO. However, it appears that this solvent 
displaces the ligand as both the 1 H and 13C NMR spectra of the solution are 
indistinguishable from that of the free ligand and, therefore, the complex was 
characterised by microanalysis and IR spectroscopy. 
The corresponding bis-thioether, 423, upon reaction with lithium 
tetrachloropalladate, gave Pd(423)2Cl2 in excellent yield. The complex was 
recrystallised from chloroform by the diffusion of petroleum ether vapour; however the 
complex is insufficiently soluble in CDCl3 to obtain NMR spectra. As with the 
bis-ether coordination complex discussed above, this complex is soluble in d6-DMSO 
but, again, the solvent displaces the pyridazine ligands to give lH and 13C NMR spectra 
identical to those of the free ligand. Hence the complex was characterised by 
microanalysis and IR spectroscopy. 
Reaction of the pyrimidine bis-ether, 420, with lithium tetrachloropalladate 
gave, in excellent yield, a yel1ow solid which was recrystallised from nitromethane and 
toluene to give yellow needle crystals formulated by microanalysis as Pd(420)2Cl2 
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(452) with the inclusion of two thirds of a molecule of toluene per molecule of 
complex. This complex is soluble in chloroform and examination of both 1 H and 13C 
NMR spectra confirm the above formulation as they show the presence of two 
inequivalent and non-cyclometallated phenyl rings. The largest coordination induced 
shift in the 1 H NMR spectrum of the complex, with respect to that of the free ligand, is 
for H-2 of the pyrimidine ring, which shifts downfield by 0.39 ppm upon coordination 
of the palladium, whilst H-5 of the pyrimidine ring shifts upfield by 0.27 ppm. These 
shifts are consistent with the expected trans geometry of the complex (shown in scheme 
4.10, with one pyrimidine ligand omitted for clarity) as H-2 is deshielded due to the 
influence of the nearby chloro ligand, whilst upon coordination the phenyl ring of the 
phenoxy substituent adjacent to the coordinating nitrogen atom twists away from the 
palladium atom and H-5 is thus affected by the shielding ring current of this group. 
420X=O 
424X=S 
4" 5" 
~6" 
3"~ 
2" X 5' 4' 
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MeOH ~-,;l }L:::I' 3' 
Scheme 4.10 
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The corresponding complex, Pd(4,6-bis(phenylthio)pyrimidine)zCh (453), was 
obtained in excellent yield as an analytically pure yellow powder from the reaction of 
lithium tetrachloropalladate with two equivalents of the bis-thioether ligand, 424 
(scheme 4.10). The same complex was obtained in poorer yield and of lower purity 
when the reaction was repeated with an equimolar ratio of palladium to ligand. 
The 1 H NMR spectrum of this complex (figure 4.4) exhibits temperature 
dependent behaviour, and at 23°C the resonances are broadened. Of particular note is 
the appearance of the signals for H-2 and H-5 of the pyrimidine ring as broadened 
doublets with a separation of 9.3 Hz for H-2 and of 17.3 Hz for H-5. The broadening is 
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also seen in the Be NMR spectrum, and C-2 and C-5 again appear as doublets with the 
signals for the phenyl rings showing two peaks for each position in a ratio of two: one. 
As the temperature is increased to 53°C the individual signals for H-2 and H-5 coalesce 
and appear as singlets, whilst one signal due to a pair of ortho protons on one of the 
phenyl rings becomes discernible, the rest of the phenyl protons forming one large 
overlapping absorption from which the individual shifts could not be resolved. In the 
13C NMR spectrum at 53°C the signals corresponding to C-2 and C-5 also appear as 
singlets and the pairs of resonances for each of the phenyl carbons are of approximately 
equal intensity. The chemical shifts for H-2 and H-5 show coordination induced shifts 
of the same sign as their counterparts in the analogous 4,6-diphenoxypyrimidine 
complex (452), with H-2 being shifted downfield by 0.22 ppm and H-5 upfield by 0.16 
ppm, suggesting that the complexes have the same, trans, stereochemistry. 
The proposed explanation for the observed temperature dependence of the NMR 
spectra of 453 is that it is the result of the an equilibrium between syn and anti rotamers, 
as has been discussed for the corresponding complexes of both 2-phenoxypyridine 
(232) and 2-phenylthiopyridine (233), and other ligands (vide supra). It is noteworthy 
that, whilst coalescence temperatures for the resonances in the spectrum of the complex 
of 203 could not-due to instrument and solution temperature limitations-be 
determined, those for 453 are approximately 28°C for H-2 and 38°C for H-5. In 
addition, the signals for the diphenoxypyrimidine complex, 452, have coalescence 
temperatures somewhat below 23°C as no broadening of the spectrum (figure 4.5b) is 
observed at ambient temperature, in contrast to the spectrum of the corresponding 232 
complex, the spectrum of which is significantly broadened at the same temperature. 
Thus, the activation energies for intramolecular rotamerisation for the disubstituted 
pyrimidine complexes are of somewhat lesser magnitude than those for the 
corresponding monosubstituted pyridine complexes. The difference between the 
observed temperature dependence in the spectra of 452 and 453 is expected to be due to 
the same factors proposed to account for the observed difference in the spectral 
temperature dependence of the complexes of 232 and 233, namely; the respective sizes 
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of the oxygen and sulfur atoms ·and possible interaction between the palladium and 
sulfur atoms. 
H-2 
H-5 
r--r--·-,--.--r-··--.-..-~,--,---,--.---,--.----,.--·~ 
9.0 8.5 8.0 7.5 7.0 6. 5 6. 0 ppm 
Figure 4.4 Variable temperature 1 H spectra of 453 
Having established that reaction with Hthium tetrachloropalladate does not lead 
to cyclometallation of these ligands, their reactions with palladium acetate were 
investigated as this has been shown to be a more reactive metallating agent.l23 For 
example, some potentially doubly metallating ligands have been singly metallated with 
the former reagent, whilst the latter reagent gives the doubly metallated complex.lll 
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Refluxing glacial acetic acid has been used as the solvent for such metallations by other 
researchers, but reaction of the pyridazine and pyrimidine his-ethers and bis-thioethers 
under these conditions failed to give any of the desired metallated complexes, as did 
reaction in acetic acid at room temperature. Attention then turned to other solvents that 
might facilitate the cyclometallation of these ligands with palladium acetate. 
In 1980 Gutierrez et al. published a paper that described the cyclometallation of 
a number of 2-arylpyridines with palladium acetate in refluxing acetic acid and noted 
that "refluxing chloroform proved to be a better solvent choice."245 This was 
presumably due to the higher yields of the acetate-bridged dimer obtained when the 
reaction was performed in the latter solvent. In an attempt to prepare the 
cyclopalladated complex the pyrimidine his-ether, 420, and palladium acetate were 
reacted together in chloroform. However, after one day under reflux, I H NMR 
examination of a sample of the reaction mixture showed only unreacted ligand. 
Another solvent which has been used for cyclometallations by palladium acetate 
is benzene.246 Reaction of the pyrimidine his-ether, 420, with palladium acetate in 
benzene under nitrogen gave a mixture of the unreacted ligand (approximately 25% by 
lH NMR spectroscopy) and the acetate-bridged dimer, [Pd(420-H)0Ac]2, which was 
characterised by 1 H NMR spectroscopy to confirm that cyclopalladation had occurred. 
Acetate-chloride metathesis gave the corresponding chloro-bridged dimer, 
[Pd( 420-H)Clh, which was fully characterised, a low chloride analysis notwithstanding. 
Ligand exchange of this dimeric complex with thallium acetylacetonate gave the 
monomeric palladium acetylacetonate complex, Pd(420-H)(acac) (454) in good yield as 
pale yellow plates (scheme 4.11). This complex was fully characterised; however 
signals corresponding to the quaternary pyrimidine carbons C-4 and C-6 were not 
observed in the 13C NMR spectrum and, in the lH NMR spectrum (figure 4.5c), the 
signals for H-4' and H-5' of the metallated phenyl ring were found to have chemical 
shifts that were insufficiently separated to allow resolution by available NMR 
techniques. 
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Reaction of the pyridazine bis-ether, 419, with palladium acetate in benzene 
under nitrogen also gave a mixture of the unreacted ligand and the acetate-bridged 
dimer, [Pd(419-H)OAc]2. This mixture was characterised by both lH and 13C NMR 
spectroscopy, the overlapping of signals being such that it was difficult to ascertain 
whether or not the ligand had been cyclometallated on the basis of the 1 H NMR 
spectrum alone. 
The corresponding chloro-bridged dimer, [Pd(419-H)C1]2, was prepared by 
reaction of the acetate-bridged dimer with lithium chloride to give a pale yellow 
insoluble solid which was characterised by IR spectroscopy. In the reaction of 
[Pd( 419-H)Clh with thallium acetylacetonate, pale yellow crystals of the resultant 
monomeric complex, Pd( 419-H)( acac) ( 455), suitable for single-crystal X -ray structure 
determination were obtained in excellent yield directly from diffusion of petroleum 
ether into a chloroform solution prepared from the filtrate of the reaction mixture. 
Therefore the crystal structure of this complex, which was also characterised by 
microanalysis and IR and lH and 13C NMR spectroscopy, was determined. 
Crystal Structure of 455. 
The cyclopalladated complex of 3,6-diphenoxypyridazine crystallises in the 
orthorhombic space group P212121, the asymmetric unit of which contains two 
Pd(419-H)(acac) his-chelate molecules (figure 4.6). This complex represents the first 
example of a crystallographically characterised structure incorporating a bidentate 
ligand with a nitrogen donor in a six -membered metallocycle formed from palladation 
of an aryl ring. Other related structures incorporate tridentate metallated ligands247-251 
or result from aliphatic palladation252-259 or both.260-265 
The two independent molecules have bonding geometries that are the same 
within experimental error but differ in the conformation of the non-metallated phenoxy 
substituent, the phenoxy and pyridazine ring meanplanes being inclined at 72.r in one 
ligand (complex with Pdl) and 63.r in the other ligand (complex with PdlA). The 
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four phenyl and two pyridazine 'rings are each essentially planar, with the maximum 
displacement from the plane being 0.023(4) A for Cl 'A 
The six-membered metallocycles each exist in a shallow boat conformation: Pdl 
and 03 are 0.640(2) and 0.368(3) A, respectively, above the meanplane defined by N2, 
C3, Cl' and C2'; and PdlA and 03A are 0.656(2) and 0.347(3) A, respectively, above 
the meanplane defined by N2A, C3A, Cl 'A and C2' A The cyclometallated phenyl 
ring is inclined to the pyridazine ring at an angle of 38.6° in one ligand and at 37.0° in 
the other ligand. 
Figure 4.6 Perspective view and atom labelling of one of the two independent 
molecules in the asymmetric unit of 455. Selected bond lengths (A) and angles (0 ) for 
the Pdl and [PdlA] molecule: Pdl-C2' 1.972(3) [1.974(3)], Pdl-N2 2.012(2) 
[2.006(2)), Pd1-01 2.080(2) [2.076(2)], Pdl-02 2.032(2) [2.018(2)]; C2'-Pdl-N2 
87.3(2) [87.6(1)], 01-Pdl-02 91.66(8) [91.92(7)), C3-03-Cl' 119.5(2) [120.7(2)]. 
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The palladium atoms have approximately square planar coordination to the 
C,N,O,O donor set and the Pd-C, Pd-N bond lengths are similar to those in related 
cyclopalladated complexes which incorporate a nitrogen donor in a five-membered 
metallocycle.266 There is evidence of a very slight tetrahedral distortion from square 
planarity around the palladium atoms, as the mean planes defined by Pd 1 (deviation 
from the plane of -0.005(2) A), N2 (0.009(3) A), C2' (-0.007(4) A), 01 (-0.006(3) A) 
and 02 (0.009(3) A) and by Pd1A (-0.007(2) A), N2A (-0.008(3) A), C2' A (0.012(4) 
A), OIA (0.011(3) A) and 02A (-0.008(3) A) show alternating displacement of the 
atoms above and below the plane. This is supported by the trans-coordination angles: 
(178.3(1) and 177.3(1)0 for Pdl; 177.8(1) and 177.7(1)0 for PdlA). 
The geometries of the two acetylacetonate subunits are very similar to those that 
have been determined for related structures.266 Of particular note is the difference in 
the Pd-0 bond lengths, with those trans to carbon being significantly longer than those 
trans to nitrogen, this variation being consistent with those seen in related structures 
and a reflection of the different trans influences of carbanion and nitrogen donors.266 
Having prepared and characterised the singly cyclopalladated complexes of both 
the pyridazine and the pyrimidine his-ethers, the corresponding bis-thioethers, 423 and 
424, were reacted with palladium acetate. The ligands were reacted with palladium 
acetate both in acetic acid and in benzene, however all attempts to cyclopalladate the 
bis-thioethers were unsuccessful. 
A number of attempts were made to doubly metallate the pyridazine and 
pyrimidine bis-ethers with palladium acetate in a variety of solvents under a range of 
conditions but these gave only the singly cyclopalladated complexes. 
Studies of 3,6-di-(2-pyridylthio )pyridazine ( 456), the tetradentate (N4) analogue 
of the pyridazine bis-ether, 419, have shown that this ligand predominantly forms 
binuclear copper(Il) complexes in which the two copper(II) ions are bridged by two 
exogenous bridges in addition to the diazine group.267-272 Examination of the 
119 
structures obtained through X-ray crystallographic studies of these complexes267-272 
shows that formation of a binuclear complex with two six-membered chelate rings 
connected only through the pyridazine ring would impose considerable strain on the 
molecule. The observed structures exhibit intermetallic separations of between 3.00 
and 3.22 A and the steric interactions between other ligands attached to the copper 
atoms would be so great as to preclude the formation of such a complex. For similar 
structures with five-membered chelate rings, the intermetallic distances are between 
3.29 and 3.46 A and these ligands form structures in which the two copper(Il) ions are 
connected by only one additional exogenous bridge.272 
s--f)-s 
d N=N ~ N N~-
456 
A similar study of 4,6-di-(2-pyridylthio)pyrimidine (457), an analogue of the 
pyrimidine his-ether, 420, has shown that this ligand forms 1: 1 complexes with copper 
salts.273 Crystallographic studies reveal that, within these complexes, the potentially 
tetradentate bridging ligand acts as a tridentate donor, coordinating in a bidentate 
fashion to one copper ion through a pyrimidine and pyridine nitrogen and acting as a 
monodentate donor to the other copper ion through the other pyridine nitrogen.273 
A recent investigation of the reactions of 457 with ruthenium(Il) and silver(!) 
also did not produce bis-bidentate complexes.274 The ligand forms 1:1 complexes, 
which were crystallographically characterised, with these metals ions, exhibiting 
monochelate coordination upon reaction with ruthenium(II) and bridging, triply 
monodentate coordination upon reaction with silver(I)-the fourth, pyrimidine nitrogen 
in this complex again uncoordinated.274 
These reports contrast with that of the analogous, diphenylpyrimidine ligand, 
209, which exhibits bis-bidentate coordination, forming a doubly cyclopalladated 
complex in which the two five-membered metallocycles are connected through the 
central pyrimidine ring.llO The difference in observed mode of coordination between 
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the two ligands is attributed to the formation of six-membered chelate rings in 
complexes of the bis-thioether, 457. As a result of this, steric interactions between 
ancillary ligands on the copper(II) ions and H-2 of the pyrimidine ring and H-6 of the 
pyridine rings lead to twisting of the bridging ligand, preventing the formation of the 
second chelate ring due to the inaccessibility of the second pyrimidine nitrogen.273 
457 
The preparation of a complex in which two six-membered chelate rings are 
connected solely through a disubstituted bis-bidentate pyridazine or pyrimidine bridging 
ligand is, therefore, yet to be achieved. 
4.4 OTHER POTENTIALLY DOUBLY CYCLOMETALLATED 
LIGANDS 
(J(N" ,.-; 
N 
458 459 
The reactions of two other potentially doubly cyclometallated ligands were 
examined in the course of this research. Both 2,3-diphenylquinoxaline (458) and 
dibenzo-[a,c]-phenazine (459), analogues of 2,3-diphenylpyrazine, 428 (vide supra), 
have previously been singly and doubly cyclopalladated.lll Given the ease with which 
these cyclopalladation reactions take place, the reactions of these two ligands with 
rhodium trichloride were investigated. 
The ligands 458 and 459 and rhodium trichloride trihydrate were reacted with a 
rhodium:ligand ratio of one:two. Had the reactions been performed with a 
rhodium:ligand ratio of one:one, it is likely that a highly insoluble polymer would have 
resulted with rhodium atoms and ligands alternating to form an extended array. 
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Reaction of 458 with rhodium trichloride in refluxing 2-methoxyethanol gave a 
chloro-bridged dimer, [Rh(458-H)2Cl]2, as a yellow powder in good yield. This 
complex was smoothly converted to the mononuclear complex, Rh(458-H)2(acac) 
( 460), by a ligand exchange reaction with sodium acetylacetonate (scheme 4.12). 
A similar reaction of 459 gave [Rh(459-H)2Cl]2 as a reddish purple powder in 
quantitative yield. Ligand exchange with sodium acetylacetonate gave the 
corresponding mononuclear complex, Rh(459-H)2(acac) (461) (scheme 4.13). Both of 
these monomeric cyclorhodated acetylacetonate complexes were characterised by FAB 
mass spectrometry and lH NMR spectroscopy (table 4.2), both complexes being 
insufficiently soluble in CDCb to permit the acquisition of Be NMR spectra. 
9 
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Scheme 4.13 
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Table 4.2 1 H NMR of the free ligands ( 458 and 459) and cyclorhodated 
acetylacetonate complexes (460 and 461) (~ = o(complex)-o(free ligand)). 
H3' H4' H5' H6' H2" H3" H4" H5" H6" H5 H6 H7 H8 
458 7.35 7.35 7.35 7.53 7.53 7.35 7.35 7.35 7.53 8.19 7.79 7.79 8.19 
460 6.52 6.60 6.67 7.08 8.00 7.61 7.61 7.61 8.00 8.12 7.69 7.55 8.48 
~ 
-0.83 -0.75 -0.68 -0.45 0.47 0.26 0.26 0.26 0.47 -0.07 -0.10 -0.24 0.29 
H13 Hl2 Hll H7 H8 H9 HIO H5 H4 H3 H2 
459 7.75 7.81 8.58 9.42 7.75 7.81 8.58 8.34 7.86 7.86 8.34 
461 6.49 7.03 8.01 9.45 7.78 7.83 8.51 8.46 7.88 7.71 8.89 
~ 
-1.26 -0.78 -0.57 0.03 0.03 0.02 -0.07 0.12 0.02 -0.15 0.55 
It is interesting to compare the CIS values observed for the structurally 
equivalent protons in the 1 H NMR spectra of the two rhodium acetylacetonate 
complexes (table 4.2). The CIS values for both the proton adjacent to the metallated 
carbon (H-3' and H -13) and for the proton adjacent to the nitrogen donor (H -8 and H-2) 
is of greater magnitude for the phenazine complex than for the quinoxaline complex. 
Perhaps the most significant CIS differences, however, are those observed between the 
protons on the unmetallated phenyl ring (H-2"-H-6") in 460 and the protons on the 
unmetallated benzo ring (H-7-H-10) in 461. The CIS values for the former protons falls 
between 0.26 to 0.47 ppm whereas~ for the latter protons range from -0.07 and 0.03 
ppm upon cyclometallation. 
This difference in the magnitude of the CIS values observed for these protons 
can be attributed to restrictions that cyclometallation places upon ligand conformation. 
Cyclometallation constrains the metallated carbon atom to lie approximately coplanar 
with the nitrogen donor atom. For complexes of 459 this coplanar geometry is already 
present by virtue of the fused structure of the ligand, therefore relatively minor changes 
occur in the ligand upon cyclometallation. In the case of 458, cyclometallation 
considerably alters the ligand conformation as a freely rotating phenyl ring is restricted 
to a conformation that has it lying approximately coplanar with the quinoxaline system. 
The unmetallated phenyl ring will, for steric reasons, lie approximately orthogonal to 
the plane of the other rings. This also accounts for the observed upfield shift of H -6' 
upon cyclometallation (L\ = -0.45 ppm) as it lies directly above the shielding plane of 
the unsubstituted phenyl ring, a similar shift being observed (L\ = -0.85 ppm) for the 
equivalent proton in the mono-palladated complex of this ligand.lll 
Attempts to prepare the corresponding rhodium benzoylacetonate and 
dibenzoylmethanate complexes by ligand exchange of the chloro-bridged dimers with 
the appropriate sodium B-diketonate were unsuccessful. In all cases the only solid, if 
any, obtained from the attempted reactions was unreacted chloro-bridged dimer. 
Examination of molecular models suggests that unfavourable steric interactions 
between the phenyl rings on these B-diketonate ligands and the benzo ring of the 
quinoxaline or phenazine prevent the formation of these monomeric rhodium 
B-diketonate complexes. 
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It is interesting to compare the product of the reaction of 458 and rhodium 
trichloride with the products of the reaction of its structural analogue, 
2-phenylquinoline, 203, under the same conditions. Upon reaction with two equivalents 
of rhodium trichloride trihydrate, 203 gives a mixture of two products which can be 
manually separated following diffusion of ether vapour into an acetonitrile solution of 
the mixture. This gives Rh(203-H)2Cl.l/4CH3CN, 204, in which the ratio 
rhodium:ligand = one:two, and [Rh(203-H)(CH3CN)Ch], 205, in which the ratio 
rhodium:Iigand = one:one (vide supra). In contrast, 458 gives only one product upon 
reaction with two equivalents of rhodium chloride, formulated as the chloro-bridged 
dimer, [Rh(458-H)zC1]2, in which the ratio rhodium:ligand = one:two. 
Given the structural similarity between 458 and 203 it is perhaps expected that 
the former would give a five-coordinate complex upon reaction with rhodium chloride, 
as is observed for reaction of the latter. However, without a single crystal X-ray 
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analysis, it is not possible to distinguish between a six-coordinate complex with a 
dimeric formulation, i.e. [Rh(458-H)2Cl]2, and the five-coordinate monomeric 
equivalent, Rh(458-H)2CI, which have the same stoichiometry. To this end, attempts 
were made to obtain crystals of the quinoxaline complex so that such an analysis might 
be performed. Unfortunately these attempts failed to give any suitable crystals and the 
precise nature of this complex remains unknown. 
The monomeric rhodium acetylacetonate complexes are potential precursors to 
heterobimetallic complexes, as the potentially doubly cyclometallated ligands each have 
one free coordination site available. Such doubly cyclometallated complexes could be 
prepared by the reaction of the monomeric rhodium acetylacetonate complex with 
another metal ion, preferably one with square planar coordination geometry. Reaction 
with a metal ion with octahedral coordination geometry could lead to an insoluble 
polymer (vide supra). 
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The complex Rh(459-H)z(acac) was thought the most likely to give a doubly 
cyclometallated complex upon reaction with another metal ion, as the required coplanar 
geometry of nitrogen and carbon donors described above is already present-by virtue 
of the planarity of the fused dibenzo-[a,c]-phenazine ligand-in the starting complex. 
A similar reaction of Rh(458-H)z(acac) would involve cyclometallation of a 
freely-rotating phenyl ring, a reaction that would be assumed to take place less readily. 
Unfortunately, all attempts to prepare a doubly cyclometallated complex by reaction of 
Rh(459-H)2(acac) were unsuccessful. 
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CONCLUSION 
This chapter has described the preparation 'and reactions of several new ligands 
which are potentially capable of bridging two metal ions via two cyclometallated sites. 
Limited success in the preparations of doubly cyclopalladated complexes has been 
reported utilising two novel ligands which are analogues of quaterpyridine. In addition, 
two ligands which have been previously cyclopalladated have been cyclorhodated and 
the resulting complexes characterised. Worthy of note are the preparations and 
cyclopalladations of the two diphenoxydiazines. These two ligands have both been 
cyclopalladated and the resultant complexes fully characterised including a single 
crystal X -ray structure determination of the cyclopalladated diphenoxypyridazine. This 
complex is a cyclometallated analogue of the phenoxypyridine coordination complex 
which is crystallographically characterised in Chapter Two. 
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Chapter • IVe 
NMR Data Tabulation 
and 
Analysis 
5.1 INTRODUCTION 
Throughout the course of this work extensive use has been made of 1 H and 13C 
NMR spectroscopy for the characterisation of both ligands and complexes. With NMR 
spectroscopy being a technique more commonly associated with organic chemistry, its 
application to ligand characterisation is not unusual. However the application of lH and 
13C NMR characterisation to metal complexes is somewhat less common, though 
becoming more frequent. Often the spectra reported in the literature are not fully 
assigned, their acquisition and assignment being of minor importance relative to the 
information gleaned from the more traditional inorganic techniques such as 
electrochemistry and IR and electronic spectroscopy. Also, single crystal X-ray 
diffraction data provides definitive structural information, though it must be 
remembered that this information applies to the solid state only; the conformations of 
the molecule in solution may be very different (possibly dynamic )-by way of example, 
consider the characterisation of the coordination complex, Pd(2-phenoxypyridine )2Cb, 
234, discussed in Chapter Two. 
Despite their relatively infrequent use for cyclometallated and coordination 
complexes, different one- and two-dimensional homo- and hetero-nuclear NMR 
experiments usually permit the full assignment of both 1 H and 13C spectra, these 
techniques having been illustrated by example in the preceding chapters. A complete 
review of the use of NMR spectroscopy for the characterisations of molecules of the 
type discussed in this work is beyond the scope of this chapter and the subject has been 
discussed elsewhere in the literature. 54,56,275 
In 1975 a paper was published by Todd and co-workers entitled "Application of 
13C NMR spectroscopy to the determination of metal-carbon a bond formation in 
cyclometallation reactions with nitrogen donor ligands".276 This detailed the use of 
single frequency off resonance decoupling experiments to establish the number of 
quaternary and C-H carbon atom resonances in the Be NMR spectrum of a given 
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cyclometallated complex, from which it could be established, given the numbers in the 
spectmm of the free ligand, whether or not cyclometallation had occurred. 
Twelve years later, Steel and Caygill published definitively assigned lH and l3C 
NMR spectra of nineteen cyclopalladated acetylacetonate complexes together with a 
statistical analysis of the CIS data for the phenyl ring of the cyclopalladated ligand. 54 
This study showed that the Pd( acac) substituent leads to characteristic CIS values in 
both the lH and l3C NMR spectra. This paper has been frequently cited since, despite 
criticism from other authors that no mention is made of the chemical shift of the 
quaternary deprotonated aromatic carbons, including that directly joined to the metal-
which should show the greatest CIS upon cyclopalladation.277,278 
In the same year, Arz et al. published a study of a variety of rhodium(III) 
complexes which contain two cyclometallated Schiff base ligands.279 This paper 
included-in addition to the lH chemical shifts of the coordinated hydride and the 31p 
NMR shifts of the ancillary triphenylphosphine ligands-103Rh NMR spectral data, and 
was directed toward developing systematic chemical shift-stmcture correlations. The 
1 H and Be NMR chemical shifts of the cyclometallated ligands were not included. 
In 1986, von Zelewsky and co-workers published the preparation and lH NMR 
spectrum of [Rh(201)2(bipy)]+, a mononuclear complex obtained from the chloro-
bridged dimer, [Rh(201)2Cl]2.102 This report was followed, six years later, by another 
which detailed the preparation and 1 H NMR spectra of a number of analogous 
complexes-with the general formula, [Rh(C-N)2(N-N)]+-incorporating a variety of 
cyclorhodated (C-N) and diimine (N-N) ligands.l07 Whilst these two papers included 
fully assigned 1 H NMR spectra of the complexes, no discussion of the CIS values was 
included; indeed these could not even be calculated due to the absence of 1 H NMR 
spectral data for the free ligands. 
Garces and Watts published "1 H and 13c NMR Assignments with Coordination-
Induced Shift Calculations of Carbon a-Bonded Ortho-Metalated Rhodium(III) and 
Iridium(III) Complexes", in 1993.109 This was the first paper to address the concept of 
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CIS calculations as they apply to rhodium(III) and iridium(III) cyclometallated 
complexes. However, the two rhodium complexes considered-[Rh(201)2Clh and 
[Rh(201)2(bipy)]+-had previously been studied. The authors used the obtained CIS 
data to provide "insight into how cr-donation and rc-back-bonding affect the electronic 
environment of the H and C sites in the ortho-metalated complexes."109 
It is apparent, therefore, that there is a dearth of definitive assignments for the 
spectra of cyclorhodated complexes and there are no corresponding theoretical or 
empirical rules to predict the lH and 13C NMR CIS values that cyclometallation by 
rhodium(III) might effect. Having prepared, during the course of this research, a series 
of cyclometallated rhodium B-diketonate complexes and assigned their 1 H and 13C 
NMR spectra-all of which were acquired under identical conditions-this chapter 
discusses the CIS values found for such complexes. Also the results of a statistical 
analysis of these data for the cyclorhodated phenyl ring-a structural element common 
to all of the complexes-are presented. Given that ten years have passed since the 
publication of Steel and Caygill's analysis of cyclopalladated acetylacetonate 
complexes (vide supra), a timely updating of their results to include data published 
subsequently, in addition to those obtained in the course of this research, is also 
presented. 
5.2 CYCLOPALLADATED COMPLEXES: lH AND 13C NMR 
DATA TABULATION AND ANALYSIS 
6' 6' 
::o:~D s·(J(xD ~I N 4' Pd~ 
3' ~ ' 0 0 3' 
~ 
LH PdL(acac) 
Figure 5.1 Numbering scheme used for the free ligands (LH) and palladium 
acetylacetonate complexes (PdL(acac)) where X represents the presence (six-membered 
palladacycle) or absence (five-membered palladacycle) of a spacer group. 
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Table 5.1 lH NMR chemical shifts of the phenyl ring for the free ligands and 
palladium acetylacetonate complexes where Ll = CIS = o(complex(ppm)) - o(free 
ligand(ppm)). 
H-3' H-4' H-5' H-6' 
Acyclic Nitrogen Donor Complexes 
(Five"membered palladacycles) 
LH=E-acetophenone oxime 7.38 7.38 7.38 7.62 54 
PdL(acac) 7.42 7.13 7.06 7.10 54 
6. 0.04 -0.25 -0.32 -0.52 
LH=N-benzylideneaniline 7.47 7.47 7.47 7.90 54 
PdL(acac) 7.62 7.23 7.10 7.39 54 
6. 0.15 -0.24 -0.37 -0.51 
LH=N "( 4-methoxypheny1)-ar 7.31 7.42 7.31 7.75 278 
benzoylbenzylidene amine 
PdL(acac) 7.69 7.25 7.00 7.00 278 
6. 0.38 -0.17 -0.31 -0.75 
LH=N-benzy lidenebenzylamine 7.41 7.41 7.41 7.78 54 
PdL(acac) (endo-cyclic imine) 7.51 7.20 7.02 7.21 54 
6. 0.10 -0.21 -0.39 -0.57 
LH=N-benzylidenebenzylamine 7.34 7.27 7.34 7.34 54 
PdL(acac) (exo-cyclic imine) 7.40 7.06 7.06 6.98 54 
6. 0.06 -0.21 -0.28 -0.36 
LH=azobenzene 7.49 7.44 7.49 7.92 54 
PdL(acac) 7.60 7.28 7.26 7.93 54 
6. 0.11 -0.16 -0.23 0.01 
LH=azoxybenzene 7.51 7.56 7.51 8.32 54 
PdL(acac) 7.73 7.42 7.22 7.59 54 
6. 0.22 -0.14 -0.29 -0.73 
N-Heterocyclic Donor Complexes 
(Five-membered palladacycles) 
LH=l-phenylpyrazole (116) 7.44 7.27 7.44 7.69 54,89 
PdL(acac) 7.55 7.07 7.12 7.06 54,89 
6. 0.11 -0.20 -0.32 -0.63 
LH=3,5-dimethylpyrazole 7.43 7.33 7.43 7.43 54,89 
PdL(acac) 7.60 7.01 7.08 7.13 54,89 
6. 0.17 -0.32 -0.35 -0.30 
LH=3-phenyl-l-methylpyrazole 7.30 7.30 7.30 7.81 280 
PdL(acac) 7.50 7.05 7.05 7.23 280 
6. 0.20 -0.25 -0.25 -0.58 
131 
H-3' H-4' H-5' H-6' 
LH=1,5-diphenyl-3-methylpyrazole 7.28 7.25 7.28 7.27 54,89 
PdL(acac) 7.55 6.93 6.74 6.34 54,89 
11 0.27 -0.32 -0.54 -0.93 
LH=3 ,5-diphenyl-1-methy lpyrazole 7.40 7.40 7.40 7.83 280 
PdL(acae) 7.53 7.06 7.06 7.24 280 
11 0.13 -0.34 -0.34 -0.59 
LH=l,3,5-triphenylpyrazole 7.31 7.28 7.31 7.35 54,89 
PdL(acac) 7.57 6.96 6.76 6.39 54,89 
11 0.26 -0.32 -0.55 -0.96 
LHz=bis(3-phenyl-l-pyrazolyl)methane 7.38 7.38 7.38 7.80 281 
L(Pd(acac)]z 7.30 7.00 7.45 7.00 281 
11 -0.08 -0.38 0.07 -0.80 
LHz=(3-phenyl-1-pyrazolyl)(5-pheny1- 7.51 7.51 7.51 7.51 281 
1-pyrazolyl)methane 
L[Pd(acac)]z 7.31 7.05 7.50 7.05 281 
11 -0.20 -0.46 -0.01 -0.46 
LH=2-phenylimidazoline (101) 7.35 7.41 7.35 7.77 
PdL(acac) (105) 7.57 7.18 7.01 7.01 
11 0.22 -0.23 -0.34 -0.76 
LH=2-phenylthiazole (115) 7.45 7.45 7.45 7.95 54 
PdL(acac) 7.58 7.17 7.09 7.36 54 
11 0.13 -0.28 -0.36 -0.59 
LH=2-phenylbenzoxazole (121) 7.53 7.53 7.53 8.26 54 
PdL(acac) 7.65 7.27 7.15 7.54 54 
11 0.12 -0.26 -0.38 -0.72 
LH=2-phenylbenzothiazole (126) 7.49 7.49 7.49 8.10 54 
PdL(acac) 7.65 7.21 7.13 7.44 54 
11 0.16 -0.28 -0.36 -0.66 
LH=2-phenyl-1,2,3-triazole (127) 7.48 7.35 7.48 8.09 54 
PdL(acac) 7.58 7.18 7.21 7.52 54 
11 0.10 -0.17 -0.27 -0.57 
LH=2-phenylpyridine (201) 7.46 7.39 7.46 7.98 54 
PdL(acac) 7.60 7.17 7.11 7.42 54 
11 0.14 -0.22 -0.35 -0.56 
LH=2-phenyl-6-(2-thienyl)pyridine 7.47 7.50 7.47 8.12 30e 
PdL(acac) 7.52 7.14 7.14 7.52 30e 
L'. 0.05 -0.36 -0.33 -0.60 
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H-3' H-4' H-5' H-6' 
LH=2,2'-diphenyl-4,4'-bipyridine ( 402) 7.51 7.45 7.51 8.06 
PdL(acac) (413) 7.63 7.22 7.15 7.52 
A 0.12 -0.23 -0.36 -0.54 
LH=2-phenylquinoline (203) 7.49 7.44 7.49 8.16 111 
PdL(acac) 7.69 7.19 7.14 7.52 111 
A 0.20 -0.25 -0.35 -0.64 
LH=benzo[h]quinoline (462) 7.74 7.68 7.89 54 
PdL(acac) 7.70 7.51 7.56 54 
A -0.04 -0.17 -0.33 
LH=3,2'-trimethylene-2-phenylpyridine Not listed 7.34 7.23 282 
PdL(acac) 6.89 7.02 7.56 282 
A -0.32 0.33 
LH=4-phenylpyrimidine (202) 7.52 7.52 7.52 8.09 110 
PdL(acac) 7.63 7.26 7.14 7.50 110 
A 0.11 -0.26 -0.38 -0.59 
LH=4-methyl-6-phenylpyrimidine 7.50 7.50 7.50 8.07 110 
PdL(acac) 7.62 7.25 7.13 7.50 110 
A 0.12 -0.25 -0.37 -0.57 
LH=4,6-diphenylpyrimidine (209) 7.54 7.54 7.54 8.15 110 
PdL(acac) 7.65 7.27 7.16 7.62 110 
A 0.11 -0.27 -0.38 -0.53 
LH=4-(para-nitrophenyl)-6- 7.57 7.57 7.57 8.18 110 
phenylpyrimidine 
PdL(acac) 7.67 7.31 7.19 7.64 110 
A 0.10 -0.26 -0.38 -0.54 
LH=4, 6-dimethy 1-2-pheny !pyrimidine 7.46 7.46 7.46 8.43 110 
PdL(acac) 7.61 7.20 7.12 7.81 110 
A 0.15 -0.26 -0.34 -0.62 
LH=2,4-diphenyl-6-methylpyrimidine 7.50 7.50 7.50 8.58 110 
PdL(acac) 7.65 7.24 7.17 7.99 110 
A 0.15 -0.26 -0.33 -0.59 
LH=2,4,6-triphenylpyrimidine 7.53 7.53 7.53 8.73 110 
PdL(acac) (2-phenyl ring metallated) 7.65 7.28 7.22 8.06 110 
A 0.12 -0.25 -0.31 -0.67 
LH=2,4,6-triphenylpyrimidine 7.53 7.53 7.53 8.29 110 
PdL(acac) (4-phenyl ring metallated) 7.67 7.28 7.21 7.70 110 
A 0.14 -0.25 -0.32 -0.59 
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H-3' H-4' H-51 H-6' 
LH=2,3-diphenylpyrazine ( 458) 7.30 7.30 7.30 7.45 Ill 
PdL(acac) 7.62 7.10 6.75 6.64 111 
~ 0.32 -0.20 -0.55 -0.81 
LH=2,3-dihydro-5,6-diphenylpyrazine 7.24 7.30 7.24 7.40 111 
PdL(acac) 7.60 7.13 6.74 6.45 111 
~ 0.36 -0.17 -0.50 -0.95 
LH=dibenzo(f,h ]quinoxaline 7.68 7.73 8.53 111 
PdL(acac) 7.67 7.56 8.14 111 
~ -0.01 -0.17 -0.39 
LH=2,3-dipheny lquinoxaline ( 458) 7.34 7.34 7.34 7.53 111 
PdL(acac) 7.69 7.08 6.76 6.68 111 
~ 0.35 -0.26 -0.58 -0.85 
LH=dibenzo[a,c ]phenazine ( 459) 7.72 7.77 8.52 111 
PdL(acac) 7.56 7.37 7.56 111 
~ -0.16 -0.40 -0.56 
N-Heterocyclic Donor Complexes 
(Six-membered palladacycles) 
LH= 1-benzylpyrazole 7.33 7.30 7.33 7.20 54,89 
PdL(acac) 7.52 7.10 7.00 6.96 54,89 
~ 0.19 -0.20 -0.30 -0.24 
LH=l-benzoylpyridine (301) 7.47 7.58 7.47 8.06 54 
PdL(acac) 7.81 7.52 7.19 7.77 54 
~ 0.34 -0.26 -0.28 -0.29 
LH=2-phenoxypyridine (232) 7.40 7.20 7.40 7.14 
PdL(acac) (237) 7.62 7.06 7.12 6.98 
~ 0.22 -0.14 -0.28 -0.16 
LH=2-phenylthiopyridine (233) 7.41 7.41 7.41 7.59 
PdL(acac) (239) 7.44 7.07 7.01 7.30 
~ 0.03 -0.34 -0.30 -0.29 
LH=3,6-diphenoxypyridazine ( 419) 7.36 7.17 7.36 7.18 
PdL(acac) ( 455) 7.60 7.10 7.07 6.96 
~ 0.24 -0.07 -0.29 -0.22 
LH=4,6-diphenoxypyrimidine ( 420) 7.44 7.28 7.44 7.16 
PdL(acac) (454) 7.65 7.10 7.10 6.94 
~ 0.21 -0.18 -0.34 -0.22 
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Table 5.2 Results of a statistical analysis of the data in table 5.1, the 1 H NMR 
chemical shifts of the phenyl ring of the free ligands and palladium acetylacetonate 
complexes. 
H-3' H-4' H-5' H-6' 
#ACYCLIC NITROGEN DONOR COMPLEXES 7 7 7 7 
(Five-membered palladacycles) 
Mean CIS (ppm) +0.15 -0.20 -0.31 -0.49 
Standard deviation 0.11 0.04 0.05 0.24 
# N-HETEROCYCLIC DONOR COMPLEXES 31 32 32 28 
(Five-membered palladacycles) 
Mean CIS (ppm) +0.13 -0.27 -0.34 -0.65 
Standard deviation 0.12 0.07 0.18 0.15 
# N-HETEROCYCLIC DONOR COMPLEXES 6 6 6 6 
(Six-membered palladacycles) 
Mean CIS (ppm) +0.21 -0.20 -0.30 -0.24 
Standard deviation 0.09 0.09 0.02 0.05 
# N-HETEROCYCLIC DONOR COMPLEXES 37 38 38 34 
(Five- and six-membered palladacycles) 
Mean CIS (ppm) +0.14 -0.26 -0.33 -0.58 
Standard deviation 0.12 0.08 0.16 0.21 
#ALL NITROGEN DONOR COMPLEXES 44 45 45 41 
(Five- and six-membered palladacycles) 
Mean CIS (ppm) +0.14 -0.25 -0.33 -0.56 
Standard deviation 0.12 0.07 0.15 0.22 
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Table 5.3 13c NMR chemical shifts of the phenyl ring for the free ligands and 
palladium acetylacetonate complexes where il = CIS = 8(complex(ppm)) - 8(free 
ligand(ppm)). 
C-3' C4' C-5' C-6' 
Acyclic Nitrogen Donor Complexes 
(Five-membered palladacycles) 
LH=E-acetophenone oxime 128.5 129.3 128.5 126.1 54 
PdL(acac) 130.4 128.6 124.5 124.6 54 
,::\ 1.9 -0.7 -4.0 -1.5 
LH=N -benzy lideneaniline 128.8 131.4 128.8 128.8 54 
PdL(acac) 130.9 130.5 124.6 127.9 54 
A 2.1 -0.9 -4.2 -0.9 
LH=N -( 4-methoxyphenyl)-a- 129.2 131.3 129.2 128.8 278 
benzoylbenzylidene amine 
PdL(acac) 131.4 131.0 124.4 128.0 278 
11 2.2 -0.3 -4.8 -0.8 
LH=N-benzy lidenebenzylamine 128.6 130.7 128.6 128.3 54 
PdL(acac) (endo-cyclic imine) 130.9 129.8 124.2 126.8 54 
,::\ 2.3 -0.9 -4.4 -1.5 
LH=N-benzylidenebenzylamine 128.5 127.0 128.5 128.0 54 
PdL(acac) (exo-cyclic imine) 130.6 125.1 124.7 119.8 54 
,::\ 2.1 -1.9 -3.8 -8.2 
LH=azobenzene 129.1 131.0 129.1 122.9 54 
PdL(acac) 131.5 131.2 125.7 128.8 54 
,::\ 2.4 0.2 -3.4 5.9 
LH=azoxybenzene 128.8 131.6 128.8 122.4 54 
PdL(acac) 130.7 132.7 125.3 121.5 54 
A 1.9 1.1 -3.5 -0.9 
N-Heterocyclic Donor Complexes 
(Five-membered palladacycles) 
LH=l-phenylpyrazole (116) 129.4 126.4 129.4 119.2 54,89 
PdL(acac) 132.0 125.1 124.9 110.5 54,89 
A 2.6 -1.3 -4.5 -8.7 
LH=3,5-dimethylpyrazole 128.9 127.2 128.9 124.7 54,89 
PdL(acac) 131.5 123.8 124.8 111.5 54,89 
A 2.6 -3.4 -4.1 -13.2 
LH= 1 ,5-dipheny 1-3-methy lpyrazole 128.8 127.0 128.8 125.1 54,89 
PdL(acac) 131.2 124.0 124.3 112.7 54,89 
A 2.4 -3.0 -4.5 -12.4 
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C-3' C4' C-5' C-6' 
LH= 1 ,3 ,5-tripheny lpyrazole 128.9 127.4 128.9 125.3 54,89 
PdL(acac) 131.4 124.5 124.3 113.4 54,89 
Ll 2.5 -2.9 -4.6 -11.9 
LH=2-phenylimidazoline (101) 128.2 130.4 128.2 126.8 
PdL(acac) (105) 131.0 129.8 123.3 123.6 
Ll 2.8 -0.6 -4.9 -3.2 
LH=2-phenylthiazole (115) 129.1 130.4 129.1 126.8 54 
PdL(acac) 131.1 129.0 124.7 122.9 54 
Ll 2.0 -1.4 -4.4 -3.9 
LH=2-phenylbenzoxazole (121) 128.9 131.5 128.9 127.6 54 
PdL(acac) 130.9 131.0 124.8 124.4 54 
Ll 2.0 -0.5 -4.1 -3.2 
LH=2-phenylbenzothiazole (126) 129.0 131.0 129.0 127.6 54 
PdL(acac) 130.9 130.6 124.9 124.4 54 
A 1.9 -0.4 -4.1 -3.2 
LH=2-pheny1-1,2,3-triazole (127) 129.3 127.5 129.3 118.9 54 
PdL(acac) 131.4 126.8 125.5 113.6 54 
A 2.1 -1.3 -3.8 -5.3 
LH=2-phenylpyridine (201) 128.6 128.8 128.6 126.8 54 
PdL(acac) 131.4 129.1 124.6 122.8 54 
A 2.8 0.2 -4.0 -4.0 
LH=2,2'-diphenyl-4,4'-bipyridine (402) 128.8 129.3 128.8 127.0 
PdL(acac) (413) 131.5 129.5 124.7 123.0 
A 2.7 0.2 -4.1 -4.0 
LH=2-phenylquinoline (203) 128.8 129.3 128.8 127.5 111 
PdL(acac) 130.7 129.0 124.8 124.4 111 
A 1.9 -0.3 -4.0 -3.1 
LH=benzo[h ]quinoline ( 462) 127.1 128.2 127.8 54 
PdL(acac) 128.9 122.4 122.8 54 
A 1.8 -5.8 -5.0 
LH=4-phenylpyrimidine (202) 129.0 131.0 129.0 127.1 110 
PdL(acac) 131.8 131.2 124.9 124.5 110 
A 2.8 0.2 -4.1 -2.6 
LH=4-methyl-6-phenylpyrimidine 128.8 130.7 128.8 127.0 110 
PdL(acac) 131.6 130.7 124.6 123.9 110 
A 2.8 0.0 -4.2 -3.1 
LH=4,6-diphenylpyrimidine (209) 128.9 130.8 128.9 127.1 110 
PdL(acac) 131.8 130.9 124.7 124.1 110 
A 2.9 0.1 -4.2 -3.0 
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C-3' C4' C-5' C-6' 
LH=4-(para-nitrophenyl)-6- 129.2 131.4 129.2 127.3 110 
phenylpyrimidine 
PdL(acac) 132.0 131.6 125.0 124.5 110 
~ 2.8 0.2 -4.2 -2.8 
LH=4,6-dimethyl-2-phenylpyrimidine 128.3 130.1 128.3 128.1 110 
PdL(acac) 129.6 130.0 124.9 126.7 110 
~ 1.3 -0.1 -3.4 -1.4 
LH=2, 4-dipheny 1-6-methy !pyrimidine 128.3 130.4 128.3 128.2 110 
PdL(acac) 129.5 130.0 124.8 126.8 110 
~ 1.2 -0.4 -3.5 -1.4 
LH=2,4,6-triphenylpyrimidine 128.4 130.5 128.4 128.3 110 
PdL(acac) (2-phenyl ring metallated) 129.9 130.1 124.8 126.9 110 
~ 1.5 -0.4 -3.6 -1.4 
LH=2,4,6-triphenylpyrimidine 128.8 130.7 128.8 127.2 110 
PdL(acac) (4-phenyl ring metallated) 129.9 130.2 124.7 124.0 110 
L1 1.1 -0.5 -4.1 -3.2 
LH=2,3-diphenylpyrazine ( 428) 128.6 129.6 128.6 128.2 111 
PdL(acac) 131.2 129.5 124.2 127.3 111 
~ 2.6 -0.1 -4.4 -0.9 
LH"'2,3-dihydro-5,6-diphenylpyrazine 128.1 129.6 128.1 127.8 111 
PdL(acac) 131.3 130.2 123.5 128.9 111 
~ 3.2 0.6 -4.6 1.1 
LH=dibenzo(f,h ]quinoxaline 127.6 129.5 122.6 111 
PdL(acac) 130.3 129.7 118.2 111 
~ 2.7 0.2 -4.4 
LH=2,3-diphenylquinoxaline ( 458) 128.2 128.8 128.2 129.8 111 
PdL(acac) 130.7 129.0 124.3 129.0 111 
~ 2.5 0.2 -3.9 -0.8 
N-Heterocyclic Donor Complexes 
(Six-membered palladacycles) 
LH=l-benzylpyrazole 128.8 128.0 128.8 127.6 54,89 
PdL(acac) 134.2 126.8 124.2 125.1 54,89 
~ 5.4 -1.2 -4.6 -2.5 
LH=l-benzoylpyridine (301) 128.1 132.9 128.1 130.9 54 
PdL(acac) 128.4 131.1 125.0 134.2 54 
~ 0.3 -1.8 -3.1 3.3 
LH=2-phenoxypyridine (232) 129.7 124.6 129.7 121.1 
PdL(acac) (237) 133.8 123.7 125.7 115.4 
~ 4.1 -0.9 -4.0 -5.7 
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C-3' C4' C-5' C-6' 
LH=2-phenylthiopyridine (233) 129.5 129.0 129.5 134.8 
PdL(acac) (239) 135.8 126.0 124.6 126.8 
A 6.3 -3.0 -4.9 -8.0 
LH=3,6-diphenoxypyridazine (419) 129.6 125.0 129.6 121.0 
PdL(acac) (455) 134.3 125.5 124.3 115.1 
A 4.7 0.5 -5.3 -5.9 
LH=4,6-diphenoxypyrimidine ( 420) 129.9 125.9 129.9 121.5 
PdL(acac) (454) 133.7 124.3 126.5 115.5 
A 3.8 -1.6 -3.4 -6.0 
Table 5.4 Results of a statistical analysis of the data in table 5.3, the 13C NMR 
chemical shifts of the phenyl ring of the free ligands and palladium acetylacetonate 
complexes. 
C-3' C-4' C-5' C-6' 
#ACYCLIC NITROGEN DONOR COMPLEXES 7 7 7 7 
(Five-membered palladacycles) 
Mean CIS (ppm) +2.1 -0.5 -4.0 -1.1 
Standard deviation 0.2 0.9 0.5 4.1 
# N-HETEROCYCLIC DONOR COMPLEXES 25 25 25 23 
(Five-membered palladacycles) 
Mean CIS (ppm) +2.3 -0.8 -4.2 -4.2 
Standard deviation 0.6 1.5 0.4 3.7 
# N-HETEROCYCLIC DONOR COMPLEXES 6 6 6 6 
(Six-membered palladacycles) 
Mean CIS (ppm) +4.1 -1.3 -4.2 -4.1 
Standard deviation 1.9 1.1 0.8 3.7 
# N-HETEROCYCLIC DONOR COMPLEXES 31 31 31 29 
(Five- and six-membered palladacycles) 
Mean CIS (ppm) +2.6 -0.9 -4.2 -4.2 
Standard deviation 1.2 1.4 0.5 3.7 
#ALL NITROGEN DONOR COMPLEXES 
(Five- and six-membered palladacycles) 
Mean CIS (ppm) 
Standard deviation 
C-3' 
38 
+2.6 
1.1 
C-4' 
38 
-0.8 
1.3 
C-5' 
38 
-4.2 
0.5 
C-6' 
36 
-3.6 
3.9 
Tables 5.1 and 5.3 list the assigned 1 H and 13c NMR chemical shifts 
respectively for the ligand LH and PdL(acac) complex, along with the CIS = ~ = 
o(complex)- o(free ligand). Note that the spectra are grouped together according to the 
type of nitrogen donor and the size of the resultant metallocycle. In addition tables 5.2 
and 5.4 list the results of statistical analyses of the data from tables 5.1 and 5.3 
respectively, with the data for each of the three classes of complex analysed separately 
and in two groups, namely: (i) all N-heterocyclic donor PdL(acac) complexes; and (ii) 
all PdL(acac) complexes. 
Consideration of the CIS values observed in the NMR spectra of the 
cyclopalladated complexes shows that some consistent patterns exist. Figures 5.2 and 
5.3 show a graphical representation of the data in tables 5.1 and 5.3 and illustrate more 
clearly the consistent patterns as the calculated standard deviations for the mean CIS 
values are somewhat exaggerated, due to the presence in each data set of several 
outlying data points. The two figures demonstrate that the most reliable signals for 
predicting the chemical shifts of the cyclopalladated phenyl ring, based on the CIS of 
signals in the spectra of the 1igands, are those for H-4' and C-5'. 
Protons H-3' and the carbons to which they are attached (C-3') show a small-
but consistent-downfield shift, the magnitude of which is significantly greater for 
those ligands which form a six-membered metallocycle. In the square planar palladium 
acetylacetonate complexes, these two atoms are influenced by the deshielding effect of 
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Figure 5.2 Plot of frequency versus CIS for the 1 H NMR chemical shifts of the 
phenyl ring in cyclometallated palladium acetylacetonate complexes. 
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Figure 5.3 Plot of frequency versus CIS for the 13C NMR chemical shifts of the 
phenyl ring in cyclometallated palladium acetylacetonate complexes. 
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the lone pair on the oxygen atom of the acac ligand. Comparing the proximity of C-3' 
and H-3' to this lone pair for a complex with a five-membered palladacycle, relative to 
that with a six-membered palladacycle, provides an explanation for the difference in 
magnitude of this downfield shift in the two systems. 1-Phenylpyrazole forms a 
five-membered metallocycle (A, figure 5.4) upon cyclopalladation, whilst 
1-benzylpyrazole forms a six-membered metallocycle (B, figure 5.4). As can be seen in 
figure 5.4, the geometry of the six-membered metallocycle (B) is such that C-3' and 
H-3' must lie closer to the oxygen atom of the acac ligand in this structure, than in that 
which contains the five-membered metallocycle (A). Thus 1-phenylpyrazole has CIS 
values of 0.11 ppm and 2.6 ppm for H-3' and C-3' respectively, whilst 1-benzylpyrazole 
has CIS values of greater magnitude, 0.19 ppm and 5.4 ppm, for the corresponding 
positions. 
Q-;? 
H Pd 
o' 'o 
~ 
A B 
Figure 5.4 
C-5', which is para to the palladium atom and unaffected by steric interactions, 
exhibits a consistent, and relatively large, upfield shift and this has been attributed to 
the existence of some metal-to-ligand back-bonding.54 Protons H-6' and carbons C-6' 
show inconsistent CIS values of often relatively large magnitude and this can be 
attributed to the cyclometallation-induced conformational changes which occur within 
the ligand. 54 For example, in the case of a ligand in which two rings are constrained to 
be coplanar in a cyclopalladated complex, but not in the free ligand, a large upfield shift 
may be observed for H-6' and C-6'.54 H-6' may be less affected by such conformational 
changes in the case of a ligand which forms a six-membered palladacycle hence the 
observed CIS for this atom are more consistent and of relatively lesser magnitude. 
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5.3 CYCLORHODATED COMPLEXES: lH AND 13C NMR DATA 
TABULATION AND ANALYSIS 
5' 6' 
4'G-O 
3' 2' 
LH RhL2(acac) R=R'=CH3 
RhL2(dbm) R=R'=C6H5 
RhLz(bac) R=CH3, R'=C6Hs 
Figure 5.4 Numbering scheme used for free ligands (LH) and rhodium 
acetylacetonate (RhL2(acac)), dibenzoylmethanate (RhL2(dbm)) and benzoylacetonate 
(RhL2(bac)) complexes (note that analogous numbering is employed for the lH NMR 
spectra of the chloro-bridged dimers, [RhL2Cl]2). 
Table 5.5 1 H NMR chemical shifts of the phenyl ring for the free ligands and 
cyclorhodated complexes where A= CIS= 3(complex(ppm))- ()(free ligand(ppm)). 
H-3' H-4' H-5' H-6' 
LH=l-phenylpyrazole (116) 7.44 7.27 7.44 7.69 96 
[RhL2CI]z 6.01 6.60 6.84 7.12 96 
Li -1.43 -0.67 -0.60 -0.57 
RhL2(acac) 6.22 6.70 6.88 7.13 96 
Li -1.22 -0.57 -0.56 -0.56 
RhLz(dbm) 6.34 6.77 6.94 7.17 96 
Li -1.10 -0.50 -0.50 -0.52 
LH=2-phenylthiazole (115) 7.45 7.45 7.45 7.95 
[RhL2Cl]z 6.02 6.72 6.83 7.45 
A -1.43 -0.73 -0.62 -0.50 
RhL2(acac) 6.30 6.80 6.88 7.49 
A -1.15 -0.65 -0.57 -0.46 
RhLz(dbm) (116) 6.41 6.85 6.92 7.52 
A -1.04 -0.60 -0.53 -0.43 
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H-3' H-4' H-5' H-6' 
LH=2-phenylindazole (117) 7.54 7.41 7.54 7.92 
[RhL2Cl]z 5.75 6.50 6.87 7.38 
A -1.79 -0.91 -0.67 -0.54 
RhL2(acac) (118) 6.08 6.65 6.89 7.37 
A -1.46 -0.76 -0.65 -0.55 
RhL2(dbm) (119) 6.20 6.72 6.98 7.45 
A -1.34 -0.69 -0.56 -0.47 
RhL2(bac) (120) 6.12 6.69 6.95 7.41 
6.18 7.44 
LH=2-phenylbenzoxazole (121) 7.55 7.55 7.55 8.27 
[RhL2Cl]z (122) 6.22 6.74 7.07 7.28 
A -1.33 -0.81 -0.48 -0.99 
RhL2(acac) (123) 6.54 6.86 6.97 7.73 
A -1.01 -0.69 -0.58 -0.54 
RhL2(dbm) (124) 6.66 6.92 7.02 7.77 
A -0.89 -0.63 -0.53 -0.50 
RhL2(bac) (125) 6.59 6.89 6.99 7.74 
6.61 7.00 7.76 
LH=2-phenylbenzothiazole (126) 7.51 7.51 7.51 8.11 
[RhL2Clh 5.99 6.56 6.85 7.57 
A -1.52 -0.95 -0.66 -0.54 
LH=2-phenyl-1 ,2,3-triazole (127) 7.42 7.36 7.42 8.09 
[RhL2Cl]2 6.13 6.90 7.08 7.69 
A -1.29 -0.46 -0.34 -0.40 
RhL2(acac) (128) 6.19 6.83 7.01 7.66 
A -1.23 -0.53 -0.41 -0.43 
RhL2(dbm) (129) 6.30 6.89 7.06 7.70 
A -1.12 -0.47 -0.36 -0.39 
RhL2(bac) (130) 6.23 6.86 7.03 7.67 
6.26 7.04 
LH=2-phenylpyridine (201) 7.47 7.40 7.47 7.99 
[RhL2Clh 5.95 6.65 6.82 7.55 
A -1.52 -0.75 -0.65 -0.44 
RhL2(acac) 6.29 6.77 6.89 7.59 
A -1.18 -0.63 -0.58 -0.40 
RhL2(dbm) 6.40 6.82 6.94 7.63 
A -1.07 -0.58 -0.53 -0.36 
RhL2(bac) 6.34 6.80 6.92 7.62 
6.36 
LH=2-phenylquinoline (203) 7.52 7.48 7.52 8.17 
RhL2(acac) (206) 6.54 6.70 7.01 7.87 
A -0.98 -0.78 -0.51 -0.30 
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H-3' H-4' H-5' H-6' 
LH=benzo[h]quinoline (462) 7.74 7.68 7.89 96 
[RhL2Cl]2 5.99 6.88 7.26 96 
A -1.75 -0.80 -0.63 
RhL2(acac) 6.23 6.98 7.30 96 
A -1.51 -0.70 -0.59 
RhL2(dbm) 6.36 7.05 7.36 96 
A -1.38 -0.63 -0.53 
RhL2(bac) 6.28 7.02 7.33 96 
6.31 7.34 
LH=2,3-diphenylquinoxaline ( 458) 7.35 7.35 7.35 7.53 
[RhL2Clh 5.73 6.26 6.50 6.90 
A -1.62 -1.09 -0.85 -0.63 
RhL2(acac) (460) 6.52 6.60 6.67 7.08 
A -0.83 -0.75 -0.68 -0.45 
LH=dibenzo[a,c ]phenazine ( 459) 7.75 7.81 8.58 
[RhL2Cl]2 6.14 6.94 7.92 
A -1.61 -0.87 -0.66 
RhL2(acac) (461) 6.49 7.03 8.01 
A -1.26 -0.78 -0.57 
Table 5.6 l3C NMR chemical shifts of the phenyl ring for the free ligands and 
cyclorhodated complexes where~= CIS= o(complex(ppm))- o(free ligand(ppm)). 
C-3' C-4' C-5' C6' 
LH=l-phenylpyrazole (116) 129.4 126.4 129.4 119.2 96 
RhL2(acac) 135.0 125.4 122.4 110.9 96 
A 5.6 -1.0 -7.0 -8.3 
RhL2(dbm) 135.2 125.3 122.4 111.0 96 
A 5.8 -1.1 -7.0 -8.2 
LH=2-phenylthiazole (115) 129.1 130.4 129.1 126.7 
RhL2(acac) 134.1 129.1 122.3 124.0 
A 5.0 -1.3 -6.8 -2.7 
RhL2(dbm) (116) 134.2 130.1 122.1 123.9 
A 5.1 -0.3 -7.0 -2.8 
LH=2-phenylindazole (117) 129.5 127.8 129.5 120.9 
RhL2(acac) (118) 135.7 126.6 122.8 113.0 
A 6.2 -1.2 -6.7 -7.9 
RhL2(dbm) (119) 135.9 126.5 122.6 112.8 
A 6.4 -1.3 -6.9 -8.1 
RhL2(bac) (120) 135.7 126.5 122.6 112.8 
135.9 126.7 122.8 113.0 
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C-3' C-4' C-5' C6' 
LH=2-phenylbenzoxazole (121) 128.8 131.4 128.8 127.6 
RhLz(acac) (123) 134.5 130.8 122.6 125.4 
,1 5.7 -0.6 -6.2 -2.2 
RhLz(dbm) (124) 134.6 130.6 122.4 125.3 
,1 5.8 -0.8 -6.4 -2.3 
RhLz(bac) (125) 134.4 130.6 122.4 125.2 
134.7 130.8 122.6 125.5 
LH=2-phenyl-1,2,3-triazole (127) 129.2 127.5 129.2 118.9 
RhLz(acac) (128) 134.1 127.4 123.5 114.3 
,1 4.9 -0.1 -5.7 -4.6 
RhLz(dbm) (129) 134.2 127.3 123.4 114.3 
A 5.0 -0.2 -5.8 -4.6 
RhLz(bac) (130) 134.0 127.3 123.4 114.3 
134.2 127.5 123.5 114.4 
LH=2-phenylpyridine (201) 128.7 128.9 128.7 126.9 
RhLz(acac) 133.7 128.9 122.0 123.6 
A 5.0 0.0 -6.7 -3.3 
RhLz(dbm) 133.9 128.7 121.8 123.4 
A 5.2 -0.2 -6.9 -3.5 
RhLz(bac) 133.7 128.7 121.8 123.4 
133.9 128.9 122.0 123.6 
LH=2-phenylquinoline (203) 128.8 129.3 128.8 127.5 
RhLz(acac) (206) 136.1 128.5 122.2 125.5 
,1 7.3 -0.8 -6.6 -2.0 
LH=benzo[h]quinoline (462) 127.1 128.2 127.8 96 
RhLz(acac) 131.2 128.4 120.1 96 
,1 4.1 0.2 -7.7 
RhLz(dbm) 131.1 128.1 119.8 96 
A 4.0 -0.1 -8.0 
RhLz(bac) 130.9 129.2 119.6 96 
131.1 129.3 119.8 
Table 5.7 Results of a statistical analysis of the data in table 5.5, the lH NMR 
chemical shifts of the phenyl ring of the free ligands and cyclorhodated complexes. 
# [RhL2Cl]2 COMPLEXES 
(Five-membered rhodacycles) 
Mean CIS (ppm) 
Standard deviation 
# RhL2(acac) COMPLEXES 
(Five-membered rhodacycles) 
Mean CIS (ppm) 
Standard deviation 
# RhL2( dbm) COMPLEXES 
(Five-membered rhodacycles) 
Mean CIS (ppm) 
Standard deviation 
H-3' H-4' H-5' H-6' 
10 10 10 8 
-1.53 -0.80 -0.62 -0.58 
0.16 0.16 0.13 0.17 
10 10 10 8 
-1.18 -0.68 -0.57 -0.46 
0.20 0.08 0.07 0.08 
7 7 7 6 
-1.13 -0.59 -0.51 -0.45 
0.16 0.07 0.06 0.06 
Table 5.8 Results of a statistical analysis of the data in table 5.6, the 13C NMR 
chemical shifts of the phenyl ring of the free ligands and cyclorhodated complexes. 
# RhL2(acac) COMPLEXES 
(Five-membered rhodacycles) 
Mean CIS (ppm) 
Standard deviation 
# RhL2(dbm) COMPLEXES 
(Five-membered rhodacycles) 
Mean CIS (ppm) 
Standard deviation 
C-3' 
8 
+5.5 
0.9 
7 
+5.3 
0.7 
C-4' 
8 
-0.6 
0.5 
7 
-0.6 
0.5 
C-5' 
8 
-6.7 
0.5 
7 
-6.9 
0.6 
C-6' 
7 
-4.4 
2.5 
6 
-4.9 
2.4 
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Tables 5.5 and 5.6 list the assigned lH and 13C NMR spectra respectively for 
the ligand LH and the cyclorhodated complexes-[RhL2Cl]2; RhL2(acac); RhL2(dbm); 
and RhL2(bac)-along with the CIS; A = o(complex) - o(free ligand). In addition, 
tables 5.7 and 5.8 list the results of a statistical analysis of the CIS data from tables 5.5 
and 5.6 respectively. 
As with the statistical analyses of the cyclopalladated complexes (vide supra), 
the analyses of CIS values observed in the spectra of cyclorhodated complexes show 
consistent patterns, despite the relatively small sample size. Consideration of these 
trends, both independently and relative to those for the cyclopalladated complexes, is 
both interesting and informative. 
Perhaps the most obvious difference between the rhodium(III) system and the 
palladium(II) system is the coordination geometry, octahedral and square planar 
respectively. The octahedral geometry about the rhodium(III) centre means that the two 
cyclometallated moieties in such complexes experience inter-ligand through space 
effects that are absent in the analogous palladium complexes. This is most obviously 
illustrated by the observed mean CIS for H-3' and C-3'. In the cyclopalladated 
complexes, both of these atoms exhibit a consistent, small downfield shift due to 
interaction with the acetylacetonate oxygen lone pair. However, for H-3' in 
cyclorhodated complexes, a consistent and very large upfield shift is observed. This 
difference is a result of interaction between this proton and the shielding ring current of 
the coordinated heterocycle of the other cyclometallated ligand, which is coordinated 
cis to the cyclorhodated ring. This observation is consistent with observations made of 
analogous octahedral rhodium(III) and iridium(III) complexes.l07,109 Since the 
through-space ring current anisotropy effects are less important in 13C NMR, C-3' 
shows a consistent downfield shift. 
Carbons C-5', para to the rhodium atom again shows the consistent and 
relatively large upfield shift observed for the equivalent position in cyclopalladated 
complexes. In the cyclorhodated acetylacetonate complexes, however, this shift-and 
the CIS of the attached proton-is of greater magnitude (-6.7 ppm) than that in the 
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corresponding cyclopalladated acetylacetonate complexes ( -4.2 ppm), suggesting that 
the metal-to-ligand back-bonding ability of rhodium(III) is greater than that of 
palladium(Il). Although H-4' shows a significant upfield mean CIS (-0.68 ppm for 
RhLz(acac)) this is not the case with C-4' (-0.6 ppm) and this suggests that the shift of 
H -4' is also influenced by the shielding ring current of the other cyclorhodated ligand. 
Carbons C-6' and their attached protons, H -6', again show relatively inconsistent 
CIS values, those observed for H-6' being somewhat more consistent than those for 
C-6'. That these shifts are perhaps more consistent than those observed for the 
cyclopalladated complexes, is most probably a reflection of the greater structural 
diversity of the ligands in the latter series, than of any inherent difference between the 
two systems. 
The differences in observed CIS values between [RhLzC1]2, RhL2( acac) and 
RhLz(dbm) for atoms in equivalent positions are relatively small. This is to be 
expected because the cyclorhodated phenyl rings are the least susceptible to the 
difference in through space effects that result from a change in ligand coordinated to the 
rhodium at the sites trans to them. 
5.4 CONCLUSION 
It is hoped that these CIS values will prove useful for other workers, since they 
allow relatively accurate prediction of the NMR chemical shifts of cyclopalladated and 
cyclorhodated compounds from a knowledge of the assignments of the starting ligands. 
This is particularly true in the case of predicting the CIS of H-4' and C-5' in 
cyclopalladated complexes. Such predictions can be useful, for example, to distinguish 
between structural isomers resulting from the cyclometallation of ligands that can 
undergo the reaction at more than one site.llO 
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Conclusi n 
CONCLUSION 
Over the past three decades there has been increasing interest in the synthesis 
and study of cyclometallated compounds. Being at the interface between the traditional 
disciplines of organometallic and coordination chemistry, cyclometallated complexes 
have a unique combination of properties, and have attracted interest from researchers in 
many fields, both applied and theoretical. Complexes of this type have found a wide 
variety of applications and, with the increasing amount of research being reported, these 
can only be expected to increase. 
This thesis has described the preparations of a number of new cyclopalladated 
and cyclorhodated complexes, all of which have been fully characterised. The 1 H and 
13C NMR data accumulated in the course of this research has been used to refine, in the 
case of cyclopalladated acetylacetonate complexes, and to elucidate, in the case of 
cyclorhodated B-diketonate complexes, trends in the CIS values observed, such that 
relatively accurate predictions of chemical shifts for specific positions in the ligand, 
upon cyclometallation, may be made. In addition, the single crystal X-ray structure 
determinations of several complexes, both cyclometallated and non-cyclometallated, 
have been reported and their significance discussed. 
Syntheses have been developed for the preparation of two doubly 
cyclometallated analogues of quaterpyridine. Their cyclopalladated complexes have 
also been prepared and, as a result, the foundations for further research of these and 
related ligands have been laid. 
A series of phenoxy- and phenylthio-substituted heterocycles have been 
prepared with a view to the targeted synthesis of six- and seven-membered 
metallocycles, reports of which are relatively uncommon. Despite the limited success 
of this strategy, the target ligands have been shown to possess interesting coordination 
chemistry. In particular, trends in temperature dependent behaviour have been 
established and a possible explanation for these observations proposed. 
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E perimental · 
INSTRUMENTATION AND REAGENTS 
Infrared spectra were recorded on a Perkin Elmer 1600 FTIR or Shimadzu 8201 
FTIR spectrophotometer. Mass spectra were obtained with a Kratos MS80RFA 
spectrometer with a Mac 3 data system. Electron impact (EI) spectra were obtained at 
70 eV with a source temperature of 150°C. Fast atom bombardment (FAB) spectra 
were acquired in a nitrobenzyl alcohol matrix using an Iontech ZNlFW FAB gun 
operated at 8 KV and 2 rnA. Melting points were determined using an Electrothermal 
melting point apparatus and are uncorrected. Microanalyses were performed by the 
Chemistry Department, University of Otago, Dunedin. For a number of the metallated 
complexes low carbon analyses are consistently observed and this is attributed to the 
non-stoichiometric formation of metal carbides during the combustion process, as noted 
in the literature.204 
lH NMR spectra were recorded on a Varian Unity 300 spectrometer with a 3 
mm or 5 mm probe and are referenced to the Me4Si signal for CDCl3 solutions and to 
the residual protonated solvent signal for CD3CN and d6-DMSO solutions. Be NMR 
spectra were recorded on a Varian Unity 300 or a Varian XL-300 spectrometer with a 3 
mm or 5mm probe and are referenced to the solvent signal. All other one-dimensional 
and two-dimensional NMR experiments were performed on a Varian Unity 300 
spectrometer using standard pulse sequences and parameters. 
Radial chromatography was performed on a Chromatotron (Harrison and 
Harrison) using Merck type 60 P.F.254 silica gel. Column chromatography was 
performed with silica gel (grade 923, 100-200 mesh). Unless otherwise stated 
petroleum ether refers to that fraction boiling at 50-70°C and ether to diethyl ether. 
Solvents were purified according to standard literature procedures. 
Thallium acetylacetonate and dibenzoylmethanate were prepared from thallium 
carbonate and acacH or dbmH according to a literature procedure.283 Unless otherwise 
stated, reagents were obtained from commercial sources and were used as received. 
150 
GENERAL PROCEDURES 
(i) REACTION WITH LITHIUM TETRACHLOROPALLADATE: 
A solution of one equivalent of palladium chloride and three equivalents of 
lithium chloride in methanol was refluxed for two hours and then filtered. The filtrate 
was added to a methanol solution of the ligand and the resultant solution stirred for one 
to four days. The resultant precipitate was filtered off and washed with methanol then 
with ether. 
(ii) REACTION WITH PALLADIUM ACETATE: 
Method A: A solution containing the ligand and one or two equivalents of 
palladium acetate in glacial acetic acid was refluxed for one hour. The acetic acid was 
then removed under reduced pressure. The resultant 1-1-diacetato dipalladium complex 
was then converted to the 1-1-dichloro dipalladium complex by stirring with an 
acetone/water (60/40, v/v) solution containing excess lithium chloride (four 
equivalents) for up to four days. The resultant precipitate was filtered off and washed 
with acetone then with ether. 
Method B: A solution containing the ligand and one or two equivalents of 
palladium acetate in benzene was degassed by passing a stream of nitrogen bubbles 
through it for five minutes and then heated at 60°C under an atmosphere of nitrogen for 
24 hours. The benzene was then removed under reduced pressure and the residue taken 
up in chloroform and filtered. The filtrate was stripped of solvent under reduced 
pressure and the residue stirred with an acetone/water (60/40, v/v) solution containing 
excess lithium chloride (four equivalents) for up to four days. The resultant precipitate 
of 1-1-dichloro dipalladium complex was filtered off and washed with acetone then with 
ether. 
(iii) REACTION WITH RHODIUM TRICHLORIDE: 
A solution containing rhodium trichloride trihydrate and two equivalents of the 
ligand in 2-methoxyethanol was stirred under reflux for two days to give a suspension 
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which was allowed to cool to room temperature and then refrigerated. The resultant 
precipitate was then filtered off. 
(iv) PREPARATION OF B-DIKETONATE COMPLEXES: 
Method A: Excess B-diketone was added to a freshly prepared solution of 
sodium methoxide in methanol and the resultant solution of sodium B-diketonate added 
to a suspension of the chloro-bridged dimer in methanol and the mixture stirred for one 
to four days. The precipitated B-diketonate complex was filtered and washed with 
methanol then with ether. 
Method B: The chi oro-bridged dimer was added to a solution of two equivalents 
of thallium B-diketonate in dichloromethane and the resultant solution stirred for 24 
hours. The precipitate of thallium chloride was filtered off using a plug of anhydrous 
magnesium sulfate and the dichloromethane removed from the filtrate under reduced 
pressure. The residue was taken up in chloroform and vapour diffusion of petroleum 
ether into this solution gave the B-diketonate complex, which was filtered off and 
washed with pentane. 
PREPARATION AND SPECTRA OF LIGANDS AND COMPLEXES 
2-Phenylimidazoline, 101. 
101 was obtained commercially (Aldrich). lH NMR (CDCb): o 3.72 (s, 4H, 
H-4 and H-5), 4.93 (br s, 1H, N-H), 7.35 (t, 2H, H-3' and H-5'), 7.41 (t, lH, H-4'), 7.77 
(d, 2H, H-2' and H-6'). 13C NMR (CDC13): o 50.05 (C-4 and C-5), 125.21 (C-1'), 
126.83 (C-2' and C-6'), 128.20 (C-3' and C-5'), 130.38 (C-4'), 164.73 (C-2). 
,H 6' 5' 
5cN~ ~4' 
4 N 2' 3' 
101 
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(i) REACTION WITH PALLADIUM ACETATE 
101 and palladium acetate were reacted according to method B to give 10453 
which was reacted with thallium acetylacetonate, as in the general procedure, to give 
Pd(101-H)(acac), 105, in 8% overall yield. Mp 195-199°C. Anal. Calcd for 
C14H16N202Pd: C, 47.95; H, 4.60; N, 7.99; Found: C, 47.80; H, 4.48; N, 8.04%. lH 
NMR (CDCI3): o 1.99 (s, 3H, acac-CH3), 2.06 (s, 3H, acac-CH3), 3.76 (m, 2H, H-5), 
3.91 (m, 2H, H-4), 5.24 (br s, 1H, N-H), 5.36 (s, IH, acac-CH), 7.01 (m, 2H, H-5' and 
H-6'), 7.18 (m, 1H, H-4'), 7.57 (d, 1H, H-3'). 13C NMR (CDCI3): o 27.57 and 27.85 
(acac-CH3), 44.47 (C-5), 50.60 (C-4), 100.26 (acac-CH), 123.25 (C-5'), 123.58 (C-6'), 
129.79 (C-4'), 130.95 (C-3'), 134.92 (C-1'), 152.11 (C-2'), 173.92 (C-2), 186.13 and 
187.86 (acac-CO). 
2-Phenyloxazole, 109. 
109 was prepared by the condensation of vinylene carbonate and benzamide in 
polyphosphoric acid as previously reported.68 lH NMR (CDCl3): o 7.24 (br s, 1H, 
H-4), 7.46 (m, 3H, H-3', H-4' and H-5'), 7.72 (br s, lH, H-5), 8.06 (m, 2H, H-2' and 
H-6'). 13C NMR (CDCb): o 126.35 (C-2' and C-6'), 127.54 (C-1'), 128.41 (C-4), 
128.78 (C-3' and C-5'), 130.35 (C-4'), 138.57 (C-5), 161.99 (C-2). 
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109 
(i) REACTION WITH LITHIUM TETRACHLOROPALLADATE 
109 and one equivalent of lithium tetrachloropalladate were reacted according to 
-
the general procedure to give Pd(109)2Cb, 112, in 36% yield. Mp >300°C. Anal. 
Calcd for C1sH14N202Cl2Pd: C, 46.23; H, 3.02; N, 5.99; Cl, 15.16; Found: C, 46.28; 
H, 2.72; N, 5.92; Cl, 15.19%. IR (KBr pellet): Vmax 1567, 1487, 1262, 916, 785, 712 
and 683 cm-1. lH NMR (CDCl3): o 7.60 (t, 2H, H-3' and H-5'), 7.65 (t, 1H, H-4'), 7.70 
(d, lH, H-4), 7.83 (d, lH, H-5), 8.94 (d, 2H, H-2' and H-6'). 13C NMR (CDCl3): o 
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124.46 (C-1 '), 128.89 (C-2' and C-6'), 129.00 (C-3' and C-5'), 129.48 (C-4), 132.42 
(C-4'), 139.53 (C-5), 162.86 (C-2). 
4-Phenyloxazole, 110. 
110 was prepared by the reaction of 2-bromoacetophenone with ammonium 
formate in formic acid as previously reported.73 lH NMR (CDCl3): o 7.32 (t, 1H, 
H-4'), 7.42 (t, 2H, H-3' and H-5'), 7.75 (d, 2H, H-2' and H-6'), 7.95 (d, 1H, H-2), 7.95 
(d, lH, H-5). lH NMR (d6-DMSO): o 7.42 (t, 1H, H-4'), 7.53 (t, 2H, H-3' and H-5'), 
7.91 (d, 2H, H-2' and H-6'), 8.57 (s, 1H, H-2), 8.72 (s, 1H, H-5). 13C NMR (CDCl3): o 
125.53 (C-2' and C-6'), 128.17 (C-4'), 128.74 (C-3' and C-5'), 130.65 (C-1'), 133.69 
(C-5), 140.31 (C-4), 151.34 (C-2). 13C NMR (d6-DMSO): o 125.34 (C-2' and C-6'), 
128.08 (C-4'), 128.90 (C-3' and C-5'), 130.84 (C-1'), 135.17 (C-5), 139.35 (C-4), 152.72 
(C-2). 
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110 
(i) REACTION WITH LITHIUM TETRACHLOROPALLADATE 
110 was reacted with one equivalent of lithium tetrachloropalladate according to 
the general procedure to give Pd(ll0)2Ch, 113, in 77% yield. Mp 262-265°C (dec.). 
Anal. Calcd for C1sHt4NzOzClzPd: C, 46.23; H, 3.02; N, 5.99; Cl, 15.16; Found: C, 
45.93; H, 3.02; N, 5.94; Cl, 15.40%. IR (KBr pellet): Vmax 1527, 1488, 1169, 1073, 
908, 841, 762, 690, 678, 613 cm-1. lH NMR (CDCl3): o 7.53 (m, 3H, H-3', H-4' and 
H-5'), 7.81 (s, 1H, H-5), 8.18 (m, 2H, H-2' and H-6'), 8.50 (s, 1H, H-2). lH NMR 
(d6-DMSO): o 7.43 (t, lH, H-4'), 7.54 (t, 2H, H-3' and H-5'), 7.90 (d, 2H, H-2' and 
H-6'), 8.57 (s, lH, H-2), 8.73 (s, 1H, H-5). 13C NMR (d6-DMSO): o 125.28 (C-2' and 
C-6'), 128.07 (C-4'), 128.90 (C-3' and C-5'), 130.78 (C-1'), 135.20 (C-5), 139.26 (C-4), 
152.74 (C-2). 
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2,4-Diphenyloxazole, 111. 
111 was prepared by the reaction of 2-bromoacetophenone and benzamide as 
previously reported.75 Purification of the crude solid was by recrystallisation from 
ethanol, rather than by distillation, and the oxazole was obtained as white needles. 
Yield 13.3%. Mp 103.5-105°C (lit.75 l02.5-103.5°C). Anal. Calcd for CtsH11NO: C, 
81.43; H, 5.01; N, 6.33; Found: C, 81.19; H, 5.05; N, 6.40%. IR (KBr pellet): Vmax 
1554, 1489, 1448, 1124, 1070, 943, 931, 783, 757, 719, 706 and 693 cm-1. lH NMR 
(CDCl3): 8 7.33 (t, 1H, H-4"), 7.43 (t, 2H, H-3" and H-5"), 7.47 (m, 3H, H-3', H-4' and 
H-5'), 7.83 (d, 2H, H-2" and H-6"), 7.95 (s, H-5), 8.13 (m, 2H, H-2' and H-6'). lH NMR 
(d6-DMSO): 8 7.45 (t, 1H, H-4"), 7.56 (t, 2H, H-3" and H-5"), 7.67 (m, 3H, H-3', H-4' 
and H-5'), 7.97 (d, 2H, H-2" and H-6"), 8.16 (m, 2H, H-2' and H-6'), 8.80 (s, H-5). Be 
NMR (CDCh): 8125.62 (C-2" and C-6"), 126.49 (C-2' and C-6'), 127.48 (C-1"), 128.09 
(C-4"), 128.73 (C-3', C-5', C-3" and C-5"), 130.37 (C-4'), 131.11 (C-1'), 133.42 (C-5), 
141.99 (C-2), 161.91 (C-4). Be NMR (d6-DMSO): 8 125.44 (C-2" and C-6"), 126.25 
(C-2' and C-6'), 126.91 (C-1"), 128.34 (C-4"), 129.02 (C-3" and C-5"), 129.38 (C-3' and 
C-5'), 130.86 (C-1'), 130.97 (C-4'), 135.69 (C-5), 141.21 (C-2), 161.19 (C-4). 
111 
(i) REACTION WITH LITHIUM TETRACHLOROPALLADATE 
Lithium tetrachloropalladate was reacted with two equivalents of 111 according 
to the general procedure to give Pd(111)2Ch in 42% yield. Mp=220-221 oc. Calcd for 
C3oH22N20235CJl08pd: M+, 585.0409; Found (FAB):M+, 585.0421. IR (KBr pellet): 
Vmax 1592, 1539, 1480, 1448, 1360, 934, 778, 758, 721, 694 cm-1. 
155 
(ii) REACTION WITH MERCURIC ACETATE 
A solution of 111 (204 mg, 0.92 mmol) and mercuric acetate (262 mg, 0.82 
mmol) in ethanol (15 cm3) and acetic acid (0.2 cm3) was stirred under reflux for 5 days. 
The solution was cooled and the resultant precipitate filtered off, washed with chilled 
ethanol (10 cm3) and then dried under reduced pressure to give Hg(111-H)(OAc), 114, 
in 67% yield. Mp 181.5-184.5°C. Anal. Calcd for C17H13N03Hg: C, 42.55; H, 2.73; 
N, 2.92; Found: C, 42.03; H, 2.39; N, 3.04%. IR (KBr pellet): Vmax 1649, 1610, 1554, 
1488, 1446, 1368, 1279, 970, 780, 716, 692 cm-1. lH NMR (d6-DMSO): 8 2.07 (s, 3H, 
CH3COO), 7.44 (t, 1H, H-4"), 7.53 (t, 2H, H-3" and H-5"), 7.67 (m, 3H, H-3', H-4' and 
H-5'), 8.15 (d, 4H, H-2', H-6', H-2" and H-6"). Be NMR (d6-DMSO): 8 23.01 
(CH3COO), 125.88 (C--2" and C-6"), 126.11 (C-2' and C-6'), 127.32 (C-1"), 128.18 
(C-4"), 128.80 (C-3" and C-5"), 129.38 (C-3' and C-5'), 130.71 (C-4'), 132.14 (C-1'), 
148.60 (C-2), 164.02 (C-4), 175.09 (CH3COO). 
2-Phenylthiazole, 115. 
115 was available in the department. lH NMR (CDCl3): 8 7.36 (d, 1H, H-5), 
7.45 (m, 3H, H-3', H-4' and H-5'), 7.93 (d, lH, H-4), 7.95 (m, 2H, H-2' and H-6'). 13C 
NMR (CDCI3): 8 119.04 (C-5), 126.73 (C-2' and C-6'), 129.05 (C-3' and C-5'), 130.42 
(C-4'), 142.79 (C-4). 
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115 
(i) REACTION WITH RHODIUM TRICHLORIDE 
Reaction of 115 with rhodium trichloride trihydrate gave [Rh(115-H)2Cl]2 in 
56% yield. A sample was recrystallised from chloroform/petroleum ether for elemental 
analysis. Mp >300°C. Anal. Calcd for C36H24N4S4Cl2Rh2.CHCl3: C, 42.86; H, 2.43; 
N, 5.40; Cl, 17.09; Found: C, 42.43; H, 2.45; N, 5.57; Cl, 17.56%. lH NMR (CDCI3): 
156 
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8 6.02 (d, 1H, H-3'), 6.72 (t, 1H, H-4'), 6.83 (t, 1H, H-5'), 7.17 (d, 1H, H-5), 7.45 (d, 
lH, H-6'), 8.08 (d, lH, H-4). 
Ligand exchange of [Rh(115-H)2Clh with thallium acetylacetonate gave 
Rh(115-Hh (acac) in 29% yield. Mp >300°C. Anal. Calcd for 
C23H19NzOzSzRh.lf2HzO: C, 51.98; H, 3.79; N, 5.27; Found: C, 51.99; H, 3.67; N, 
5.28%. lH NMR (CDCl3): 8 1.90 (s, 6H, acac-CH3), 5.21 (s, 1H, acac-CH), 6.30 (d, 
2H, H-3'), 6.80 (t, 2H, H-4'), 6.88 (t, 2H, H-5'), 7.35 (d, 2H, H-5), 7.49 (d, 2H, H-6'), 
7.70 (d, 2H, H-4). 13C NMR (CDCI3): 8 28.79 (acac-CH3), 98.11 (acac-CH), 116.29 
(C-5), 122.28 (C-5'), 124.00 (C-6'), 129.11 (C-4'), 134.10 (C-3'), 140.02 (C-4), 187.67 
(acac-CO). 
Ligand exchange of [Rh(115-H)zClh with thallium dibenzoylmethanate gave 
Rh(115-H)2(dbm), 116, in 46% yield. Mp 231°C (dec.). Anal. Calcd for 
C33H23N202S2Rh: C, 61.03; H, 3.59; N, 4.33; Found: C, 58.67; H, 3.57; N, 4.17%. lH 
NMR (CDCl3): 8 6.41 (d, 2H, H-3'), 6.54 (s, 1H, dbm-CH), 6.85 (t, 2H, H-4'), 6.92 (t, 
2H, H-5'), 7.25 (d, 2H, H-5), 7.31 (t, 4H, dbm-meta), 7.37 (t, 2H, dbm-para), 7.52 (d, 
2H, H-6'), 7.73 (d, 2H, H-4), 7.82 (d, 4H, dbm-ortho). 13C NMR (CDCl3): 8 92.63 
(dbm-CH), 116.22 (C-5), 122.07 (C-5'), 123.85 (C-6'), 127.10 (dbm-ortho), 128.03 
(dbm-meta), 130.05 (C-4' and dbm-para), 134.20 (C-3'), 140.09 (C-4), 182.79 
(dbm-CO). 
2-Phenylindazole, 117. 
117 was available in the department. lH NMR (CDCl3): 8 7.12 (t, 1H, H-5), 
7.33 (t, lH, H-6), 7.41 (t, lH, H-4'), 7.54 (t, 2H, H-3' and H-5'), 7.72 (d, 1H, H-4), 7.80 
(d, 1H, H-7), 7.92 (d, 2H, H-2' and H-6'), 8.43 (s, 1H, H-3). 13C NMR (CDCl3): 8 
117.85 (C-7), 120.33 (C-3 and C-4), 120.85 (C-2' and C-6'), 122.36 (C-5), 126.74 (C-6), 
127.78 (C-4'), 129.45 (C-3' and C-5'). 
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(i) REACTION WITH RHODIDM TRICHLORIDE 
Reaction of 117 with rhodium trichloride trihydrate gave [Rh(117-H)2Cl]2 in 
65% yield. lH NMR (CDCl3): 8 5.75 (d, 1H, H-3'), 6.50 (t, 1H, H-4'), 6.55 (t, 1H, 
H-6), 6.80 (t, 1H, H-5), 6.87 (t, lH, H-5'), 7.38 (d, lH, H-6'), 7.41 (d, 1H, H-4), 8.34 (d, 
1H, H-7), 8.55 (s, lH, H-3). 
Ligand exchange of [Rh(117-H)2Clh with sodium acetylacetonate gave 
Rh(ll7-H)2(acac), 118, in 57% yield. Vapour diffusion of pentane into a chloroform 
solution of the complex gave the analytical sample. Mp 323°C (dec.). Anal. Calcd for 
C31H2sN402Rh: C, 63.27; H, 4.28; N, 9.52; Found: C, 62.84; H, 4.01; N, 9.36%. 1H 
NMR (CDCl3): 8 1.90 (s, 6H, acac-CH3), 5.28 (s, 1H, acac-CH), 6.08 (d, 2H, H-3'), 
6.65 (t, 2H, H-4'), 6.89 (t, 2H, H-5'), 7.21 (t, 2H, H-5), 7.37 (d, 2H, H-6'), 7.37 (t, 2H, 
H-6), 7.74 (d, 4H, H-4 and H-7), 8.62 (s, 2H, H-3). 13C NMR (CDCl}): 8 28.78 
(acac-CH3), 99.10 (acac-CH), 112.96 (C-6'), 115.59 (C-7), 118.65 (C-3), 120.77 (C-4), 
122.79 (C-5'), 122.95 (C-5), 126.63 (C-4'), 128.49 (C-6), 135.68 (C-3'), 187.93 
(acac-CO). 
Ligand exchange of [Rh(1l7-H)2Clh with sodium dibenzoylmethanate gave 
Rh(117-H)2(dbm), 119, in 88% yield. Vapour diffusion of pentane into a chloroform 
solution of the complex gave the analytical sample. Mp >300°C. Anal. Calcd for 
C41H29N402Rh.lhH20: C, 68.24; H, 4.19; N, 7.76; Found: C, 68.11; H, 3.88; N, 
7.84%. lH NMR (CDCl3): <5 6.20 (d, 2H, H-3'), 6.60 (s, lH, dbm-CH), 6.72 (t, 2H, 
H-4'), 6.98 (t, 2H, H-5'), 7.12 (t, 2H, H-5), 7.17 (t, 2H, H-6), 7.28 (t, 4H, dbm-meta), 
7.35 (t, 2H, dbm-para), 7.45 (d, 2H, H-6'), 7.71 (d, 2H, H-4), 7.74 (d, 2H, H-7), 7.81 (d, 
4H, dbm-ortho), 8.64 (s, 2H, H-3). 13C NMR (CDCl3): 8 93.48 (dbm-CH), 112.83 
(C-6'), 115.77 (C-7), 118.52 (C-3), 120.61 (C-4), 122.64 (C-5'), 122.94 (C-5), 126.50 
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(C-4'), 127.20 (dbm-ortho), 127.97 (dbm-meta), 128.53 (C-6), 129.92 (dbm-para), 
135.85 (C-3'), 182.95 (dbm-CO). 
Ligand exchange of [Rh(l17-H)2Clh with sodium benzoylacetonate gave 
Rh(117-H)2(bac), 120, in 65% yield. Vapour diffusion of pentane into a chloroform 
solution of the complex gave the analytical sample. Mp 311 oc (dec.). Anal. Calcd for 
C36H27N402Rh.lhH20: C, 65.55; H, 4.28; N, 8.49; Found: C, 65.50; H, 4.02; N, 
8.47%. lH NMR (CDCI3): o 2.05 (bac-CH3), 5.93 (bac-CH), 6.12 (d, 1H, H-3'a or 
H-3'b), 6.18 (d, lH, H-3'a or H-3'b), 6.69 (t, 2H, H-4'a and H-4'b), 6.95 (t, 2H, H-5'a 
and H-5'b), 7.17 (m, 2H, H-5a and H-5b), 7.19 (t, 1H, H-6a or H-6b), 7.24 (t, 2H, 
bac-meta), 7.29 (t, 1H, bac-para), 7.36 (t, 1H, H-6a or H-6b), 7.41 (d, 1H, H-6'a or 
H-6'b), 7.44 (d, 1H, H-6'a or H-6'b), 7.69 (d, 1H, H-7a or H-7b), 7.72 (d, 3H, bac-ortho 
and H-4a or H-4b), 7.75 (d, 1H, H-4a or H-4b), 7.79 (d, 1H, H-7a or H-7b), 8.62 (s, 1H, 
H-3a or H-3b), 8.66 (s, 1H, H-3a or H-3b). 13C NMR (CDCl3): o 29.53 (bac-CH3), 
96.12 (bac-CH), 112.80 (C-6'a or C-6'b), 112.99 (C-6'a or C-6'b), 115.59 (C-7a or 
C-7b), 115.77 (C-7a or C-7b), 118.54 (C-3a or C-3b), 118.60 (C-3a or C-3b), 120.64 
(C-4a or C-4b), 120.73 (C-4a or C-4b), 122.63 (C-5'a or C-5'b), 122.82 (C-5'a or C-5'b), 
122.95 (C-5a and C-Sb), 126.48 (C-4'a or C-4'b), 126.67 (C-4'a or C-4'b), 127.12 
(bac-ortho), 127.89 (bac-meta), 128.46 (C-6a or C-6b), 128.56 (C-6a or C-6b), 129.79 
(bac-para), 135.66 (C-3'a or C-3'b), 135.89 (C-3'a or C-3'b), 181.12 and 189.78 
(bac-CO). 
2~ Phenylbenzoxazole, 121. 
121 was available in the department. lH NMR (CDCl3): o 7.37 (m, 2H, H-5 and 
H-6), 7.55 (m, 3H, H-3', H-4' and H-5'), 7.60 (m, 1H, H-7), 7.79 (m, lH, H-4), 8.27 (m, 
2H, H-2' and H-6'). 13C NMR (CDCb): o 110.51 (C-7), 119.94 (C-4), 124.49 (C-6), 
125.02 (C-5), 127.55 (C-2' and C-6'), 128.82 (C-3' and C-5'), 131.42 (C-4'). 
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(i) REACTION WITH RHODIUM TRICHLORIDE 
Reaction of 121 with rhodium trichloride trihydrate gave [Rh(121-H)2Clh, 122, 
in 72% yield. lH NMR (CDCl3): () 6.22 (d, lH, H-3'), 6.74 (t, lH, H-4'), 6.85 (t, lH, 
H-5), 6.92 (t, lH, H-6), 7.07 (t, lH, H-5'), 7.28 (d, lH, H-6'), 7.68 (d, 1H, H-7), 8.24 (d, 
1H, H-4). 
Ligand exchange of 122 with sodium acetylacetonate gave Rh(121-H)2(acac) , 
123, in 79% yield. Vapour diffusion of pentane into a chloroform solution of the 
complex gave the analytical sample. Mp >300°C. Anal. Calcd for 
C31H2sN204Rh.lhH20: C, 62.11; H, 4.04; N, 4.67; Found: C, 62.03; H, 4.02; N, 
4.39%. lH NMR (CDCiJ): () 1.95 (s, 6H, acac-CH3), 5.25 (s, 1H, acac-CH), 6.54 (d, 
2H, H-3'), 6.86 (t, 2H, H-4'), 6.97 (t, 2H, H-5'), 7.41 (t, 2H, H-5), 7.44 (t, 2H, H-6), 7.59 
(d, 2H, H-4), 7.69 (d, 2H, H-7), 7.73 (d, 2H, H-6'). 13C NMR (CDCiJ): () 28.78 
(acac-CH3), 98.83 (acac-CH), 111.33 (C-7), 117.35 (C-4), 122.56 (C-5'), 125.10 (C-5), 
125.42 (C-6'), 125.91 (C-6), 130.80 (C-4'), 134.45 (C-3'), 187.89 (acac-CO). 
Ligand exchange of 122 with sodium dibenzoylmethanate gave 
Rh(121-H)2( dbm), 124, in 86% yield. Vapour diffusion of pentane into a chloroform 
solution of the complex gave the analytical sample. Mp 233°C. Anal. Calcd for 
C41H27N204Rh: C, 68.92; H, 3.81; N, 3.92; Found: C, 68.87; H, 3.72; N, 4.07%. lH 
NMR (CDCl3): () 6.62 (s, lH, dbm-CH), 6.66 (d, 2H, H-3'), 6.92 (t, 2H, H-4'), 7.02 (t, 
2H, H-5'), 7.20 (t, 2H, H-5), 7.32 (t, 4H, dbm-meta), 7.33 (t, 2H, H-6), 7.38 (t, 2H, 
dbm-para), 7.54 (d, 2H, H-4), 7.63 (d, 2H, H-7), 7.77 (d, 2H, H-6'), 7.87 (d, 4H, 
dbm-ortho). 13C NMR (CDCl3): () 92.77 (dbm-CH), 111.21 (C-7), 117.49 (C-4), 
122.38 (C-5'), 124.98 (C-6), 125.26 (C-6'), 125.93 (C-5), 127.22 (dbm-ortho), 128.08 
(dbm-meta), 130.09 (dbm-para), 130.63 (C-4'), 134.58 (C-3'), 182.73 (dbm-CO). 
Ligand exchange of 122 with sodium benzoylacetonate gave Rh(121-H)2(bac), 
125, in 64% yield. Vapour diffusion of pentane into a chloroform solution of the 
complex gave the analytical sample. Mp 290-291 °C (dec.). Anal. Calcd for 
C36H2sN204Rh.lhH20: C, 65.36; H, 3.96; N, 4.23; Found: C, 65.57; H, 3.99; N, 
160 
3.98%. lH NMR (CDCh): () 2.10 (s, 3H, bac-CH3), 5.94 (s, 1H, bac-CH), 6.59 (d, 1H, 
H-3'a or H-3'b), 6.61 (d, lH, H-3'a or H-3'b), 6.89 (t, 2H, H-4'a and H-4'b), 6.99 (t, lH, 
H-5'a or H-5'b), 7.00 (t, lH, H-5'a or H-5'b), 7.21 (d, 1H, H-6a or H-6b), 7.28 (t, 2H, 
bac-meta), 7.32 (t, lH, bac-para), 7.36 (t, 1H, H-5a or H-5b), 7.40 (m, 2H, H-5a or 
H-5b and H-6a or H-6b), 7.49 (d, lH, H-4a or H-4b), 7.64 (d, lH, H-4a or H-4b), 7.65 
(d, lH, H-7a or H-7b), 7.66 (d, 1H, H-7a or H-7b), 7.74 (d, 1H, H-6'a or H-6'b), 7.76 (d, 
1H, H-6'a or H-6'b), 7.77 (d, 2H, bac-ortho). l3C NMR (CDCl3): () 29.57 (bac-CH3), 
95.60 (bac-CH), 111.24 (C-7a or C-7b), 111.33 (C-7a or C-7b), 117.33 (C-4a or C-4b), 
117.53 (C-4a or C-4b), 122.39 (C-5'a or C-5'b), 122.56 (C-5'a or C-5'b), 125.01 (C-5a 
or C-5b), 125.07 (C-5a or C-5b), 125.23 (C-6'a or C-6'b), 125.46 (C-6'a or C-6'b), 
125.89 (C-6a or C-6b), 125.98 (C-6a or C-6b), 127.17 (bac-ortho), 128.00 (bac-meta), 
129.97 (bac-para), 130.60 (C-4'a or C-4'b), 130.81 (C-4'a or C-4'b), 134.39 (C-3'a or 
C-3'b), 134.65 (C-3'a or C-3'b), 180.84 and 189.77 (bac-CO). 
2-Phenylbenzothiazole, 126 
126 was available in the department. lH NMR (CDCl3): () 7.40 (t, lH, H-6), 
7.51 (m, 4H, H-5, H-3', H-4' and H-5'), 7.92 (d, IH, H-7), 8.09 (d, lH, H-4), 8.11 (m, 
2H, H-2' and H-6'). l3C NMR (CDCI3): o 121.56 (C-7), 123.18 (C-4), 125.13 (C-6), 
126.25 (C-5), 127.49 (C-2' and C-6'), 128.96 (C-3' and C-5'), 130.89 (C-4'). 
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(i) REACTION WITH RHODIUM TRICHLORIDE 
Reaction of 126 with rhodium trichloride trihydrate gave [Rh(126-H)2Clh in 
25% yield. lH NMR (CDCh): o 5.99 (d, lH, H-3'), 6.56 (t, 1H, H-4'), 6.85 (t, lH, 
H-5'), 7.02 (m, 2H, H-5 and H-6), 7.41 (d, lH, H-7), 7.57 (d, lH, H-6'), 8.94 (d, lH, 
H-4). 
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2-Phenyl-1,2,3-triazole, 127 
127 was available in the department. lH NMR (CDClg): o 7.36 (t, 1H, H-4'), 
7.42 (t, 2H, H-3' and H-5'), 7.82 (s, 2H, H-4 and H-5), 8.09 (d, 2H, H-2' and H-6'). 13C 
NMR (CDClg): o 118.88 (C-2' and C-6'), 127.48 (C-4'), 129.21 (C-3' and C-5'), 135.41 
(C-4 and C-5). 
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(i) REACTION WITH RHODIUM TRICHLORIDE 
Reaction of 127 with rhodium trichloride trihydrate gave [Rh(127-H)2Clh in 
79% yield. lH NMR (CDClg): o 6.13 (br s, lH, H-3'), 6.90 (t, lH, H-4'), 7.08 (t, 1H, 
H-5'), 7.69 (d, 1H, H-6'), 8.25 (s, lH, H-4), 8.53 (s, 1H, H-5). 
Ligand exchange of [Rh(127-H)2Cl]2 with sodium acetylacetonate gave 
Rh(127-H)2(acac), 128, in 76% yield. Vapour diffusion of pentane into a chloroform 
solution of the complex gave the analytical sample. Mp 240°C (dec.). Anal. Calcd for 
C21H19N602Rh: C, 51.44; H, 3.91; N, 17.14; Found: C, 49.82; H, 3.86; N, 17.01%. lH 
NMR (CDCl3): o 1.91 (s, 6H, acac-CH3), 5.25, (s, lH, acac-CH), 6.19 (d, 2H, H-3'), 
6.83 (t, 2H, H-4'), 7.01 (t, 2H, H-5'), 7.66 (d, 2H, H-6'), 7.90 (s, 2H, H-5), 7.97 (s, 2H, 
H-4). 13C NMR (CDClg): o 28.67 (acac-CHg), 98.17 (acac-CH), 114.32 (C-6'), 123.47 
(C-5'), 127.44 (C-4'), 133.36 (C-5), 134.09 (C-4'), 134.86 (C-4), 188.14 (acac-CO). 
Ligand exchange of [Rh(127-H)2Clh with sodium dibenzoylmethanate gave 
Rh(127-H)2(dbm), 129, in 84% yield. Vapour diffusion of pentane into a chloroform 
solution of the complex gave the analytical sample. Mp 231-232°C (dec.). AnaL Calcd 
for CgrH23N602Rh: C, 60.60; H, 3.77; N, 13.68; Found: C, 60.46; H, 3.99; N, 13.74%. 
lH NMR (CDCb): o 6.30 (d, 2H, H-3'), 6.58 (s, 1H, dbm-CH), 6.89 (t, 2H, H-4'), 7.06 
(t, 2H, H-5'), 7.33 (t, 4H, dbm-meta), 7.40 (t, 2H, dbm-para), 7.70 (d, 2H, H-6'), 7.80 
(d, 4H, dbm-ortho), 7.92 (s, 4H, H-4 and H-5). 13C NMR (CDClg): o 92.72 (dbm-CH), 
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114.28 (C-6'), 123.40 (C-5'), 127.12 (dbm-ortho), 127.29 (C-4'), 128.16 (dbm-meta), 
130.49 (dbm-para), 133.41 (C-5), 134.15 (C-3'), 134.90 (C-4), 183.35 (dbm-CO). 
Ligand exchange of [Rh(127-H)2Clh with sodium benzoylacetonate gave 
Rh(127-H)2(bac), 130, in 63% yield. Vapour diffusion of pentane into a chloroform 
solution of the complex gave the analytical sample. Mp 223-225°C (dec.). Anal. Calcd 
for C26H21N602Rh: C, 56.53; H, 3.83; N, 15.21; Found: C, 56.41; H, 4.01; N, 15.15%. 
lH NMR (CDCl3): o 2.05 (s, 3H, bac-CH3), 5.91 (s, lH, bac-CH), 6.23 (d, 1H, H-3'a or 
H-3'b), 6.26 (d, 1H, H-3'a or H-3'b), 6.86 (t, 2H, H-4'a and H-4'b), 7.03 (t, lH, H-5'a or 
H-5'b), 7.04 (t, 1H, H-5'a or H-5'b), 7.29 (t, 2H, bac-meta), 7.36 (t, 1H, bac-para), 7.67 
(d, 2H, H-6'a and H-6'b), 7.70 (d, 2H, bac-ortho), 7.86 (s, lH, H-5a or H-5b), 7.94 (s, 
lH, H-4a or H-4b), 7.95 (s, 2H, H-4a or H-4b and H-5a or H-5b). 13C NMR (CDCb): 
o 29.43 (bac-CH3), 95.31 (bac-CH), 114.26 (C-6'a or C-6'b), 114.36 (C-6'a or C-6'b), 
123.38 (C-5'a or C-5'b), 123.50 (C-5'a or C-S'b), 127.04 (bac-ortho), 127.29 (C-4'a or 
C-4'b), 127.50 (C-4'a or C-4'b), 128.08 (bac-meta), 130.31 (bac-para), 133.39 (C-5a 
and C-5b), 134.03 (C-3'a or C-3'b), 134.23 (C-3'a or C-3'b), 134.89 (C-4a and C-4b), 
181.38 and 190.20 (bac-CO). 
2-Phenylpyridine, 201. 
201 was obtained commercially (EGA-Chemie). lH NMR (CDCb): o 7.20 (m, 
1H, H-5), 7.40 (t, 1H, H-4'), 7.47 (t, 2H, H-3' and H-5'), 7.72 (m, 2H, H-3 and H-4), 
7.99 (d, 2H, H-2' and H-6'), 8.69 (d, 1H, H-6). 13C NMR (CDCb): o 120.56 (C-3), 
122.08 (C-5), 126.90 (C-2' and C-6'), 128.73 (C-3' and C-5'), 128.93 (C-4'), 136.72 
(C-4), 149.67 (C-6). 
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(i) REACTION WITH RHODIUM TRICHLORIDE 
201 and rhodium trichloride trihydrate were reacted in glycerol to give 
[Rh(201-H)2Clh, as previously reported.so Mp >300°C. Anal. Calcd for 
C44H32N4Cl2Rh2.lhCHzCh: C, 57.68; H, 3.57; N, 6.08; Found: C, 57.73; H, 3.61; N, 
5.98%. lH NMR (CDCl3): o 5.95 (d, lH, H-3'), 6.65 (t, lH, H-4'), 6.78 (t, 1H, H-5), 
6.82 (t, 1H, H-5'), 7.55 (d, IH, H-6'), 7.81 (t, lH, H-4), 7.87 (d, 1H, H-3), 9.22 (d, 1H, 
H-6). 
Ligand exchange of [Rh(201-H)2Cl]z with sodium acetylacetonate gave 
Rh(201-H)2(acac) in 82% yield. Mp >300°C. Anal. Calcd for C27H23NzOzRh.l/zHzO: 
C, 62.43; H, 4.66; N, 5.39; Found: C, 62.50; H, 4.61; N, 5.41 %. lH NMR (CDCl3): o 
1.87 (s, 6H, acac-CH3), 5.22 (s, lH, acac-CH), 6.29 (d, 2H, H-3'), 6.77 (t, 2H, H-4'), 
6.89 (t, 2H, H-5'), 7.20 (t, 2H, H-5), 7.59 (d, 2H, H-6'), 7.84 (t, 2H, H-4), 7.87 (d, 2H, 
H-3), 8.51 (d, 2H, H-6). 13C NMR (CDCl3): o 29.05 (acac-CH3), 98.05 (acac-CH), 
118.69 (C-3), 121.63 (C-5), 121.95 (C-5'), 123.56 (C-6'), 128.93 (C-4'), 133.73 (C-3'), 
136.90 (C-4), 148.99 (C-6), 187.33 (acac-CO). 
Ligand exchange of [Rh(201-H)2Clh with sodium dibenzoylmethanate gave 
Rh(201-H)2(dbm) in quantitative yield. Vapour diffusion of pentane into a chloroform 
solution of the complex gave the analytical sample. Mp 286-287°C. Anal. Calcd for 
C37H27N20zRh.l/zCHCl3: C, 64.88; H, 3.99; N, 4.04; Found: C, 64.52; H, 4.31; N, 
4.08%. lH NMR (CDC}J): o 6.40 (d, 2H, H-3'), 6.55 (s, lH, dbm-CH), 6.82 (t, 2H, 
H-4'), 6.94 (t, 2H, H-5'), 7.10 (t, 2H, H-5), 7.29 (t, 4H, dbm-meta), 7.36 (t, 2H, 
dbm-para), 7.63 (d, 2H, H-6'), 7.78 (t, 2H, H-4), 7.79 (d, 4H, dbm-ortho), 7.87 (d, 2H, 
H-3), 8.59 (d, 2H, H-6). l3C NMR (CDCl3): o 92.49 (dbm-CH), 118.57 (C-3), 121.65 
(C-5), 121.79 (C-5'), 123.43 (C-6'), 127.09 (dbm-ortho), 127.97 (dbm-meta), 128.70 
(C-4'), 130.00 (dbm-para), 133.89 (C-3'), 136.93 (C-4), 149.06 (C-6), 182.35 
(dbm-CO). 
Ligand exchange of [Rh(201-H)2Clh with sodium benzoylacetonate gave 
Rh(201-H)2(bac) in 71% yield. Vapour diffusion of pentane into a chloroform solution 
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of the complex gave the analytical sample. Mp 270-271 °C. Anal. Calcd for 
C32H2sN202Rh.3hH20: C, 64.11; H, 4.71; N, 4.67; Found: C, 64.05; H, 4.48; N, 
4.89%. 1H NMR (CDCb): 8 2.01 (bac-CH3), 5.88 (s, IH, bac-CH), 6.34 (d, 1H, H-3'a 
or H-3'b), 6.36 (d, lH, H-3'a or H-3'b), 6.80 (t, 2H, H-4'a and H-4'b), 6.92 (m, H-5'a and 
H-5'b), 7.14 (t, lH, H-5a or H-5b), 7.17 (t, 1H, H-5a or H-5b), 7.25 (t, 2H, bac-meta), 
7.32 (t, lH, hac-para), 7.62 (d, 2H, H-6'a and H-6'b), 7.70 (d, 2H, bac-ortho), 7.81 (m, 
2H, H-4a and H-4b), 7.87 (m, 2H, H-3a and H-3b), 8.54 (d, 1H, H-6a or H-6b), 8.56 (d, 
1H, H-6a or H-6b). 13C NMR (CDCl3): 8 29.53 (bac-CH3), 95.15 (bac-CH), 118.57 
(C-3a or C-3b), 118.66 (C-3a or C-3b), 121.61 (C-5a or C-5b), 121.68 (C-5a or C-5b), 
121.77 (C-5'a or C-5'b), 121.97 (C-5'a or C-5'b), 123.38 (C-6'a or C-6'b), 123.59 (C-6'a 
or C-6'b), 126.98 (bac-ortho), 127.89 (bac-meta), 128.66 (C-4'a or C-4'b), 128.89 (C-4'a 
or C-4'b), 129.87 (bac-para), 133.69 (C-3'a or C-3'b), 133.87 (C-3'a or C-3'b), 136.93 
(C-4a and C-4b), 148.92 (C-6a or C-6b), 148.98 (C-6a or C-6b), 180.54 and 189.14 
(bac-CO). 
4-Phenylpyrimidine, 202. 
202 was obtained commercially (EGA Chemie). lH NMR (CDCI3): 8 7.53 (m, 
3H, H-3', H-4' and H-5'), 7.73 (d, 1H, H-5), 8.10 (m, 2H, H-2' and H-6'), 8.78 (d, 1H, 
H-6), 9.28 (s, 1H, H-2). 13C NMR (CDCl3): o 116.88 (C-5), 127.01 (C-2' and C-6'), 
128.92 (C-3' and C-5'), 130.98 (C-4'), 136.36 (C-1'), 157.33 (C-6), 158.97 (C-2), 163.74 
(C-4). 
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(i) REACTION WITH RHODIUM TRICHLORIDE 
A solution of rhodium trichloride trihydrate (204 mg, 0.77 mmol) and 202 (387 
mg, 2.47 mmol) in 2-methoxyethanol (20 cm3) was heated under reflux for two days. 
The resultant suspension was stripped of solvent under reduced pressure and the oily 
residue taken up in dichloromethane (10 cm3). Addition of ether gave 
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mer-Rh(202)3Cl3 as a yellow powder in 73% yield. Recrystallisation from 
dichloromethane/ether gave the analytical sample as orange crystals. Mp 216°C. Anal. 
Calcd for C3oH24N6Cl3Rh: C, 53.16; H, 3.57; N, 12.40; Cl, 15.69; Found: C, 53.19; H, 
3.50; N, 12.60; Cl, 15.99%. lH NMR (CDCh): o 7.55 (t, 2H, H-3'-cis and H-5'-cis), 
7.58 (t, 4H, H-3'-trans and H-5'-trans), 7.59 (t, 2H, H-4'-trans), 7.62 (t, lH, H-4'-cis), 
7.82 (d, lH, H-6-cis), 7.85 (d, 2H, H-6-trans), 8.14 (d, 4H, H-2'-trans and H-6'-trans), 
8.16 (H-2'-cis and H-6'-cis), 8.97 (d, lH, H-5-cis), 9.40 (s, 2H, H-2-trans), 9.42 (d, 2H, 
H-5-trans), 9.46 (s, 1H, H-2-cis). 13C NMR (CDCl3): o 116.74 (C-6-trans), 117.26 
(C-6-cis), 127.82 (C-2'-trans and C-6'-trans), 127.90 (C-2'-cis and C-6'-cis), 129.32 
(C-3'-trans and C-5'-trans), 129.45 (C-3'-cis and C-5'-cis), 132.63 (C-4'-trans), 133.19 
(C-4'-cis), 133.86 (C-1'-cis), 134.46 (C-1'-trans), 160.27 (C-5-cis), 162.18 (C-2-cis), 
162.72 (C-2-trans and C-5-trans), 165.21 (C-4-trans), 165.77 (C-4-cis). 
2:-Phenylquinoline, 203. 
203 was obtained commercially (Aldrich). lH NMR (CDCh): o 7.48 (t, 1H, 
H-4'), 7.52 (t, 2H, H-3' and H-5'), 7.56 (t, 1H, H-6), 7.74 (t, 1H, H-7), 7.85 (d, lH, H-5), 
7.89 (d, lH, H-3), 8.17 (d, 2H, H-2' and H-6'), 8.19 (d, 1H, H-8), 8.24 (d, 1H, H-4). lH 
NMR (CD3CN): o 7.56 (t, IH, H-4'), 7.63 (t, 2H, H-3' and H-5'), 7.65 (t, 1H, H-6), 7.83 
(t, lH, H-7), 8.00 (d, lH, H-5), 8.10 (d, lH, H-3), 8.16 (d, lH, H-8), 8.31 (d, 2H, H-2' 
and H-6'), 8.42 (d, 1H, H-4). 13C NMR (CDC13): o 118.94 (C-3), 126.22 (C-6), 127.12 
(C4a), 127.41 (C-5), 127.53 (C-2' and C-6'), 128.80 (C-3' and C-5'), 129.27 (C-4'), 
129.60 (C-7), 129.69 (C-8), 136.72 (C-4), 139.63 (C-1'), 148.24 (C-8a), 157.31 (C-2). 
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(i) REACTION WITH RHODTIJM TRICHLORIDE 
A solution of 203 (498 mg, 2.43 mmol) and rhodium trichloride trihydrate (202 
mg, 0.77 mmol) in 2-methoxyethanol (20 cm3) was stirred at room temperature for one 
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day then stirred under reflux for one day after which the resultant suspension was 
cooled to room temperature and refrigerated overnight. The precipitate was filtered off, 
washed with 2-rnethoxyethanol (20 crn3) and dried under reduced pressure to give 299 
rng of a yellow/green powder. Vapour diffusion of ether into an acetonitrile solution of 
this powder followed by manual separation gave Rh(203-H)2CJ.l/4CH3CN, 204, as 
orange crystals suitable for single crystal X-ray structure determination and 
[Rh(203-H)(CH3CN)Ch]x, 205, as amorphous yellow blocks. 204: Mp 303-306°C 
(dec.). Anal. Calcd for C3oH2oN2ClRh.l/4CH3CN: C, 65.76; H, 3.75; N, 5.66; Cl, 6.36; 
Found: C, 66.23; H, 3.81; N, 5.88; Cl, 6.37%. lH NMR (CD3CN, 23°C): 8 6.22 (d, 1H, 
H-3'), 6.77 (t, lH, H-4'), 7.07 (t, 1H, H-5'), 7.76 (t, IH, H-6), 7.89 (t, IH, H-7), 7.96 (d, 
lH, H-6'), 8.13 (d, lH, H-5), 8.31 (d, lH, H-3), 8.65 (d, 1H, H-4). lH NMR (CD3CN, 
60°C): 8 6.23 (d, lH, H-3'), 6.77 (t, lH, H-4'), 7.07 (t, lH, H-5'), 7.75 (t, 1H, H-6), 7.87 
(t, lH, H-7), 7.96 (d, lH, H-6'), 8.12 (d, 1H, H-5), 8.30 (d, lH, H-3), 8.63 (d, lH, H-4), 
9.48 (br m, lH, H-8). 13C NMR (CD3CN): complex not sufficiently soluble to obtain 
data. 205: Mp >300°C. Anal. Calcd for [CtsHwNChRh.CH3CN]x: C, 48.72; H, 3.13; 
N, 6.68; Cl, 16.92; Found: C, 48.48; H, 2.83; N, 6.50; Cl, 17.09%. lH NMR (CD3CN): 
8 7.28 (t, lH, H-5'), 7.39 (t, 1H, H-4'), 7.74 (t, 1H, H-6), 7.97 (d, 1H, H-6'), 8.00 (d, 1H, 
H-5), 8.00 (t, IH, H-7), 8.03 (d, 1H, H-3'), 8.14 (d, lH, H-3), 8.44 (d, 1H, H-4), 9.52 (d, 
lH, H-8). 13C NMR (CD3CN): complex not sufficiently soluble to obtain data. 
Ligand exchange of the mixture of 204 and 205 ( 41.5 mg) with sodium 
acetylacetonate gave 36.8 mg of a yellow powder. Vapour diffusion of pentane into a 
chloroform solution of this powder gave Rh(203-H)2(acac), 206, as orange blocks,. Mp 
265°C (dec.). Anal. Calcd for C35H27N202Rh: C, 68.86; H, 4.46; N, 4.59; Found: C, 
68.46; H, 4.25; N, 4.56%. lH NMR (CDCh): 8 1.55 (s, 6H, acac-CH3), 4.65 (s, 1H, 
acac-CH), 6.54 (d, 2H, H-3'), 6.70 (t, 2H, H-4'), 7.01 (t, 2H, H-5'), 7.47 (t, 2H, H-6), 
7.50 (t, 2H, H-7), 7.81 (rn, 2H, H-5), 7.87 (d, 2H, H-6'), 8.09 (d, 2H, H-3), 8.29 (d, 2H, 
H-4), 8.67 (rn, 2H, H-8). 13C NMR (CDCb): 8 28.74 (acac-CH3), 98.02 (acac-CH), 
116.90 (C-3), 122.19 (C-5'), 125.54 (C-6'), 126.11 (C-6), 127.25 (C-8), 127.48 (C-5), 
128.49 (C-4'), 130.07 (C-7), 136.14 (C-3'), 137.77 (C-4), 187.43 (acac-CO). Vapour 
diffusion of pentane into the supernatant from these orange crystals gave 
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Rh(203-H)(acac)2, 207, as an amorphous yellow solid. Anal. Calcd for C2sH24N04Rh: 
C, 59.42; H, 4.79; N, 2.77; Found: C, 59.75; H, 4.54; N; 2.81 %. lH NMR (CDCl3): o 
1.60 (s, 3H, acaca-CH3), 1.82 (s, 3H, acacb-CH3), 2.19 (s, 6H, acaca-CH3 and 
acacb-CH3), 5.17 (s, 1H, acacb-CH), 5.45 (s, 1H, acaca-CH), 7.23 (t, 1H, H-5'), 7.27 (t, 
lH, H-4'), 7.52 (t, 1H, H-6), 7.60 (m, lH, H-3'), 7.71 (t, lH, H-7), 7.75 (d, IH, H-5), 
7.87 (m, 1H, H-6'), 8.00 (d, lH, H-3), 8.17 (d, 1H, H-4), 9.18 (d, lH, H-8). 13C NMR 
(CDCl3): o 26.63 (acacb-CH3), 27.03 (acaca-CH3 or acaq-CH3), 27.55 (acaca-CH3), 
28.91 (acaca-CH3 or acaCb-CH3), 98.62 (acacb-CH), 99.77 (acaca-CH), 116.86 (C-3), 
123.50 (C-5'), 125.62 (C-6'), 126.26 (C-6), 126.43 (C-8), 127.69 (C-5), 129.20 (C-4'), 
130.64 (C-7), 134.47 (C-3'), 138.25 (C-4). 
4-Phenyl-6-(2-pyridyl)pyrimidine, 210. 
Methanol (2.5 cm3) was added to a stirred mixture of sodium chips (0.96 g, 42 
mmol) in ether (100 cm3) under a nitrogen atmosphere. To the resultant mixture were 
added dropwise a solution of ethyl picolinate (5.4 cm3, 40 mmol) in ether (40 cm3) 
followed by a solution of acetophenone (9.4 cm3, 80 mmol) in ether (40 cm3). The 
resultant suspension was then stirred under reflux for two hours after which it was 
cooled to room temperature and the yellow solid filtered off and washed with ether (50 
cm3) then air dried. This solid was then added, with stirring, to a solution of acetic acid 
(40 cm3) in water (50 cm3) and ice (125 g) to give a suspension which was filtered and 
the cream coloured solid washed with water (300 cm3) to give 
1-phenyl-3-(2-pyridyl)-1,3-propanedione, 211, in 85% yield. Mp 85-85.5°C (lit.117 
87-87.5°C). IR (KBr pellet): Vmax 1601, 1552, 1478, 1459, 1423, 1310,775,751, 709, 
689, 611 cm-1. lH NMR (CDCl3): o 7.44 (t, 1H, H-5"), 7.49 (t, 2H, H-3' and H-5'), 
7.54 (t, lH, H-4'), 7.59 (s, 2H, H-2), 7.87 (t, 1H, H-4"), 8.08 (d, 2H, H-2' and H-6'), 8.17 
(d, lH, H-3"), 8.71 (d, lH, H-6"). 13C NMR (CDCl3): o 93.51 (C-2), 122.10 (C-3"), 
126.33 (C-5"), 127.45 (C-2' and C-6'), 128.60 (C-3' and C-5'), 132.62 (C-4'), 135.26 
(C-1'), 137.02 (C-4"), 149.24 (C-6"), 152.47 (C-2"), 183.64 (C-1 or C-3), 186.26 (C-1 or 
C-3). 
168 
2 
0 0 
211 
4' 
3' 
2' 
210 was prepared by the reaction of 211 with formamide as previously 
reported.l16 Mp 100-l05°C (lit.l16 102-l03°C). Calcd for C1sH11N3: M+, 233.0953; 
Found (El): M+, 233.0953. IR (KBr pellet): Vmax 1593, 1576, 1520, 1454, 1371, 748, 
687, 631 cm-1. lH NMR (CDCl3): 67.44 (t, 1H, H-5"), 7.54 (m, 3H, H-3', H-4' and 
H-5'), 7.91 (t, 1H, H-4"), 8.25 (m, H-2' and H-6'), 8.54 (d, 1H, H-3"), 8.77 (d, lH, H-6"), 
8.84 (s, 1H, H-5), 9.34 (s, lH, H-2). lH NMR (d6-DMSO): () 7.69 (m, 3H, H-3', H-4' 
and H-5'), 7.70 (t, 1H, H-5"), 8.14 (t, lH, H-4"), 8.36 (m, 2H, H-2' and H-6'), 8.58 (d, 
lH, H-3"), 8.90 (d, lH, H-6"), 8.91 (s, lH, H-5), 9.44 (s, 1H, H-2). 13C NMR (CDCl3): 
() 113.04 (C-5), 121.79 (C-3"), 125.39 (C-5"), 127.29 (C-2' and C-6'), 128.92 (C-3' and 
C-5'), 130.97 (C-4'), 136.79 (C-1'), 137.21 (C-4"), 149.48 (C-6"), 153.99 (C-2"), 158.77 
(C-2), 163.24 (C-4 or C-6), 165.08 (C-4 or C-6). 13C NMR (d6-DMSO): () 112.16 
(C-5), 121.48 (C-3"), 126.13 (C-5"), 127.14 (C-2' and C-6'), 129.21 (C-3' and C-5'), 
131.36 (C-4'), 136.22 (C-1'), 137.83 (C-4"), 149.85 (C-6"), 153.17 (C-2"), 158.97 (C-2), 
162.98 (C-4 or C-6), 164.10 (C-4 or C-6). 
210 
(i) REACTION WITH PALLADIUM ACETATE 
Palladium acetate (19.6 mg, 0.087 mmol) was dissolved in benzene (5 cm3) and 
the resultant solution filtered into a solution of 210 (20.3 mg, 0.087 mmol) in benzene 
(2.5 cm3). The mixture was briefly stirred then allowed to stand at room temperature 
for several days after which the resultant suspension was filtered and the yellow solid 
washed with benzene (25 cm3) then ether (15 cm3) to give Pd(210)(0Ac)2, 212, in 79% 
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yield. Mp 228°C (dec.). Anal. Calcd for C19H17N304Pd: C, 49.85; H, 3.74; N, 9.18; 
Found: C, 49.57; 3.83; N, 9.20%. IR (KBr pellet): Vmax 1632, 1609, 1526, 1464, 1389, 
1364, 1319, 735, 689 cm-1. lH NMR (CDCl3): () 2.09 (s, 3H, CH3COO), 2.18 (s, 3H, 
CH3COO), 7.28 (t, 1H, H-5"), 7.56 (t, 2H, H-3' and H-5'), 7.64 (t, lH, H-4'), 7.94 (d, 
1H, H-6"), 8.37 (t, 1H, H-4"), 8.39 (d, 2H, H-2' and H-6'), 8.54 (s, 1H, H-2), 9.06 (s, 1H, 
H-5), 9.30 (d, 1H, H-3"). Be NMR (CDCb): () 23.20 and 23.27 (CH3COO), 113.97 
(C-5), 126.26 (C-3"), 127.49 (C-5"), 128.53 (C-2' and C-6'), 129.45 (C-3' and C-5'), 
130.17 (C-1'), 133.67 (C-4'), 141.61 (C-4"), 149.92 (C-6"), 153.71 (C-2"), 157.45 (C-2), 
167.39 (C-4 or C-6), 178.54 (C-4 or C-6), 200.58 and 205.86 (CH3COO). 
Ligand exchange of 212 with excess lithium chloride in acetone/water (60/40, 
v/v) gave Pd(210)Cb, 220, in 84% yield. Mp >300°C. Anal. Calcd for 
CtsHuN3Cl2Pd: C, 43.88; H, 2.70; N, 10.23; Cl, 17.27; Found: C, 43.82; H, 2.48; N, 
10.09; Cl, 16.53%. IR (KBr pellet): Vmax 1607, 1524, 1489, 1464, 1439, 1389, 791, 
752, 735, 689 cm-1. This complex was insoluble in common NMR solvents. 
2-Benzylpyridine, 221. 
221 was obtained commercially (Aldrich). lH NMR (CDCl3): 3 4.16 (s, 2H, 
-CH2-), 7.11 (m, 2H, H-3 and H-5), 7.27 (m, 4H, H-2', H-3', H-5' and H-6'), 7.31 (t, lH, 
H-4'), 7.57 (t, lH, H-4), 8.55 (d, 1H, H-6). Be NMR (CDC13): 344.63 (-CH2-), 121.12 
(C-5), 122.98 (C-3), 126.26 (C-4'), 128.47 (C-2' and C-6'), 129.00 (C-3' and C-5'), 
136.40 (C-4'), 139.40 (C-1'), 149.23 (C-6), 160.89 (C-2). 
3 6' 4((0'-':: 5' I I 
5 ::::::..,. N 2' ~ 4' 
6 3' 
221 
(i) REACTION WITH RHODIUM TRICHLORIDE 
A solution of 221 (184 mg, 1.09 mmol) and anhydrous rhodium trichloride (102 
mg, 0.49 mmol) in anhydrous ethanol (20 cm3) was stirred under reflux in a nitrogen 
atmosphere for one day after which the solution was filtered and the filtrate stripped of 
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solvent to give fac-Rh(221)3Cl3 as an oil in quantitative yield. lH NMR (CDCIJ): o 
4.64 (s, 2H, -CH2-), 7.33 (m, lH, H-4'), 7.38 (m, 4H, H-2', H-3', H-5' and H-6'), 7.52 (d, 
lH, H-3), 7.70 (t, 1H, H-5), 8.21 (t, lH, H-4), 8.73 (d, lH, H-6). Be NMR (CDCb): o 
39.13 (-CH2-), 124.15 (C-5), 126.66 (C-3), 127.81 (C-4'), 129.28 (C-3' and C-5'), 
129.39 (C-2' and C-6'), 134.79 (C-1'), 141.16 (C-6), 144.88 (C-4), 156.84 (C-2). 
2-Phenoxypyridine, 232. 
232 was prepared by the reaction of phenol with 2-bromopyridine in the 
presence of anhydrous potassium carbonate, as previously reported.135 The product, 
obtained as white crystals from the ether extracts of the steam distillate of the basified 
reaction mixture, was used without further purification. Mp 41.5-43.5°C. Calcd for 
C11H9NO: M+, 171.0684; Found (EI): M+, 171.0687. IR (KBr pellet): Vmax 1588, 
1569, 1488, 1466, 1426, 1284, 1264, 1240, 1201, 1160, 876, 775, 694 cm-1. lH NMR 
(CDCl3): o 6.90 (d, 1H, H-3), 6.99 (t, 1H, H-5), 7.14 (d, 2H, H-2' and H-6'), 7.20 (t, lH, 
H-4'), 7.40 (t, 2H, H-3' and H-5'), 7.68 (t, lH, H-4), 8.20 (d, lH, H-6). lH NMR 
( d6-DMSO): o 7.12 ( d, lH, H -3), 7.22 (t, lH, H-5), 7.23 ( d, 2H, H-2' and H-6'), 7.30 (t, 
lH, H-4'), 7.51 (t, 2H, H-3' and H-5'), 7.94 (t, lH, H-4), 8.25 (d, 1H, H-6). 13C NMR 
(CDCb): o 111.47 (C-3), 118.41 (C-5), 121.12 (C-2' and C-6'), 124.62 (C-4'), 129.65 
(C-3' and C-5'), 139.36 (C-4), 147.74 (C-6), 154.11 (C-1'), 163.72 (C-2). 13C NMR 
(d6-DMSO): o 111.58 (C-3), 119.08 (C-5), 121.25 (C-2' and C-6'), 124.53 (C-4'), 
129.74 (C-3' and C-5'), 140.20 (C-4), 147.51 (C-6), 153.98 (C-1'), 163.11 (C-2). 
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(i) REACTION WITH LITHIUM TETRACHLOROPALLADATE 
232 was reacted with one equivalent of lithium tetrachloropalladate to give 
Pd(232)2Cl2, 234, in 87% yield. Vapour diffusion of petroleum ether into a chloroform 
solution of the complex gave the analytical sample as orange crystals suitable for single 
crystal X-ray structure determination. Mp >300°C. Anal. Calcd for 
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CnHtsN202ChPd.lf7CHCl3: C, 49.55; H, 3.41; N, 5.22; Cl, 16.04; Found: C, 49.62; 
H, 3.22; N, 5.24; Cl, 15.96%. IR (KBr pellet): Vmax 1605, 1574, 1488, 1472, 1437, 
1295, 1280, 1263, 1197, 1154,770, 760, 695 cm-1. lH NMR (CDCb, 23°C): 8 6.60 (d, 
IH, H-3), 7.04 (t, lH, H-5), 7.23-7.47 (br m, 5H, H-2', H-3', H-4', H-5' and H-6'), 7.64 
(t, lH, H-4), 8.65 (d, lH, H-6). lH NMR (CDCb, 53°C): 8 6.60 (d, 1H, H-3), 7.01 (t, 
lH, H-5), 7.25 (t, 1H, H-4'), 7.32 (d, 2H, H-2' and H-6'), 7.40 (t, 2H, H-3' and H-5'), 
7.61 (t, lH, H-4), 8.65 (d, lH, H-6). 13C NMR (CDCl3, 23°C): o 111.90 (C-3), 119.15 
(C-5), 121.33 (C-2' and C-6'), 125.95 (C-4'), 130.20 (C-3' and C-5'), 140.47 (C-4), 
151.19 (C-6), 154.02 (C-1'), 164.52 (C-2). 13C NMR (CDCb, 53°C): 8 111.98 (C-3), 
119.11 (C-5), 121.36 (C-2' and C-6'), 125.90 (C-4'), 130.19 (C-3' and C-5'), 140.89 
(C-4), 151.40 (C-6). 
(ii) REACTION WITH PALLADIUM ACETATE 
An acetic acid (15 cm3) solution of 232 (186 mg, 1.09 mmol) and palladium 
acetate (204 mg, 0.91 mmol) was stirred at room temperature for one day. The resultant 
pale yellow precipitate was filtered off and washed with water (50 cm3), methanol (20 
cm3) then ether (20 cm3) to give [Pd(232-H)OAc]2, 235, in 69% yield. Vapour 
diffusion of petroleum ether into a chloroform solution of the complex gave the 
analytical sample. Mp 226-228°C. Anal. Calcd for C26H22N202Pd2: C, 46.52; H, 
3.03; N, 4.17; Found: C, 46.24; H, 3.10; N, 4.14%. IR (KBr pellet): Vmax 1610, 1583, 
1568, 1478, 1454, 1422, 1327, 1298, 1181, 775, 756 cm-1. lH NMR (CDCb): 8 2.12 
(s, 3H, CH3COO), 6.62 (d, 1H, H-6'), 6.63 (t, lH, H-5), 6.66 (t, 1H, H-4'), 6.82 (d, 1H, 
H-3'), 6.86 (t, 1H, H-5'), 6.88 (d, lH, H-3), 7.55 (t, lH, 4), 8.02 (d, 1H, H-6). 13C NMR 
(CDCb): o 24.53 (CH3COO), 114.29 (C-3), 115.18 (C-6'), 117.80 (C-5), 123.06 (C-4'), 
124.90 (C-5'), 134.08 (C-3'), 139.80 (C-4), 148.82 (C-6), 149.30 (C-1'), 157.30 (C-2), 
181.16 (CH3COO). 
Ligand exchange of 235 with excess lithium chloride in acetone/water (60/40, 
v/v) gave [Pd(232-H)Clh, 236, in 69% yield. Mp >300°C. Anal. Calcd for 
C22H16N202ChPd2: C, 42.34; H, 2.58; N, 4.49: Cl, 11.36; Found: C, 42.49; H, 2.23; N, 
4.27; Cl, 11.27%. IR (KBr pellet): Vmax 1610, 1577, 1480, 1454, 1437, 1424, 1313, 
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1302, 1184, 770, 749, 731 cm-1. This complex was insoluble in common NMR 
solvents. 
Ligand exchange of 236 with sodium acetylacetonate gave Pd(232-H)(acac), 
237, in 43% yield. Mp 133-135°C. Anal. Calcd for C16H1sN03Pd: C, 51.15; H, 4.02; 
N, 3.73; Found: C, 50.89; H, 3.72; N, 3.84%. IR (KBr pellet): Vmax 1612, 1595, 1577, 
1528, 1479, 1441, 1426, 1406, 1314, 1300, 761, 749, 732 cm-1. lH NMR (CDCl3): 8 
2.04 (s, 3H, acac-CH3), 2.09 (s, 3H, acac-CH3), 5.42 (s, 1H, acac-CH), 6.98 (d, lH, 
H-6'), 7.06 (t, lH, H-4'), 7.08 (t, lH, H-5), 7.12 (t, lH, H-5'), 7.22 (d, lH, H-3), 7.62 (d, 
lH, H-3'), 7.82 (t, lH, H-4), 8.81 (d, 1H, H-6). 13C NMR (CDCI3): 8 27.58 and 27.95 
(acac-CH3), 100.39 (acac-CH), 114.91 (C-3), 115.47 (C-6'), 118.53 (C-5), 123.68 
(C-4'), 125.65 (C-5'), 133.83 (C-3'), 140.27 (C-4), 148.22 (C-6), 187.02 and 188.12 
(acac-CO). 
(iii) REACTION WITH BUTYLLITHIUM 
A solution of 232 (250 mg, 1.46 mmol) in ether was degassed by passing a 
stream of nitrogen bubbles through it for 5 minutes, after which time n-butyllithium 
(1.6mol dm-3 in hexane, 1.0 cm3) was added and the resultant solution was stirred at 
room temperature under a nitrogen atmosphere. After 12 hours a sample (1.0 cm3) was 
withdrawn, quenched with D20 and the lH NMR spectrum of the evaporated organic 
phase recorded to give a spectrum largely indistinguishable from that of unreacted 232. 
An additional aliquot of n-butyllithium (1.6 mol dm-3 in hexane, 1.0 cm3) was added to 
the reaction mixture and the resultant solution stirred for a further 24 hours at room 
temperature under a nitrogen atmosphere, after which time the solution was quenched 
with D20 (0.5 cm3). The reaction mixture was then washed with water (10 cm3) and 
the aqueous phase extracted with ether (10 cm3). The organic phases were combined 
and washed with saturated aqueous sodium chloride solution (10 cm3) then dried over 
anhydrous magnesium sulfate and the solvent removed to give 
6-butyl-2-phenoxypyridine, 240, as a yellow oil. Yield 60%. Calcd for C15H17NO: 
M+, 227.1310; Found (EI): M+, 227.1308. lH NMR (CDCl]): 8 0.91 (t, 3H, 
-CH2CH2CH2CH3 ), 1.35 (sxt, 2H, -CH2CH2CH2CH3 ), 1.67 (qnt, 2H, 
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-CH2CH2CH2CH3), 2.70 (t, 2H, -CH2CH2CH2CH3), 6.57 (d, 1H, H-3), 6.86 (d, 1H, 
H-5), 7.13 (d, 2H, H-2' and H-6'), 7.20 (t, 1H, H-4'), 7.38 (t, 2H, H-3' and H-5'), 7.55 (t, 
1H, H-4). 13 C NMR (CDCl3 ): o 13.88 ( -CH2CH2CH2CH3), 22.35 
(-CH2CH2CH2CH3), 31.58 (-CH2CH2CH2CH3), 37.48 (-CH2CH2CH2CH3), 117.40 
(C-5), 120.65 (C-2' and C-6'), 124.23 (C-4'), 129.27 (C-6), 129.57 (C-3' and C-5'), 
139.51 (C-4), 154.64 (C-1'), 161.75 (C-2). 
2-Phenylthiopyridine, 233 
233 was prepared by the reaction of thiophenol with 2-chloropyridine in the 
presence of triethylamine as previously described.140 Calcd for C11H9NS: M+, 
187.0456; Found (EI): M+, 187.0454. lH NMR (CDC~)): o 6.87 (d, 1H, H-3), 6.98 (t, 
1H, H-5), 7.41 (m, 3H, H-3', H-4' and H-5'), 7.42 (t, 1H, H-4), 7.59 (d, 2H, H-2' and 
H-6'), 8.41 (d, lH, H-6). 13C NMR (CDCIJ): o 119.77 (C-5), 121.20 (C-3), 128.98 
(C-4'), 129.52 (C-3' and C-5'), 130.88 (C-1 '), 134.83 (C-2' and C-6'), 136.61 (C-4), 
149.44 (C-6), 161.40 (C-2). 
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(i) REACTION WITH LITHIUM TETRACHLOROPALLADATE 
233 was reacted with one equivalent of lithium tetrachloropalladate to give 
Pd(233)2 Cl2 in 75% yield. Mp 265-266.5°C (dec.). AnaL Calcd for 
C22H18N2S2Cl2Pd: C, 47.88; H, 3.29; N, 5.08; Cl, 12.85; Found: C, 47.18; H, 3.18; N, 
5.20; Cl, 13.22%. IR (KBr pellet): Vmax 1589, 1558, 1474, 1452, 1421, 1275, 1094, 
760, 702, 691 cm-1. 
(ii) REACTION WITH PALLADIUM ACETATE 
232 and palladium acetate were reacted according to method B to give 
[Pd(232-H)Cl]2, 238, in 47% yield. IR (KBr pellet): Vmax 1587, 1551, 1458, 1431, 
174 
1421, 1157, 1020, 762, 746 cm-1. This complex was insoluble in common NMR 
solvents. 
Ligand exchange of 238 with thallium acetylacetonate followed by the vapour 
diffusion of pentane into a chloroform solution of the complex gave Pd(232-H)(acac), 
239, in 20% yield. Mp 199-200°C (dec.). Anal. Calcd for C16HtsN02SPd: C, 49.05; 
H, 3.86; N, 3.58; Found: C, 48.81; H, 4.02; N, 3.55%. IR (KBr pellet): Vmax 1592, 
1559, 1511, 1420, 1394, 774, 745, 612 cm-1. lH NMR (CDC!)): o 2.00 (s, 3H, 
acac-CH3), 2.05 (s, 3H, acac-CH3), 5.42 (s, 1H, acac-CH), 7.01 (t, 1H, H-5'), 7.07 (t, 
1H, H-4'), 7.17 (t, 1H, H-5), 7.30 (d, 1H, H-6'), 7.44 (d, 1H, H-3'), 7.66 (t, lH, H-4), 
7.73 (d, lH, H-3), 8.81 (d, lH, H-6). 13C NMR (CDCI3): o 27.52 and 27.98 
(acac-CH3), 100.34 (acac-CH), 121.56 (C-5), 124.64 (C-5'), 125.82 (C-3), 126.02 
(C-4'), 126.83 (C-6'), 131.75 (C-2'), 135.75 (C-3'), 137.32 (C-4), 145.63 (C-1'), 153.77 
(C-6), 158.68 (C-2), 186.57 and 187.92 (acac-CO). 
2-Phenylmethoxypyridine, 241. 
241 was prepared by a phase-transfer reaction between benzyl alcohol and 
2-chloropyridine in toluene in the presence of potassium hydroxide and a catalyst as 
previously reported.165 The catalyst employed in the literature preparation was 
18-crown-6, however, given the cost of this reagent, tetrabutylammonium hydroxide 
was used for this preparation to give, after reduced pressure distillation, the ligand in 
56% yield (lit.165 80%). Calcd for C12H11NO: M+, 185.0841; Found (EI): M+, 
185.0840. lH NMR (CDCl3): o 5.38 (s, 2H, -CH2-), 6.81 (d, 1H, H-3), 6.88 (t, lH, 
H-5), 7.31 (t, lH, H-4'), 7.38 (t, 2H, H-3' and H-5'), 7.47 (d, 2H, H-2' and H-6'), 7.58 (t, 
1H, H-4), 8.18 (d, lH, H-6). 13C NMR (CDCb): 367.49 (-CH2-), 111.31 (C-5), 116.89 
(C-3), 127.80 (C-4'), 127.93 (C-2' and C-6'), 128.44 (C-3' and C-5'), 137.31 (C-1'), 
138.61 (C-4), 146.79 (C-6). 
241 
175 
(i) REACTION WITH LITHIUM TETRACHLOROPALLADATE 
Lithium tetrachloropalladate was reacted with two equivalents of 241 without 
stirring to give Pd(241)2Clz, 246, in 71% yield. Mp 196.5-197°C (dec.). AnaL Calcd 
for C24H22N202ClzPd: C, 52.63; H, 4.05; N, 5.11; CI, 12.94; Found: C, 52.42; H, 4.10; 
N, 5.11; Cl, 13.14%. IR (KBr pellet): Vmax 1607, 1576, 1489, 1445, 1317, 1300, 1043, 
1016, 988,775,750,733,692 cm-1. lH NMR (CDCl3, 23°C): o 5.34 (br s, 2H, -CH2-), 
6.72 (d, lH, H-3), 6.95 (t, 1H, H-5), 7.34 (br s, 3H, H-3', H-4' and H-5'), 7.65 (t, lH, 
H-4), 7.72 (br s, H-2' and H-6'), 8.57 (br s, lH, H-6). lH NMR (CDCh, 53°C): o 5.38 
(s, 2H, -CHz-), 6.71 (d, 1H, H-3), 6.94 (t, 1H, H-5), 7.29 (t, 1H, H-4'), 7.36 (t, 2H, H-3' 
and H-5'), 7.63 (t, lH, H-4), 7.71 (d, 2H, H-2' and H-6'), 8.57 (d, 1H, H-6). 13C NMR 
(CDCl3, 23°C): o 71.54 (-CH2-), 109.01 (C-5), 118.13 (C-3), 127.41 (C-4'), 128.21 
(C-2' and C-6'), 128.66 (C-3' and C-5'), 135.07 (C-1'), 140.89 (C-4), 151.21 (C-6), 
163.75 (C-2). 
2-Phenoxymethylpyridine, 242. 
Phenol (4.63 g, 49.2 mmol) and 2-chloromethylpyridine hydrochloride (8.74 g, 
53.3 mmol) were reacted under phase-transfer conditions in benzene (15 cm3) and 
aqueous sodium hydroxide ( 10 mol dm-3, 17 cm3, 170 mmol) with tetrabutylammonium 
hydroxide as catalyst. The mixture was stirred under reflux for one day then cooled. 
The crude reaction mixture was extracted with ether/water (50/50, v/v, 30 cm3) then 
ether (2 x 20 cm3) and the combined organic extracts dried over anhydrous sodium 
sulfate. Removal of solvent, followed by distillation at reduced pressure, gave 242. 
Yield 62%. Calcd for C12H11NO: M+, 185.0841; Found (EI): M+, 185.0842. 1H NMR 
(CDCb): o 5.21 (s, 2H, -CH2-), 6.97 (t, lH, H-4'), 6.99 (d, 2H, H-2' and H-6'), 7.22 (t, 
IH, H-5), 7.30 (t, 2H, H-3' and H-5'), 7.53 (d, IH, H-3), 7.71 (t, IH, H-4), 8.60 (d, lH, 
H-6). 13C NMR (CDCI3): o 70.45 (-CH2-), 114.75 (C-2' and C-6'), 121.09 (C-4'), 
121.23 (C-3), 122.56 (C-5), 129.49 (C-3' and C-5'), 136.81 (C-4), 149.14 (C-6). 
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(i) REACTION WITH LITHIUM TETRACHLOROPALLADATE 
Lithium tetrachloropalladate was reacted with two equivalents of 242 without 
stirring to give Pd(242)2Ch, 247, in 77% yield. Diffusion of petroleum ether into a 
chloroform solution of the complex gave the analytical sample as yellow crystals 
suitable for single crystal X-ray stmcture determination. Mp 209.5-210°C (dec.). Anal. 
Calcd for C24H22N202ChPd: C, 52.63; H, 4.05; N, 5.11; Cl, 12.94; Found: C, 52.35; 
H, 3.84; N, 5.04; Cl, 13.40%. IR (KBr pellet): Vmax 1599, 1587, 1497, 1441, 1261, 
1242, 1227, 1080, 1063, 775, 752, 691 cm-1. lH NMR (CDCl3, 23°C): o 6.34 (s, 2H, 
-CH2-), 6.92-7.27 (br m, 5H, H-2', H-3', H-4', H-5' and H-6'), 7.32 (br s, 1H, H-5), 7.64 
(d, 1H, H-3), 7.79 (t, lH, H-4), 8.96 (br d, lH, H-6). lH NMR (CDCl3, 53°C): o 6.33 
(s, 2H, -CH2-), 6.98 (t, lH, H-4'), 7.12 (d, 2H, H-2' and H-6'), 7.27 (t, 2H, H-3' and 
H-5'), 7.29 (t, 1H, H-5), 7.63 (d, 1H, H-3), 7.76 (t, 1H, H-4), 8.95 (br s, lH, H-6). 13C 
NMR (CDCl3, 23°C): o 69.82 (-CH2-), 114.93 (C-2' and C-6'), 121.70 (C-4'), 123.92 
(C-3 and C-5), 129.79 (C-3' and C-5'), 138.90 (C-4), 152.11 (C-6). 
(ii) REACTION WITH POTASSIUM TETRABROMOPALLADATE 
A solution of potassium tetrabromopalladate (102 mg, 0.20 mmol) in methanol 
(30 cm3) was heated to boiling then filtered. To the filtrate was added 242 (85 mg, 0.46 
mmol) and the solution was left to stand overnight. The resultant crystals were filtered 
and washed with methanol (10 cm3) then ether (20 cm3) to give Pd(242)2Brz, 249, in 
46% yield. Mp 238.5-239.5°C (dec.). Anal. Calcd for C24H22N202Br2Pd: C, 45.28; H, 
3.48; N, 4.40; Br, 25.10; Found: C, 44.05; H, 3.51; N, 4.47; Br, 25.24%. IR (KBr 
pellet): Vmax 1611, 1597, 1587, 1574, 1496, 1439, 1373, 1240, 1225, 1171, 1080, 1061, 
773, 752, 691 cm-1. 
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2-[ (Phenylmethyl)thio ]pyridine, 243. 
2-Chloropyridine (14.1 g, 124 mmol) and benzyl mercaptan (17.0 g, 137 mmol) 
were reacted under phase-transfer conditions in toluene (150 cm3) with potassium 
hydroxide (17.1 g, 305 mmol) and tetrabutylammonium hydroxide (1.39 g, 5.4 mmol) 
as catalyst. The mixture was stirred under reflux for 2 hours after which it was cooled 
and poured into ice/water (100 cm3). The organic phase was separated and the aqueous 
phase extracted with toluene (50 cm3). The organic extracts were combined and 
washed with saturated aqueous potassium chloride solution (2 x 100 cm3) then dried 
over anhydrous sodium sulfate. Removal of solvent followed by distillation at reduced 
pressure gave 243. Yield 25%. Calcd for C12HuNS: M+, 201.0612; Found (EI): M+, 
201.0614. lH NMR (CDCl3): o 4.44 (s, 2H, -SCH2-), 6.98 (t, 1H, H-5), 7.15 (d, 1H, 
H-3), 7.22 (t, lH, H-4'), 7.29 (t, 2H, H-3' and H-5'), 7.40 (d, 2H, H-2' and H-6'), 7.45 (t, 
1H, H-4), 8.45 (d, IH, H-6). 13C NMR (CDCl3): o 34.36 (-SCH2-), 119.53 (C-5), 
122.02 (C-3), 127.04 (C-4'), 128.42 (C-2' and C-6'), 128.90 (C-3' and C-5'), 135.91 
(C-4), 137.89 (C-1'), 149.34 (C-6). 
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(i) REACTION WITH LITHIUM TETRACHLOROPALLADATE 
Lithium tetrachloropalladate was reacted with two equivalents of 243 to give 
Pd(243)2Ch in 82% yield. Mp 217°C. Anal. Calcd for C24H22N2S2Cl2Pd: C, 49.71; 
H, 3.82; N, 4.83; S, 11.06; Cl, 12.23; Found: C, 49.60; H, 3.99; N, 4.72; S, 10.91; Cl, 
12.24%. IR (KBr pellet): Vmax 1585, 1558, 1495, 1456, 1437, 1425, 1161, 1148, 1101, 
766, 729, 704 cm-1. This complex is insoluble in common NMR solvents. 
2-[ (Phenylthio )methyl]pyridine, 244. 
244 was prepared by the reaction of freshly prepared sodium thiophenoxide and 
2-chloromethylpyridine hydrochloride as previously reported.l70 Calcd for C12HuNS: 
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M+, 201.0612; Found (EI): M+, 201.0613. lH NMR (CDCl3): o 4.26 (s, 2H, -CH2S-), 
7.13 (t, 1H, H-5), 7.16 (t, 1H, H-4'), 7.24 (t, 2H, H-3' and H-5'), 7.31 (d, lH, H-3), 7.33 
(d, 2H, H-2' and H-6'), 7.59 (t, 1H, H-4), 8.54 (d, lH, H-6). lH NMR (d6-DMSO): o 
4.43 (s, 2H, -CHzS-), 7.25 (t, 1H, H-4'), 7.34 (t, lH, H-5), 7.37 (t, 2H, H-3' and H-5'), 
7.46 (d, 2H, H-2' and H-6'), 7.52 (d, 1H, H-3), 7.81 (t, 1H, H-4), 8.58 (d, 1H, H-6). 13C 
NMR (CDCl3): o 40.38 (-CH2S-), 121.90 (C-5), 122.80 (C-3), 126.18 (C-4'), 128.72 
(C-3' and C-5'), 129.45 (C-2' and C-6'), 135.69 (C-2), 136.47 (C-4), 149.18 (C-6), 
157.53 (C-1'). 13C NMR (d6-DMSO): o 38.71 (-CH2S-), 122.30 (C-5), 123.07 (C-3), 
125.85 (C-4'), 128.16 (C-3' and C-5'), 129.01 (C-2' and C-6'), 136.13 (C-2), 136.82 
(C-4), 149.07 (C-6), 157.55 (C-1'). 
2' 3' 
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(i) REACTION WITH LITHIUM TETRACHLOROPALLADATE 
Lithium tetrachloropalladate was reacted with two equivalents of 244 to give 
Pd(244)Ch, 248, in 88% yield. Mp 262.5°C. Anal. Calcd for C12HuNSCI2Pd: C, 
38.07; H, 2.93; N, 3.70; S, 8.47; Cl, 18.73; Found: C, 38.02; H, 2.91; N, 3.88; S, 8.45; 
Cl, 18.68%. Calcd for C12HuNSCizPd: M+, 343.9340; Found (FAB): M+, 343.9356. 
IR (KBr pellet): Vmax 1605, 1475, 1439, 1400, 1277, 1165, 781, 739, 685 cm-1. lH 
NMR (d6-DMSO): o 4.92 (d, 1H, -CHz-Ha), 5.47 (d, 1H, -CH2-Hb), 7.59 (br m, 3H, 
H-3', H-4' and H-5'), 7.67 (t, lH, H-5), 7.88 (d, lH, H-3), 7.92 (d, 2H, H-2' and H-6'), 
8.20 (t, lH, H-4), 9.21 (d, 1H, H-6). l3c NMR (d6-DMSO): o 46.07 (-CH2-), 124.37 
(C-3), 124.67 (C-5), 129.39 (C-1'), 130.20 (C-3' and C-5'), 130.29 (C-2' and C-6'), 
130.67 (C-4'), 140.68 (C-4), 151.45 (C-6), 163.21 (C-2). 
1-Benzyl-2(1H)-pyridone, 245. 
In an attempt to prepare 241, 2-hydroxypyridine (1.01 g, 10.6 mmol) and benzyl 
chloride (1.32 g, 10.4 mmol), were reacted under phase-transfer conditions in benzene 
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( 15 cm3) and aqueous sodium hydroxide (1 0 mol dm-3, 1.5 cm3, 15 mmol) with 
tetrabutylammonium hydroxide as catalyst. The mixture was stirred under reflux for 
one day then cooled. The crude reaction mixture was extracted with ether/water (50/50, 
v/v, 10 cm3) then ether (10 cm3) and the combined organic extracts dried over 
anhydrous sodium sulfate. Removal of solvent, followed by recrystallisation of the 
crude residue from petroleum ether and drying under reduced pressure gave 245. Yield 
52%. Mp 67.5-69°C (lit. 162 75°C). Calcd for C12H11NO: M+, 185.0841; Found (EI): 
M+, 185.0838. IR (KBr pellet): Vmax 1659, 1582, 1540, 1458, 764, 734, 698 cm-1. lH 
NMR (CDCl3): 8 5.14 (s, 2H, -CH2-), 6.13 (t, 1H, H-5), 6.61 (d, 1H, H-3), 7.26 (d, 1H, 
H-6), 7.30 (t, 1H, H-4), 7.32 (m, 5H, H-2', H-3', H-4', H-5' and H-6'). 13C NMR 
(CDCl3): 8 51.74 (-CH2-), 106.12 (C-5), 121.12 (C-3), 127.89 (C-4'), 128.01 (C-2' and 
C-6'), 128.77 (C-3' and C-5'), 136.27 (C-1'), 137.15 (C-4), 139.32 (C-6), 162.57 (C-2). 
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2-Benzoylpyridine, 301. 
301 was obtained commercially (EGA-Chemie). IR (KBr pellet): Vmax 1669, 
1579, 1448, 1322, 1302, 1283, 943, 778, 750, 732, 705, 650 cm-1. lH NMR (CDCl3): 8 
7.50 (t, 3H, H-5, H-3' and H-5'), 7.60 (t, 1H, H-4'), 7.92 (t, 1H, H-4), 8.05 (d, 1H, H-3), 
8.07 (d, 2H, H-2' and H-6'), 8.74 (d, 1H, H-6). lH NMR (d6-DMSO): 8 7.64 (t, 2H, 
H-3' and H-5'), 7.77 (t, 2H, H-5 and H-4'), 8.06 (d, 2H, H-2' and H-6'), 8.09 (d, lH, 
H-3), 8.17 (t, H-4), 8.82 (d, 1H, H-6). lH NMR (CD3CN): 8 7.57 (t, 2H, H-3' and 
H-5'), 7.64 (t, lH, H-5), 7.70 (t, 1H, H-4'), 8.05 (m, 2H, H-3 and H-4), 8.06 (d, 2H, H-2' 
and H-6'), 8.74 (d, 1H, H-6). 13C NMR (CDCl3): 8 124.55 (C-3), 126.11 (C-5), 128.10 
(C-3' and C-5'), 130.91 (C-2' and C-6'), 132.87 (C-4'), 136.18 (C-1'), 137.00 (C-4), 
148.49 (C-6), 155.01 (C-2), 193.86 (-CO-). 13C NMR (d6-DMSO): 8 124.32 (C-3), 
126.91 (C-5), 128.38 (C-3' and C-5'), 130.74 (C-2' and C-6'), 133.17 (C-4'), 136.12 
(C-1'), 137.83 (C-4), 148.73 (C-6), 154.61 (C-2), 193.64 (-CO-). 13C NMR (CD3CN): 
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8 125.14 (C-3), 127.44 (C-5), 129.04 (C-3' and C-5'), 131.68 (C-2' and C-6'), 133.77 
(C-4'), 137.60 (C-1'), 138.30 (CA), 149.51 (C-6), 156.03 (C-2), 194.94 (-CO-). 
0 
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(i) REACTION WITH RHODIUM TRICHLORIDE IN 2-METHOXYETHANOL 
A solution of 301 (243 mg, 1.33 mmol) and rhodium trichloride trihydrate (100 
mg, 0.38 mmol) in 2-methoxyethanol (10 cm3) was stirred at room temperature for four 
days. The resultant dark red suspension was then stirred under reflux for one day 
during which time a yellow precipitate formed. The suspension was cooled to room 
temperature, refrigerated then filtered and the solid dried under reduced pressure to give 
Rh(301-H)(301-N,O)Cb, 308, in 75% yield. Mp >300°C. Anal. Calcd for 
Cz4H17N20zClzRh: C, 53.46; H, 3.18; N, 5.20; Cl, 13.15; Found: C, 53.44; H, 3.43; N, 
5.27; Cl, 13.46%. IR (KBr pellet): Vmax 1676, 1612, 1587, 1574, 1446, 1328, 1306, 
1287, 1260, 766, 753, 702, 688 cm-1. lH NMR (CDCl3): 8 7.30 (t, lH, H-5'a), 7.45 (t, 
lH, H-4'a), 7.60 (t, lH, H-5a), 7.69 (t, 2H, H-3'b and H-5'b), 7.73 (t, 1H, H-5b), 7.82 (t, 
1H, H-4'b), 7.89 (d, 1H, H-3'a), 7.99 (d, 1H, H-6'a), 8.05 (t, 1H, H-4a), 8.08 (t, 1H, 
H-4b), 8.09 (d, 2H, H-2'b and H-6'b), 8.19 (d, 1H, H-3b), 8.33 (d, 1H, H-3a), 8.99 (d, 
1H, H-6b), 9.70 (d, 1H, H-6a). lH NMR (d6-DMSO): 8 7.40 (t, 1H, H-5'a), 7.57 (t, 1H, 
H-4'a), 7.87 (d, lH, H-6'a), 7.88 (t, 2H, H-3'b and H-5'b), 7.90 (d, 1H, H-3'a), 8.03 (t, 
2H, H-5a and H-4'b), 8.16 (t, 1H, H-5b), 8.26 (d, 2H, H-2'b and H-6'b), 8.35 (d, 1H, 
H-3a), 8.42 (t, 1H, H-4a), 8.46 (t, 1H, H-4b), 8.53 (d, 1H, H-3b), 8.88 (d, 1H, H-6b), 
9.63 (d, 1H, H-6a). 13c NMR (d6-DMSO): 8 124.09 (C-5'a), 125.91 (C-3a), 127.52 
(C-Sa), 128.03 (C-6'a), 129.55 (C-3'b and C-5'b), 130.69 (C-2'b and C-6'b), 130.83 
(C-Sb), 131.14 (C-4'a), 133.60 (C-3b), 135.08 (C-4'b), 139.95 (C-3'a), 140.22 (C-4a and 
C-4b), 153.65 (C-6a), 155.33 (C-6b), 187.76 (-COa-), 201.51 (-COb-). Quaternary 
· signals observed but not assigned 139.24, 153.43, 155.22, 156.53 and 156.90. 
Diffusion of pentane into a dimethyl sulfoxide/chloroform solution of 308 gave 
Rh(301-H)(DMS0)2Cl2, 309, as yellow crystals suitable for single crystal X-ray 
structure determination. Mp >300°C. Anal. Calcd for C16H2oN03S2Ch.l/2(CH3)2SO: 
C, 37.03; H, 4.20; N, 2.54; Found: C, 37.27; H, 4.03; N, 2.51 %. 
Ligand exchange of 308 with thallium acetylacetonate for five days followed by 
the vapour diffusion of ether into a dichloromethane solution of the complex gave 
Rh(301-H)(301-N)(acac)Cl, 310, in 22% yield. Mp 211-215°C (dec.). Calcd for 
C29H24N204ClRh: (M-C[)+, 567.0791; Found (FAB): 567.0788. IR (KBr pellet): Vmax 
1651, 1597, 1576, 1518, 1439, 1387, 1310, 1286, 984, 932, 793, 775, 750, 692 cm-1. 
lH NMR (CDCb): o 1.78 (s, 3H, acac-CH3), 2.01 (s, 3H, acac-CH3), 5.09 (s, 1H, 
acac-CH), 6.92 (d, lH, H-3'a), 7.08 (d, 1H, H-3b), 7.12 (t, 1H, H-5b), 7.14 (t, 1H, 
H-4'a), 7.18 (t, lH, R-5'a), 7.32 (t, 1H, H-4'b), 7.39 (t, 2H, H-3'b and H-5'b), 7.43 (t, 
1H, H-5a), 7.71 (t, 1H, H-4b), 7.78 (d, lH, H-6b), 7.92 (d, 2H, H-2'b and H-6'b), 7.93 
(d, lH, H-6'a), 7.94 (t, 1H, H-4a), 8.14 (d, 1H, H-3a), 9.22 (d, 1H, H-6a). 13C NMR 
(CDCb): o 27.82 (acac-CH3), 28.87 (acac-CH3), 99.14 (acac-CH), 123.13 (C-5b), 
123.59 (C-5'a), 123.73(C-3b), 125.36 (C-3a), 126.01 (C-5a), 127.16 (C-2'b and C-6'b), 
127.70 (C-4'b), 128.09 (C-3'b and C-5'b), 129.45 (C-6a), 130.19 (C-4'a), 136.54 (C-3'a), 
138.24 (C-4b), 138.28 (C-4a), 148.15 (C-6b), 152.34 (C-6a). 
(ii) REACTION WITH RHODIUM TRICHLORIDE IN ETHANOL 
(a) WITH SODIUM PERCHLORATE 
Reaction of 301, rhodium trichloride trihydrate and sodium perchlorate in 
refluxing ethanol/water (5/1, v/v) gave the yellow solid, trans-Rh(301-N,0)2Cl2.Cl04, 
302, as previously reported.l88 Recrystallisation from acetonitrile/methanol gave the 
complex as yellow blocks suitable for single crystal X-ray structure determination. IR 
(KBr pellet): Vmax 1596, 1574, 1522, 1446, 1351, 1275, 1090,758, 696, 687, 623 cm-1. 
1H NMR (CD3CN): o 7.87 (t, 2H, H-3' and H-5'), 8.08 (t, lH, H-4'), 8.29 (d, 2H, H-2' 
and H-6'), 8.43 (t, 1H, H-5), 8.66 (t, lH, H-4), 8.83 (d, IH, H-3), 9.93 (d, lH, H-6). 13C 
NMR (CD3CN): complex not sufficiently soluble to obtain data. 
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After standing for 24 hours at room temperature, an acetonitrile solution of 302 
gave a solution of cis-Rh(301-N,O)zCb.Cl04, 304, in quantitative yield. Vapour 
diffusion of ether into an acetonitrile solution of the complex gave the complex as thin 
ye1low plates suitable for single crystal X -ray structure determination. 1 H NMR 
(CD3CN): 8 7.75 (t, 2H, H-3' and H-5'), 7.96 (t, 1H, H-4'), 8.04 (d, 2H, H-2' and H-6'), 
8.39 (t, lH, H-5), 8.62 (t, IH, H-4), 8.75 (d, 1H, H-3), 9.93 (d, 1H, H-6). 13C NMR 
(CD3CN): 8 130.55 (C-3' and C-5'), 132.15 (C-2' and C-6'), 134.57 (C-5), 137.12 (C-3), 
137.76 (C-4'), 142.79 (C-4), 155.64 (C-6), 190.51 (-CO-). 
Warming the yellow complex, 302, in water gave a dark orange solid as 
previously reported.188 This material was recrystallised from methanol/acetonitrile to 
give Rh(301-N,0)(301-0)(0H)Cb, 306, as fine, dark red needles. IR (KBr pellet): 
Ymax 1574, 1543, 1446, 1339, 1271, 1101, 1044, 1027, 784, 777, 758, 707, 696 cm-1. 
lH NMR (CD3CN): 8 6.99 (d, 1H, H-H-3a), 7.43 (m, 3H, H-3'a, H-4'a and H-5'a), 7.67 
(t, lH, H-5a), 7.81 (t, 2H, H-3'b and H-5'b), 7.84 (d, 2H, H-2'a and H-6'a), 7.95 (t, 1H, 
H-4a), 8.00 (t, 1H, H-4'b), 8.17 (d, lH, H-5b), 8.17 (d, 2H, H-2'b and H-6'b), 8.44 (t, 
lH, H-4b), 8.64 (d, lH, H-3b), 9.52 (d, lH, H-6a), 9.54 (d, 1H, H-6b). 13C NMR 
(CD3CN): complex not sufficiently soluble to obtain data. 
After standing for six days at room temperature, an acetonitrile solution of 306 
gave a solution of 307 (a different isomer of Rh(301-N,0)(301-0)(0H)Cb) in 
quantitative yield. lH NMR (CD3CN): 8 7.08 (d, IH, H-3a), 7.29 (m, 3H, H-3'a, H-4'a 
and H-5'a), 7.51 (m, 2H, H-2'a and H-6'a), 7.68 (t, IH, H-5a), 7.75 (t, 2H, H-3'b and 
H-5'b), 7.97 (t, 1H, H-4a), 8.00 (d, 2H, H-2'b and H-6'b), 8.22 (t, IH, H-5b), 8.44 (t, 1H, 
H-4b), 8.57 (d, lH, H-3b), 9.74 (d, 1H, H-6a), 9.83 (d, lH, H-6b). 13C NMR (CD3CN): 
8 125.15 (C-3a), 125.69 (C-5a), 127.37 (C-2'a and C-6'a), 128.63 (C-4'a), 128.73 (C-3'a 
and C-5'a), 130.47 (C-3'b and C-5'b), 131.30 (C-2'b and C-6'b), 133.26 (C-5b), 135.68 
(C-3b), 136.73 (C-4'b), 140.40 (C-4a), 141.15 (C-4b), 151.18 (C-6a), 154.82 (C-6b). 
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(b) WITHOUT SODIUM PERCHLORATE 
Reaction of 2-benzoylpyridine and rhodium trichloride trihydrate in ethanol 
gave an orange solid as previously reported.l88 IR (KBr pellet): Vmax 1594, 1575, 
1539, 1509, 1445, 1349, 1272, 1036, 756, 695 cm-1. This complex is insoluble in 
common NMR solvents. 
The orange solid was stirred under reflux in water for fifteen minutes to give the 
red solid, Rh(301-N,0)(301-0)(0H)Cl2, 306, as previously reported.l88 The complex 
was characterised by comparison of the 1 H NMR and IR spectra of the sample with that 
prepared above. 
Stirring the red solid, 306 (80 mg), under reflux in ethanol/water (8.0 cm3, 311, 
v/v) for three hours gave Rh(301-H)(301-N,O)Cl2, 308, (28 mg), identified by 
comparison of the lH NMR and IR spectra of the sample with that prepared above. 
Direct bromination of 2-phenylpyridine, 201. 
(i) REACTION WITH BROMINE AND IRON POWDER IN ACETIC ACID 
Bromine (0.08 cm3, 3.1 mmol) was added to a stirred mixture of iron powder 
(19 mg, 0.3 mmol) and 201 (0.2 cm3, 215 mg, 1.4 mmol) in acetic acid (2.5 cm3) and 
the resultant mixture stirred overnight at room temperature. This gave no 
decolourisation of the solution, so it was stirred under reflux for three hours after which 
water ( 1 cm3) was added and the solution refluxed overnight, after which it was poured 
into water (20 cm3). The solution was decolourised by the addition of a small amount 
of sodium metabisulfite and then basified by the addition of sodium hydroxide. The 
resultant mixture was then extracted with chloroform (3 x 15 cm3) and the combined 
extracts washed with sodium metabisulfite solution then dried over anhydrous 
magnesium sulfate. Removal of solvent under reduced pressure gave a quantitative 
return of 201. 
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(ii) REACTION WITH BROMINE AND ANTIMONY PENT A CHLORIDE IN 
DICHLOROETHANE 
201 (0.2 cm3, 215 mg, 1.4 mmol) was added to a stirred solution of antimony 
pentachloride (0.1 cm3, 0.8 mmol) and bromine (0.04 cm3, 1.6 mmol) in 
1 ,2-dichloroethane (2 cm3) and the resultant suspension stirred overnight at room 
temperature, after which it was poured into water (20 cm3). The mixture was stirred 
and basified by the addition of sodium hydroxide, then transferred to a separating 
funnel and the organic phase separated. The aqueous phase was extracted with 
additional 1 ,2-dichloroethane (2 x 10 cm3) and all organic extracts combined and dried 
over anhydrous magnesium sulfate. Removal of solvent under reduced pressure gave 
226 mg of an oil. This oil was estimated by 1 H NMR to contain the following 
compounds: 2-(3-bromophenyl)pyridine, 407, (trace); 2-(4-bromophenyl)pyridine, 408, 
(11%) 7.89 ppm (d, H-2' and H-6'); 201 (89%). 
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(iii) REACTION WITH BROMINE AND SILVER SULFATE IN AQUEOUS 
SULPHURIC ACID 
Bromine (0.08 cm3, 3.1 mmol) was added to a solution of201 (0.2 cm3, 215 mg, 
1.4 mmol) and silver sulfate (725 mg, 2.3 mmol) in aqueous sulfuric acid (16 mol dm-3, 
2.5 cm3) and the resultant suspension left to stand overnight at room temperature after 
which it was poured into water (15 cm3). The precipitate was filtered off and the filtrate 
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basified by the addition of sodium hydroxide, then extracted with chloroform (3 x 20 
cm3) and the combined extracts dried over anhydrous magnesium sulfate. The solvent 
was removed under reduced pressure to give 87 mg of an oiL This oil was estimated by 
1 H NMR to contain the following compounds: 2-(2,5-dibromophenyl)pyridine, 409, 
(26%) 7.39 (d, H-4'); 408 (36%) 7.61 ppm (d, H-3' and H-5'); 201 (12%) 7.99 (d, H-2' 
and H-6'); 407 (16%) 8.18 (s, H-2'); 2-(3,4-dibromophenyl)pyridine, 410, (10%) 8.30 (s, 
H-2'). 
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(iv) REACTION WITH POTASSIUM BROMATE IN SULFURIC ACID 
201 (0.2 cm3, 215 mg, 1.4 mmol) was added to a solution of potassium bromate 
(240 mg, 1.4 mmol) in aqueous sulfuric acid (9 mol dm-3, 3 cm3) and the mixture was 
stirred overnight at room temperature, the flask shielded from light with aluminium foil. 
The solution was poured, with stirring, into water (20 cm3) and basified by the addition 
of sodium hydroxide, then extracted with chloroform (3 x 10 cm3). The combined 
organic extracts were then dried o.ver anhydrous magnesium sulfate and the solvent 
remo.ved under reduced pressure to. give 272 mg of an o.il. This oil was estimated by 1 H 
NMR to contain the follo.wing compounds: 408 (24%) 7.61 ppm (d, H-3' and H-5'); 201 
(39%) 7.99 (d, H-2' and H-6'); 407 (18%) 8.18 (s, H-2'); 410 (5%) 8.30 (s, H-2'); 409 
( <5%, estimated due to signal overlap). 
This mixture was subjected to radial chromatography, eluting with an increasing 
gradient of chloroform in petroleum ether to give a pure sample of 410. Calcd for 
CuH7N79Br81Br (CllH7N79Br2, CuH7N8lBr2): M+, 312.8927 (310.8946, 314.8907); 
Found (EI): M+, 312.8921 (310.8935, 314.8906). lH NMR (CDCb): o 7.30 (t, 1H, 
H-5), 7.70 (d, 1H, H-3), 7.72 (d, 1H, H-5'), 7.79 (t, 1H, H-4), 7.80 (d, lH, H-6'), 8.30 (s, 
lH, H-2'), 8.70 (d, lH, H-6). 13C NMR (CDCl3): o 120.40 (C-5), 122.92 (C-3), 126.74 
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(C-6'), 132.02 (C-2'), 133.89 (C-5'), 137.06 (C-4), 149.87 (C-6). lH NMR analysis of 
another mixed fraction facilitated the partial characterisation of two further compounds: 
408 (31% of mixture, estimated by lH NMR). lH NMR (CDCl3): o 7.27 (t, lH, H-5), 
7.61 (d, 2H, H-3' and H-5'), 7.72 (d, 1H, H-3), 7.78 (t, lH, H-4), 7.89 (d, 2H, H-2' and 
H-6'), 8.72 (d, lH, H-6). 409 (69%). lH NMR (CDCl3): o 7.33 (t, lH, H-5), 7.39 (d, 
H-4'), 7.54 (d, lH, H-3'), 7.61 (d, IH, H-3), 7.70 (s, lH, H-6'), 7.79 (t, lH, H-4), 8.72 
(d, lH, H-6). 
2-(3-Bromophenyl)pyridine, 407. 
(i) VIA DIAZOTISATION OF 3-BROMOANILINE WITH NITROUS ACID 
3-Bromoaniline (25.0 g, 145 mmol) was dissolved in a solution of hydrochloric 
acid (10 mol dm-3, 60 cm3) and water (400 cm3) and the resultant solution cooled to 
3°C by the addition of dry ice. A chilled solution of sodium nitrite (11.02 g, 160 mmol) 
in water (60 cm3) was added in 2 cm3 portions to the solution prepared above with the 
temperature of the mixture maintained below 5°C. The resultant solution was 
transferred to a chilled dropping funnel and added slowly, with stirring, to pyridine (250 
cm3) at room temperature. Throughout the addition dry ice was added periodically to 
the solution of diazonium salt to prevent thermal decomposition. The resultant mixture 
was then stirred overnight at room temperature, after which it was made strongly 
alkaline by the addition of sodium hydroxide and left to stand for two days. The 
mixture was steam distilled and the distillate collected when cloudy, after all of the 
pyridine had been removed. The distillate (1200 cm3) was extracted with ether 
(combined volume 600 cm3) and the extracts washed with water (250 cm3), then dried 
over anhydrous magnesium sulfate and the solvent removed under reduced pressure to 
give 750 mg of a yellow oil. This oil was estimated by 1 H NMR to contain the 
following compounds: 3-bromoaniline (9%) 6.58 ppm (d, H-6); 3-bromophenol (7%) 
7.60 (s, H-2); 407 (51%) 8.18 (s, H-2'); 3-nitrobromobenzene (l%) 8.40 (s, H-2); 
3-(3-bromophenyl)pyridine (14%) 8.82 (s, H-2); 4-(3-bromophenyl)pyridine (<10%, 
estimated due to signal overlap). 
187 
This mixture was subjected to radial chromatography, eluting with a gradient of 
chloroform in petroleum ether, to give 407 (320 mg) as an oil contaminated by 
3-bromoaniline (estimated by lH NMR 22% of the mixture) as well as a small quantity 
(2.7 mg) of the pure compound. Calcd for C11HsN79Br (CuHsN81Br): M+, 232.9840 
(234.9820); Found (EI): M+, 232.9838 (234.9821). lH NMR (CDCh): 8 7.27 (t, 1H, 
H-5), 7.35 (t, 1H, H-5'), 7.55 (d, 1H, H-4'), 7.71 (d, 1H, H-3), 7.78 (t, 1H, H-4), 7.92 (d, 
1H, H-6'), 8.18 (s, 1H, H-2'), 8.71 (d, IH, H-6). 13C NMR (CDCl3): 8 120.60 (C-3), 
122.67 (C-5), 123.02 (C-3'), 125.38 (C-6'), 130.00 (C-2'), 130.23 (C-5'), 131.84 (C-4'), 
136.93 (C-4), 141.32 (C-1'), 149.72 (C-6), 155.80 (C-2). 
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(i) VIA DIAZOTISATION OF 3-BROMOANILINE WITH /SO-AMYL NITRITE 
A solution of freshly distilled 3-bromoaniline (13.5 cm3, 21 g, 120 mmol) in 
pyridine (125 cm3) was treated with isoamyl nitrite (40.0 cm3, 35 g, 300 mmol) to give, 
after work-up, an oil containing a mixture of 407, 3-(3-bromophenyl)pyridine and 
4-(3-bromophenyl)pyridine as previously reported.21 7 The proportions of 
(bromophenyl)pyridines in the oil were estimated by lH NMR analysis as: 407 (42%); 
3-(3-bromophenyl)pyridine (28% ); 4-(3-bromophenyl)pyridine (30% ). 
A sample of this oil ( 1.50 g) was subjected to chromatography on a silica gel 
column, with chloroform as eluent, to give a pure sample of each of the 
(bromophenyl)pyridines. 3-(3-bromophenyl)pyridine (A). Calcd for Ct1HsN79Br 
(CnH8N81Br): M+, 232.9840 (234.9820); Found (EI): M+, 232.9840 (234.9817). lH 
NMR (CDCl3): 8 7.36 (t, 1H, H-5'), 7.39 (t, 1H, H-5), 7.52 (d, 1H, H-6'), 7.54 (d, 1H, 
H-4'), 7.73 (s, 1H, H-2'), 7.85 (d, 1H, H-4), 8.62 (d, 1H, H-6), 8.82 (s, 1H, H-2). 13C 
NMR (CDCl3): 8 123.18 (C-3'), 123.62 (C-5), 125.76 (C-6'), 130.19 (C-2'), 130.57 
(C-5'), 130.62 (C-3), 131.07 (C-4'), 134.38 (C-4), 139.92 (C-1'), 148.18 (C-2), 149.04 
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(C-6). 4-(3-bromophenyl)pyridine (B). Calcd for CuHgN79Br (CnHsN81Br): M+, 
232.9840 (234.9820); Found (EI): M+, 232.9833 (234.9820). lH NMR (CDCl3): 8 7.36 
(t, 1H, H-5'), 7.48 (d, 2H, H-3 and H-5), 7.56 (d, 1H, H-6'), 7.58 (d, 1H, H-4'), 7.78 (s, 
1H, H-2'), 8.68 (d, 2H, H-2 and H-6). 13C NMR (CDCI3): 8 121.52 (C-3 and C-5), 
123.19 (C-3'), 125.57 (C-6'), 130.02 (C-2'), 130.57 (C-5'), 131.94 (C-4'), 140.16 (C-1'), 
146.84 (C-4), 150.27 (C-2 and C-6). 
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The remainder of the oil (7.34 g) was subjected to chromatography on a silica 
gel column, eluting with an increasing gradient of chloroform in petroleum ether 
(40-60°C), to give 407 (3.48 g) as a dark brown oil which was used without further 
purification. Yield 12% (based on 3-bromoaniline). 
2-Phenylpyridine 1-oxide, 412. 
Reaction of pyridine (81.0 cm3, 1.01 mol) and freshly prepared phenyllithium 
[from lithium (7.35 g, 1.06 mol) and bromobenzene (52.5 cm3, 0.50 mol)] in toluene 
gave 201 as previously reported.284 Yield 26%. During the isolation of the product a 
small fraction ( 1.11 g) was collected from the initial distillation under reduced pressure 
which, upon standing at room temperature, solidified to give a pale yellow product 
which was identified as 4,4'-bipyridine by comparison of its lH NMR spectrum with 
that of an authentic sample. 
Reaction of 201 with hydrogen peroxide in acetic acid gave 412, as previously 
reported.228 Mp 155-157°C (lit.228 157°C). lH NMR (CDCb): 8 7.20 (t, lH, H-5), 
7.29 (t, lH, H-4), 7.40 (d, 1H, H-3), 7.44 (t, 2H, H-3' and H-5'), 7.46 (t, lH, H-4'), 7.80 
(d, 2H, H-2' and H-6'), 8.31 (d, lH, H-6). 13C NMR (CDCb): 8 124.13 (C-3), 125.50 
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(C-5), 126.92 (C-4), 127.74 (C-2' and C-6'), 128.75 (C-3' and C-5'), 129.07 (C-4'), 
139.87 (C-6). 
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2-Phenyl-4-chloropyridine, 411. 
Reaction of 412 with sulfuryl chloride followed by treatment with alcoholic 
picric acid gave the picrate of 2-phenyl-4-chloropyridine as previously reported. 226 Mp 
179-182°C (lit.226I77-182°C). 
The picrate of 2-phenyl-4-chloropyridine (5.41 g, 12.9 mmol) was warmed with 
aqueous sodium hydroxide (1.3 mol dm-3, 100 cm3) to give a dark brown solution, 
which was cooled to room temperature, then diluted with water (200 cm3). The 
resultant solution was extracted with ether (4 x 100 cm3) and the combined extracts 
dried over anhydrous magnesium sulfate and the ether removed under reduced pressure. 
The residue was taken up in chloroform (100 cm3), the solution filtered and the solvent 
removed under reduced pressure to give, in quantitative yield, 411 as a brown oil, which 
was used without further purification. Calcd for CuHsN35CI: M+, 189.0345; Found 
(EI): M+, 189.0344. lH NMR (CDCl3): o 7.22 (d, lH, H-5), 7.42 (t, lH, H-4'), 7.47 (t, 
2H, H-3' and H-5'), 7.71 (s, lH, H-3), 7.96 (d, 2H, H-2' and H-6'), 8.57 (d, 1H, H-6). 
Be NMR (CDCb): o 120.78 (C-3), 122.21 (C-5), 126.90 (C-2' and C-6'), 128.79 (C-3' 
and C-5'), 129.54 (C-4'), 138.03 (C-1'), 144.65 (C-4), 150.41 (C-6), 158.90 (C-2). 
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2,2'-Diphenyl-4,4'-bipyridine, 402. 
A mixture of tetraethylammonium iodide (1.03 g, 4.01 mmol), zinc powder (399 
mg, 6.11 mmol) and NiBr2(PPh3)2 (893 mg, 1.20 mmol) was placed into a flask and the 
flask evacuated then filled with argon, and the cycle repeated five times. THF (20 cm3) 
was transferred into the flask and the resultant mixture stirred and heated at 50°C for 30 
minutes, after which an argon-purged solution of 411 (703 mg, 3.71 mmol) in THF (15 
cm3) was transferred into the flask. The mixture was kept at 50°C and stirred under an 
argon atmosphere for 25 hours. The resultant suspension was poured into aqueous 
ammonia solution (2 mol dm-3, 100 cm3) and ether/benzene (50/50, v/v, 100 cm3) was 
then added and the resultant mixture filtered. The solid was washed with ether/benzene 
(50150, v/v, 20 cm3), the filtrates combined and transferred into a separating funnel. 
The separated aqueous solution was extracted with ether/benzene (50/50, v/v, 2 x 50 
cm3) and the combined organic extracts washed with water (100 cm3), then with 
saturated aqueous sodium chloride solution (100 cm3) and dried over anhydrous 
magnesium sulfate. The solvent was removed under reduced pressure and the residue 
subjected to chromatography on a silica gel column, eluting with chloroform/petroleum 
ether (60-80°C) (111, v/v), to give 402 as a white solid in 47% yield. Mp 112-113.5°C. 
Anal. Calcd for Cz2H16N2: C, 85.69; H, 5.23; N, 9.08; Found: C, 85.31; H, 5.37; N, 
9.10%. Calcd for C22H16N2: M+, 308.1314; Found (EI): M+, 308.1313. IR (KBr 
pellet): Vmax 1591, 1531, 1389, 835, 777, 745, 725, 696 cm-1. lH NMR (CDCl3): o 
7.45 (t, 2H, H-4" and H-4"'), 7.49 (d, 2H, H-5 and H-5'), 7.51 (t, 4H, H-3", H-5", H-3'" 
and H-5"'), 7.97 (s, 2H, H-3 and H-3'), 8.06 (d, 4H, H-2", H-6", H-2'" and H-6'"), 8.82 
(d, 2H, H-6 and H-6'). 13C NMR (CDCl3): o 118.46 (C-3 and C-3'), 119.96 (C-5 and 
C-5'), 127.01 (C-2", C-6", C-2'" and C-6"'), 128.83 (C-3", C-5", C-3"' and C-5'"), 129.26 
(C-4" and C-4"'), 138.96 (C-1" and C-1'"), 146.85 (C-4 and C-4'), 150.47 (C-6 and C-6'), 
158.52 (C-2 and C-2'). 
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(i) REACTION WITH LITHIUM TETRACHLOROPALLADATE 
(a) ONE EQUIVALENT 
402 was reacted with one equivalent of lithium tetrachloropalladate to give 
[Pd(402-H)Clh in quantitative yield. Mp >300°C. IR (KBr pellet): Vmax 1609, 1578, 
1533, 1475, 1435, 1383, 827, 773, 739, 700 cm-1. 
Ligand exchange of [Pd(402-H)Clh with thallium acetylacetonate in chloroform 
gave Pd(402-H)(acac), 413, in 22% yield. Mp >300°C. Anal. Calcd for 
C27H22N202Pd.l!JCHCI3: C, 59.40; H, 4.07; N, 5.07; Found: C, 59.06; H, 3.88; N, 
5.35%. Calcd for C27H22N202106pd: M+, 512.0713; Found (FAB): M+, 512.0706. IR 
(KBr pellet): Vmax 1578, 1533, 1514, 1391, 1263, 773, 735, 696 cm-1. lH NMR 
(CDCl3): o 2.09 (s, 3H, acac-CH3), 2.13 (s, 3H, acac-CH3), 5.43 (s, 1H, acac-CH), 7.15 
(t, lH, H-5"), 7.22 (t, 1H, H-4"), 7.43 (d, lH, H-5), 7.48 (t, 1H, H-4"'), 7.52 (d, 2H, H-5' 
and H-6"), 7.54 (t, 2H, H-3"' and H-5"'), 7.63 (d, 1H, H-3"), 7.86 (s, lH, H-3), 7.97 (s, 
1H, H-3'), 8.07 (d, 2H, H-2"' and H-6"'), 8.85 (d, 1H, H-6), 8.87 (d, lH, H-6'). 13C 
NMR (CDCIJ): o 28.14 and 29.69 (acac-CH3), 100.69 (acac-CH), 116.18 (C-3), 118.31 
(C-3'), 119.53 (C-5), 119.77 (C-5'), 122.95 (C-6"), 124.72 (C-5"), 127.08 (C-2'" and 
C-6'"), 128.94 (C-3'" and C-5"'), 129.54 (C-4" and C-4"'), 131.50 (C-3"), 148.79 (C-6'), 
150.71 (C-6). 
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(b) TWO EQUIVALENTS 
A solution of 402 (50 mg, 0.16 mmol) and lithium tetrachloropalladate (0.39 
mmol) in methanol (15 cm3) was stirred under reflux for one day after which it was 
filtered and the precipitate washed with methanol (3 x 10 cm3), acetone (5 cm3) then 
ether (15 cm3) to give [Pd2(402-2H)Ch]x in 95% yield. Mp >300°C. IR (KBr pellet): 
Vmax 1609, 1578, 1531, 1479, 1435, 1381, 1022,768,729 cm-1. 
Ligand exchange of [Pd2(402-2H)ChJx with sodium acetylacetonate gave 
Pd2(402-2H)(acac)2 , 414, in 54% yield. Mp >300°C. Calcd for 
C32H29N204l06pdl08pd: M+, 719.0198; Found (FAB): M+, 719.0206. IR (KBr pellet): 
Vmax 1611, 1578, 1533, 1512, 1394, 772 cnr 1. lH NMR (CDC!)): o 2.09 (s, 6H, 
acac-CH3), 2.13 (s, 6H, acac-CH3), 5.43 (s, 2H, acac-CH), 7.17 (t, 2H, H-5" and H-5"'), 
7.22 (t, 2H, H-4" and H-4"'), 7.41 (d, 2H, H-5 and H-5'), 7.54 (d, 2H, H-6" and H-6"'), 
7.65 (d, 2H, H-3" and H-3"'), 7.87 (s, 2H, 3 and H-3'), 8.93 (d, 2H, H-6 and H-6'). 13C 
NMR (CDCh): complex not sufficiently soluble to obtain data. 
(ii) REACTION WITH PALLADIUM ACETATE 
402 and two equivalents of palladium acetate were reacted according to method 
A to give [Pd2(402-2H)Ch)x in 94% yield. 
3,3'-Di(2-pyridyl)biphenyl, 403. 
By the method described above for the preparation of 402, a mixture of 
tetraethylammonium iodide (1.05 g, 4.08 mmol), zinc powder (405 mg, 6.19 mmol) and 
NiBr2(PPh3)2 (896 mg, 1.21 mmol) was used to couple 407 (926 mg, 3.96 mmol). This 
gave, after work-up, 403 as an oil in 50% yield. Calcd for C22H16N2: M+, 308.1314; 
Found (EI): M+, 308.1313. lH NMR (CDCl3): o 7.24 (t, 2H, H-5" and H-5"'), 7.56 (t, 
2H, H-5 and H-5'), 7.73 (t, 2H, H-6 and H-6'), 7.76 (t, 2H, H-4" and H-4"'), 7.80 (d, 2H, 
H-3" and H-3"'), 7.99 (d, 2H, H-4 and H-4'), 8.30 (s, 2H, H-2 and H-2'), 8.72 (d, 2H, 
H-6" and H-6'"). l3C NMR (CDCl3): o 120.73 (C-3" and C-3"'), 122.19 (C-5" and 
C-5'"), 125.90 (C-2 and C-2'), 125.97 (C-4 and C-4'), 127.88 (C-6 and C-6'), 129.16 
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(C-5 and C-5'), 136.73 (C-4" and C-4"'), 139.92 (C-1 and C-1'), 141.60 (C-3 and C-3'), 
149.66 (C-6" and C-6'"), 157.33 (C-2" and C-2"'). 
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(i) REACTION WITH LITHIUM TETRACHLOROPALLADATE 
A solution of 403 (38 mg, 0.12 mmol) and lithium tetrachloropalladate (0.12 
mmol) in methanol (15 cm3) was stirred under reflux for four days after which it was 
filtered and the precipitate washed with methanol (3 x 10cm3) then ether (5 cm3) to give 
[Pd2(403-H2)Ch]x in quantitative yield. Mp >300°C. IR (KBr pellet): Ymax 1605, 
1564, 1481, 1458, 1425, 1016,772 cm-1. 
Ligand exchange of [Pdz(403-H2)Ch]x with sodium acetylacetonate gave 
Pdz(403-2H)(acac)2 , 415, in 69% yield. Mp >300°C. Anal. Calcd for 
C32H28N204Pdz: C, 53.57; H, 3.93; N, 3.91; Found: C, 53.44; H, 3.99; N, 4.13%. 
Calcd for C3zHzsN204l06pdl08pd: M+, 718.0120; Found (FAB): M+, 718.0125. IR 
(KBr pellet): Ymax 1605, 1580, 1514, 1479, 1425, 1396, 1263, 1022, 772 cm-1. lH 
NMR (CDCl3): B 2.08 (s, 6H, acac-CH3), 2.13 (s, 6H, acac-CH3), 5.43 (s, 2H, 
acac-CH), 7.19 (t, 2H, H-5" and H-5"'), 7.43 (d, 2H, 6 and H-6'), 7.64 (s, 2H, H-2 and 
H-2'), 7.68 (d, 2H, H-5 and H-5'), 7.75 (d, 2H, H-3" and H-3"'), 7.84 (t, 2H, H-4" and 
H-4"'), 8.81 (d, 2H, H-6" and H-6"'). 13C NMR (CDCb): B 27.70 and 28.13 
(acac-CH3), 100.65 (acac-:CH), 118.46 (C-3" and C-3"'), 121.25 (C-2 and C-2'), 121.72 
(C-5" and C-5'"), 127.74 (C-6 and C-6'), 131.71 (C-4 and C-4'), 138.46 (C-4" and C-4"'), 
148.37 (C-6" and C-6'"), 187.00 and 188.21 (acac-CO). 
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(ii) REACTION WITH PALLADIUM ACETATE 
403 and two equivalents of palladium acetate were reacted according to method 
A to give [Pd2(403-H2)Ch]x in 68% yield. 
3,6-Diphenoxypyridazine, 419. 
419 was prepared by the reaction of two equivalents of sodium phenoxide with 
3,6-dichloropyridazine, 442, as previously reported.230 Mp 141.5-142°C (lit.230 
140-141°C). Calcd for C16H12N202: M+, 264.0899; Found (EI): M+, 264.0894. IR 
(KBr pellet): Vmax 1589, 1491, 1429, 1351, 1257, 1198, 1160, 872, 861, 809, 763, 736, 
690 cm-1. lH NMR (CDCl3): 8 7.17 (br t, 2H, H-4' and H-4"), 7.18 (br d, 4H, H-2', 
H-6', H-2" and H-6"), 7.19 (br s, 2H, H-4 and H-5), 7.36 (br t, 4H, H-3', H-5', H-3" and 
H-5"). lH NMR (d6-DMSO): 8 7.30 (br d, 4H, H-2', H-6', H-2" and H-6"), 7.33 (br t, 
2H, H-4' and H-4"), 7.53 (br t, 4H, H-3', H-5', H-3" and H-5"), 7.68 (br s, 2H, H-4 and 
H-5). Be NMR (CDCI3): 8 120.97 (C-2', C-6', C-2" and C-6"), 121.75 (C-4 and C-5), 
125.02 (C-4' and C-4"), 129.56 (C-3', C-5', C-3" and C-5"), 153.52 (C-1' and C-1"), 
162.96 (C-3 and C-6). 13C NMR (d6-DMSO): 8 120.96 (C-2', C-6', C-2" and C-6"), 
121.78 (C-4 and C-5), 125.02 (C-4' and C-4"), 129.57 (C-3', C-5', C-3" and C-5"), 
153.00 (C-1' and C-1"), 162.97 (C-3 and C-6). 
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(i) REACTION WITH LITHIUM TETRACHLOROPALLADATE 
419 was reacted with one equivalent of lithium tetrachloropalladate to give 
Pd( 419)2Ch in 85% yield. Recrystallisation from nitromethane gave the analytical 
sample. Mp 215-220°C (dec.). Anal. Calcd for C32H24N404Cl2Pd.lhH20: C, 53.76; 
H, 3.52; N, 7.83; Cl, 9.92; Found: C, 53.47; H, 3.38; N, 7.96; Cl, 10.10%. IR (KBr 
pellet): Vmax 1490, 1444, 1274, 1193, 1164, 847,749,739, 688 cm-1. 
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(ii) REACTION WITH PALLADIUM ACETATE 
419 and one equivalent of palladium acetate were reacted according to method B 
to give [Pd(419-H)Clh in 63% yield. IR (KBr pellet): Vmax 1491, 1441, 1425, 1418, 
1279, 1180, 1163, 1111, 883, 764, 750, 689 cm-1. This complex is insoluble in 
common NMR solvents. 
During the preparation of [Pd(419-H)Cl]2, a sample of the corresponding 
J.t-diacetato dipalladium complex, [Pd(419-H)OAc]2, was isolated and characterised by 
NMR. lH NMR (CDCh): () 1.68 (s, 3H, CH3COO), 6.70 (d, 1H, H-6'), 6.83 (t, 1H, 
H-4'), 6.91 (t, lH, H-5'), 6.95 (d, 3H, H-5, H-2" and H-6"), 7.11 (d, 1H, H-4), 7.16 (t, 
lH, H-411), 7.17 (d, lH, H-3'), 7.33 (t, 2H, H-3" and H-5"). 13C NMR (CDCl3): o 23.99 
(CH3COO), 114.56 (C-6'), 120.22 (C-2" and C-6"), 123.20 (C-4'), 123.26 (C-5), 124.78 
(C-5'), 124.89 (C-4), 125.02 (C-411), 129.55 (C-3" and C-5"), 134.99 (C-3'), 180.01 
(CH3COO). 
Ligand exchange of [Pd(419-H)Cl]2 with thallium acetylacetonate gave, in 87% 
yield, Pd(419-H)(acac), 455, as pale yellow crystals suitable for single crystal X-ray 
stmcture determination. Mp 186-188°C. Anal. Calcd for C21H1&N204Pd: C, 53.80; H, 
3.87; N, 5.98; Found: C, 53.70; H, 3.84; N, 5.94%. IR (KBr pellet): Vmax 1593, 1570, 
1514, 1458, 1443, 1420, 1394, 1269, 1190, 1163, 754 cm-1. lH NMR (CDCl3): o 1.90 
(s, 3H, acac-CH3), 2.03 (s, 3H, acac-CH3), 5.34 (s, 1H, acac-CH), 6.96 (m, 1H, H-6'), 
7.07 (m, lH, H-5'), 7.10 (m, 1H, H-4'), 7.21 (m, 1H, H-411), 7.36 (d, lH, H-5), 7.41 (m, 
4H, H-2", H-3", H-5" and H-6"), 7.44 (d, 1H, H-4), 7.60 (m, 1H, H-3'). 13C NMR 
(CDCI3): o 27.30 and 27.63 (acac-CH3), 100.08 (acac-CH), 115.13 (C-6'), 120.58 
(C-2'), 120.88 (C-2" and C-6"), 123.58 (C-5), 124.34 (C-5'), 125.32 (C-4"), 125.54 
(C-4'), 125.60 (C-4), 129.48 (C-3" and C-511), 134.32 (C-3'), 150.86 (C-1'), 152.87 
(C-1"), 156.81 (C-3), 160.82 (C-6), 185.84 and 188.45 (acac-CO). 
3,6-Bis(phenyltbio )pyridazine, 423. 
423 was prepared by the reaction of sodium thiophenoxide with 
3,6-dichloropyridazine in ethanol as previously reported.232 Mp 79.5-80.5°C (lit.232 
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78°C). Calcd for C16H12N2S2: M+, 296.0442; Found (EI): M+, 296.0443. IR (KBr 
pellet): Ymax 1511, 1472, 1439, 1372, 1147, 1087, 1024, 753, 704, 693 cm-1. lH NMR 
(CDCl3): 8 6.82 (s, 2H, H-4 and H-5), 7.40 (m, 6H, H-3', H-4', H-5', H-3", H-4" and 
H-5"), 7.57 (m, 4H, H-2', H-6', H-2" and H-6"). lH NMR (d6-DMSO): 8 7.23 (s, 2H, 
H-4 and H-5), 7.55 (m, 6H, H-3', H-4', H-5', H-3", H-4" and H-5"), 7.65 (m, 4H, H-2', 
H-6', H-2" and H-6"). 13C NMR (CDCl3): 8 125.39 (C-4 and C-5), 129.26 (C-1' and 
C-1"), 129.55 (C-4' and C-4"), 129.79 (C-3', C-5', C-3" and C-5"), 134.95 (C-2', C-6', 
C-2" and C-6"), 162.20 (C-3 and C-6). 13C NMR (d6-DMSO): 8 126.60 (C-4 and C-5), 
128,95 (C-1' and C-1 "), 129.96 (C-4' and C-4"), 130.28 (C-3', C-5', C-3" and C-5"), 
134.80 (C-2', C-6', C-2" and C-6"), 161.59 (C-3 and C-6). 
5 4 
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423 
(i) REACTION WITH LITHIUM TETRACHLOROPALLADATE 
423 was reacted with one equivalent of lithium tetrachloropalladate to give 
Pd(423)2Cl2 in 91% yield. Vapour diffusion of petroleum ether into a chloroform 
solution of the complex gave the analytical sample. Mp 240°C (dec.). Anal. Calcd for 
C32H24N4S4Cl2Pd: C, 49.91; H, 3.14; N, 7.28; Cl, 9.21; Found: C, 49.69; H, 3.13; N, 
7.18; Cl, 9.47%. IR (KBr pellet): Ymax 1474, 1440, 1395, 1154, 1022,753,741,694 
6-Phenylthiopyridazin -3(2H)one, 444. 
Triethylamine (19.0 cm3, 136 mmol) was added dropwise to a rapidly stirred 
solution of 3-chloropyridazin-6(1H)one, 445, (5.0 g, 38 mmol) in thiophenol (14.0 cm3, 
136 mmol). The resultant mixture was stirred at 11 0°C for two days after which it was 
allowed to cool to room temperature. The mixture was basified by the addition of 
aqueous sodium hydroxide (8 mol dm-3, 35 cm3) and water (20 cm3) and the mixture 
extracted with benzene (4 x 50 cm3) to remove phenyl disulfide. The basic aqueous 
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solution was neutralised with hydrochloric acid (3 mol dm-3, 60 cm3) and extracted 
with ether ( 4 x 100 cm3) and the organic extracts combined and dried over anhydrous 
sodium sulfate. Removal of solvent under reduced pressure followed by 
recrystallisation of the residue from ethanol/petroleum ether gave 444 in 47.7% yield. 
Mp 130-131 °C. Anal. Calcd for CwHsN20S: C, 58.80; H, 3.95; N, 13.72; Found: C, 
58.66; H, 3.99; N, 13.80%. Calcd for CwHsN20S: M+, 204.0357; Found (EI): M+, 
204.0362. IR (KBr pellet): Vmax 1664, 1638, 1582, 1568, 1474, 1440, 1423, 1141, 998, 
838, 754, 512, 480 cm-1. lH NMR (CDCb): o 6.85 (d, 1H, H-4), 7.06 (d, lH, H-5), 
7.38 (m, 3H, H-3', H-4' and H-5'), 7.50 (m, 2H, H-2' and H-6'), 12.56 (br s, lH, N-H). 
lH NMR (d6-DMSO): o 6.94 (d, lH, H-4), 7.34 (d, lH, H-5), 7.49 (t, 1H, H-4'), 7.52 (d, 
2H, H-2' and H-6'), 7.57 (t, 2H, H-3' and H-5'), 13.21 (br s, 1H, N-H). l3C NMR 
(CDCb): o 129.05 (C-4'), 129.59 (C-3' and C-5'), 130.17 (C-1'), 130.19 (C-4), 133.58 
(C-2' and C-6'), 134.39 (C-5), 146.71 (C-6), 161.14 (C-3). l3C NMR (d6-DMSO): o 
128.83 (C-4'), 129.86 (C-3' and C-5'), 130.79 (C-1'), 130.82 (C-4), 132.71 (C-2' and 
C-6'), 134.65 (C-5), 143.21 (C-6), 159.67 (C-3). 
444 
3-Chloro-6-phenoxypyridazine, 446. 
446 was prepared by the reaction of one equivalent of sodium phenoxide with 
442 in benzene as previously reported.231 NMR analysis of the product showed it to be 
contaminated by the corresponding his-ether, 419, with the product being 
approximately 85% 446. Mp 62-63°C (lit.231 69-70°C). Calcd for CwH7N2035Cl: 
M+, 206.0247; Found (EI): M+, 206.0250. IR (KBr pellet): Vmax 1574, 1492, 1409, 
1324, 1284, 1258, 1193, 1136, 874, 854,766 cm-1. lH NMR (CDCb): o7.14 (d, 1H, 
H-5), 7.18 (d, 2H, H-2' and H-6'), 7.24 (t, 1H, H-4'), 7.41 (t, 2H, H-3' and H-5'), 7.46 (d, 
1H, H-4). lH NMR (d6-DMSO): o 7.35 (d, 2H, H-2' and H-6'), 7.38 (t, 1H, H-4'), 7.56 
(t, 2H, H-3' and H-5'), 7.67 (d, lH, H-5), 8.04 (d, lH, H-4). 13C NMR (CDCb): o 
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119.93 (C-5), 120.89 (C-2' and C-6'), 125.57 (C-4'), 129.79 (C-3' and C-5'), 131.41 
(C-4), 151.94 (C-1'), 165.03 (C-6). Be NMR (d6-DMSO): 6 121.15 (C-2' and C-6'), 
121.37 (C-5), 125.57 {C-4'), 130.02 (C-3' and C-5'), 132.57 (C-4), 151.86 (C-1'), 165.33 
(C-6). 
3' 4' 
446 
4,6-Diphenoxypyrimidine, 420. 
A mixture of phenol (2.88 g, 3.1 mmol), potassium carbonate (2.81 g, 2.0 mmol) 
and 4,6-dichloropyrimidine, 443, (1.53 g, 1.0 mmol) was heated at 160°C for one hour 
after which it was allowed to cool to room temperature. Water (10 cm3) and aqueous 
potassium hydroxide (0.13 mol dm-3, 30 cm3) were added and the suspension 
ultrasonicated to break up the solid. The mixture was filtered and the solid washed with 
water (50 cm3) then dried under reduced pressure to give 420 in 89% yield. Mp 
109-109.5°C. Anal. Calcd for Ct6H12N202: C, 72.72; H, 4.58; N, 10.60; Found: C, 
72.55; H, 4.42; N, 10.61%. Calcd for Ct6H12N202: M+, 264.0899; Found (EI): M+, 
264.0897. IR (KBr pellet): Vmax 1606, 1579, 1562, 1489, 1456, 1382, 1240, 1219, 
1207, 1152, 820, 763, 695 cm-1. lH NMR (CDCl3): 6 6.29 (s, lH, H-5), 7.16 (d, 4H, 
H-2', H-6', H-2" and H-6"), 7.28 (t, 2H, H-4' and H-4"), 7.44 (t, 4H, H-3', H-5', H-3" and 
H-5"), 8.45 (s, lH, H-2). 13C NMR (CDCl3): 6 92.11 (C-5), 121.48 (C-2', C-6', C-2" 
and C-6'), 125.90 (C-4' and C-4"), 129.87 (C-3', C-5', C-3" and C-5"), 152.43 (C-1' and 
C-1"), 158.42 (C-2), 171.61 (C-4 and C-6). 
6" 5 6' 
5" r(Yoj(yo~ 5' 
4"v2" ~~N 2'v4. 
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420 
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(i) REACTION WITH LITHIUM TETRACHLOROPALLADATE · 
420 was reacted with one equivalent of lithium tetrachloropalladate to give 
Pd( 420)2Cb, 452, in 82% yield. Recrystallisation from nitromethane/toluene gave the 
analytical sample. Mp 209.5-212°C (dec.). Anal. Calcd for 
C32H24N404ClzPd.2/3Ph-CH3: C, 57.40; H, 3.85; N, 7.30; Cl, 9.24; Found: C, 57.24; 
H, 3.71; N, 7.34; Cl, 9.38%. IR (KBr pellet): Vmax 1621, 1582, 1547, 1492, 1469, 1412, 
1252, 1204, 749, 685 cm-1. 1H NMR (CDCl3): 8 6.02 (s, 1H, H-5), 7.03 (d, 2H, H-2" 
and H-6"), 7.27 (t, 1H, H-4"), 7.35 (t, 1H, H-4'), 7.36 (d, 2H, H-2' and H-6'), 7.40 (t, 2H, 
H-3" and H-5"), 7.46 (t, 2H, H-3' and H-5'), 8.84 (s, 1H, H-2). 13C NMR (CDCb): 8 
92.57 (C-5), 121.19 (C-2" and C-6"), 121.29 (C-2' and C-6'), 126.34 (C-4"), 127.14 
(C-4'), 129.76 (C-3" and C-5"), 130.49 (C-3' and C-5'), 151.63 (C-1' or C-1"), 152.11· 
(C-1' or C-1"), 160.30 (C-2), 170.72 (C-4 or C-6), 171.72 (C-4 or C-6). 
(ii) REACTION WITH PALLADIUM ACETATE 
420 and one equivalent of palladium acetate were reacted according to method B 
to give [Pd(420-H)Cl]2 in 37% yield. Mp 244-245°C (dec.). Anal. Calcd for 
C32H22N404Cl2Pd2: C, 47.34; H, 2.74; N, 6.91; Cl, 8.75; Found: C, 47.44; H, 2.80; N, 
6.97; Cl, 8.16%. IR (KBr pellet): Vmax 1611, 1585, 1572, 1547, 1491, 1468, 1454, 
1431, 1408, 1244, 1198,758 cm-1. lH NMR (CDC}J): 86.62 (s, 1H, H-5), 6.92 (d, 1H, 
H-6'), 6.95 (t, 1H, H-4'), 7.08 (t, lH, H-5'), 7.14 (d, 2H, H-2" and H-6"), 7.34 (t, 1H, 
H-4"), 7.41 (d, 1H, H-3'), 7.47 (t, 2H, H-3" and H-5"), 8.93 (s, 1H, H-2). 13C NMR 
(CDCl3): o 94.62 (C-5), 116.48 (C-6'), 121.32 (C-2" and C-6"), 124.85 (C-4'), 126.30 
(C-4"), 126.63 (C-5'), 130.10 (C-3" and C-5"), 136.80 (C-3"), 160.00 (C-2). 
During the preparation of [Pd(420-H)Cl]2, a sample of the corresponding 
J!-diacetato dipalladium complex, [Pd(420-H)OAc]2, was isolated and characterised by 
NMR. lH NMR (CDCl3): 8 2.10 (s, 3H, CH3COO), 6.23 (s, 1H, H-5), 6.71 (d, lH, 
H-6'), 6.84 (t, 1H, H-4'), 6.97 (d, 1H, H-3'), 7.02 (t, 1H, H-5'), 7.04 (d, 2H, H-2" and 
H-6"), 7.32 (t, 1H, H-4"), 7.47 (t, 2H, H-3" and H-5"), 8.38 (s, lH, H-2). 
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Ligand exchange of [Pd( 420-H)Cl]z with thallium acetylacetonate gave 
Pd(420-H)(acac), 454, in 62% yield. Mp 202-206°C (dec.). Anal. Calcd for 
C21H1sN204Pd: C, 53.80; H, 3.87; N, 5.98; Found: C, 53.81; H, 4.16; N, 5.88%. IR 
(KBr pellet): Vmax 1611, 1585, 1548, 1509, 1490. 1471, 1456, 1432, 1394, 1309, 1241, 
1227, 1196, 749 cm-1. lH NMR (CDCl3): 8 1.90 (s, 3H, acac-CH3), 2.09 (s, 3H, 
acac-CH3), 5.42 (s, 1H, acac-CH), 6.57 (s, 1H, H-5), 6.94 (d, 1H, H-6'), 7.10 (br t, 2H, 
H-4' and H-5'), 7.17 (d, 2H, H-2" and H-6"), 7.34 (t, 1H, H-4"), 7.49 (t, 2H, H-3" and 
H-5"), 7.65 (d, 1H, H-3'), 9.19 (s, 1H, H-2). 13C NMR (CDCl3): 8 27.56 and 27.71 
(acac-CH3), 93.97 (C-5), 100.44 (acac-CH), 115.53 (C-6'), 119.12 (C-2'), 121.39 (C-2" 
and C-6"), 124.27 (C-4'), 125.86 (C-4"), 126.52 (C-5'), 130.12 (C-3" and C-5"), 133.70 
(C-3'), 145.05 (C-1'), 152.08 (C-1"), 158.91 (C-2), 187.00 and 188.13 (acac-CO). 
4,6-Bis(phenylthio )pyrimidine, 424. 
Thiophenol (2.1 cm3, 2.0 mmol) was added to a freshly prepared solution of 
sodium ethoxide (0.52 g sodium, 2.3 mmol) in ethanol (20 cm3) and to the resultant 
solution was added 443 (1.5 g, 1.0 mmol) dissolved in ethanol (20 cm3). The reaction 
mixture was stirred under reflux for one day after which it was allowed to cool to room 
temperature and the precipitate of sodium chloride removed by filtration. The filtrate 
was chilled and the precipitate filtered to give 424. The filtrate was stripped of solvent 
and the residue taken up in water (50 cm3). Aqueous sodium hydroxide (8 mol dm-3, 5 
cm3) was added and the solution extracted with chloroform (3 x 25 cm3). The organic 
extracts were combined, dried over magnesium sulfate and the solvent removed under 
reduced pressure to give a residue which crystallised upon standing overnight. The 
supernatant was removed and the solid recrystallised from ethanol to give an additional 
quantity of the ligand. Total yield 47%. Mp 116.5-l17°C. Anal. Calcd for 
C16H12N2S2: C, 64.83; H, 4.08; N, 9.45; Found: C, 64.53; H, 3.91; N, 9.44%. Calcd 
for C16H12N2S2: M+, 296.0442; Found (El): M+, 296.0443. IR (KBr pellet): Vmax 
1530, 1494, 1474, 1427, 1281, 1082, 802,748, 689 cm-1. lH NMR (CDCl3): 8 6.03 (s, 
lH, H-5), 7.31 (t, 4H, H-3', H-5', H-3" and H-5"), 7.36 (t, 2H, H-4' and H-4"), 7.41 (d, 
4H, H-2', H-6', H-2" and H-6"), 8.62 (s, lH, H-2). lH NMR (d6-DMSO): 8 6.09 (s, 1H, 
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H-5), 7.48 (t, 4H, H-3', H-5', H-3" and H-5"), 7.53 (d, 4H, H-2', H-6', H-2" and H-6"), 
7.56 (t, 2H, H-4' and H-4"), 8.75 (s, IH, H-2). 13C NMR (CDCb): 8 111.91 (C-5), 
127.28 (C-1' and C-1"), 129.76 (C-3', C-5', C-3" and C-5"), 129.97 (C-4' and C-4"), 
135.50 (C-2', C-6', C-2" and C-61), 156.70 (C-2), 172.20 (C-4 and C-6). 13C NMR 
(d6-DMSO): 8 111.10 (C-5), 126.36 (C-1' and C-1"), 130.27 (C-3', C-5', C-3" and C-5"), 
130.51 (C-4' and C-4"), 135.33 (C-2', C-6', C-2" and C-6'), 156.78 (C-2), 171.67 (C-4 
and C-6). 
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(i) REACTION WITH LITHIUM TETRACHLOROPALLADATE 
Lithium tetrachloropalladate was reacted with two equivalents of 424 without 
stirring to give Pd(424)2Ch, 453, in 93% yield. Mp 241 °C (dec.). Anal. Calcd for 
C32H24N4S4Cl2Pd: C, 49.91; H, 3.14; N, 7.28; Cl, 9.21; Found: C, 49.74; H, 3.06; N, 
7.42; Cl, 9.34%. IR (KBr pellet): Vmax 1547, 1495, 1474, 1429, 1315, 1290, 1157, 822, 
745, 687 cm-1. lH NMR (CDCl3, 23°C): 8 5.79 (br d, 1H, H-5), 7.24-7.50 (br m, 10H, 
H-2' H-3' H-4' H-5' H-6' H-2" H-3" H-4" H-5" and H-6") 8 99 (br d 1H H-2) lH 
' ' ' ' ' ' ' ' ' . ' ' . 
NMR (CDCl3, 53°C): 8 5.87 (br s, lH, H-5), 7.23-7.39 (m, 8H, H-3', H-4', H-5', H-3", 
H-4", H-5" and H-2' and H-6' or H-2" and H-6"), 7.48 (d, 2H, H-2' and H-6' or H-2" and 
H-6"), 8.97 (br s, 1H, H-2). 13C NMR (CDC}J, 23°C): 8 113.73 and 113.91 (C-5), 
126.22 (C-1' and C-1"), 130.07 (C-3' and C-5' or C-3" and C-5"), 130.27 (C-3' and C-5' 
or C-3" and C-5"), 130.52 (C-4' or C-4"), 130.85 (C-4' or C-4"), 135.42 (C-2' and C-6' or 
C-2" and C-6"), 135.79 (C-2' and C-6' or C-2" and C-6"), 157.26 and 157.62 (C-2). 13C 
NMR (CDC!), 53°C): 8 114.09 (C-5), 127.26 (C-1' and C-1 "), 130.07 (C-3' and C-5' or 
C-3" and C-5"), 130.29 (C-3' and C-5' or C-3" and C-5"), 130.47 (C-4' or C-4"), 130.84 
(C-4' or C-4"), 135.46 (C-2' and C-6' or C-2" and C-6"), 135.85 (C-2' and C-6' or C-2" 
and C-6"), 157.73 (C-2). 
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2,3-Diphenylquinoxaline, 458. 
458 was available in the department. lH NMR (CDCl3): 3 7.35 (m, 6H, H-3', 
H-4' H-5' H-3" H-4" and H-5") 7 53 (m 4H H-2' H-6' H-2" and H-6") 7 79 (m 2H 
' ' ' ' . ' ' ' ' ' . ' ' 
H-6 and H-7), 8.19 (m, H-5 and H-8). 
5 N 6(X1 -...;:: 
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(i) REACTION WITH RHODIUM TRICHLORIDE 
Reaction of 458 with rhodium trichloride trihydrate gave [Rh(458-H)2Clh in 
62% yield. lH NMR (CDCI3): 3 5.73 (d, lH, H-3'), 6.26 (t, lH, H-4'), 6.50 (t, lH, 
H-5'), 6.70 (t, lH, H-7), 6.90 (d, lH, H-6'), 7.27 (t, lH, H-6), 7.65 (d, lH, H-5), 7.67 (br 
m, 3H, H-3", H-4" and H-5"), 8.12 (br d, 2H, H-2" and H-6"), 8.74 (d, lH, H-8). 
Ligand exchange of [Rh(458-H)2Clh with sodium acetylacetonate gave 
Rh(458-H)z(acac), 460, in 74% yield. Mp >300°C. Calcd for C45H33N402Rh: M+, 
764.1659; Found(FAB): M+, 764.1648. lH NMR (CDCl3): 3 1.62 (s, 6H, acac-CH3), 
4.65 (s, lH, acac-CH), 6.52 (d, 2H, H-3'), 6.60 (t, 2H, H-4'), 6.67 (t, 2H, H-5'), 7.08 (d, 
2H, H-6'), 7.55 (t, 2H, H-7), 7.61 (br m, 6H, H-3", H-4" and H-5"), 7.69 (t, 2H, H-6), 
8.00 (br d, 4H, H-2" and H-6"), 8.12 (d, 2H, H-5), 8.48 (d, 2H, H-8). 13C NMR 
(CDCl3): complex not sufficiently soluble to obtain data. 
Dibenzo[ a,c ]phenazine, 459. 
459 was available in the department. lH NMR (CDCb): 3 7.75 (t, 2H, H-8 and 
H-13), 7.81 (t, 2H, H-9 and H-12), 7.86 (m, 2H, H-3 and H-4), 8.34 (m, 2H, H-2 and 
H-5), 8.58 (d, 2H, H-10 and H-11), 9.42 (d, 2H, H-7 and H-14). 
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(i) REACTION WITH RHODIUM TRICHLORIDE 
Reaction of 459 with rhodium trichloride trihydrate gave [Rh(459-H)2Clh in 
quantitative yield. lH NMR (CDCl3): o 6.14 (br d, lH, H-13), 6.94 (br t, lH, H-12), 
7.78 (m, lH, H-8), 7.81 (m, lH, H-9), 7.92 (d, lH, H-11), 7.96 (br m, 2H, H-3 and 
H-4), 8.43 (m, 1H, H-10), 8.49 (br m, 1H, H-5), 9.44 (m, 1H, H-7), 10.11 (br s, 1H, 
H-2). 
Ligand exchange of [Rh(459:..H)2Cl]z with sodium acetylacetonate gave 
Rh(459-H)2(acac), 461, in 82% yield. Mp > 300°C. Calcd for C45H3oN402Rh: MH+, 
761.1424; Found(FAB): MH+, 761.1414. lH NMR (CDCl3): o 1.60 (s, 6H, acac-CH3), 
4.91 (s, lH, acac-CH), 6.49 (d, 2H, H-13), 7.03 (t, 2H, H-12), 7.71 (t, 2H, H-3), 7.78 
(m, 2H, H-8), 7.83 (m, 2H, H-9), 7.88 (t, 2H, H-4), 8.01 (d, 2H, H-11), 8.46 (d, 2H, 
H-5), 8.51 (d, 2H, H-10), 8.89 (d, 2H, H-2), 9.45 (d, 2H, H-7). l3C NMR (CDCl3): 
complex not sufficiently soluble to obtain data. 
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X-RAY CRYSTALLOGRAPHY 
Intensity data were collected with a Nicolet R3m four-circle diffractometer, or 
in the case of 455, with a SMART CCD area detector, using graphite-
monochromatised Mo Ka radiation (A 0.7107 A). Cell parameters were determined by 
least-squares refinement using the setting angles of accurately centred reflections with 
20 > 20°. Throughout data collections (ro scans) the intensities of three standard 
reflections were monitored and, in most cases, this showed no significant crystal 
decomposition. However, crystals of 304 were obtained as very fine plates that rapidly 
decomposed at room temperature. The plates were also prone to cracking at low 
temperature. Several attempts were made to collect full data sets from these crystals, 
but in no case was this successful. The data used were obtained from an incomplete 
shell of low angle (20max 36°) reflections obtained prior to the sudden decomposition 
of the crystal. The intensities of all data sets were corrected for Lorentz and 
polarisation effects and for absorption by a procedure based on azimuthal 'J1 scans. 
All structures were solved by direct methods using SHELXS-9o285 and refined 
on p2 by full-matrix least squares procedures using SHELXL-93.286 In general, all 
non-hydrogen atoms were refined with anisotropic displacement parameters. 
However, due to the paucity of data for structure of 304 only the rhodium and chlorine 
atoms were made anisotropic. Hydrogens were included in calculated positions and 
were assigned isotropic displacement parameters 1.3 times the isotropic equivalent of 
their carrier atoms. All data were used in the refinements; the functions minimised 
were L:w(F0 2- Fc2), with w = [cr2(F0 2) + aP2 + bP]-1 where P = [max(Fo2) + 2Fc2]/3. 
The site occupancies of the disordered solvate molecules were determined by 
refinement. 
Final atomic coordinates and equivalent isotropic displacement parameters 
(defined as one third of the trace of the orthogonalised Uij tensor) are listed in Tables 
2-6. Final bonding geometries are listed in Tables 7-10. 
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Table 1 X-ray crystal data and details of data collections and structure refinements 
Compound 234 455 302 304 309 
Formula CzzH 1sClzNzOzPd C21H1sNz04Pd Cz4lirsC13Nz06Rh CzsH24Cl3N406Rh C16HzoChN03S2Rha 
Formula Weight 519.7 468.8 639.7 721.8 611 
Crystal System monoclinic orthorhombic monoclinic monoclinic monoclinic 
a (A) 9.385(3) 13.0994(3) 19.705(4) 27.36(2) 16.399(2) 
b cA) 8.516(3) 14.4413(4) 7.839(1) 9.960(9) 7.916(1) 
c CA) 13.171(4) 20.1011(4) 15.748(3) 22.10(1) 19.012(3) 
~ (0) 101.88(2) 90 97.25(1) 93.75(2) 103.32(1) 
v cA3) 1030.1(6) 3802.6(2) 2413(1) 6010(7) 2401(1) 
Space Group P2r/c P2r2I2r C2/c C2/c P2r/n 
z 2 8 4 8 4 
De (Mgm-3) 1.68 1.64 1.76 1.60 1.69 
F(OOO) 520 1888 1280 2912 1232 
Temperature (K) 132(2) 142(2) 130(2) 130(2) 130(2) 
Crystal Size (mm) 0.45 X 0.21 X 0.11 0.53 X 0.35 X 0.13 0.44 X 0.21 X 0.18 0.42 X 0.35 X 0.01 0.62 X 0.30 X 0.06 
J1. (mm-1) 1.18 1.48 1.09 0.88 1.34 
28max(o) 48 53 55 36 47 
Unique reflections 1625 7048 2776 1336 3513 
Parameters 133 509 165 204 283 
GooF 1.07 1.07 1.04 1.07 1.04 
Rh [I>2cr(l)] 0.040 0.022 0.031 0.049 0.041 
wRc (all data) 0.099 0.050 0.069 0.080 0.102 
a Also includes 0.5DMSO and 0.5CHCI3 disordered solvate. b R =L. (IF0 1-1Fc!)/E IF0 1. c wR = (L. [w(F02 _ Fc2)2]/L.[w(F02)2])112. 
N 
0 
0\ 
Table 2 Atomic coordinates and equivalent isotropic displacement parameters (A2) for 
234. 
Atom 1Q4 X 1Q4y 104 z 1Q3 Ueq 
Pd1 0 0 5000 19(1) 
Cll -1199(2) 967(2) 6211(1) 29(1) 
N1 866(5) 2147(5) 4838(3) 19(1) 
C2 2008(6) 2713(7) 5514(4) 22(1) 
C3 2583(6) 4166(7) 5408(5) 25(1) 
C4 1933(6) 5089(8) 4579(4) 26(1) 
C5 771(6) 4500(7) 3870(5) 25(1) 
C6 273(6) 3030(7) 4025(4) 22(1) 
01 2554(4) 1684(5) 6283(3) 32(1) 
Cl' 3702(7) 2210(7) 7077(4) 23(2) 
C2' 5116(7) 2060(8) 6948(5) 37(2) 
C3' 6214(8) 2511(9) 7739(6) 48(2) 
C4' 5936(8) 3099(8) 8640(6) 45(2) 
C5' 4534(10) 3244(9) 8751(5) 47(2) 
C6' 3389(8) 2830(8) 7946(5) 38(2) 
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Table 3 Atomic coordinates and equivalent isotropic displacement parameters (A2) for 
455. 
Atom 104 X 104 y 104 z 103 Ueq 
Pd1 1191(1) -1476(1) 3415(1) 16(1) 
Nl 3016(2) -650(2) 2889(1) 18(1) 
N2 2663(2) -1483(2) 3129(1) 18(1) 
C3 3293(2) -2193(2) 3196(1) 20(1) 
C4 4346(2) -2121(2) 3043(2) 25(1) 
C5 4702(2) -1303(2) 2812(1) 28(1) 
C6 3978(2) -575(2) 2750(1) 21(1) 
03 2981(1) -3022(1) 3429(1) 24(1) 
C1' 2001(2) -3367(2) 3246(1) 20(1) 
C2' 1151(2) -2803(2) 3188(1) 19(1) 
C3' 263(2) -3232(2) 2952(1) 21(1) 
C4' 222(3) -4173(2) 2804(1) 25(1) 
C5' 1087(3) -4719(2) 2910(1) 28(1) 
C6' 1986(2) -4317(2) 3124(1) 24(1) 
06 4354(2) 252(1) 2538(1) 27(1) 
C1" 3677(2) 1012(2) 2491(1) 20(1) 
C2" 2973(2) 1057(2) 1982(1) 23(1) 
C3" 2389(2) 1845(2) 1924(2) 27(1) 
. C4 11 2484(2) 2567(2) 2377(1) 25(1) 
C5" 3189(2) 2503(2) 2889(1) 24(1) 
C6" 3809(2) 1726(2) 2948(1) 23(1) 
01 1277(2) -73(1) 3644(1) 21(1) 
02 -293(1) -1535(1) 3707(1) 22(1) 
Cll 752(2) 1421(2) 3951(1) 27(1) 
C12 541(2) 409(2) 3858(1) 19(1) 
C13 -448(2) 66(2) 4014(1) 19(1) 
209 
C14 -791(2) -837(2) 3947(1) 19(1) 
C15 -1866(2) 1064(2) 4168(2) 25(1) 
Pd1A 14066(1) -1327(1) 900(1) 15(1) 
NlA 13318(2) 376(2) 374(1) 17(1) 
N2A 14207(2) -9(2) 597(1) 16(1) 
C3A 15048(2) 494(2) 646(1) 18(1) 
C4A 15051(2) 1458(2) 509(1) 21(1) 
C5A 14169(2) 1844(2) 297(1) 22(1) 
C6A 13315(2) 1264(2) 234(1) 18(1) 
03A 15944(1) 118(1) 837(1) 23(1) 
C1'A 16206(2) -802(2) 651(1) 18(1) 
C2'A 15498(2) -1515(2) 623(1) 17(1) 
C3'A 15866(2) -2373(2) 396(1) 20(1) 
C4'A 16888(2) -2505(2) 235(1) 24(1) 
C5'A 17580(2) -1778(2) 303(1) 24(1) 
C6'A 17240(2) -916(2) 513(1) 23(1) 
06A 12430(2) 1667(1) 27(1) 21(1) 
C1"A 11541(2) 1107(2) -24(1) 18(1) 
C2"A 11494(2) 394(2) -485(1) 20(1) 
C3"A 10590(2) -99(2) -537(1) 22(1) 
C4"A 9755(2) 108(2) -131(1) 24(1) 
C5"A 9826(2) 833(2) 324(1) 25(1) 
C6"A 10717(2) 1339(2) 377(1) 20(1) 
OIA 12574(2) -1074(1) 1197(1) 20(1) 
02A 13983(2) -2661(1) 1191(1) 20(1) 
CllA 10902(2) -1361(2) 1563(2) 29(1) 
Cl2A 11975(2) -1685(2) 1424(1) 19(1) 
C13A 12230(2) -2618(2) 1549(1) 19(1) 
C14A 13171(2) -3034(2) 1439(1) 19(1) 
C15A 13300(2) -4043(2) 1629(2) 26(1) 
Table 4 Atomic coordinates and equivalent isotropic displacement parameters (A 2) for 
302. 
Atom 1Q4 X 1Q4y 104 z 103 Ueq 
Rh 2500 2500 0 9.25(8) 
Cl 2347.7(3) 5428.0(8) 88.4(4) 15.0(1) 
N(1) 2420(1) 2360(3) 1264(1) 13(1) 
C(2) 1759(1) 2417(4) 1441(2) 14(1) 
C(3) 1609(1) 2709(4) 2268(2) 18(1) 
C(4) 2152(2) 2834(4) 2928(2) 22(1) 
C(5) 2817(2) 2654(4) 2744(2) 22(1) 
C(6) 2937(1) 2447(4) 1894(2) 16(1) 
C(1) 1255(1) 2237(3) 665(2) 13(1) 
0(1) 1481(1) 2253(2) -49(1) 13(1) 
C(l') 518(1) 2053(3) 681(2) 16(1) 
C(2') 78(1) 2823(4) 25(2) 20(1) 
C(3') -626(1) 2625(5) 15(2) 28(1) 
C(4') -875(2) 1607(5) 624(2) 32(1) 
C(5') -441(2) 791(4) 1248(2) 29(1) 
C(6') 262(2) 1024(4) 1297(2) 22(1) 
Cl(l) 0 6107(1) 2500 25.5(6) 
0(11) -356(2) 5094(5) 1842(2) 84(1) 
0(12) -484(1) 7164(4) 2857(2) 58(1) 
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Table 5 Atomic coordinates and equivalent isotropic displacement parameters (A2) for 
304. 
Atom 104x 1Q4y 104z 103 Ueq 
Rh(l) 2856.1(5) 249.7(9) 1409.9(4) 17.4(5) 
Cl(l) 2235(2) 1539(3) 1743(1) 25(2) 
Cl(2) 2423(2) -1700(3) 1552(1) 23(2) 
N(l) 2602(4) 222(9) 536(3) 16(3) 
C(2) 2866(5) -547(10) 175(4) 7(3) 
C(3) 2748(5) -645(10) -442(5) 24(4) 
C(4) 2327(5) 44(10) -684(4) 18(3) 
C(5) 2076(5) 833(10) -311(5) 24(4) 
C(6) 2228(5) 895(10) 298(4) 10(4) 
C(1) 3313(5) -1160(10) 488(4) 8(3) 
0(1) 3391(3) -863(6) 1037(3) 14(2) 
C(l') 3664(6) -1932(11) 182(5) 18(4) 
C(2') 3528(6) -2971(11) -218(5) 24(4) 
C(3') · 3907(6) -3719(11) -491(5) 29(4) 
C(4') 4383(6) -3439(11) -330(5) 33(4) 
C(5') 4522(6) -2397(11) 78(5) 30(4) 
C(6') 4156(6) -1647(10) 319(4) 4(3) 
N(IA) 3168(4) 386(8) 2258(3) 14(3) 
C(2A) 3430(5) 1569(10) 2358(4) 8(3) 
C(3A) 3655(5) 1818(11) 2913(4) 19(4) 
C(4A) 3663(5) 873(10) 3375(5) 14(4) 
C(5A) 3401(5) -299(11) 3273(4) 15(3) 
C(6A) 3159(5) -532(10) 2704(4) 11(3) 
C(1A) 3427(5) 2398(10) 1829(5) 17(4) 
O(lA) 3257(3) 1974(7) 1332(3) 15(2) 
C(1'A) 3631(5) 3787(10) 1831(4) 10(3) 
C(2'A) 3492(5) 4718(10) 2250(4) 13(3) 
C(3'A) 3669(5) 6048(11) 2186(5) 21(4) 
C(4'A) 3929(5) 6402(12) 1709(5) 29(4) 
C(5'A) 4093(5) 5470(11) 1306(5) 30(4) 
C(6'A) 3920(5) 4153(11) 1358(5) 24(4) 
Cl(ll) 4017(2) -8102(3) -229(1) 44(2) 
0(11) 4306(4) -8961(8) -576(4) 43(3) 
0(12)a 4200(7) -8398(14) 408(6) 51(5) 
0(13)a 3507(8) -8571(15) -272(7) 53(6) 
0(14)a 4081(8) -6833(17) -351(8) 66(6) 
0(12A)b 3708(13) -8536(22) 166(11) 57(8) 
0(13A)b 3745(10) -7272(20) -724(10) 54(8) 
0(14A)b 4351(9) -7010(18) 60(8) 29(7) 
N(11) 4366(5) -257(11) 2085(4) 53(4) 
C(11) 4621(6) 356(12) 1816(5) 32(4) 
C(l2) 4957(6) 1085(15) 1460(6) 85(6) 
N(21) 4568(5) -4377(11) -1814(5) 56(4) 
C(21) 4612(6) -5504(14) -1780(6) 52(5) 
C(22) 4670(6) -6962(12) -1732(6) 62(5) 
a Disordered; site occupancy 0.6. b Disordered; site occupancy 0.4. 
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Table 6 Atomic coordinates and equivalent isotropic displacement parameters (A2) for 
309. 
Atom 104 X 104y 104 z 103 Ueq 
Rh(l) 2872.9(3) 1623.0(5) -41.0(2) 12.5(2) 
Cl(l) 3681.5(9) -721(2) 467.8(7) 21.0(3) 
Cl(2) 2605.9(9) 2390(2) 1076.7(7) 21.6(3) 
N(1) 3184(3) 1078(5) -1001(2) 15(1) 
C(2) 2644(4) 793(7) -1636(3) 20(1) 
C(3) 2915(4) 540(8) -2260(3) 27(1) 
C(4) 3748(4) 616(8) -2247(3) 30(2) 
C(5) 4306(3) 891(7) -1593(3) 19(1) 
C(6) 4012(3) 1124(7) -985(3) 19(1) 
C(7) 1725(4) 574(7) -1675(3) 20(1) 
0(7) 1244(3) 727(6) -2269(2) 30(1) 
C(1') 1422(3) -48(7) -1053(3) 18(1) 
C(2') 1856(3) 151(6) -333(3) 14(1) 
C(3') 1527(3) -605(7) 203(3) 19(1) 
C(4') 797(4) -1515(7) 38(3) 24(1) 
C(5') 355(4) -1690(7) -674(3) 27(1) 
C(6') 672(4) -963(7) -1211(3) 25(1) 
S(l) 4542.7(9) 3180(2) 1035.3(7) 18.4(3) 
0(1) 4004(2) 3276(4) 264(2) 16(1) 
C(11) 5574(3) 3528(8) 926(3) 24(1) 
C(12) 4404(4) 5157(7) 1435(3) 27(1) 
8(2) 2095.1(9) 3831(2) -513.1(7) 15.8(3) 
0(2) 1940(3) 3985(5) -1303(2) 30(1) 
C(21) 1105(3) 3889(8) -282(3) 26(1) 
C(22) 2545(4) 5741(7) -118(3) 27(2) 
C(lS)a 3813(7) 785(15) 2669(7) 19(3) 
Cl(3)a 4699(2) 1963(6) 2901(2) 51(1) 
Cl(4)a 4020(3) -1365(5) 2744(3) 61(1) 
Cl(S)a 3007(3) 1396(6) 3071(2) 55(1) 
S(3)a 3667(7) 823(7) 3142(4) 149(4) 
0(3)a 4247(8) 353(14) 3830(6) 67(3) 
C(31)a 4039(19) 2406(38) 2865(15) 134(10) 
C(32)a 3657(15) -748(32) 2512(13) 93(8) 
a Site occupancy 0.5. 
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Table 7 Bond lengths (A) and angles (degrees) for 234. 
Pdl-N1 2.029(5) Pd1-Cll 2.286(2) N1-C6 1.332(7) 
Nl-C2 1.335(7) C2-01 1.358(7) C2-C3 1.368(8) 
C3-C4 1.382(8) C4-C5 1.375(8) C5-C6 1.366(8) 
01-C1' 1.410(7) C1'-C6' 1.347(9) C1'-C2' 1.378(8) 
C2'-C3' 1.361(9) C3'-C4' 1.362(10) C4'-C5' 1.359(10) 
C5'-C6' 1.391(9) 
Nl-Pdl-Cll 90.82(13) NlA-Pdl-Cll 89.19(13 
Cll-Pdl-CllA 180.0 
C6-Nl-C2 118.5(5) C6-N1-Pd1 118.9(4) 
C2-Nl-Pdl 122.6(4) N1-C2-01 113.1(5) 
Nl-C2-C3 122.6(5) 01-C2-C3 124.3(5) 
C2-C3-C4 118.4(6) C5-C4-C3 119.2(6) 
C6-C5-C4 118.7(6) Nl-C6-C5 122.6(5) 
C2-0l-Cl' 117.5(5) C6'-Cl'-C2' 121.7(6) 
C6'-C1 '-01 119.2(6) C2'-C1'-01 119.2(5) 
C3'-C2'-Cl' 118.4(6) C2'-C3'-C4' 121.3(7) 
C5'-C4'-C3' 119.4(6) C4'-C5'-C6' 120.5(7) 
Cl'-C6'-C5' 118.6(7) 
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Table 8. Bond lengths (A) and angles (degrees) for 455. 
Pdl-C2' 1.972(3) Pdl-N2 2.012(2) Pd1-02 2.032(2) 
Pdl-01 2.080(2) N1-C6 1.297(4) Nl-N2 1.376(3) 
N2-C3 1.322(4) C3-03 1.349(3) C3-C4 1.417(4) 
C4-C5 1.353(4) C5-C6 1.421(4) C6-06 1.360(3) 
03-Cl' 1.426(3) Cl'-C2' 1.384(4) C1'-C6' 1.394(4) 
C2'-C3' 1.401(4) C3'-C4' 1.392(4) C4'-C5' 1.397(4) 
C5'-C6' 1.382(4) 06-C1" 1.414(3) Cl"-C2" 1.378(4) 
Cl"-C6" 1.391(4) C2"-C3" 1.376(4) C3"-C4" 1.390(4) 
C4"-C5" 1.387(4) C5"-C6" 1.390(4) 01-C12 1.264(3) 
02-C14 1.294(3) Cll-C12 1.498(4) C12-Cl3 1.423(4) 
C13-C14 1.386(4) C14-C15 1.512(4) Pd1A-C2'A 1.974(3) 
Pd1A-N2A 2.006(2) Pd1A-02A 2.018(2) Pd1A-01A 2.076(2) 
N1A-C6A 1.313(3) N1A-N2A 1.365(3) N2A-C3A 1.323(4) 
C3A-03A 1.351(3) C3A-C4A 1.418(4) C4A-C5A 1.352(4) 
C5A-C6A 1.404(4) C6A-06A 1.362(3) 03A-C1'A 1.422(3) 
Cl'A-C2'A 1.387(4) Cl'A-C6'A 1.392(4) C2'A-C3'A 1.406(4) 
C3'A-C4'A 1.391(4) C4'A-C5'A 1.394(4) C5'A-C6'A 1.387(4) 
06A-C1"A 1.423(3) C1"A-C2"A 1.386(4) Cl"A-C6"A 1.388(4) 
C2"A-C3"A 1.384(4) C3"A-C4"A 1.398(4) C4"A-C5"A 1.394(4) 
C5"A-C6"A 1.380(4) 01A-C12A 1.267(3) 02A-C14A 1.292(3) 
C11A-C12A 1.507(4) Cl2A-C13A 1.411(4) Cl3A-C14A 1.389(4) 
Cl4A-C15A 1.515(4) 
C2'-Pd1-N2 87.35(11) C2'-Pd1-02 90.02(10) 
N2-Pd1-02 177.26(9) C2'-Pd1-01 178.32(10) 
N2-Pd1-01 90.97(8) 02-Pd1-01 91.66(8) 
C6-N1-N2 118.4(2) C3-N2-Nl 120.3(2) 
C3-N2-Pd1 125.0(2) N1-N2-Pd1 114.6(2) 
N2-C3-03 122.3(3) N2-C3-C4 121.9(3) 
03-C3-C4 115.8(2) C5-C4-C3 118.3(3) 
C4-C5-C6 116.5(3) Nl-C6-06 119.5(3) 
N1-C6-C5 124.6(3) 06-C6-C5 115.8(2) 
C3-03-Cl' 119.5(2) C2'-C1 '-C6' 123.6(3) 
C2'-C1'-03 122.7(2) C6'-C1'-03 113.7(3) 
Cl'-C2'-C3' 115.9(2) C1'-C2'-Pd1 122.1(2) 
C3'-C2'-Pd1 122.0(2) C4'-C3'-C2' 122.3(3) 
C3'-C4'-C5' 119.2(3) C6'-C5'-C4' 120.1(3) 
C5'-C6'-C1 I 118.7(3) C6-06-C1" 118.4(2) 
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C2"-Cl"-C6" 122.5(3) C2"-C1"-06 120.4(2) 
C611-C1"-06 116.9(2) C3"-C2"-C1 II 118.3(3) 
C2"-C3"-C411 120.9(3) C5"-C4"-C3" 119.8(3) 
C4"-C5"-C6" 120.3(3) C5"-C6"-C1" 118.1(3) 
C12-0l-Pdl 124.8(2) C14-02-Pd1 123.8(2) 
Ol-C12-Cl3 125.2(3) 01-Cl2-C11 116.1(2) 
Cl3-C12-C11 118.7(2) C14-Cl3-Cl2 127.0(3) 
02-C14-Cl3 127.3(3) 02-C14-C15 114.3(2) 
C13-C14-C15 118.4(2) C2'A-PdlA-N2A 87.61(10) 
C2'A-Pd1A-02A 90.09(9) N2A-Pd1A-02A 177.70(9) 
C2'A-PdlA-01A 177.75(10) N2A-PdlA-OlA 90.38(8) 
02A-PdlA-OlA 91.92(7) C6A-N1A-N2A 118.1(2) 
C3A-N2A-N1A 120.7(2) C3A-N2A-Pd1A 125.1(2) 
N1A-N2A-Pd1A 114.0(2) N2A-C3A-03A 121.6(2) 
N2A-C3A-C4A 121.8(3) 03A-C3A-C4A 116.6(2) 
C5A-C4A-C3A 117.6(3) C4A-C5A-C6A 117.6(2) 
N1A-C6A-06A 119.1(2) N1A-C6A-C5A 124.1(2) 
06A-C6A-C5A 116.8(2) C3A-03A-C1'A 120.7(2) 
C2'A-C 1'A-C6'A 123.7(3) C2'A-C1'A-03A 122.9(2) 
C6'A-Cl'A-03A 113.4(2) Cl'A-C2'A-C3'A 115.9(2) 
C1'A-C2'A-Pd1A 121.5(2) C3'A-C2'A-Pd1A 122.6(2) 
C4'A-C3'A-C2'A 121.8(3) C3'A-C4'A-C5'A 120.0(3) 
C6'A-C5'A-C4'A 119.8(3) C5'A-C6'A-Cl'A 118.6(3) 
C6A-06A-C1"A 118.4(2) C2"A-C1"A-C6"A 122.2(3) 
C2"A-C1 "A-06A 120.5(2) C6"A-C1 "A-06A 117.2(2) 
C3"A-C2"A-C1 "A 118.0(3) C2"A-C3"A-C4"A 121.0(3) 
C5"A-C4"A-C3"A 119.4(3) C6"A-C5"A-C4"A 120.3(3) 
C5"A-C6"A-C1 "A 119.0(2) C12A-01A-Pd1A 124.4(2) 
C14A-02A-Pd1A 123.7(2) 01A-C12A-C13A 125.6(3) 
OlA-Cl2A-CllA 115.4(2) Cl3A-C12A-C11A 119.0(2) 
C14A-Cl3A-C12A 126.6(3) 02A-C14A-C13A 127.7(2) 
02A-C14A-C15A 113.9(2) C13A-C14A-C15A 118.4(2) 
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Table 9 Bond lengths (A) and angles (degrees) for 302 and 304. 
302 304 304 
Rh(l)-N(1) 2.019(2) 2.009(8) Rh(l)-N(1A) 2.013(8) 
Rh(l)-0(1) 2.009(2) 2.051(8) Rh(l)-O(lA) 2.051(8) 
Rh(l)-Cl(1) 2.3212(7) 2.290(4) N(lA)-C(6A) 1.35(1) 
Rh(l)-Cl(2) 2.307(4) N(1A)-C(2A) 1.39(1) 
N(l)-C(6) 1.332(3) 1.31(1) C(2A)-C(3A) 1.36(1) 
N(l)-C(2) 1.367(3) 1.35(1) C(2A)-C(1A) 1.43(1) 
C(2)-C(3) 1.390(3) 1.38(1) C(3A)-C(4A) 1.39(1) 
C(2)-C(l) 1.481(3) 1.50(2) C(4A)-C(5A) 1.38(2) 
C(3)-C(4) 1.398(4) 1.42(2) C(5A)-C(6A) 1.40(1) 
C(4)-C(5) 1.385(4) 1.36(2) C(lA)-0(1A) 1.24(1) 
C(5)-C(6) 1.398(4) 1.38(1) C(1A)-C(l'A) 1.49(2) 
C(l)-0(1) 1.261(3) 1.25(1) C(l'A)-C(2'A) 1.38(1) 
C(1)-C(1') 1.463(3) 1.43(2) C(1'A)-C(6'A) 1.40(2) 
C(l ')-C(6') 1.404(4) 1.39(2) C(2'A)-C(3'A) 1.42(1) 
C(1')-C(2') 1.399(4) 1.40(1) C(3'A)-C( 4'A) 1.36(2) 
C(2')-C(3') 1.393(4) 1.44(2) C( 4'A)-C(5'A) 1.38(2) 
C(3')-C(4') 1.385(5) 1.36(2) C(5'A)-C(6'A) 1.40(2) 
C( 4')-C(5') 1.376(5) 1.41(2) Cl(11)-0(12A) 1.33(3) 
C(5')-C(6') 1.390(4) 1.38(2) Cl(11)-0(13A) 1.53(2) 
Cl(ll)-0(11) 1.419(3) 1.42(1) Cl(ll)-0(14A) 1.53(2) 
Cl(11)-0(12) 1.431(3) 1.49(2) N(ll)-C(l1) 1.13(2) 
C1(11)-0(13) 1.47(2) C(11)-C(l2) 1.44(2) 
Cl(11 )-0(14) 1.31(2) N(21)-C(21) 1.13(2) 
C(21)-C(22) 1.46(2) 
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302 304 304 
N(1 )-Rh(1 )-N(1A) 180.0 174.2(4) N( lA)-Rh(l )-O(lA) 79.9(3) 
N(1)-Rh(l)-0(1) 80.25(8) 79.5(3) N(1A)-Rh(1)-Cl(2) 96.9(3) 
N(l )-Rh(l )-0(1A) 99.75(8) 94.8(3) N(lA)-Rh(l)-0(1) 98.1(3) 
0(1 A)-Rh(l )-0(1) 180.0 91.1(3) N(l )-Rh( 1 )-Cl(2) 88.3(3) 
N(l)-Rh(l)-Cl(l) 88.17(7) 95.7(3) O(l)-Rh(l)-Cl(2) 89.2(2) 
N(lA)-Rh(l)-Cl(l) 91.83(7) 86.6(3) 0(1A)-Rh(l)-Cl(2) 176.9(2) 
0(1 )-Rh(l)-Cl(1) 87.79(5) 175.1(2) C(6A)-N(lA)-C(2A) 119.6(8) 
0(1A)-Rh(l)-Cl(l) 92.21(5) 88.3(3) C(6A)-N(1A)-Rh(l) 127.5(7) 
Cl(1)-Rh(1)-Cl(2) 180.0 91.7(1) C(2A)-N(1A)-Rh(l) 112.8(6) 
C(6)-N(1)-C(2) 120.4(2) 119.2(9) C(3A)-C(2A)-N(1A) 119.8(9) 
C(6)-N(l)-Rh(l) 125.7(2) 126.4(8) C(3A)-C(2A)-C( lA) 127.6(11) 
C(2)-N(l)-Rh(l) 113.2(2) 114.3(8) N(lA)-C(2A)-C(lA) 112.6(9) 
N(1)-C(2)-C(3) 121.1(2) 121.7(11) C(2A)-C(3A)-C( 4A) 121.7(11) 
N(l )-C(2)-C(1) 112.7(2) 114.3(9) C(5A)-C( 4A)-C(3A) 118.0(10) 
C(3 )-C(2 )-C( 1) 126.1(2) 123.8(11) C( 4A)-C(5A)-C( 6A) 119.9(10) 
C(2)-C(3)-C(4) 118.4(2) 117.9(11) N(1A)-C(6A)-C(5A) 120.8(10) 
C(5)-C(4)-C(3) 119.5(2) 118.8(10) 0(1A)-C(1A)-C(2A) 120.6(10) 
C( 4 )-C( 5)-C( 6) 119.4(2) 119.1(13) 0(1A)-C( lA)-C(l'A) 116.0(9) 
N (1 )-C( 6)-C( 5) 120.9(2) 123.1(11) C(2A)-C(1A)-C( 1 'A) 123.4(10) 
0( 1 )-C( 1 )-C( 1') 118.7(2) 120.4(12) C(1A)-0(1A)-Rh(1) 112.5(7) 
O(l)-C(l)-C(2) 117.3(2) 115.7(11) C(2'A)-C( 1 'A)-C(6'A) 121.3(10) 
C(l ')-C(l )-C(2) 124.0(2) 123.7(9) C(2'A)-C(l 'A)-C(1A) 120.3(11) 
C(l )-0( 1 )-Rh(1) 115.5(2) 115.9(8) C(6'A)-C(l'A)-C(1A) 118.0(10) 
C( 6')-C( l')-C(2') 121.0(2) 120.2(13) C(1 'A)-C(2'A)-C(3'A) 116.6(11) 
C( 6')-C( 1')-C( 1) 120.9(3) 117.2(11) C( 4'A)-C(3'A)-C(2'A) 121.3(11) 
C(2')-C(1 ')-C( 1) 118.0(2) 122.5(14) C(3'A)-C( 4'A)-C(5'A) 122.3(11) 
C( 1')-C(2')-C(3') 118.9(3) 118.7(14) C( 4'A)-C( 5'A)-C( 6'A) 116.8(12) 
C( 4')-C(3')-C(2') 119.7(3) 119.2(12) C(l 'A)-C(6'A)-C(5'A) 121.0(11) 
C(3')-C( 4')-C(5') 121.3(3) 122.2(14) 0(12A)-Cl(11)-0(11) 123.9(11) 
C( 6')-C( 5')-C( 4 ') 120.2(3) 118.0(14) 0(14)-Cl(ll)-0(13) 115.7(12) 
C(5')-C(6')-C(1') 118.7(3) 121.5(11) 0(12A)-Cl(11 )-0(13A) 110(2) 
0(11)-Cl(l1)-0(12) 1 08.5(2) 103.1(8) 0(11)-Cl(ll)-0(13A) 101.7(9) 
0( 11)-Cl(11)-0(13) 112.0(4) 109.4(8) 0(12A)-Cl(11)-0(14A) 110.1(14) 
0(14 )-Cl(11 )-0(11) 109.3(2) 112.7(9) 0(11)-Cl(ll)-0(14A) 108.5(10) 
0(14)-Cl(ll)-0(12) 109.3(3) 110.2(10) 0(13A)-Cl(ll)-0(14A) 99.5(11) 
0(13)-Cl(11)-0(12) 109.2(2) 104.8(9) N(11)-C(l1)-C(12) 177(2) 
N(21)-C(21)-C(22) 180(1) 
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Table 10 Bond lengths (A) and angles (degrees) for 309. 
Rh(1)-C(2') 2.005(5) C(2')-C(3') 1.393(7) Rh(1)-N(1) 2.051(4) 
C(3')-C(4') 1.370(8) Rh(l)-S(2) 2.227(1) C(4')-C(5') 1.388(9) 
Rh(1)-0(1) 2.234(3) C(5')-C(6') 1.374(8) Rh(l )-Cl(2) 2.346(1) 
S(l)-0(1) 1.530(3) Rh(1)-Cl(1) 2.355(1) S(l)-C(11) 1.772(6) 
N(1)-C(2) 1.341(7) S(1)-C(12) 1.776(6) N(l)-C(6) 1.352(7) 
S(2)-0(2) 1.468(4) C(2)-C(3) 1.374(8) S(2)-C(22) 1.771(5) 
C(2)-C(7) 1.502(8) S(2)-C(21) 1.777(6) C(3)-C(4) 1.361(8) 
C(1S)-Cl(3) 1.70(1) C(4)-C(5) 1.380(8) C(1S)-Cl(5) 1.74(1) 
C(5)-C(6) 1.363(8) C(1S)-Cl(4) 1.735(12) C(7)-0(7) 1.225(6) 
S(3)-0(3) 1.48(1) C(7)-C(1') 1.469(8) S(3)-C(31) 1.54(3) 
C( 1 ')-C(2') 1.398(7) S(3)-C(32) 1.72(2) C( 1')-C( 6') 1.40(1) 
C(2')-Rh(l)-N(1) 89.6(2) C( 1 ')-C(7)-C(2) 121.3(5) 
C(2')-Rh(l )-S(2) 89.0(2) C(2')-C( 1')-C( 6') 119.5(5) 
N(l)-Rh(1)-S(2) 92.5(1) C(2')-C( 1 ')-C(7) 124.1(5) 
C(2')-Rh( 1 )-0(1) 179.0(2) C( 6')-C( 1')-C(7) 116.4(5) 
N(l)-Rh(1)-0(1) 89.6(2) C(3')-C(2')-C( 1') 118.2(5) 
S(2)-Rh(1)-0(1) 90.5(1) C(3')-C(2 ')-Rh( 1) 119.0(4) 
C(2')-Rh(l)-Cl(2) 94.8(2) C( l')-C(2')-Rh( 1) 122.6(4) 
N(1)-Rh(l)-Cl(2) 175.6(1) C( 4')-C(3')-C(2') 121.5(5) 
S(2)-Rh(l)-Cl(2) 87.30(5) C(3')-C( 4')-C( 5') 120.6(5) 
0(1 )-Rh(l )-Cl(2) 86.0(1) C(6')-C( 5')-C( 4') 118.7(5) 
C(2')-Rh(l )-Cl (1) 90.6(2) C( 5')-C( 6')-C( 1') 121.4(6) 
N(1)-Rh(1)-Cl(l) 88.2(1) 0(1)-S(l)-C(11) 103.6(2) 
S(2)-Rh(1)-C1(1) 179.20(5) 0(1)-S(l)-C(12) 105.3(2) 
0(1)-Rh(1)-Cl(1) 90.0(1) C(11)-S(1)-C(12) 97.6(3) 
Cl(2)-Rh(l )-Cl( 1) 92.11(5) S(l)-0(1)-Rh(1) 118.7(2) 
C(2)-N(1)-C(6) 118.4(5) 0(2)-S(2)-C(22) 108.7(3) 
C(2)-N(l)-Rh(l) 126.1(4) 0(2)-S(2)-C(21) 107.3(3) 
C(6)-N(l)-Rh(l) 115.4(3) C(22)-S(2)-C(21) 100.9(3) 
N(l)-C(2)-C(3) 121.6(5) 0(2)-S(2)-Rh(1) 115.2(2) 
N(l)-C(2)-C(7) 120.7(5) C(22)-S(2)-Rh(1) 110.8(2) 
C(3)-C(2)-C(7) 117.5(5) C(21)-S(2)-Rh(1) 113.0(2) 
C( 4 )-C(3 )-C(2) 120.0(5) Cl(3 )-C( 1 S)-Cl( 5) 115.2(8) 
C(3)-C(4)-C(5) 118.5(5) Cl(3)-C(1S)-Cl(4) 112.2(7) 
C( 6)-C(5)-C( 4) 119.6(5) Cl(5)-C( 1 S)-Cl( 4) 113.0(7) 
N ( 1 )-C( 6)-C( 5) 121.8(5) 0(3)-S(3)-C(31) 106(1) 
0(7)-C(7)-C(l ') 120.7(5) 0(3)-S(3)-C(32) 110(1) 
0(7)-C(7)-C(2) 117.3(5) C(31)-S(3)-C(32) 107(2) 
eferences 
REFERENCES 
1 M.l. Bruce,Angew. Chern., Int. Ed. Engl., 16 (1977) 73. 
2 G. B. Caygill, M.Sc. Thesis, University of Canterbury, (1987). 
3 G. Bahr and G. E. Muller, Chern. Ber., 88 (1955) 251. 
4 S. Trofimenko, Inorg. Chern., 12 (1973) 1215. 
5 E. C. Constable, Polyhedron, 3 (1984) 1037. 
6 A. Crispini and M. Ghedini, J. Chern. Soc., Dalton Trans., (1997) 75. 
7 A. J. Canty and G. van Koten, Ace. Chern. Res., 28 (1995) 406. 
8 M. Pfeffer, Reel. Trav. Chim. Pays-Bas, 109 (1990) 567. 
9 A. D. Ryabov, Chern. Rev., 90 (1990) 403. 
10 D. W. Evans, G. R. Baker and G. R. Newkome, Coord. Chern. Rev., 93 (1989) 
155. 
11 G. van Koten, Pure Appl. Chern., 61 ( 1989) 1681. 
12 I. Omae, Coord. Chern. Rev., 83 (1988) 137. 
13 I. P. Rothwell, Ace. Chern. Res., 21 (1988) 153. 
14 G. R. Newkome, W. E. Puckett, V. K. Gupta and G. E. Kiefer, Chern. Rev., 86 
(1986) 451. 
15 I. P. Rothwell, Polyhedron, 4 (1985) 177. 
16 A. D. Ryabov, Synthesis, (1985) 233-252. 
17 I. Omae, Chern. Rev., 79 (1979) 287. 
18 H.-P. Abicht and K. Issleib, Z. Chern., 17 (1977) 1. 
19 J. Dehand and M. Pfeffer, Coord. Chern. Rev., 18 (1976) 327. 
20 I. Omae, J. Organomet. Chem. Library, 18 (1986). 
21 J.P. Kleiman and M. Dubeck, J. Am. Chern. Soc., 85 (1963) 1544. 
22 A. C. Cope and R. W. Siekman, J. Am. Chern. Soc., 87 (1965) 3272. 
23 A. Kasahara, Bull. Chern. Soc. Jpn., 41 (1968) 1272. 
24 P. M. Maitlis, P. Espinet and M. J. H. Russell, in Palladium (Comprehensive 
Organometallic Chemistry; v. 6) (G. Wilkinson, F. G. A. Stone and E. W. Abel, 
eds), Pergamon Press Ltd., Oxford, 1982, p. 320-325. 
219 
25 A. J. Canty, in Palladium-Carbon a-Bonded Complexes (Comprehensive 
Organometallic Chemistry II; v. 8) (R. J. Puddephatt, ed.; E. W. Abel, F. G. A. 
Stone and G. Wilkinson, eds-in-chief), Elsevier Science Ltd., Oxford, 1995, p. 
242-248. 
26 R. P. Hughes, in Rhodium (Comprehensive Organometallic Chemistry; v. 5) (G. 
Wilkinson, F. G. A. Stone and E. W. Abel, eds), Pergamon Press Ltd., Oxford, 
1982, p. 392-397. 
27 P.R. Sharp, in Rhodium (Comprehensive Organometallic Chemistry II; v. 8) (J. 
D. Attwood, ed.; E. W. Abel, F. G. A. Stone and G. Wilkinson, eds-in-chief), 
Elsevier Science Ltd., Oxford, 1995, p. 205-210. 
28 M. A. Bennett and P. A. Longstaff, J. Am. Chem. Soc., 91 (1969) 6266. 
29 M. Nonoyama and K. Yamasaki, Inorg. Nucl. Chem. Lett., 7 (1971) 943. 
30 See, for example: (a) P. A. Bonnardel, R. V. Parish and R. G. Pritchard, J. 
Chem. Soc., Dalton Trans., (1996) 3185; (b) M. A. Cinellu, A. Zucca, S. 
Stoccoro, G. Minghetti, M. Manaserro and M. Sansoni, J. Chem. Soc., Dalton 
Trans., (1996) 4217; (c) J. Vicente, M.-D. Bermudez, F.-J. Carrion and P. G. 
Jones, Chem. Ber., 129 (1996) 1301; (d) M.A. Cinellu, A. Zucca, S. Stoccoro, 
G. Minghetti, M. Manassero and M. Sansoni, J. Chem. Soc., Dalton Trans., 
(1995) 2865; (e) E. C. Constable, R. P. G. Henney and D. A. Tocher, J. Chern. 
Soc., Dalton Trans., (1992) 2467; (f) E. C. Constable, R. P. G. Henney, T. A. 
Leese and D. A. Tocher, J. Chem. Soc., Dalton Trans., (1990) 443; (g) E. C. 
Constable and T. A. Leese, J. Organomet. Chem., 363 (1989) 419; (h) E. C. 
Constable, R. P. G. Henney and T. A. Leese, J. Organomet. Chem., 361 (1989) 
277. 
31 See, for example: (a) M.G. Colombo, T. C. Brunold, T. Riedener, H. U. Gtidel, 
M. Fortsch and H.-B. Burgi, Inorg. Chem., 33 (1994) 545; (b) M.G. Colombo 
and H. U. Gtidel, Inorg. Chem., 32 (1993) 3081; (c) F. 0. Garces, K. Dedeian, 
N. L. Keder and R. J. Watts, Acta Cryst., C49 (1993) 1117; (d) K. Dedeian, P. I. 
Djurovich, F. 0. Garces, G. Carlson and R. J. Watts, Inorg. Chern., 30 (1991) 
1685; (e) F. Neve, M. Ghedini, G. De Munno and A. Crispini, Organometallics, 
220 
10 (1991) 1143; (f) J. H. van Diemen, J. G. Haasnoot, R. Hage, E. MUller and J. 
Reedijk, Inorg. Chim. Acta, 181 (1991) 245; (g) K. Ichimura, T. Kobayashi, K. 
A. King and R. l Watts, J. Phys. Chem., 91 (1987) 6104; (h) R. H. Crabtree, 
M. Holt, M. Lavin and S.M. Morehouse, Inorg. Chem., 24 (1985) 1986; (i) M. 
Nonoyama, Bull. Chem. Soc. Jpn., 47 (1974) 767. 
32 See, for example: (a) W. J. Grigsby, L. Main and B. K. Nicholson, J. 
Organmnet. Chem., 540 (1997) 185; (b) J. M. Vila, M. Miguel Gayoso, T. 
Pereira, M. L. Torres, J. J. Fernandez, A. Fernandez and J. M. Ortigueira, J. 
Organomet. Chem., 506 (1996) 165; (c) M. Pfeffer, E. P. Urriolabeitia and J. 
Fischer, Inorg. Chem., 34 (1995) 643; (d) R. C. Cambie, P. S. Rutledge, D. R. 
Welch and P. D. Woodgate, J. Organomet. Chem., 467 (1994) 237; (e) R. C. 
Cambie, L. C. Mui Mui, P. S. Rutledge and P. D. Woodgate, J. Organomet. 
Chem., 464 (1994) 171; (f) R. C. Cambie, M. R. Metzler, C. E. F. Rickard, P. S. 
Rutledge and P. D. Woodgate, J. Organomet. Chem., 425 (1992) 59; (g) N. P. 
Robinson, L. Main and B. K. Nicholson, J. Organomet. Chem., 430 (1992) 79; 
(h) A. Suarez, J. M. Vila, M. T. Pereira, E. Gayoso and M. Gayoso, J. 
Organomet. Chem., 335 (1987) 359; (i) R. F. Heck, J. Am. Chem. Soc., 90 
(1968) 313. 
33 See, for example: (a) A. Ford, E. Sinn and S. Woodward, J. Organomet. Chem., 
493 (1995) 215; (b) C.-W. Chan, S.-M. Peng and C.-M. Che, Inorg. Chem., 33 
(1994) 3656; (c) J. Vicente, J.-A. Abad, A. Sandoval and P. G. Jones, J. 
Organomet. Chem., 434 (1992) 1; (d) E. C. Constable, A. M. W. Cargill 
Thompson, T. A. Leese, D. G. F. Reese and D. A. Tocher, Inorg. Chim. Acta, 
182 (1991) 93; (e) E. C. Constable and T. A. Leese, J. Organomet. Chem., 335, 
(1987) 293. 
34 See, for example: (a) D. A. Bardwell, A.M. W. Cargill Thompson, J. C. Jeffery, 
J. A. McCleverty and M.D. Ward, J. Chem. Soc., Dalton Trans., (1996) 873; (b) 
S. Chodorowski-Kimmes, M. Beley, J.-P. Collin and J.-P. Sauvage, Tetrahedron 
Lett., 37 (1996) 2963; (c) E. C. Constable, S. J. Dunne, D. G. F. Rees and C. X. 
Schmitt, Chem. Commun., (1996) 1169; (d) D. A. Bardwell, J. C. Jeffery, E. 
221 
Schatz, E. E. M. Tilley and M.D. Ward, J. Organomet. Chem., (1995) 825; (e) 
E. C. Constable, A.M. W. Cargill Thompson, J. Cherryman and T. Liddiment, 
Inorg. Chim. Acta, 235 (1995) 165; (f) P. Ghosh, A. Pramanik, N. Bag, G. K. 
Lahiri and A. Chakravorty, J. Organomet. Chem., 454 (1993) 237; (g) J.-P. 
Collin, M. Beley, J.-P. Sauvage and F. Barigelletti, Inorg. Chim. Acta, 186 
(1991) 91; (h) E. C. Constable and C. E. Housecroft, Polyhedron, 9 (1990) 
1939; (i) P. Reveco, W. R. Cherry, J. Medley, A. Garber, R. J. Gale and J. 
Selbin, Inorg. Chem., 25 (1986) 1842. 
35 C. M. Hartshorn, Ph.D. Thesis, University of Canterbury, (1996). 
36 G. W. Parshall, Ace. Chem. Res., 3 (1970) 139. 
37 M. Beller, T. H. Riermeier, S. Haber, H.-J. Kleiner and W. A. Herrmann, Chem. 
Ber., 129 (1996) 1259. 
38 See, for example: (a) J. Spencer, M. Pfeffer, N. Kyritsakas and J. Fischer, 
Organometallics, 14 (1995) 2214; (b) J. Vicente, I. Saura-Llamas and M. C. 
Ramirez de Arellano, J. Chem. Soc., Dalton Trans., (1995) 2529; (c) M. Pfeffer, 
J.-P. Suter, M.A. Rotteveel, A. De Cian and J. Fischer, Tetrahedron, 48 (1992) 
2427; (d) N. Beydoun, M. Pfeffer, A. DeCian and J. Fischer, Organometallics, 
10 (1991) 3693; (e) F. Maassarani, M. Pfeffer and G. Le Borgne, 
Organometallics, 6 (1987) 2043; (f) F. Maassarani, M. Pfeffer and G. Le 
Borgne, J. Chem. Soc., Chem. Comnzun., (1986) 488. 
39 See, for example: (a) J. Albert, J. Granell, G. Muller, D. Sainz, M. Font-Bardia 
and X. Solans, TetrahedronAsymm., 6 (1995) 325; (b) C. E. Barclay, G. Deeble, 
R. J. Doyle, S. A. Elix, G. Salem, T. L. Jones, S. B. Wild and A. C. Willis, J. 
Chem. Soc., Dalton Trans., (1995) 57; (c) S. Gladiali, A. Dore, D. Fabbri, 0. De 
Lucchi and M. Manassero, Tetrahedron Asymm., 5 (1994) 511; (d) M. Pabel, A. 
C. Willis and B.S. Wild, Angew. Chem., Int. Ed. Engl., 33 (1994) 1835; (e) N. 
W. Alcock, J. M. Brown and D. I. Hulmes, Tetrahedron Asymm., 4 (1993) 743; 
(f) S. Y. M. Chooi, S.-Y. Siah P.-H. Leung and K. F. Mok, Inorg. Chem., 32 
(1993) 4812; (g) N. Gabbitas, G. Salem, M. Sterns and A. C. Willis, J. Chem. 
Soc., Dalton Trans., (1993) 3271. 
222 
40 M. A. Cinellu, S. Gladiali, G. Minghetti, S. Stoccoro and F. Demartin, J. 
Organornet. Chern., 401 (1991) 371, and references therein. 
41 See, for example: (a) R. G. Buckley, A. M. Elsome, S. P. Fricker, G. R. 
Henderson, B. R. C. Theobald, R. V. Parish, B. P. Howe and L. R. Kelland, J. 
Med. Chem., 39 (1996) 5208; (b) R. V. Parish, B. P. Howe, J. P. Wright, J. 
Mack, R. G. Pritchard, R. G. Buckley, A.M. Elsome and S. P. Fricker, Inorg. 
Chem., 35 (1996) 1659; (c) R. V. Parish, J. Mack, L. Hargreaves, J.P. Wright, 
R. G. Buckley, A.M. Elsome, S. P. Fricker and B. R. C. Theobald, J. Chern. 
Soc., Dalton Trans., (1996) 69. 
42 See, for example: (a) E. Ceci, R. Cini, J. Konopa, L. Maresca and G. Natile, 
Inorg. Chern., 35 (1996) 876; (b) C. Navarro-Ranninger, I. L6pez-Solera, V. M. 
Gonzalez, J. M. Perez, A. Alvarez-Valdez, A. Martin, P. R. Raithby, J. R. 
Masaguer and C. Alonso, Inorg. Chern., 35 (1996) 5181; (c) C. Navarro-
Ranninger, I. L6pez-Solera, J. M. Perez, J. Rodriguez, J. L. Garda-Ruano, P.R. 
Raithby, J. R. Masaguer and C. Alonso, J. Med. Chern., 36 (1993) 3795; A. 
Yoneda, M. Ouchi, T. Hakushi, G. R. Newkome and F. R. Fronczek, Chem. 
Lett., (1993) 709. 
43 R. F. Carina, A. F. Williams and G. Bernardinelli, J. Organomet. Chern., 548 
(1997) 45. 
44 See, for example: (a) B. R. Cameron and S. J. Loeb, Chem. Commun., (1996) 
2003; (b) J. E. Kickham and S. J. Loeb, Inorg. Chern., 34 (1995) 5656; (c) J. E. 
Kickham and S. J. Loeb, Inorg. Chem., 33 (1994) 4351; (d) S. Rtittimann, G. 
Bernardinelli and A. F. Williams, Angew. Chem,., Int. Ed. Engl., 32 (1993) 392. 
45 See, for example: (a) D. P. Lydon and J. P. Rourke, Chem. Comrnun., (1997) 
1741; (b) J. Buey and P. Espinet, J. Organornet. Chern., 507 (1996) 137; (c) A. 
T. Ionescu, D. Pucci, N. Scaramuzza, C. Versace, A. G. Petrov and R. Bartolino, 
J. Chern. Phys., 103 (1995) 5144; (d) P. Espinet, M.A. Esteruelas, L.A. Oro, J. 
L. Serrano and E. Sola, Coord. Chern. Rev., 117 (1992) 215. 
46 M. Maestri, V. Blazani, C. Deuschel-Cornioley and A. von Zelewsky, Adv. 
Photochern., 17 (1992) 1, and references therein. 
223 
47 E. C. Constable and C. E. Housecroft, Polyhedron, 9 (1990) 1939. 
48 C. A. Craig, F. 0. Garces, R. J. Watts, R. Palmans and A. J. Frank, Coord. 
Chern. Rev., 97 ( 1990) 193. 
49 Y. Ohsawa, S. Sprouse, K. A. King, M. K. DeArmond, K. W. Ranck and R. J. 
Watts, J. Phys. Chern., 91 (1987) 1047. 
50 S. Sprouse, K. A. King, P. J. Spellane and R. J. Watts, J. Am. Chern. Soc., 106 
(1984) 6647. 
51 P. J. Steel, Coord. Chern. Rev., 106 (1990) 227. 
52 J.-M. Lehn, Angew. Chern., Int. Ed. Engl., 29 (1990) 1304. 
53 C. Navarro-Ranninger, F. Zamora, I. L6pez-Solera, A. Monge and J. R. 
Masaguer, J. Organomet. Chern., 506 (1996) 149. 
54 P. J. Steel and G. B. Caygill, J. Organornet. Chern., 327 (1987) 101. 
55 M. R. Churchill, H. J. Wasserman and G. J. Young, Inorg. Chern., 19 (1980) 
762. 
56 C. Navarro-Ranninger, F. Zamora, L. A. Martinez-Cruz, R. Isea and J. R. 
Masaguer, J. Organomet. Chern., 518 (1996) 29. 
57 G. Balavoine and J. C. Clinet, J. Organomet. Chern., 390 (1990) C84. 
58 G. Balavoine, J. C. Clinet, P. Zerbib and K. Boubekeur, J. Organomet. Chern., 
389 (1990) 259. 
59 J. C. Clinet and G. Balavoine, J. Organornet. Chern., 405 (1991) C29. 
60 E. Wehman, G. van Koten, J. T. B. H. Jastrzebski, M.A. Rotteveel and C. H. 
Starn, Organometallics, 7 (1988) 1477. 
61 J. T. B. H. Jastrzebski, J. Wehman, J. Boersma, G. van Koten, K. Goubitz and 
D. Heijdenrijk, J. Organomet. Chern., 409 (1991) 157. 
62 P. A. Bonnardel and R. V. Parish, .l. Organomet. Chern., 515 (1996) 221. 
63 B. N. Cockburn, D. V. Howe, T. Keating, B. F. G. Johnson and J. Lewis, J. 
Chern. Soc., Dalton Trans., (1973) 404. 
64 M. Massacesi, R. Pinna and G. Ponticelli, Spectrochim. Acta, 37A (1981) 441. 
65 R. Pinna, G. Ponticelli, C. Preti and G. Tosi, Transition Met. Chern., 1 (1976) 
173. 
224 
66 M. I. Bruce, B. L. Goodall and I. Matsuda, Aust. J. Chern., 28 (1975) 1259. 
67 W. E. Cass, J. Am. Chern. Soc., 64 (1942) 785. 
68 P. G. Ferrini and A. Marxer, Angew. Chern., Int. Ed. Engl., 2 (1963) 99. 
69 D. J. Brown and P. B. Ghosh, J. Chern. Soc. (B), (1969) 270. 
70 M. Maeda and M. Kojima, J. Chern. Soc., Perkin Trans. 1, (1977) 239. 
71 C. Kashima and H. Arao, Synthesis, (1989) 873. 
72 H. Hiemstra, H. A. Houwing, 0. Passel and A.M. van Leusen, Can. J. Chern., 
57 (1979) 3168. 
73 H. Bredereck and R. Gompper, Chern. Ber., 87 (1954) 700. 
74 S. E. Whitney, M. Winters and B. Rickborn, J. Org. Chern., 55 (1990) 929. 
75 F. 0. Bliimlein, Chern. Ber., 17 (1884) 2578. 
76 J. L. Wardell, in Mercury (Comprehensive Organometallic Chemistry; v. 6) (G. 
Wilkinson, F. G. A. Stone and E. W. Abel, eds), Pergamon Press Ltd., Oxford, 
1982, p. 961. 
77 E. C. Constable and T. A. Leese, J. Organomet. Chern., 363 (1989) 419. 
78 J. Vicente, M.-D. Bermudez, F.-J Carrion and P. G. Jones, Chern. Ber., 129 
(1996) 1301. 
79 E. C. Constable, R. P. G. Henney, T. A. Leese and D. A. Tocher, J. Chern. Soc., 
Dalton Trans., (1990) 443. 
80 E. C. Constable and T. A. Leese, J. Organomet. Chern., 335 (1987) 293. 
81 E. C. Constable, A.M. W. Cargill Thompson, T. A. Leese, D. G. F. Reese and 
D. A. Tocher, Inorg. Chim. Acta, 182 (1991) 93. 
82 J. Vicente, J. Martin, M.-T. Chicote, X. Solans and C. Miravitlles, J. Chern. 
Soc., Chern. Conunun., (1985) 1004. 
83 E. C. Constable, T. A. Leese and D. A. Tocher, Polyhedron, 9 (1990) 1613. 
84 D. St C. Black, G. B. Deacon, G. L. Edwards and B. M. Gatehouse, Aust. J. 
Chern., 46 (1993) 1323. 
85 K. Hiraki, Y. Fuchita and S. Takakura, J. Organomet. Chern., 210 (1981) 273. 
86 F. M. El-Baih, F. M. Abu-Loha, Z. Gomaa and I. M. Al-Najjar, Transition 
Met. Chern., 19 (1994) 325. 
225 
87 P. G. Alley and D. A. Shirley, J. Am. Chern. Soc., 80 (1958) 6271. 
88 M. Nonoyama and H. Takayanagi, Transition Met. Chern., 1 (1975) 10. 
89 G. B. Caygill and P. J. Steel, J. Organomet. Chern., 327 (1987) 115. 
90 H. Drevs, Z. Anorg. Allg. Chern., 605 (1991) 145. 
91 M. Nonoyama, J. Organomet. Chern., 86 (1975) 263. 
92 M. Nonoyama, J. Organomet. Chern., 92 (1975) 89. 
93 D. Sandrini, M. Maestri, M. Ciano, U. Maeder and A. von Zelewsky, Helv. 
Chim. Acta, 73 (1990) 1306. 
94 P. J. Steel, J. Organomet. Chem., 408 (1991) 395. 
95 K. Hiraki, Y. Obayashi andY. Oki, Bull. Chem. Soc. Jpn., 52 (1979) 1372. 
96 P. J. Steel, Unpublished results. 
97 L. Chassot and A. von Zelewsky, Inorg. Chem., 26 (1987) 2814. 
98 C. Deuschel-Cornioley, R. Ltiond and A. von Zelewsky, Helv. Chim. Acta, 72 
(1989) 377. 
99 H. Drevs, Z. Chem., 16 (1976) 493. 
100 Y. Fuchita, K. Yoshinaga, H. Kusaba, M. Mori, K. Hiraki and K. Takehara, 
Inorg. Chim. Acta, 239 (1995) 125. 
101 J. A. C. Allison, H. S. El Khadem and C. A. Wilson, J. Heterocycl. Chem., 12 
(1975) 1275. 
102 U. Mader, T. Jenny and A. von Zelewsky, Helv. Chim. Acta, 69 (1986) 1085. 
103 M. Maestri, D. Sandrini, V. Balzani, U. Maeder and A. von Zelewsky, Inorg. 
Chem., 26 (1987) 1323. 
104 D. Sandrini, M. Maestri, V. Balzani, U. Maeder and A. von Zelewsky, Inorg. 
Chem., 27 (1988) 2640. 
105 A. Zilian, U. Maeder, A. von Zelewski and H. U. Giidel, J. Am. Chern. Soc., 111 
(1989) 3855. 
106 G. Frei, A. Zilian, A. Raselli, H. U. Gtidel and H.-B BUrgi, Inorg. Chem., 31 
(1992) 4766. 
107 U. Maeder, A. von Zelewsky and H. Stoeckli-Evans, Helv. Chim. Acta, 75 
(1992) 1320. 
226 
108 A. Zilian and H. U. Gtidel, Inorg. Chem., 31 (1992) 830. 
109 F. 0. Garces and R. J. Watts, Magn. Reson. Chem., 31 (1993) 529. 
110 G. B. Caygill, R. M. Hartshorn and P. J. Steel, J. Organomet. Chem., 382 (1990) 
455. 
111 P. J. Steel and G. B. Caygill, J. Organomet. Chem., 395 (1990) 359. 
112 N. Al-Salim, A. A. West, W. R. McWhinnie and T. A. Hamor, J. Chem. Soc., 
Dalton Trans., (1988) 2363. 
113 J. Fawcett, J. H. Holloway and G. C. Saunders, Inorg. Chim. Acta, 202 (1992) 
111. 
114 M. Nonoyama, J. Organomet. Chem., 74 (1974) 115. 
115 see 2 and 110. 
116 J. J. Laffetty and F. H. Case, J. Org. Chem., 32 (1967) 1591. 
117 R. Levine and J. K. Sneed, J. Am. Chem. Soc., 73 (1951) 5614. 
i 18 F. Teixidor, R. Garcia, J. Pons and J. Casab6, Polyhedron, 7 (1988) 43. 
119 T. A. Stephenson, S. M. Morehouse, A. R. Powell, J. P. Heffer and G. 
Wilkinson, J. Chem. Soc., (1965) 3632. 
120 J. E. McKeon and P. Fitton, Tetrahedron, 28 (1972) 233. 
121 B. Milani, E. Alessio, G. Mestroni, A. Sommazzi, F. Garbassi, E. Zangrando, N. 
Bresciani-Pahor and L. Randaccio, J. Chem. Soc., Dalton Trans., (1994) 1903. 
122 G. B. Deacon and R. J. Phillips, Coord. Chem. Rev., 33 (1980) 227. 
123 K. Hiraki, Y. Fuchita and K. Takechi, Inorg. Chem., 20 (1981) 4316. 
124 K. Hiraki andY. Fuchita, Inorg. Synth., 26 (1989) 208. 
125 A. D. Ryabov and G. M. Kazankov, J. Organomet. Chem., 268 (1984) 85. 
126 R. M. Ceder, M. Gomez and J. Sales, J. Organomet. Chem., 361 (1989) 391. 
127 F. Maassarani, M. Pfeffer and G. Le Borgne, J. Chem. Soc., Chem. Commun., 
(1986) 488. 
128 R. Urban, R. Kramer, S. Mihan, K. Polborn, B. Wagner and W. Beck, J. 
Organomet. Chem., 517 (1996) 191. 
129 G. Minghetti, M. A. Cinellu, S. Stoccoro and A. Zucca, Gazz. Chim. !tal., 122 
(1992) 455. 
227 
130 K. Hiraki, M. Onishi and H. Kishino, Bull. Chem. Soc. Jpn., 64 (1991) 1695. 
131 A. R. Chakravarty, F. A. Cotton and D. A. Tocher, Organometallics, 4 (1985) 
863. 
132 M. I. Bruce, B. L. Goodall, M. Z. Iqbal and F. G. A. Stone, J. Chem. Soc., 
Chem. Commun., (1971) 661. 
133 H. Onoue and I. Moritani, J. Organomet. Chem., 44 (1972) 189. 
134 A. E. Chichibabin, J. Russ. Phys. Chem. Soc., 50 (1918) 502. 
135 R. R. Renshaw and R. C. Conn, J. Am. Chem. Soc., 59 (1937) 297. 
136 K. Fujikawa, K. Kondo, I. Yokomichi, F. Kimura, T. Haga and R. Nishiyama, 
Agr. Biol. Chem., 34 (1970) 68. 
137 S. Bradamante and G. A. Pagani, J. Org. Chem., 45 (1980) 114. 
138 I. B. Cook, Aust. J. Chem., 42 (1989) 1493. 
139 C. K. Bradsher, L. D. Quin, R. E. LeBleu and J. W. McDonald, J. Org. Chem., 
26 (1961) 4944. 
140 L. G. S. Brooker, G. H. Keyes, R. H. Sprague, R. H. Van Dyke, E. Van Lare, G. 
VanZandt and F. L. White, J. Am. Chem. Soc., 73 (1951) 5326. 
141 K. F. King and L. Bauer, J. Org. Chem., 36 (1971) 1641. 
142 M. Brookhart and M. L. H. Green, J. Organomet. Chent., 250 (1983) 395. 
143 C. F. J. Barnard and M. J. H. Russell, in Palladium (Comprehensive 
Coordination Chemistry,· v. 5) (G. Wilkinson, R. D. Gillard and J. A. 
McCleverty, eds), Pergamon Press, Oxford, 1979, p. 1115. 
144 P.M. Maitlis, P. Espinet and M. J. H. Russell, in Palladium: Introduction and 
General Principles (Comprehensive Organometallic Chemistry, v. 6) (G. 
Wilkinson, F. G. A. Stone and E. W. Abel, eds), Pergamon Press Ltd., Oxford, 
1982, p. 236. 
145 J. H. K. A. Acquaye and M. F. Robinson, Inorg. Chim. Acta, 210 (1992) 101. 
146 N.J. R. van Eikema Hommes and P. von R. Schleyer, Angew. Chem., Int. Ed. 
Engl., 31 (1992) 755, and references therein. 
147 G. W. Rewcastle and A. R. Katritzsky, Adv. Heterocycl. Chem., 56 (1993) 155, 
and references therein. 
228 
148 N. Nakamura, A. Yoshino and K. Takahashi, Bull. Chern. Soc. Jpn., 67 (1994) 
26. 
149 K. M. Lo, S. Selvaratnam, S. W. Ng, C. Wei and V. G. K. Das, J. Organornet. 
Chem., 430 (1992) 149. 
150 0. Juanes, J. de Mendoza and J. C. Rodriguez-Ubis, J. Organomet. Chem., 363 
(1989) 393. 
151 P. Jolliet, M. Gianini, A. von Zelewsky, G. Bernardine11i and H. Stoeckli-Evans, 
Inorg. Chem., 35 (1996) 4883. 
152 L. Chassot, E. Muller and A. von Zelewsky, Inorg. Chern., 23 (1984) 4249. 
153 D. W. Slocum and C. A. Jennings, J. Org. Chem., 41 (1976) 3653. 
154 C. Arlen, M. Pfeffer, 0. Bars and D. Grandjean, J. Chem. Soc., Dalton Trans., 
(1983) 1535. 
155 C. Arlen, M. Pfeffer, 0. Bars and G. Le Borgne, J. Chem. Soc., Dalton Trans., 
(1986) 359. 
156 F. Maassarani, M. Pfeffer, G. Le Borgne and D. Grandjean, Organometallics, 5 
(1986) 1511. 
157 H. Ossor, M. Pfeffer, J. T. B. H. Jastrzebski and C. H. Starn, Inorg. Chern., 26 
(1987) 1169. 
158 J. Vicente, M.-T. Chicote, M.-C. Lagunas, P. G. Jones and E. Bembenek, 
Organornetallics, 13 (1994) 1243. 
159 A. Baldo, G. Chessa, G. Marangoni and B. Pitteri, Polyhedron, 4 (1985) 1429. 
160 I Suzuki, Pharm. Bull., 4 (1956) 211; Chern. Abstr., 51 (1957) 7372h. 
161 E. N. Shaw, U.S. Patent, 2540218 (1951); Chem. Abstr., 45 (1951) P6224a. 
162 0. Fischer, Chem. Ber., 32 (1899) 1297. 
163 C. Rath, Justus Liebigs Ann. Chern., 489 (1931) 107. 
164 H. J.-M. Dou, P. Hassanly and J. Metzger, J. Heterocycl. Chem., 14 (1977) 321. 
165 A. J. Serio Duggan, E. J. J. Grabowski and W. K. Russ, Synthesis, (1980) 573. 
166 R. A. Jones and A. R. Katritzky, J. Chern. Soc., (1958) 3610. 
167 H. J.-M. Dou, P. Hassanly, J. Kister and J. Metzger, Phosphorus Sulfur, 3 (1977) 
355. 
229 
168 P. Singh, S. K. Aggarwal, R. Sarin, N. Malhotra and H. Singh, Indian J. Chern., 
Sect. B, 24 (1985) 263. 
169 T. Mukaiyama, S. Ikeda and S. Kobayashi, Chenz. Lett., (1975) 1159. 
170 L. Bauer andL. A. Gardella, J. Org. Chern., 28 (1963) 1323. 
171 F. Haviv, R. W. DeNet, R. J. Michaels, J.D. Ratajczyk, G. W. Carter and Young 
P.R., J. Med. Chern., 26 (1983) 218. 
172 P. S. Pregosin, F. Wombacher, A. Albinati and F. Lianza, J. Organornet. Chern., 
418 (1991) 249. 
173 A. D. Ryabov and R. van Eldik, Angew. Chern., Int. Ed. Engl., 33 (1994) 783. 
174 A. Avshu, R. D. O'Sullivan, A. W. Parkins, N. W. Alcock and R. M. 
Countryman, J. Chern. Soc., Dalton Trans., (1983) 1619. 
175 J. Vicente, I. Sam·a-Llamas and P. G. Jones, J. Chern. Soc., Dalton Trans., 
(1993) 3619. 
176 D. Rehder and K. Thmels, Inorg. Chirn. Acta, 76 (1983) L313. 
177 L S. Ahuja and C. L. Yadava, Indian J. Chern., Sect. A, 27 (1988) 169. 
178 R. C. Maurya, D. C. Gupta, R. Shukla, R. K. Shukla and W. U. Malik, 
Transition Met. Chern., 12 (1987) 273. 
179 D. Kovala-Demertzi, A. Michaelides and A. Aubry, Inorg. Chirn. Acta, 194 
(1992) 189. 
180 M. Plytzanopoulos, G. Pneumatikakis, N. Hadjiliadis and D. Katakis, Inorg. 
Nucl. Chern. Lett., 39 (1977) 965. 
181 M.A. S. Goher and T. C. W. Mak, Inorg. Chirn. Acta, 99 (1985) 223. 
182 T. C. W. Mak and M.A. S. Goher, Inorg. Chirn. Acta, 115 (1986) 17. 
183 M.A. S. Goher, R.-J. Wang and T. C. W. Mak, J. Cryst. Spectrosc. Res., 20 
(1990) 265. 
184 F. A. Mautner, M. A. S. Goher and A. E. H. Abdou, Polyhedron, 12 (1993) 
2815. 
185 M.A. S. Goher, A. E. H. Abdou, W.-H. Yip and T. C. W. Mak, Polyhedron, 12 
(1993) 2981. 
186 Y. Fuchita, K. Hiraki andY. Kage, Bull. Chern. Soc. Jpn., 55 (1982) 955. 
230 
187 A Bose and C. R. Saha, J. Mol. Catal., 49 (1989) 271. 
188 R. R. Osborne and W. R. McWhinnie, J. Chern. Soc. (A), (1968) 2153. 
189 I. I. Bhayat and W. R. McWhinnie, Spectrochim. Acta, Part A, 28 (1972) 743. 
190 A Mercer and J. Trotter, J. Chern. Soc., Dalton Trans, (1975) 2480. 
191 W. M. Attia and M. Calligaris, Acta Cryst., C43, (1988) 1427. 
192 E. Alessio, G. Mestroni, G. Nardin, W. M. Attia, M. Calligaris, G. Sava and S. 
Zorzet, Inorg. Chern., 27 (1988) 4099. 
193 A R. Davies, F. W. B. Einstein, N. P. Farrell, B. R. James and R. S. McMillan, 
Inorg. Chern., 17 (1978) 1965. 
194 E. Alessio, G. Balducci, M. Calligaris, G. Costa, W. M. Attia, Inorg. Chern., 30 
(1991) 609. 
195 D.P. Bancroft, F. A Cotton and M. Verbruggen, Acta Cryst., C45, (1989) 1289. 
196 B. F. G. Johnson, J. Puga and P.R. Raithby, Acta Cryst., B37, (1981) 953. 
197 L. I. Elding and A. Oskarsson, Inorg. Chim. Acta, 130 (1987) 209. 
198 V.I. Sokol and M.A. Porai-Koshits, Koord. Khim., 1 (1975) 577. 
199 M. Calligaris, P. Faleschini and E. Alessio, Acta Cryst., C47, (1991) 747. 
200 A J. Downard, G. E. Honey, L. F. Phillips and P. J. Steel, Inorg. Chern., 30 
(1991) 2259. 
201 E. Ochiai and K. Arima, J. Pharm. Soc. Japan, 69 (1949) 51; Chern. Abstr., 44 
(1950) 1502c. 
202 T. Kato and H. Yamanaka, J. Org. Chern., 30 (1965) 910. 
203 E. C. Constable and M.D. Ward, J. Chern. Soc., Dalton Trans., (1990) 1405. 
204 E. C. Constable and A.M. W. Cargill Thompson, J. Chern. Soc., Dalton Trans., 
( 1992) 3467. 
205 M. Beley, J.-P. Collin, R. Louis, B. Metz and J.-P. Sauvage, J. Am. Chern. Soc., 
113 (1991) 8521. 
206 M. Beley, J.-P. Collin and J.-P. Sauvage, Inorg. Chern., 32 (1993) 4539. 
207 E. C. Constable, A.M. W. Cargill Thompson and S. Greulich, J. Chern. Soc., 
Chern. Commun., (1993) 1444. 
208 D. J. de Geest, B.Sc.(Hons) Research Project, University of Canterbury, (1991). 
231 
209 P. J. Steel,Adv. Heterocycl. Chem., 67(1997) 1. 
210 Y. Fort, S. Becker and P. Caubere, Tetrahedron, 50 (1994) 11893. 
211 M. Iyoda, H. Otsuka, K. Sato, N. Nisato and M. Oda, Bull. Chem. Soc. Jpn., 63 
(1990) 80. 
212 J. Nasielski, A. Standaert and R. Nasielski-Hinkens, Synth. Commun., 21 (1991) 
901. 
213 M. Tiecco, L. Testaferri, M. Tingoli, D. Chianelli and M. Montanucci, 
Synthesis, (1984) 736. 
214 R. Vanderesse, J.-J. Brunet and P. Caubere, J. Organomet. Chem., 264 (1984) 
263 and references therein. 
215 D. L. Comins and N. B. Mantlo, J. Org. Chem., 50 (1985) 4410. 
216 CIBA Ltd., Neth. Appl. 6,414,307; Chem. Abstr., 64 (1966) 713d. 
217 E. L. Plummer, J. Agric. Food Chem., 31 (1983) 718. 
218 J. McMurry, Organic Chemistry, 2nd edition, Brooks/Cole Publishing 
Company, Pacific Grove, 1988, p. 1040-1042. 
219 J. McMurry, Organic Chemistry, 2nd edition, Brooks/Cole Publishing 
Company, Pacific Grove, 1988, p. 534-546. 
220 B. S. Furniss, A. J. Hannaford, P. W. G. Smith and A. R. Tatchell, Vogel's 
Textbook of Practical Organic Chemistry, 5th edition, Longman Scientific and 
Technical, Harlow, 1989, p. 864. 
221 S. Uemura, A. Onoe and M. Okano, Bull. Chem. Soc. Jpn., 47 (1974) 147. 
222 P. B. D. de la Mare and J. H. Ridd, Aromatic Substitution, Nitration and 
Halogenation, Butterworths Scientific Publications, London, 1959, p. 110. 
223 Y. Furuya, A. Morita and I. Urasaki, Bull. Chem. Soc. Jpn., 41 (1968) 997. 
224 J. J. Harrison, J.P. Pellegrini and C. M. Selwitz, J. Org. Chem., 46 (1981) 2169. 
225 H. Weber, Arch. Pharm., 308 (1975) 637. 
226 H. Gilman and J. T. Edward, Can. J. Chem., 31 (1953) 457. 
227 B. S. Furniss, A. J. Hannaford, P. W. G. Smith and A. R. Tatchell, Vogel's 
Textbook of Practical Organic Chemistry, 5th edition, Longman Scientific and 
Technical, Harlow, 1989, p. 928-929. 
232 
228 A. R. Hands and A. R. Katritzky, J. Chern. Soc., 161 (1958) 1754. 
229 T. Izumi and A. Kasahara, Yamagata Daigaku Kiyo, Kogaku, 15 (1979) 513; 
Chem. Abstr., 91 (1979) 32078b. 
230 J. Druey, K. Meier and K. Eichenberger, Helv. Chim. Acta, 37 (1954) 121. 
231 S. Tamura and T. Jojima, Agr. Biol. Chem., 27 (1963) 653. 
232 T. Itai and H. Igeta, J. Pharm. Soc. Japan, 74 (1954) 1195; Chern. Abstr., 49 
(1955) 14768a. 
233 T. Matsukawa, K. Shirakawa and H. Kawasaki, J. Pharm. Soc. Japan, 71 (1951) 
1313; Chem. Abstr., 46 (1952) 8123a. 
234 T. Matsukawa and S. Ban, J. Pharm. Soc. Japan, 71 (1951) 1420; Chem. Abstr., 
46 (1952) 8095c. 
235 S. Angerstein, Chem. Ber., 34 (1901) 3956. 
236 T. Jojima and S. Tamura, Agr. Biol. Chem., 30 (1966) 896. 
237 D. J. Brown and P. W. Ford, J. Chem. Soc. (C), (1967) 568. 
238 A. P. Kroon, H. C. van der Plas and G. van Garderen, Rec. Trav. Chim. Pays-
Bas., 93 (1974) 325. 
239 S. Kushner, H. Dalalian, J. L. Sanjmjo, F. L. Bach, S. R. Safir, V. K. Smith and 
J. H. Williams, J. Am. Chem. Soc., 74 (1952) 3617. 
240 J.D. Behun, P. T. Kan, P. A. Gibson, C. T. Lenk and E. J. Fujiwara, 1. Org. 
Chem., 26 (1961) 4981. 
241 J.D. Behun and P. T. Kan, Prepr. -Am. Chem. Soc., Div. Pet. Chem., 8 (1963) 
35. 
242 D. L. Aldous and R.N. Castle, in Pyridazines (The Chemistry of Heterocyclic 
Compounds; v. 28) (R. N. Castle, ed.), John Wiley & Sons, Inc., New York, 
1973, p. 275. 
243 J. W. Mason and D. L. Aldous, in Pyridazines (The Chemistry of Heterocyclic 
Compounds; v. 28) (R.N. Castle, ed.), John Wiley & Sons, Inc., New York, 
1973, p. 66. 
244 D. A. McMorran, Personal communication. 
233 
245 M. A. Gutierrez, G. R. Newkome and J. Selbin, J. Organomet. Chem., 202 
(1980) 341. 
246 Y. Fuchita, H. Tsuchiya and A. Miyafuji, Inorg. Chim. Acta, 233 (1995) 91. 
247 G. Minghetti, M.A. Cinellu, G. Chelucci and S. Gladiali, J. Organomet. Chem., 
307 (1986) 107. 
248 A. J. Canty, N. J. Minchin, B. W. Skelton and A. H. White, J. Chem. Soc., 
Dalton Trans., (1987) 1477. 
249 S. Tollari, G. Palmisano, F. Demartin, M. Grassi, S. Magnaghi and S. Cenini, J. 
Organomet. Chem., 488 (1995) 79. 
250 C.-W. Chan, D. M.P. Mingos, A. J.P. White and D. J. Williams, J. Chem. Soc., 
Dalton Trans., (1995) 2469. 
251 C.-W. Chan, D. M.P. Mingos, A. J.P. White and D. J. Williams, Chem. Comm., 
(1996) 81. 
252 G. R. Newkome, W. E. Puckett, V. K. Gupta and F. R. Fronczek, 
Organometallics, 2 (1983) 1247. 
253 J. Albert, J. Granell, J. Sales, X. Solans and M. Font-Altaba, Organometallics, 5 
(1986) 2567. 
254 J. Barro, J. Granell, D. Sainz and J. Sales, J. Organomet. Chem., 456 (1993) 
147. 
255 J. Albert, M. Gomez, J. Granell, J. Sales and X. Solans, Organometallics, 9 
(1990) 1405. 
256 W. Klaui, H. Hamers, M. Pfeffer, A. de Cian and J. Fischer, J. Organomet. 
Chem., 394 (1990) 213. 
257 J. Barker, N.D. Cameron, M. Kilner, M. M. Mahmoud and S.C. Wallwork, J. 
Chem. Soc., Dalton Trans., (1991) 3435. 
258 R. Bosque, J. Granell, J. Sales, M. Font-Bardfa and X. Solans, J. Organomet. 
Chem., 453 (1993) 147. 
259 G. De Munno, M. Ghedini and F. Neve, lnorg. Chim. Acta, 239 (1995) 155. 
260 G. R. Newkome, G. E. Kiefer, Y. A. Frere, M. Onishi, V. K. Gupta and F. R. 
Fronczek, Organometallics, 5 (1986) 348. 
234 
261 P. L. Alsters, P. F. Engel, M.P. Hogerheide, M. Copijn, A L. Spek and G. van 
Koten, Organometallics, 12 (1993) 1831. 
262 A. Yoneda, G. R. Newkome, Y. Morimoto, Y. Higuchi and N. Yasuoka, Acta 
Cryst., C49, (1993) 476 
263 A. Yoneda, T. Hakushi, G. R. Newkome, Y. Morimoto and N. Yasuoka, Chem. 
Lett., (1994) 175. 
264 J. Vicente, I. Saura-Llamas, M. G. Palin and P. G. Jones, J. Chem. Soc., Dalton 
Trans., (1995) 2535. 
265 A Macchioni, P. S. Pregosin, P. F. Engel, S. Mecking, M. Pfeffer, J.-C. Daran 
and J. Vaissermann,Organometallics, 14 (1995) 1637. 
266 L G. Phillips and P. J. Steel, J. Organomet. Chem., 410 (1991) 247 and 
references therein. 
267 S. K. Mandai, L. K. Thompson, M. J. Newlands, F. L. Lee, Y. Lepage, J.-P 
Charland and E. J. Gabe, Inorg. Chim. Acta, 122 (1986) 199. 
268 T. C. Woon, R. McDonald, S. K. Mandai, L. K. Thompson, S. P. Connors and 
A W. Addison, J. Chem. Soc., Dalton Trans., (1986) 2381. 
269 S. K. Mandai, L. K. Thompson, E. J. Gabe, F. L. Lee and J.-P Charland, Inorg. 
Chem., 26 (1987) 2384. 
270 L. K. Thompson, S. K. Mandai, L. Rosenberg, F. L. Lee and E. J. Gabe, Inorg. 
Chim. Acta, 133 (1987) 81. 
271 S. K. Mandai, L. K. Thompson, E. J. Gabe, J.-P Charland and F. L. Lee, Inorg. 
Chem., 27 (1988) 855. 
272 L. K Thompson, F. L. Lee and E. J. Gabe, Inorg. Chem., 27 (1988) 39. 
273 L. Chen, L. K. Thompson and J. N. Bridson, Inorg. Chim. Acta, 210 (1993) 215. 
274 R. Anderson, B.Sc.(Hons) Research Project, University of Canterbury, (1997). 
275 D. J. de Geest and P. J. Steel, Aust. J. Chem., 48 (1995) 1573. 
276 A. R. Garber, P. E. Garrou, G. E. Hartwell, M. J. Smas, J. R. Wilkinson and L. J. 
Todd, J. Organomet. Chem., 86 (1975) 219. 
277 J. L. Garda-Ruano, L L6pez-Soiera, J. R. Masaguer, C. Navarro-Ranninger and 
J. H. Rodrfguez, Organometallics, 11 (1992) 3013. 
235 
278 J. L. Garda-Ruano, I. L6pez-Solera, J. R. Masaguer, M.A. Monge, C. Navarro-
Ranninger and J. H. Rodriguez, J. Organornet. Chern., 476 (1994) 111. 
279 C. Arz, P. S. Pregosin and C. Anklin, Magn. Reson. Chern., 25 (1987) 158. 
280 M. T. Alonso, 0. Juanes, J. de Mendoza and J. C. Rodrfguez-Ubis, J. 
Organornet. Chern., 430 (1992) 335. 
281 M. T. Alonso, 0. Juanes, J. de Mendoza and J. C. Rodrfguez-Ubis, J. 
Organomet. Chem., 484 (1994) 19. 
282 R. P. Thummel andY. Jahng, J. Org. Chem., 52 (1987) 73. 
283 E. Kurowski, Chem. Ber., 43 (1910) 1078. 
284 J. C. W. Evans and C. F. H. Allen, Org. Synth., 2 (1943) 517. 
285 G. M. Sheldrick, Acta Cryst., A46 (1990) 467. 
286 G. M. Sheldrick, SHELXL-93, University of Gottingen, 1993. 
236 
